Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LDLR,Low-density lipoprotein receptor,42644,-0.218561752202834,0.00475739095087074,-0.22788623846654,-0.209237265939127,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFGE8,Lactadherin,42611,-0.181376248039955,0.0040535328152122,-0.189321172357771,-0.17343132372214,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PON3,Serum paraoxonase/lactonase 3,42676,0.104440201671784,0.0026991521493473,0.0991498634590634,0.109730539884505,1.11803703479048e-308
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOM,Apolipoprotein M,42663,0.102775203076809,0.00268067770226858,0.0975210747803621,0.108029331373255,2.51695247587288e-305
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGRP,Agouti-related protein,42754,-0.184522904130213,0.00491184162240787,-0.194150113710132,-0.174895694550293,6.52081632149797e-294
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42679,0.116394166907524,0.00314051891126869,0.110238749841437,0.12254958397361,2.05718682764308e-286
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS8,Prostasin,42568,-0.136347352580996,0.00403266215340112,-0.144251370401662,-0.128443334760329,1.5690312103852e-240
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPY,Pro-neuropeptide Y,42721,-0.208204666715006,0.00616971527827244,-0.22029730866042,-0.196112024769592,9.15107721853798e-240
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCG,Pro-glucagon,42346,-0.401235538406915,0.0121344744792625,-0.425019108386269,-0.377451968427561,2.16924082020728e-230
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS4,Galectin-4,42618,-0.179837676331601,0.00544746838267393,-0.190514714361642,-0.16916063830156,7.17410953226774e-230
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD4,T-cell surface glycoprotein CD4,42570,-0.0979386760251711,0.00297577175016449,-0.103771188655493,-0.0921061633948487,1.68260790772518e-228
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42611,0.103403835072276,0.00318171325098982,0.0971676771003359,0.109639993044216,4.29175519888529e-223
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,-0.104709828221757,0.00327795386650434,-0.111134617800105,-0.0982850386434084,8.41103066555234e-216
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRAP1,Proline-rich acidic protein 1,40527,-0.126123903064261,0.00399649087662312,-0.133957025182442,-0.118290780946079,1.35974972671664e-209
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASGR1,Asialoglycoprotein receptor 1,42495,-0.0910345153388113,0.00293658420632808,-0.0967902203832143,-0.0852788102944082,8.69089039735739e-204
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPR37,Prosaposin receptor GPR37,42357,-0.203426998099359,0.00661404721993217,-0.216390530650426,-0.190463465548292,1.14041101576424e-200
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GDF15,Growth/differentiation factor 15,42794,-0.137493987024154,0.00448147768568715,-0.1462776832881,-0.128710290760207,6.21011316757451e-200
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42721,-0.0946198751080887,0.00316702447908265,-0.100827243087091,-0.0884125071290867,5.48417475571612e-190
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42585,-0.155002482532865,0.00527706877367935,-0.165345537329276,-0.144659427736453,7.73114131607022e-184
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,-0.0952622295582452,0.00324882381936224,-0.101629924244195,-0.0888945348722952,3.1340681609335e-183
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RTN4R,Reticulon-4 receptor,42721,-0.0951104711984498,0.00333720517550202,-0.101651393342434,-0.0885695490544658,1.4911017005804e-173
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOS3,"Nitric oxide synthase, endothelial",42311,-0.151083420023192,0.00530941475937071,-0.161489872951559,-0.140676967094826,6.96955240924512e-173
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,42408,-0.13182290068315,0.00464379913429982,-0.140924746986378,-0.122721054379922,4.06147618044665e-172
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLTP,Phospholipid transfer protein,42752,0.0985006707885007,0.00347514153813219,0.0916893933737616,0.10531194820324,9.50712529046109e-172
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFASC,Neurofascin,42754,-0.0798376472682722,0.00281825290595585,-0.0853614229639456,-0.0743138715725987,1.44107886896765e-171
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42692,-0.0662929592173303,0.00235754269454413,-0.0709137428986368,-0.0616721755360238,4.03417070812505e-169
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADIPOQ,Adiponectin,40539,0.18892951699553,0.00672135892600954,0.175755653500552,0.202103380490509,4.05954722593311e-168
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPL,Lipoprotein lipase,42636,0.126677552921888,0.00452950908944097,0.117799715106583,0.135555390737192,2.40055947610252e-167
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,-0.111382280212406,0.00404000093236383,-0.11930068203984,-0.103463878384973,7.58168006811717e-163
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS9,Galectin-9,42620,-0.0860702453463889,0.00313855214347365,-0.0922218075475973,-0.0799186831451806,3.79362284341992e-161
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,-0.185501546119047,0.0067700105401225,-0.198770766777687,-0.172232325460407,7.07881282515982e-161
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,-0.0975537545191511,0.00358420267242295,-0.1045787917571,-0.0905287172812022,7.54818220889168e-159
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PYY,Peptide YY,40116,-0.271985298965535,0.00998133684221974,-0.291548719176286,-0.252421878754784,3.06627470987696e-158
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,-0.146233674987355,0.00540247704679611,-0.156822529999075,-0.135644819975635,4.45830963023604e-157
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOF,Apolipoprotein F,40532,0.0629285624811761,0.0023283326831156,0.0583650304222695,0.0674920945400827,5.79092808654463e-156
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOA1,Apolipoprotein A-I,40539,0.0716757889641663,0.00269690541225754,0.0663898543561416,0.0769617235721911,4.96113415794643e-151
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGF,Placenta growth factor,42754,-0.0681669771255805,0.00259210261596878,-0.0732474982528793,-0.0630864559982817,1.05008187287927e-148
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,-0.123242464148332,0.00469707058425984,-0.132448722493481,-0.114036205803182,5.68598274257764e-148
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42705,-0.119488026931858,0.00458258239547031,-0.12846988842698,-0.110506165436736,2.86685909682014e-146
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARB2,Lysosome membrane protein 2,42302,-0.0878234513523693,0.00341111612723473,-0.0945092389617494,-0.0811376637429892,1.20865052172709e-142
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,-0.0807754775884453,0.00315051954978767,-0.0869504959060291,-0.0746004592708615,1.40667788267992e-141
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,-0.0999872034234336,0.00391009040384594,-0.107650980614972,-0.0923234262318955,6.71957901178718e-141
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFNA4,Ephrin-A4,42475,-0.0845289857744778,0.0033112540832979,-0.0910190437777417,-0.0780389277712139,2.28541792493265e-140
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,-0.0964644334196172,0.00378910730641732,-0.103891083740195,-0.0890377830990393,1.22486682953942e-139
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN1,CCN family member 1,42569,-0.182537961359465,0.00717558440182991,-0.196602106787052,-0.168473815931879,1.89280819914096e-139
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGRN,Agrin,42676,-0.0899232018219548,0.00355313240791314,-0.0968873413414646,-0.0829590623024451,4.24121331569786e-138
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST3,Cystatin-C,42659,-0.0744420789763373,0.00295145224026124,-0.0802269253672493,-0.0686572325854252,3.41471970586449e-137
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPC2,NPC intracellular cholesterol transporter 2,40367,-0.0843569838896586,0.00335042515479924,-0.0909238171930651,-0.0777901505862521,4.16124443150532e-136
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MENT,Protein MENT,40283,0.0572070338622429,0.0022738560233381,0.0527502760565003,0.0616637916679856,7.04089661469671e-136
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGSF8,Immunoglobulin superfamily member 8,42636,-0.0748611905763015,0.00299681312961655,-0.0807349443103499,-0.068987436842253,1.15284518732422e-134
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBP5,Retinol-binding protein 5,42587,-0.135604285226995,0.00544792650745959,-0.146282221181616,-0.124926349272375,9.95477780221558e-134
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42711,-0.0853030057434171,0.00347020802255711,-0.092104613467629,-0.0785013980192051,1.43479439647005e-130
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRIP2,Cysteine-rich protein 2,42495,-0.0876608720553602,0.00356935858210258,-0.0946568148762813,-0.0806649292344392,2.68719493675e-130
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HGF,Hepatocyte growth factor,42754,-0.0834250092754619,0.00340055466901092,-0.0900900964267233,-0.0767599221242005,4.43295846028289e-130
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,-0.14028030724466,0.00572072575791559,-0.151492929730175,-0.129067684759146,6.54589815415085e-130
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,-0.176489493667946,0.00727086107918206,-0.190740381383143,-0.16223860595275,6.34328056868751e-127
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MVK,Mevalonate kinase,42370,-0.188516327338113,0.00778634896948101,-0.203777571318296,-0.173255083357931,9.76382780963971e-127
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCS1,Neuronal calcium sensor 1,42721,-0.0682031574455701,0.00282565899428123,-0.0737414490743613,-0.0626648658167789,4.6402069071671e-126
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42587,-0.191320682877273,0.00795707336483346,-0.206916546672347,-0.1757248190822,4.23018083598708e-125
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,-0.0944973814108127,0.00393323438607223,-0.102206520807514,-0.0867882420141111,6.43107805739745e-125
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,-0.0822561764329588,0.00343171967943973,-0.0889823470046607,-0.0755300058612569,2.27658451881927e-124
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,-0.0720186564618919,0.0030134163931888,-0.077924952592542,-0.0661123603312419,1.17348472199079e-123
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OCLN,Occludin,40482,-0.105833835904415,0.00442046056726281,-0.11449793861625,-0.0971697331925798,1.31523816071532e-123
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF23,Fibroblast growth factor 23,42711,-0.127138330860954,0.00532859990904651,-0.137582386682685,-0.116694275039223,2.79850571525364e-123
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,-0.0924545650602384,0.00386649768476752,-0.100032900522383,-0.0848762295980941,3.16851664415513e-123
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,-0.0893875525616515,0.00374823706663637,-0.0967340972122588,-0.0820410079110443,3.81976700330379e-123
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42547,-0.0657758103191921,0.00275842253572269,-0.0711823184892086,-0.0603693021491757,4.15244893897983e-123
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AREG,Amphiregulin,42587,-0.0986930255208984,0.00417784528130708,-0.10688160227226,-0.0905044487695366,6.53992641163833e-121
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,-0.0832373849690307,0.00353099608557104,-0.0901581372967499,-0.0763166326413114,1.97470571126652e-120
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL13,C-X-C motif chemokine 13,42711,-0.144351685770213,0.00612440776676329,-0.156355524993069,-0.132347846547357,2.07303684751742e-120
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL6A3,Collagen alpha-3(VI) chain,42794,-0.087726633391288,0.00372593989926238,-0.0950294755938423,-0.0804237911887338,3.54054015473355e-120
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMPRSS15,Enteropeptidase,42587,-0.210228587866805,0.00893281363192201,-0.227736902585372,-0.192720273148238,4.8701787111559e-120
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTSL2,ADAMTS-like protein 2,40527,-0.0790191790177106,0.00335329451490438,-0.0855916362669231,-0.072446721768498,6.6083566529349e-120
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,-0.127890741997577,0.00544242685372384,-0.138557898630875,-0.117223585364278,1.19717611184089e-119
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF1,Macrophage colony-stimulating factor 1,42676,-0.064179533249376,0.00273247585352884,-0.0695351859222925,-0.0588238805764595,1.35256615896783e-119
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL23,C-C motif chemokine 23,42676,-0.0964539648094106,0.00411084557421054,-0.104511222134863,-0.0883967074839579,2.34711241979432e-119
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MUC13,Mucin-13,42311,-0.119967696224285,0.00511262490363037,-0.1299884410354,-0.109946951413169,2.62089735709465e-119
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTH,Parathyroid hormone,40182,-0.188438216919575,0.00804150972509697,-0.204199575980765,-0.172676857858385,1.53804116580218e-118
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,-0.0729157194674091,0.00312143628584864,-0.0790337345876724,-0.0667977043471458,2.46169855026316e-118
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOC1,Apolipoprotein C-I,40516,0.0847259574156751,0.00362688409320453,0.0776172645929942,0.091834650238356,6.45214604156561e-118
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL15,C-C motif chemokine 15,42794,-0.102344014095546,0.00439059171568711,-0.110949573858293,-0.0937384543327991,7.10146582684667e-118
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIGR,Polymeric immunoglobulin receptor,42464,-0.0811803020990774,0.0035015728047236,-0.0880433847963357,-0.0743172194018191,1.35101663155334e-116
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFF3,Trefoil factor 3,42613,-0.0978922003464917,0.00422993971973955,-0.106182882197181,-0.0896015184958022,3.20268368004344e-116
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,-0.103953500297797,0.00451032157938961,-0.112793730593401,-0.0951132700021938,2.89505712953097e-115
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,-0.145048016221986,0.00631437082314697,-0.157424183035354,-0.132671849408618,1.60328339145916e-114
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,-0.0985056977102758,0.00429033709467175,-0.106914758415832,-0.0900966370047192,1.87335334115109e-114
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMBP,Protein AMBP,42706,-0.0469427176829574,0.00205139944825494,-0.0509634606015371,-0.0429219747643777,9.77300133002974e-114
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD5,T-cell surface glycoprotein CD5,42706,-0.0808665975615596,0.00353457530624794,-0.0877943651618056,-0.0739388299613137,1.08015760822695e-113
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42611,-0.102255544260194,0.00447410892558042,-0.111024797754331,-0.0934862907660559,1.88834939894691e-113
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42587,-0.180031016308351,0.00790391207466519,-0.195522683974695,-0.164539348642007,1.04817654112639e-112
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOD,Apolipoprotein D,40033,0.0975740290249737,0.0042786676595069,0.0891878404123402,0.105960217637607,1.77714512909125e-112
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFRA1,GDNF family receptor alpha-1,42689,-0.0656253690542454,0.00291384805739884,-0.0713365112467471,-0.0599142268617437,2.69917893372888e-110
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPY30,Protein dpy-30 homolog,42651,-0.131775497707684,0.00590027202636709,-0.143340030879364,-0.120210964536005,1.60827303558065e-108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL16,C-C motif chemokine 16,42794,-0.114389410333652,0.00512422074830077,-0.124432883000322,-0.104345937666983,1.92655859834973e-108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPT2,Angiopoietin-2,42721,-0.0825707233521131,0.00371159991876595,-0.0898454591928944,-0.0752959875113318,1.02725185073224e-107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD72,B-cell differentiation antigen CD72,40283,-0.0972429613554631,0.00437496924732056,-0.105817901080211,-0.0886680216307148,4.02064144565751e-107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42562,-0.153178470500818,0.00692651542430011,-0.166754440732446,-0.13960250026919,1.82702074309526e-106
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42794,-0.111005612990412,0.00503534424882554,-0.12087488771811,-0.101136338262714,7.49523882516263e-106
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFR2,Fibroblast growth factor receptor 2,42679,-0.0482501403740184,0.0021927507471203,-0.0525479318383741,-0.0439523489096626,1.85604667769035e-105
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MXRA8,Matrix remodeling-associated protein 8,40283,0.0678059455510059,0.00307630169906851,0.0617763942208316,0.0738354968811802,2.07805969381831e-105
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL27,C-C motif chemokine 27,42636,-0.127133517256467,0.00578901361875202,-0.138479983949221,-0.115787050563713,4.71496560265807e-105
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGAV,Integrin alpha-V,42721,0.0352768704309499,0.00161019087675217,0.0321208963125156,0.0384328445493841,1.40497016234906e-104
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD27,CD27 antigen,42679,-0.0952358954084952,0.00435110979006509,-0.103764070597023,-0.0867077202199676,2.21000178408079e-104
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSO,Cathepsin O,42754,-0.0659186357142858,0.00301584958645678,-0.0718297009037411,-0.0600075705248305,4.10587224862192e-104
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,-0.0643011863022425,0.00295066839301041,-0.0700844963525429,-0.0585178762519421,1.70329764917213e-103
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSD,Cathepsin D,41747,-0.0896866566060884,0.0041318183347383,-0.0977850205421755,-0.0815882926700014,1.36007991240578e-102
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGSF9,Protein turtle homolog A,40511,-0.177478387376678,0.00816853573702595,-0.193488717421248,-0.161468057332107,1.39767154784748e-102
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL18R1,Interleukin-18 receptor 1,42754,-0.0701961904225582,0.00323763272438416,-0.0765419505623511,-0.0638504302827652,1.67953434324699e-102
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REN,Renin,42636,-0.182509511445037,0.00842666341112341,-0.199025771730839,-0.165993251159235,2.8020874039313e-102
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UPB1,Beta-ureidopropionase,40511,-0.191395652279327,0.0088526720581875,-0.208746889513375,-0.17404441504528,1.30092311774303e-101
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTRK3,NT-3 growth factor receptor,42711,0.0461579679711294,0.00213902760433218,0.0419654738666384,0.0503504620756205,1.4526534554721e-101
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL18BP,Interleukin-18-binding protein,42689,-0.0686817343405841,0.00318276876539873,-0.0749199611207656,-0.0624435075604026,1.45290733902748e-101
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGSF3,Immunoglobulin superfamily member 3,42587,-0.076680390791503,0.00355617748798019,-0.0836504986679442,-0.0697102829150619,2.11874894840702e-101
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP1,"Fatty acid-binding protein, liver",42618,-0.199605308451947,0.00928967573103599,-0.217813072884777,-0.181397544019116,1.01999256722811e-100
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42555,-0.0689107726070376,0.00321749652036955,-0.0752170657869619,-0.0626044794271133,4.38209744314918e-100
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300E,CMRF35-like molecule 2,42677,-0.0905388148404073,0.00425230491534783,-0.0988733324744891,-0.0822042972063256,5.72658531887274e-99
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL12A_IL12B,Interleukin-12,42587,-0.171487417527867,0.00806163750690333,-0.187288227041398,-0.155686608014337,8.80701234178595e-99
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE6,Ribonuclease K6,40468,-0.0717360365022005,0.00337139398507421,-0.078343968712946,-0.0651281042914551,1.55432305262071e-98
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASET2,Ribonuclease T2,42749,-0.057788083514573,0.00272126104811191,-0.0631217551688724,-0.0524544118602737,1.77979712484333e-98
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NHLRC3,NHL repeat-containing protein 3,40013,-0.0675590130028536,0.00318626041642363,-0.0738040834190439,-0.0613139425866633,8.5679038234636e-98
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HLA_E,,42594,-0.0640331113239574,0.00302969858819946,-0.0699713205568283,-0.0580949020910865,1.46670489999493e-97
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41948,-0.0904473567256601,0.00430268370849967,-0.0988806167943195,-0.0820140966570008,1.80148933343897e-96
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42611,-0.0758584602308629,0.00361124874093162,-0.0829365077630889,-0.0687804126986369,2.0391607012516e-96
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACE2,Angiotensin-converting enzyme 2,42357,-0.111163406971009,0.00529690827236895,-0.121545347184852,-0.100781466757166,3.25677981439536e-96
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,-0.0933551189636053,0.00445366328880425,-0.102084299009662,-0.084625938917549,5.22604970631619e-96
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,-0.0864023891442967,0.00413611353127913,-0.0945091716656038,-0.0782956066229896,4.12814397565998e-95
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE4,Ribonuclease 4,40169,-0.0601256578596286,0.00289323466956471,-0.0657963978119754,-0.0544549179072817,4.07852148156581e-94
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COLEC12,Collectin-12,42618,-0.0572416267547045,0.00276062075953887,-0.0626524434434007,-0.0518308100660083,4.94457433038278e-94
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMP1,Metalloproteinase inhibitor 1,42501,-0.0597478543867362,0.00288132866703842,-0.0653952585741315,-0.0541004501993409,4.97332039467685e-94
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL3,C-C motif chemokine 3,42594,-0.116725090663034,0.00564720077721821,-0.127793604186382,-0.105656577139686,1.85674628166828e-93
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,42346,-0.0764713730660222,0.00370001267985942,-0.0837233979185467,-0.0692193482134977,2.04294775495087e-93
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXNB2,Plexin-B2,42743,-0.0491335693052969,0.00238023678509951,-0.0537988334040919,-0.0444683052065019,3.09443695213773e-93
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSC2,Desmocollin-2,42488,-0.0717442270686875,0.0034832422465794,-0.0785713818719831,-0.0649170722653919,8.16199814544925e-93
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,-0.0816278790222363,0.00397812776431087,-0.0894250094402856,-0.073830748604187,3.63078745042857e-92
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGA11,Integrin alpha-11,42594,0.0685391835901268,0.00334007683817318,0.0619926329873074,0.0750857341929463,3.68344779686832e-92
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,-0.0966870155682475,0.00472126500263521,-0.105940694973413,-0.0874333361630825,8.06234766543508e-92
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GZMA,Granzyme A,42754,-0.0714731141219213,0.00349561282023905,-0.0783245152495898,-0.0646217129942527,1.54012082250858e-91
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL12B,Interleukin-12 subunit beta,42754,-0.114034748312829,0.00558523143761577,-0.124981801930556,-0.103087694695102,2.75808358674725e-91
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA3F,Semaphorin-3F,42636,-0.0545707155438398,0.00267281499122475,-0.0598094329266403,-0.0493319981610393,2.84796253563967e-91
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLUL1,Clusterin-like protein 1,42621,0.0902499609097823,0.00442234835337804,0.0815821581371613,0.0989177636824033,3.43335081636492e-91
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,-0.100307434645684,0.00491209420959918,-0.109935139296498,-0.0906797299948696,5.1302284548298e-91
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NECTIN2,Nectin-2,42613,-0.063383311659334,0.00311116503803598,-0.0694811951338846,-0.0572854281847835,6.86350139816841e-91
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XCL1,Lymphotactin,42721,-0.112386148696713,0.00552325700968571,-0.123211732435697,-0.101560564957729,1.09962257115941e-90
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCG2,Secretogranin-2,42636,-0.0684072466395644,0.00336771325734836,-0.0750079646239671,-0.0618065286551616,2.24553703633953e-90
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACY1,Aminoacylase-1,42636,-0.120897733664462,0.00595188293661114,-0.13256342422022,-0.109232043108704,2.252238648533e-90
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHISA5,Protein shisa-5,40527,-0.0556247917021577,0.00275286963896957,-0.0610204161945381,-0.0502291672097773,3.19419600077085e-89
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,0.0782495577836774,0.00387873216127217,0.0706472427475839,0.0858518728197708,3.4774838173996e-89
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CES1,Liver carboxylesterase 1,42661,-0.160438638780327,0.00796532208653393,-0.176050670069934,-0.144826607490721,6.40113167420152e-89
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,-0.161380174792175,0.00802370438993419,-0.177106635396446,-0.145653714187904,1.21395444578669e-88
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42594,-0.0770166915565911,0.00383575127712806,-0.0845347640597622,-0.0694986190534201,2.25059086779652e-88
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,-0.11292089652595,0.00562107603110643,-0.123938205546918,-0.101903587504981,3.21759008727311e-88
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP12,Macrophage metalloelastase,42592,-0.11040467617848,0.00552713461489098,-0.121237860023666,-0.0995714923332936,1.6969628793717e-87
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB6A,Ras-related protein Rab-6A,42594,0.0899165572061198,0.00452046842642004,0.0810564390903365,0.0987766753219031,8.66726006812363e-87
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CKAP4,Cytoskeleton-associated protein 4,42713,-0.0567706352987004,0.00285522392688517,-0.0623668741953953,-0.0511743964020055,9.85357869799621e-87
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FURIN,Furin,42679,-0.0634565776212022,0.00320494896686763,-0.0697382775962628,-0.0571748776461417,4.98506461364902e-86
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELN,Elastin,40511,-0.0718649418127204,0.00362685408701681,-0.0789735758232734,-0.0647563078021675,6.31190426858006e-86
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL9,C-X-C motif chemokine 9,42676,-0.13234002974357,0.00668891544956307,-0.145450304024713,-0.119229755462426,6.60790841279316e-86
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,-0.0687487081995605,0.00347694913048418,-0.0755635284953095,-0.0619338879038115,8.51133733604327e-86
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD80,T-lymphocyte activation antigen CD80,40511,-0.0682089056412475,0.00345436380764818,-0.0749794587042379,-0.061438352578257,2.36688869590305e-85
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,42477,-0.290958676553363,0.0147613800104573,-0.319890981373859,-0.262026371732866,2.86747140250908e-85
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B2M,Beta-2-microglobulin,40539,-0.0611760421056584,0.00310941545071358,-0.067270496389057,-0.0550815878222597,9.16440497921367e-85
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42676,-0.0583218867360201,0.00297031494512772,-0.0641437040284705,-0.0525000694435698,1.17971587854347e-84
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFA,Protransforming growth factor alpha,42594,-0.0912631403808303,0.00467095891464056,-0.100418219853526,-0.0821080609081348,7.56760407850032e-84
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD302,CD302 antigen,42587,-0.061804432974176,0.00316410681107799,-0.0680060823238889,-0.0556027836244632,8.4047415276299e-84
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42706,-0.127276935814649,0.00653189936522879,-0.140079458570497,-0.1144744130588,2.02877158261063e-83
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPPC,C-type natriuretic peptide,42594,-0.0960302888360115,0.0049359250189186,-0.105704701873092,-0.086355875798931,3.66832443528889e-83
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42636,-0.0665164868528777,0.00342449480094323,-0.0732284966627264,-0.0598044770430289,6.62924922105588e-83
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM3B,Protein FAM3B,42587,-0.0672974386335699,0.00348277095755809,-0.0741236697103838,-0.0604712075567561,4.49299279901458e-82
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KITLG,Kit ligand,42636,0.0714755576009294,0.00370750959897462,0.0642088387869391,0.0787422764149196,1.02656447920246e-81
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4A,C-type lectin domain family 4 member A,42594,0.0666826781853007,0.00346532303094237,0.0598906450446536,0.0734747113259478,2.02531483156228e-81
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,-0.0887354151683048,0.0046048875575435,-0.0977609947810901,-0.0797098355555196,2.05048932922423e-81
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,-0.143241191391015,0.00744528024245204,-0.157833940666221,-0.128648442115809,3.44238832771395e-81
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL10,C-X-C motif chemokine 10,42676,-0.128068916988396,0.00666979746339279,-0.141141720016646,-0.114996113960146,4.34772979081156e-81
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADA2,Adenosine deaminase 2,42572,-0.0840106024049813,0.00438809100622252,-0.0926112607771774,-0.0754099440327851,1.26784335514085e-80
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHI3L1,Chitinase-3-like protein 1,42416,-0.155115043499911,0.0081447914704792,-0.17107883478205,-0.139151252217771,8.47945575641075e-80
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHA2,Ephrin type-A receptor 2,42125,-0.0630034344463112,0.00333431773097804,-0.0695386971990282,-0.0564681716935943,1.4173993224112e-78
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHA1,Ephrin type-A receptor 1,42658,-0.0615175772133248,0.00325737130840875,-0.0679020249778059,-0.0551331294488436,1.54493478615337e-78
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UMOD,Uromodulin,42764,0.102675536551474,0.00545285485531594,0.0919879410350551,0.113363132067894,4.2562124460145e-78
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ULBP2,UL16-binding protein 2,42495,-0.0741907891965957,0.00394090594415074,-0.0819149648471311,-0.0664666135460603,4.78233527827576e-78
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42594,-0.0701590475878838,0.00374332345113325,-0.0774959615521049,-0.0628221336236626,2.17189428952784e-77
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42733,-0.0579576079005029,0.00310211492978799,-0.0640377531628873,-0.0518774626381184,6.26783655232688e-77
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FSTL3,Follistatin-related protein 3,42574,-0.0625027817142928,0.0033453760126128,-0.0690597186990139,-0.0559458447295717,6.42356848634051e-77
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGR2,Anterior gradient protein 2 homolog,42215,-0.186937778147243,0.010006853899169,-0.206551211789614,-0.167324344504872,7.1279788803873e-77
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300C,CMRF35-like molecule 6,42711,-0.0661070100279407,0.00354647476788226,-0.07305810057299,-0.0591559194828915,1.37975501193062e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL21,C-C motif chemokine 21,42676,-0.0777222918417245,0.00417370991085976,-0.0859027632670096,-0.0695418204164393,1.93760010874497e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MME,Neprilysin,42587,-0.149143429103967,0.00800876936887947,-0.164840617066971,-0.133446241140963,1.94283440812006e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42594,-0.0951004341474577,0.00511568019538514,-0.105127167330413,-0.0850737009645028,3.50666860765584e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAYN,Layilin,42476,-0.0692489657875942,0.00373083664044345,-0.0765614056028634,-0.061936525972325,6.0245655655494e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,-0.0515190816594892,0.00278117411201858,-0.0569701829190456,-0.0460679803999328,1.1410311135009e-75
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,-0.100809558149393,0.00544150851672049,-0.111474914842165,-0.0901442014566209,1.18397221641126e-75
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL17,C-X-C motif chemokine 17,42754,-0.0741041812364511,0.00400226936755353,-0.081948629196856,-0.0662597332760462,1.31972017652084e-75
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,-0.051697328775083,0.00279566633163984,-0.057176834785097,-0.0462178227650689,2.04727969228745e-75
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG4,Regenerating islet-derived protein 4,42638,-0.0961850060923047,0.00520639860340893,-0.106389547354986,-0.0859804648296232,2.82941953898001e-75
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42594,-0.126479900393721,0.00684994942065881,-0.139905801258212,-0.11305399952923,3.41486467971377e-75
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD160,CD160 antigen,42754,-0.0893609154803566,0.00484708856238066,-0.0988612090626227,-0.0798606218980905,5.55732898534685e-75
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNF,Tumor necrosis factor,42339,-0.070253320246932,0.00381265846781653,-0.0777261308438524,-0.0627805096500116,7.06149829268264e-75
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INHBC,Inhibin beta C chain,42611,-0.0742581655679318,0.00403531122803332,-0.0821673755748771,-0.0663489555609865,1.04658706281302e-74
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCLY,Selenocysteine lyase,42674,-0.0846190604093414,0.0046042117632693,-0.0936433154653492,-0.0755948053533335,1.58110987089925e-74
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSTB,Cystatin-B,42437,-0.0771808437214018,0.00420230124168386,-0.0854173541551022,-0.0689443332877015,2.04591667581438e-74
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUOM,Fucose mutarotase,40283,-0.115329679512255,0.0062803662338114,-0.127639197330525,-0.103020161693984,3.22356127097003e-74
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,-0.0534188159182301,0.00290933277981751,-0.0591211081666725,-0.0477165236697878,3.24042631498198e-74
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLL1,Delta-like protein 1,42679,-0.0569604525145069,0.00310827801977459,-0.0630526774332651,-0.0508682275957487,4.10824046861414e-74
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BMPER,BMP-binding endothelial regulator protein,40283,-0.0422390895641715,0.00230583476265613,-0.0467585256989775,-0.0377196534293655,7.22147110385577e-74
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42676,-0.0507351806426333,0.00277374258651809,-0.0561717161122087,-0.0452986451730578,7.58103846752184e-74
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42618,-0.0493038043684107,0.0027078971050014,-0.0546112826942134,-0.0439963260426079,3.4175089991648e-73
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE1,Ribonuclease pancreatic,40532,-0.0479103338873125,0.00262998973064886,-0.0530651137593842,-0.0427555540152407,4.16072407332478e-73
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM3C,Protein FAM3C,42613,-0.0559828796189033,0.00307856693406687,-0.0620168708096743,-0.0499488884281322,5.12359294899424e-73
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,-0.106302519700206,0.00585502855330391,-0.117778375664682,-0.0948266637357302,8.60836712608663e-73
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRPB1,Signal-regulatory protein beta-1,42600,-0.0865048270067082,0.00477114010867986,-0.0958562616197207,-0.0771533923936957,1.33744259561187e-72
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42636,0.0485674021638815,0.00267885475186361,0.0433168468502288,0.0538179574775342,1.35276291257089e-72
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGFR,Epidermal growth factor receptor,42794,0.0292292596582625,0.00161250469483632,0.0260687504563833,0.0323897688601417,1.40194407095351e-72
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,-0.0734688808281778,0.00406399039991603,-0.0814343020120133,-0.0655034596443424,3.35330419553466e-72
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,-0.0619789396783253,0.00344251123753082,-0.0687262617038857,-0.0552316176527649,1.24041572997794e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD83,CD83 antigen,42594,-0.0627418079991589,0.00348737604477868,-0.0695770650469252,-0.0559065509513927,1.58441446764289e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42636,-0.0666658629811605,0.00370584234614563,-0.073929313979606,-0.0594024119827151,1.62366942253276e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF21,Fibroblast growth factor 21,42689,-0.20753087244097,0.0115479201174368,-0.230164795871146,-0.184896949010794,2.21745322822138e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LSP1,Lymphocyte-specific protein 1,42594,-0.0703450475774458,0.00391758465559348,-0.078023513502409,-0.0626665816524826,2.92849686619554e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRELD1,Protein disulfide isomerase CRELD1,40283,-0.0675341041857472,0.00375691978448722,-0.0748976669633422,-0.0601705414081523,3.07204609933399e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLA,Alpha-galactosidase A,40267,-0.0664387639830383,0.00369910816896402,-0.0736890159942078,-0.0591885119718689,4.02025618010225e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42595,-0.057330272809134,0.00320482743400864,-0.063611734579791,-0.0510488110384771,9.57872413921112e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPY,Pancreatic prohormone,42600,-0.182528592265633,0.0102081732753568,-0.202536611885332,-0.162520572645933,1.10301368932451e-70
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL16,Pro-interleukin-16,42754,-0.0725592488552927,0.00407372521367971,-0.080543750274105,-0.0645747474364805,3.61728812378917e-70
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THBS2,Thrombospondin-2,42611,-0.068127002616485,0.00383301875173005,-0.0756397193698759,-0.0606142858630941,7.12908236341806e-70
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUCB2,Nucleobindin-2,42683,-0.064656918527021,0.00364055578604031,-0.07179240786766,-0.057521429186382,8.93825757195723e-70
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGBL1,Integrin beta-like protein 1,40527,-0.0686039920723285,0.00386273937263383,-0.0761749612426908,-0.0610330229019662,1.25150570118516e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL2,Angiopoietin-related protein 2,42640,-0.0703098922326371,0.0039642444009632,-0.078079811258525,-0.0625399732067493,1.36873487386836e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTA1,Glutathione S-transferase A1,42611,-0.144278917013362,0.00813648781630318,-0.160226433133316,-0.128331400893408,1.4648201213715e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,-0.0612785696606879,0.00345730434606242,-0.0680548861789703,-0.0545022531424056,1.67638687001112e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,-0.142750612025511,0.00805541819229282,-0.158539231682405,-0.126961992368617,1.84707718838243e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADM,Pro-adrenomedullin,42721,-0.0469581016854258,0.00265065545706181,-0.0521533863812669,-0.0417628169895847,1.92881057342959e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,-0.161317808344473,0.0091469284711529,-0.179245788147932,-0.143389828541013,8.01144515992714e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,-0.0536917654761087,0.00304821945097466,-0.059666275600019,-0.0477172553521984,1.12482678233671e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,-0.0977168406803222,0.00554912194034349,-0.108593119683395,-0.0868405616772489,1.83424181125839e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,42240,-0.0701840111616819,0.00399592611713755,-0.0780160263512715,-0.0623519959720923,2.83738974301644e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPM,Carboxypeptidase M,42655,-0.0581605180698741,0.00332291830146897,-0.0646734379407533,-0.0516475981989949,7.67419726715971e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL20,C-C motif chemokine 20,42754,-0.158467567312616,0.009061619257989,-0.176228341058275,-0.140706793566958,9.81642138459186e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,-0.0478842839354348,0.00273842602259631,-0.0532515989397235,-0.042516968931146,1.02085509224966e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC6A,C-type lectin domain family 6 member A,42346,-0.0822975647301202,0.00471318225528333,-0.0915354019504756,-0.0730597275097649,1.63227108951909e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40462,-0.147954765001939,0.00847938394606132,-0.164574357536219,-0.131335172467658,2.68805128070051e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,42476,-0.125631212331079,0.00724836940369287,-0.139838016362317,-0.111424408299841,1.44564540365537e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFNA1,Ephrin-A1,42590,-0.051844433195175,0.00299339666720214,-0.0577114906628912,-0.0459773757274588,1.77014132292115e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSL,Cathepsin L1,42636,-0.0424440530920073,0.00245706030654645,-0.0472598912928384,-0.0376282148911763,3.7965483757846e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,-0.0734501151848289,0.00425330512494644,-0.081786593229724,-0.0651136371399339,4.17112181374895e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PON1,Serum paraoxonase/arylesterase 1,40532,0.0470494437992878,0.00272337928505386,0.0417116204005822,0.0523872671979934,4.96936301579777e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,-0.0602290628955955,0.00349172394216337,-0.0670728418222357,-0.0533852839689553,5.85624017373227e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFBR2,TGF-beta receptor type-2,42679,-0.061156321111611,0.00354754939526898,-0.0681095179263382,-0.0542031242968838,6.86712034600072e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SULT2A1,Bile salt sulfotransferase,42594,-0.0953347482125595,0.00553494877936739,-0.10618324782012,-0.0844862486049994,8.9241374130277e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD59,CD59 glycoprotein,42130,-0.0426474268183808,0.00248330113472373,-0.0475146970424393,-0.0377801565943223,2.21451569153409e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PALM2,Paralemmin-2,40483,-0.0644391780029329,0.00374946317217688,-0.0717881258203996,-0.0570902301854662,2.2777245380329e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHBG,Sex hormone-binding globulin,40532,0.0862774645338764,0.00502233356931015,0.0764336907380285,0.0961212383297243,2.56190834660403e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM20A,Pseudokinase FAM20A,40511,-0.048162088927655,0.00280479220581224,-0.053659481651047,-0.042664696204263,2.91116803277234e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGLN1,Egl nine homolog 1,42594,-0.0937285756914841,0.00546716454677491,-0.104444218203163,-0.0830129331798053,3.45461477905594e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KYNU,Kynureninase,42754,-0.0751880137437207,0.00438789604210056,-0.0837882899862378,-0.0665877375012036,3.91829324887302e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNCG,Gamma-synuclein,42495,-0.116375691357722,0.00679258640380066,-0.129689160709171,-0.103062222006272,4.217264104981e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD48,CD48 antigen,42654,-0.0525558436798621,0.00307375550166359,-0.0585804044631228,-0.0465312828966015,7.39155576218192e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPO,Erythropoietin,42594,-0.124945829263904,0.0073089144799091,-0.139271301644525,-0.110620356883282,7.8618469792031e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA6,Carbonic anhydrase 6,42581,0.105560082939387,0.00617512183534024,0.0934568441421198,0.117663321736654,7.95056107811328e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEG1,Protein HEG homolog 1,40283,-0.0458659609553456,0.00268292702885923,-0.0511244979319097,-0.0406074239787815,1.07782358831346e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DKK4,Dickkopf-related protein 4,42477,-0.0781230024760545,0.00458141560352851,-0.0871025770589703,-0.0691434278931386,1.63442201591822e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,-0.0653240347740605,0.00384093911543116,-0.0728522754403056,-0.0577957941078154,3.50344813825265e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4D,C-type lectin domain family 4 member D,42594,-0.104506976424761,0.00615290498201001,-0.1165666701895,-0.0924472826600209,4.95561308389796e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42566,-0.064990961519923,0.00382979065811755,-0.0724973512098334,-0.0574845718300126,6.39867082093868e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALCA,Calcitonin,42476,-0.105625845718736,0.00623682324989948,-0.117850019288539,-0.0934016721489328,1.13886031750724e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THY1,Thy-1 membrane glycoprotein,42711,-0.0504531349218442,0.00298005015308005,-0.0562940332218811,-0.0446122366218073,1.2164196167896e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,-0.0987842473581166,0.00583988873047462,-0.110230429269847,-0.0873380654463864,1.62291992986295e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,-0.057474200052609,0.00340122437651208,-0.0641405998305726,-0.0508078002746453,2.07532699134034e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEPH,Hephaestin,40511,-0.0445182665889529,0.00263431718724422,-0.0496815282759516,-0.0393550049019543,2.70907789433228e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH2,Cadherin-2,42636,-0.0593514652810931,0.00351579558677068,-0.0662424246311636,-0.0524605059310226,2.76453343656832e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC1,Sialoadhesin,42676,-0.0722108394895664,0.00428260493437138,-0.0806047451609343,-0.0638169338181985,3.83127461097828e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSR1,Macrophage scavenger receptor types I and II,42711,-0.0767429728885446,0.00455503703628008,-0.0856708454796535,-0.0678151002974356,4.77270878527185e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,-0.0701492970098082,0.00417577628986196,-0.0783338185379376,-0.0619647754816787,1.07271796323082e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OGN,Mimecan,42611,-0.0735636219385349,0.00438212206533752,-0.0821525811865964,-0.0649746626904734,1.31630719873809e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEL1L,Protein sel-1 homolog 1,40223,-0.0545873807769054,0.00324852668198626,-0.0609544930735985,-0.0482202684802124,1.37198671938315e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BPIFB1,BPI fold-containing family B member 1,42573,0.103422677597459,0.00618211926981764,0.0913057238286168,0.115539631366302,3.42978484508713e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42594,-0.105844845588989,0.00634612838948803,-0.118283257232385,-0.0934064339455923,7.86496757656397e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42587,-0.142429920403298,0.00854169633915771,-0.159171645228047,-0.125688195578549,8.40209621691184e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,-0.0713931998785911,0.00428689696382231,-0.0797955179276829,-0.0629908818294994,1.16978086832145e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL7,Angiopoietin-related protein 7,42721,-0.0598314566286937,0.00359585242273486,-0.0668793273772541,-0.0527835858801334,1.48553506662844e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40482,-0.0666399089014063,0.00400282432948173,-0.0744854445871905,-0.0587943732156221,1.68283844935822e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,-0.072319378247854,0.00434924845913118,-0.0808439052277511,-0.0637948512679569,1.80327756184415e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300LG,CMRF35-like molecule 9,42611,0.0630022337204502,0.00379610856710001,0.0555618609289342,0.0704426065119662,3.00856296723095e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL7,C-C motif chemokine 7,42594,-0.0967723482336515,0.00584110772696507,-0.108220919378503,-0.0853237770887999,4.84141452205062e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100P,Protein S100-P,42357,-0.0896504399913725,0.00541376562390084,-0.100261420614218,-0.0790394593685268,5.63019321524595e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGR3,Anterior gradient protein 3,42326,-0.0976895378078923,0.00591860960255825,-0.109290012628906,-0.0860890629868781,1.36392182354546e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42663,0.0490474923779402,0.00298453733859693,0.0431977991942902,0.0548971855615902,4.2046945409855e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STC1,Stanniocalcin-1,42711,-0.0733207107854502,0.00446341235320647,-0.0820689989977349,-0.0645724225731655,4.67238517156067e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH17,Protocadherin-17,42636,-0.0605591452093137,0.00369592277365494,-0.0678031538456774,-0.05331513657295,9.22194290248318e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELE,E-selectin,42794,-0.0820863777058922,0.0050224925430599,-0.0919304630902896,-0.0722422923214947,1.77614535581126e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40483,-0.0501628863052452,0.00308497552006046,-0.0562094383245637,-0.0441163342859267,8.75948600458367e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSS,Cathepsin S,39872,-0.0391704699267238,0.00240924725295255,-0.0438925945425108,-0.0344483453109368,9.85950704563508e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL18,Interleukin-18,42566,-0.074604487466105,0.00459916500363987,-0.0836188508732391,-0.0655901240589708,1.29179073518776e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HAO1,Hydroxyacid oxidase 1,42721,-0.199518179007166,0.0123508992674273,-0.223725941571323,-0.175310416443008,3.71419682262897e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GOLM2,Protein GOLM2,42711,-0.0368037226433366,0.00227960599655822,-0.0412717503965907,-0.0323356948900825,4.31488621149369e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PXN,Paxillin,42311,-0.0815168300375658,0.00505727241431751,-0.0914290839696281,-0.0716045761055035,6.77444880648028e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,-0.071364423123554,0.00442874903204211,-0.0800447712263566,-0.0626840750207515,9.31229895216443e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS2,Trypsin-2,42689,-0.0889087588486964,0.0055323427168826,-0.0997521505737863,-0.0780653671236065,1.39965873307516e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFF2,Trefoil factor 2,42654,-0.0928290643175743,0.0057778755063837,-0.104153700310086,-0.0815044283250622,1.50601372328311e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,42351,-0.0874132963106685,0.00545356242458572,-0.0981022786628565,-0.0767243139584805,2.80704793394737e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LMNB2,Lamin-B2,40483,-0.0458068417173009,0.00285635263539894,-0.0514052928826828,-0.040208390551919,3.02515867400858e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,-0.105601048360999,0.00659846802543565,-0.118534045690852,-0.0926680510311447,5.09997264485479e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42660,-0.0837302050570176,0.00524687479875063,-0.0940140796625688,-0.0734463304514664,8.2933151017472e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,-0.0550837932846031,0.00345734836019158,-0.0618601960705786,-0.0483073904986276,1.24483603913941e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42681,-0.0431267309209477,0.00270849618252797,-0.0484353834387025,-0.0378180784031928,1.44235472793078e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,-0.0536405283457039,0.00336983225275389,-0.0602453995611015,-0.0470356571303062,1.57033492683415e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C9,Complement component C9,40532,0.0841461902211303,0.00528711722343279,0.0737834404632021,0.0945089399790586,2.02182301214175e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD274,Programmed cell death 1 ligand 1,42495,-0.0549339950626123,0.00346183546283975,-0.0617191925697782,-0.0481487975554463,3.43155075230561e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCD1,Programmed cell death protein 1,42689,-0.0706504937009787,0.00446491894821302,-0.0794017348394762,-0.0618992525624811,6.81324615887449e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFF1,Trefoil factor 1,42556,-0.129521354550323,0.00820635811844584,-0.145605816462476,-0.113436892638169,1.29322849892152e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42770,0.187556584201213,0.0119029850607412,0.16422673348216,0.210886434920265,1.90127781091507e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWC2,Brorin,42456,-0.0641116678103883,0.00407108484784839,-0.0720909941121712,-0.0561323415086055,2.24671213894926e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IMMT,MICOS complex subunit MIC60,40451,-0.0708928519216836,0.00450141776640935,-0.0797156307438459,-0.0620700730995213,2.71127375081308e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42580,-0.0319420054954071,0.00203121496527567,-0.0359231868273474,-0.0279608241634668,3.15115017615634e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,-0.0659731719960359,0.00419651485866286,-0.0741983411190151,-0.0577480028730567,3.45020586973488e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OXT,Oxytocin-neurophysin 1,42711,-0.214644936557219,0.013671132375716,-0.241440356013623,-0.187849517100816,4.58933124642486e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM1,Intercellular adhesion molecule 1,42595,-0.0453744613157077,0.00289377959253638,-0.051046269317079,-0.0397026533143364,6.37216807516837e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP7,Matrilysin,42333,-0.0786886341188369,0.00501888422271719,-0.0885256471953626,-0.0688516210423112,6.66619417261449e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN5,CCN family member 5,42611,-0.0598093868227849,0.00382144345675956,-0.0672994159980336,-0.0523193576475361,9.96066972892785e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,-0.162501440374782,0.0103827931183477,-0.182851714886744,-0.142151165862821,9.9881943739402e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42746,-0.0588852725022297,0.00376293714323038,-0.0662606293029613,-0.0515099157014982,1.01987891322528e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,-0.0790328719444467,0.00505890380266111,-0.0889483233976625,-0.0691174204912309,1.5792722819065e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRD1,Natural killer cells antigen CD94,42754,-0.0727985094178301,0.00466169333097022,-0.0819354283465317,-0.0636615904891285,1.68041913354184e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL22,C-C motif chemokine 22,42509,-0.0821268388396585,0.00526001930969366,-0.0924364766866581,-0.071817200992659,1.79275228724092e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RETN,Resistin,42598,-0.0670466363757458,0.00430056678962217,-0.0754757472834052,-0.0586175254680863,2.54412110664402e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPL,N-acetylneuraminate lyase,40511,-0.0706657919416452,0.00453082380365539,-0.0795462065968098,-0.0617853772864806,2.81196468367653e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HNMT,Histamine N-methyltransferase,42439,-0.0738045347446928,0.00474036814967186,-0.0830956563180496,-0.0645134131713359,3.54881310160722e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH1,Cadherin-1,42188,-0.061264989997778,0.00395013174490368,-0.0690072482177892,-0.0535227317777668,9.05348027029182e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCOF1,Treacle protein,40511,-0.0496530677106996,0.00320882179726145,-0.055942358433332,-0.0433637769880671,1.83332098959408e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,-0.0653341829409863,0.0042373493633155,-0.0736393876930846,-0.0570289781888879,3.48257093507345e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40451,-0.0796564571503365,0.00516748501484589,-0.0897847277794344,-0.0695281865212385,4.5203304024109e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG1B,Lithostathine-1-beta,42794,-0.089549166702096,0.00581650473065524,-0.10094951597418,-0.0781488174300117,4.8973210784737e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA7A,Semaphorin-7A,42760,-0.043265372411152,0.00282687942496886,-0.0488060560840909,-0.037724688738213,1.94065107891378e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42676,-0.0595339576043098,0.00390601279856276,-0.0671897426894928,-0.0518781725191268,5.0772204756145e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VCAM1,Vascular cell adhesion protein 1,42663,-0.0422346932244922,0.00277567716411393,-0.0476750204661555,-0.0367943659828289,7.47041490266508e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGXT,Serine--pyruvate aminotransferase,42636,-0.113698333157401,0.0074748011458061,-0.128348943403181,-0.0990477229116208,8.08254180826783e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EZR,Ezrin,42711,-0.0358508386063727,0.00236008540410783,-0.040476605998424,-0.0312250712143213,1.09184698691265e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PENK,Proenkephalin-A,40283,-0.0496977073302047,0.00327176028981047,-0.0561103574982332,-0.0432850571621762,1.36170489067404e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,-0.0459078223352345,0.00302264517631624,-0.0518322068808143,-0.0399834377896546,1.37754048010243e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42594,-0.0871261783734564,0.00575275325220854,-0.0984015747477852,-0.0758507819991277,2.17192187486581e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSME2,Proteasome activator complex subunit 2,42441,-0.0541224782977443,0.00357529291152158,-0.0611300524043266,-0.047114904191162,2.44637053066189e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAFA5,Chemokine-like protein TAFA-5,42587,-0.0579799932280469,0.00383030037629211,-0.0654873819655794,-0.0504726044905143,2.44671842320007e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300A,CMRF35-like molecule 8,40283,-0.0471799298006427,0.00311438462256988,-0.0532841236608797,-0.0410757359404058,2.50576244434529e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,-0.102142982776012,0.00674236439547606,-0.115358016991145,-0.0889279485608793,2.53590565159167e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCAM,Cell surface glycoprotein MUC18,42689,0.0504151077778448,0.00333242425429406,0.0438835562394284,0.0569466593162611,2.75931067355054e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,-0.118805588376317,0.00785642904465726,-0.134204189303846,-0.103406987448789,3.06622261549899e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,42311,-0.0430781867895662,0.00285179893889983,-0.0486677127098099,-0.0374886608693226,4.00031603752351e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSME1,Proteasome activator complex subunit 1,42480,-0.055366330727016,0.00366839893696672,-0.0625563926434708,-0.0481762688105612,4.7844293168202e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,-0.0611537312261067,0.00406239351002951,-0.0691160225057645,-0.0531914399464488,1.00909590227622e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4M,C-type lectin domain family 4 member M,40504,0.0741606273258484,0.00492719917309267,0.0645033169465868,0.08381793770511,1.04768560021418e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RLN2,Prorelaxin H2,40257,-0.0748251791782563,0.0049860914156492,-0.0845979183529287,-0.0650524400035838,2.07437439535116e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPB6,Heat shock protein beta-6,42721,-0.0586286941679415,0.00391075714006682,-0.0662937781624725,-0.0509636101734106,2.11355201389003e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDCP1,CUB domain-containing protein 1,42495,-0.0805907428800093,0.00537706080933253,-0.091129782066301,-0.0700517036937175,2.27006353170726e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,-0.0411032502605728,0.00274331973320318,-0.0464801569376511,-0.0357263435834946,2.41511806012794e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELOA,Elongin-A,42587,-0.079355282499449,0.00530477025634003,-0.0897526322018755,-0.0689579327970226,3.44582656511962e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,-0.153880845129538,0.0103397492680828,-0.174146753694981,-0.133614936564096,1.06869083089335e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MDK,Midkine,42638,-0.0751723334428249,0.00505558797166961,-0.0850812858672973,-0.0652633810183525,1.29495215021366e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTNB,Dystrobrevin beta,40430,-0.0634138801999098,0.00426419996742087,-0.0717717121360547,-0.0550560482637649,1.49805894505802e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,40223,-0.0480747712246586,0.00323491432658387,-0.054415203304763,-0.0417343391445543,1.76956775650077e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,-0.0442070339989439,0.00297880366284981,-0.0500454891781295,-0.0383685788197583,1.96571833224419e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFC1,Cryptic protein,42346,-0.0698580807719985,0.00470709889960515,-0.0790839946152246,-0.0606321669287724,1.99678777096214e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VEGFA,Vascular endothelial growth factor A,42716,-0.0859968573000767,0.00579528269320555,-0.0973556113787596,-0.0746381032213938,2.00246880116105e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAXX,Protein PAXX,40283,-0.0672685221214751,0.00453186622620158,-0.0761509799248302,-0.05838606431812,2.28144865488941e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,42346,-0.119256810164873,0.00805088145137734,-0.135036537809573,-0.103477082520174,3.01446458592908e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTA3,Glutathione S-transferase A3,42346,-0.111958130434294,0.00756418567320155,-0.126783934353769,-0.097132326514819,3.5828445509273e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPA2,Carboxypeptidase A2,42670,-0.0965873491043617,0.00653856862412478,-0.109402943607646,-0.0837717546010771,5.36788327639096e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,-0.0756868127551317,0.00512423323043821,-0.0857303098867906,-0.0656433156234728,5.47804602637811e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG1A,Lithostathine-1-alpha,42575,-0.076541020776622,0.00518861540906764,-0.0867107069783946,-0.0663713345748494,7.25451415640138e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MLN,Promotilin,42594,-0.129405611867866,0.00878322839038105,-0.146620739513013,-0.112190484222719,9.48225038429766e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,-0.0417623164177593,0.00284258202600857,-0.0473337771887361,-0.0361908556467825,1.71594263142995e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,-0.0678136897439869,0.00461675843856891,-0.076862536283582,-0.0587648432043919,1.80226895795805e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,-0.0388112959636717,0.00264402752862939,-0.0439935899197853,-0.0336290020075581,2.10756069783903e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40511,-0.0391705749937372,0.00266844670475634,-0.0444007305350597,-0.0339404194524148,2.43649723244069e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LBR,Delta(14)-sterol reductase LBR,42711,-0.0963512717312459,0.00657554695416399,-0.109239343761407,-0.0834631997010845,3.02193833646871e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD28,T-cell-specific surface glycoprotein CD28,42346,-0.0552454837436577,0.00377310060508253,-0.0626407609296195,-0.047850206557696,3.62932435253899e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,-0.083389016701092,0.00569139867058816,-0.0945441580954448,-0.0722338753067392,3.71714498704834e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F11R,Junctional adhesion molecule A,42611,-0.0800435620027017,0.00548202293585821,-0.0907883269569838,-0.0692987970484196,6.43914325784478e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SRP14,Signal recognition particle 14 kDa protein,42587,-0.0856238614688939,0.00586780264264242,-0.097124754648473,-0.0741229682893147,7.33800279334914e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,-0.0864276159979691,0.005922199200141,-0.0980351264302454,-0.0748201055656927,8.39285203270009e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOMO1,Nodal modulator 1,42611,-0.0333096445950937,0.00228663458822498,-0.0377914483880147,-0.0288278408021727,1.05141285653284e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GUCA2A,Guanylin,42563,-0.0525143862219688,0.00360911186668587,-0.0595882454806731,-0.0454405269632645,1.33933748786533e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINF1,Pigment epithelium-derived factor,40351,-0.0386498155990964,0.00265614366225139,-0.0438558571771091,-0.0334437740210836,1.56440453015049e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40511,-0.0968927509165211,0.00667155440679633,-0.109968997553842,-0.0838165042792003,2.29935911140446e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFI,Complement factor I,40539,-0.0282367916555672,0.00194860575321944,-0.0320560589318773,-0.0244175243792571,3.65202226384167e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPB1,Carboxypeptidase B,42794,-0.0871826676137709,0.00602111367220128,-0.0989840504112854,-0.0753812848162564,3.66139146319057e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHCHD6,MICOS complex subunit MIC25,40451,-0.0417924189669009,0.00288503410406643,-0.0474470858108711,-0.0361377521229307,3.94243801239574e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL11,C-X-C motif chemokine 11,42711,-0.114310454357726,0.00790320797692918,-0.129800741992507,-0.098820166722945,4.60604922429974e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDC1,Syndecan-1,42636,-0.0584765851326607,0.00404368489193924,-0.0664022075208616,-0.0505509627444598,4.80149898475256e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40449,-0.0642666671479751,0.00444949543672391,-0.072987678203954,-0.0555456560919962,7.21546863525558e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,-0.105971041565336,0.00735561380915222,-0.120388044631275,-0.0915540384993982,1.2111893279963e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP5,Fatty acid-binding protein 5,42678,-0.0962098122890192,0.00668354512685137,-0.109309560737648,-0.0831100638403905,1.2321015763957e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HJV,Hemojuvelin,40482,-0.0632568272362272,0.00439536607949917,-0.0718717447520456,-0.0546419097204088,1.50497352436858e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH2D1A,SH2 domain-containing protein 1A,42594,-0.0819163708158526,0.00571237591750579,-0.093112627614164,-0.0707201140175413,2.70138302899402e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,-0.0461749383787235,0.00321814548904866,-0.0524825035372589,-0.0398673732201882,2.78461779776716e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IDUA,Alpha-L-iduronidase,42721,-0.0656964679396786,0.00458823119932183,-0.0746894010903493,-0.0567035347890078,3.6472707501765e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEPTIN8,Septin-8,40470,-0.0464153097321646,0.00323996850927611,-0.0527656480103458,-0.0400649714539834,3.8300186837711e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRC1,Macrophage mannose receptor 1,40532,-0.0418274015634398,0.00292238201389353,-0.0475552703106711,-0.0360995328162085,4.58425300140825e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YAP1,Transcriptional coactivator YAP1,40483,-0.0409986289514166,0.00287269000618482,-0.0466291013635388,-0.0353681565392943,8.19707519670726e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,-0.0426808152763856,0.00299437944925353,-0.0485497989969225,-0.0368118315558486,1.07671322015769e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42676,-0.0570522978289242,0.00400743216903543,-0.0649068648802337,-0.0491977307776148,1.16274675769657e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KHK,Ketohexokinase,40223,-0.0889249513441472,0.0062474626490703,-0.101169978136325,-0.0766799245519695,1.43074990643702e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,-0.0411997446285502,0.00290388849830424,-0.0468913660852265,-0.0355081231718739,2.29682097227125e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HYAL1,Hyaluronidase-1,42544,-0.0326276813528351,0.00230243326032038,-0.037140450543063,-0.0281149121626071,2.94930146959806e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,-0.0555380401017719,0.00392010328875038,-0.0632214425477227,-0.0478546376558212,3.05385563272079e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POF1B,Protein POF1B,40199,-0.0659815663261382,0.00466490350421574,-0.075124777194401,-0.0568383554578753,5.02140456258569e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F9,Coagulation factor IX,42663,-0.0252878179503151,0.00179024335517043,-0.0287966949264491,-0.021778940974181,5.55041734703915e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN4,CCN family member 4,42721,-0.056051122843933,0.00397134044364138,-0.0638349501134701,-0.0482672955743959,6.49352223548903e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSZ,Cathepsin Z,42648,-0.0451235029969194,0.00319800425141018,-0.0513915913296834,-0.0388554146641555,6.89499780762458e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,-0.0694101446227826,0.00492351223729424,-0.0790602286078793,-0.0597600606376859,9.78087257720208e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALDH1A1,Retinal dehydrogenase 1,42611,-0.0746457035240288,0.00530071470816372,-0.0850351043520297,-0.0642563026960279,1.01702618066762e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB8,Serpin B8,42754,-0.0804550581506503,0.00572310002512664,-0.0916723341998985,-0.0692377821014021,1.41500548642282e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BST2,Bone marrow stromal antigen 2,42711,-0.0712102194315903,0.00507340316828565,-0.0811540896414302,-0.0612663492217504,1.92517621284795e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,0.0348971602126754,0.00248704520016916,0.0300225516203439,0.039771768805007,2.06046279732534e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGA5,Integrin alpha-5,42611,-0.0347231634758205,0.00247743612370262,-0.0395789382782777,-0.0298673886733634,2.56317909468164e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL6,Interleukin-6,42587,-0.106842300918324,0.00764526450659149,-0.121827019351243,-0.0918575824854042,4.51841043440742e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERMAP,Erythroid membrane-associated protein,40199,-0.0623887839306211,0.00446551789907428,-0.0711411990128067,-0.0536363688484355,5.54253161514825e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,-0.0392976143547194,0.00281545262352915,-0.0448159014968365,-0.0337793272126023,5.73973766309333e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,-0.0808378189763284,0.00579458845963683,-0.0921952123572166,-0.0694804255954402,6.31560068797155e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42587,-0.0441691677471229,0.00316909948684124,-0.0503806027413318,-0.0379577327529141,7.5899900101417e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOLR1,Folate receptor alpha,42600,-0.0418698215465693,0.00301216733428112,-0.0477736695217602,-0.0359659735713783,1.26725467458598e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC39A5,Zinc transporter ZIP5,42594,-0.0740843791391789,0.00533076831541104,-0.0845326850373846,-0.0636360732409733,1.31613922283717e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42794,-0.0903376565780743,0.00650643967383044,-0.103090278338782,-0.0775850348173666,1.56161406270298e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH3,Cadherin-3,42711,-0.0514532386527359,0.00372223890992381,-0.0587488269161866,-0.0441576503892853,3.63088104427806e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHB4,Ephrin type-B receptor 4,42794,-0.0362321381294561,0.00262542285867704,-0.0413779669324631,-0.0310863093264491,4.93416580432396e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL6,C-X-C motif chemokine 6,42754,-0.104578932977253,0.00757966962506455,-0.119435085442379,-0.0897227805121264,5.16513278403564e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOLR2,Folate receptor beta,42711,-0.0405318598059711,0.002938227613647,-0.0462907859287192,-0.034772933683223,5.36567919014913e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,-0.059573464560851,0.00432208244477633,-0.0680447461526126,-0.0511021829690894,6.287764499173e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMOT,Angiomotin,40283,-0.0534024779011093,0.00387243063305531,-0.0609924419418977,-0.0458125138603209,6.5725131450816e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS1,Galectin-1,42636,-0.0479822473289653,0.00348499770223203,-0.0548128428253401,-0.0411516518325905,7.72777285750892e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLAMF8,SLAM family member 8,42346,-0.0757477699558586,0.00550733443766546,-0.0865421454536829,-0.0649533944580342,9.52329819076536e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40482,-0.0727578337586398,0.00528973270935878,-0.083125709868983,-0.0623899576482966,1.0562936875501e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,-0.0529862914106083,0.00385542027060704,-0.0605429151409981,-0.0454296676802185,1.08660592825555e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHRDL1,Chordin-like protein 1,42654,-0.0440117857854199,0.0032151646468258,-0.0503135084931984,-0.0377100630776413,2.27553237314632e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PI3,Elafin,42446,-0.0772790492624983,0.00565201091486027,-0.0883569906556245,-0.0662011078693722,2.85468385592021e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL11,Eotaxin,42754,-0.0497404949540477,0.00363941347059501,-0.0568737453564139,-0.0426072445516815,3.03720052145556e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42689,-0.0557970502876817,0.0040844096009014,-0.0638024931054484,-0.047791607469915,3.31310021280767e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL14,C-C motif chemokine 14,42618,-0.0547075420664509,0.00401049894983601,-0.0625681200081295,-0.0468469641247723,4.35207813659758e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JAM2,Junctional adhesion molecule B,42711,-0.0384946134057297,0.00282278127917823,-0.044027264712919,-0.0329619620985404,4.57130107877819e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL3,Angiopoietin-related protein 3,42652,0.0482825569712354,0.0035487175869166,0.0413270705008788,0.0552380434415919,7.01395091573884e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NECTIN4,Nectin-4,42679,-0.0466247560700813,0.00342952979177568,-0.0533466344619616,-0.0399028776782009,8.07611275560242e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARA5,Scavenger receptor class A member 5,42711,-0.0415600698054397,0.00306117318132635,-0.0475599692408393,-0.03556017037004,1.03568337027626e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,-0.0597377121954674,0.00440096052169849,-0.0683635948179964,-0.0511118295729383,1.08064198067846e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42721,-0.0532379501075427,0.00394052547532404,-0.0609613800391778,-0.0455145201759076,2.51749495345802e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABL1,Tyrosine-protein kinase ABL1,42587,-0.089277066346613,0.0066196621671014,-0.102251604194132,-0.0763025284990943,3.47975041369548e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,0.0263397090282091,0.00195642553954501,0.0225051149707009,0.0301743030857173,4.76209006194389e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RSPO3,R-spondin-3,42721,-0.0397249101787725,0.00295384564648011,-0.0455144476458735,-0.0339353727116715,5.75524056872012e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G15,Phospholipase A2 group XV,42679,-0.035466171001987,0.00263767273765413,-0.0406360095677891,-0.030296332436185,5.96402868399522e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42590,-0.0668492050967252,0.00497783104983953,-0.0766057539544106,-0.0570926562390397,7.47362161760445e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC7A,C-type lectin domain family 7 member A,42754,-0.0811135087573906,0.00604506356900445,-0.0929618333526394,-0.0692651841621419,8.61809902557796e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MARCO,Macrophage receptor MARCO,42636,-0.0349474747151311,0.00260943637768773,-0.040061970015399,-0.0298329794148631,1.21469057336341e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,-0.139444932831944,0.0104285613234588,-0.159884913025923,-0.119004952637965,1.80708233945554e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,-0.065236559549806,0.0048907866682447,-0.0748225014195657,-0.0556506176800464,2.51929115530082e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTN,Pleiotrophin,42357,-0.0657937678969716,0.00493410853152688,-0.0754646206187643,-0.056122915175179,2.66272041391282e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42495,-0.0311174676303448,0.00234129504637196,-0.0357064059212338,-0.0265285293394558,4.71817275234152e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EBI3_IL27,Interleukin-27,42689,-0.040735226139827,0.00306537385805742,-0.0467433589016196,-0.0347270933780345,4.79625497010742e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIP,Gastric inhibitory polypeptide,40223,-0.0778693962773644,0.00585677018887028,-0.0893486658475501,-0.0663901267071787,4.9859049352037e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,-0.0573347394118409,0.00431367177006937,-0.0657895360811768,-0.0488799427425049,5.18622577893449e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42654,-0.0682908440383116,0.00514279039287053,-0.0783707132083378,-0.0582109748682853,5.47179784598342e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK11,Kallikrein-11,42543,-0.0431421804241522,0.00325036148606726,-0.049512888936844,-0.0367714719114604,5.94298388963392e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42737,-0.0561248659906766,0.00423940262220267,-0.0644340951301938,-0.0478156368511594,9.241657953381e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMG3,Proteasome assembly chaperone 3,42594,-0.0671390254503845,0.00507208013625986,-0.0770803025174538,-0.0571977483833151,9.53016249622006e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42587,-0.0442400071583695,0.00334430802172629,-0.050794850880953,-0.0376851634357859,1.06635266728015e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42517,-0.0549493336892102,0.00415675566808896,-0.0630965747986645,-0.0468020925797558,1.20626489201813e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42794,-0.0413647149037991,0.00312945651028573,-0.0474984496639591,-0.0352309801436391,1.2148589755243e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD209,CD209 antigen,42668,0.0510082233991023,0.00386585705310569,0.0434311435750151,0.0585853032231895,1.65786128992049e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS3,Galectin-3,42669,-0.0391875418305796,0.00297660632340707,-0.0450216902244574,-0.0333533934367017,2.43471277407403e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40482,-0.0817285632675073,0.00620802646360784,-0.0938962951361787,-0.0695608313988359,2.71701312395337e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANG,Angiogenin,42618,-0.0437919503246912,0.00333490187435362,-0.0503283579984242,-0.0372555426509581,3.79162732889723e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ROBO1,Roundabout homolog 1,42638,-0.0319950314428309,0.00243953490270266,-0.0367765198521281,-0.0272135430335336,4.67830528437801e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL19,Interleukin-19,42261,-0.0945320358092133,0.00721053518825558,-0.108664684778194,-0.0803993868402324,5.06915431943646e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,-0.0897134939014236,0.00684119949356506,-0.103122244908811,-0.0763047428940361,5.38489035166118e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBP1,Guanylate-binding protein 1,40466,-0.0858802116966706,0.00655168448552251,-0.0987215132882947,-0.0730389101050464,5.70026843190451e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,40223,0.0793154772085218,0.00605597765458395,0.0674457610055373,0.0911851934115063,6.67436987757351e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOP2B,DNA topoisomerase 2-beta,40199,-0.103748798208707,0.00793534749354659,-0.119302079296058,-0.0881955171213557,8.98122599202422e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALCAM,CD166 antigen,42794,-0.0255555627293513,0.00195621987511512,-0.029389753684577,-0.0217213717741257,9.07780275090466e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42636,-0.0488812488135176,0.00374364799085283,-0.0562187988755892,-0.0415436987514461,9.95531011439959e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,-0.0388889606669636,0.00298305291193766,-0.0447357443743614,-0.0330421769595658,1.31359402811569e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,-0.0692674560717845,0.005314968930827,-0.0796847951762054,-0.0588501169673636,1.54059121939577e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,40283,-0.0491849760250858,0.00377793191521222,-0.0565897225789017,-0.0417802294712698,1.82481122645915e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEP1A,Meprin A subunit alpha,40449,-0.094155462568185,0.00723935471516592,-0.10834459780991,-0.0799663273264598,2.13649524340447e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,42370,-0.0465146975662708,0.00359122520778245,-0.0535534989735244,-0.0394758961590172,3.89550208319344e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42620,-0.0633394848892236,0.00489229109659552,-0.0729283754385509,-0.0537505943398964,4.14133719283312e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENO3,Beta-enolase,40223,-0.0761782912899034,0.00588407294922866,-0.0877110742703916,-0.0646455083094152,4.65273186720331e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42760,-0.0429136086387993,0.00332011275092683,-0.0494210296306159,-0.0364061876469827,5.42666463694742e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FMNL1,Formin-like protein 1,42311,-0.0793835870906241,0.00614118602657924,-0.0914203117027194,-0.0673468624785288,5.44660194339776e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP3,"Fatty acid-binding protein, heart",40511,-0.0677115566754182,0.00524902130791162,-0.0779996384389249,-0.0574234749119114,8.32592193155724e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTDH,Protein LYRIC,40199,-0.120539148187076,0.00935908898699456,-0.138882962601585,-0.102195333772566,1.10026515845267e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD207,C-type lectin domain family 4 member K,42365,-0.050838380950593,0.00395180559274424,-0.0585839199123717,-0.0430928419888143,1.19998411074288e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRN,Progranulin,42552,-0.0313219015826644,0.00243551970102353,-0.0360955201966705,-0.0265482829686583,1.25599985400716e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WNT9A,Protein Wnt-9a,42370,-0.0378074858025483,0.00294819509329217,-0.043585948185401,-0.0320290234196957,2.01555989029301e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RTBDN,Retbindin,42587,-0.0379203266298199,0.00297015013911059,-0.0437418209024766,-0.0320988323571631,4.11641064830792e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSAP,Prosaposin,40440,-0.0369658934445144,0.00289460728200998,-0.0426393237172539,-0.0312924631717748,4.32866210246281e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,-0.123629010467773,0.00968027842527087,-0.142602356181304,-0.104655664754242,4.34486583379618e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC14A,C-type lectin domain family 14 member A,42611,-0.0421352344473313,0.00331306858418154,-0.0486288488723272,-0.0356416200223355,7.67509369073303e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFH,Complement factor H,39956,-0.0291702411235962,0.00229552799043543,-0.0336694759848496,-0.0246710062623427,9.86954180820564e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD2AP,CD2-associated protein,42636,-0.0800664856854376,0.00631678902252391,-0.0924473921695845,-0.0676855792012907,1.31455095346318e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,-0.0578805195837178,0.00456364555161839,-0.0668252648648898,-0.0489357743025457,1.32351878900918e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT8,"Keratin, type II cytoskeletal 8",40136,-0.103151431244663,0.00813543424248056,-0.119096882359925,-0.0872059801294012,1.39261763768101e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,-0.0500064770352506,0.00395275096091374,-0.0577538689186415,-0.0422590851518597,1.78436127888161e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAL,Galanin peptides,42676,0.0809109215839795,0.00639816308122778,0.068370521944773,0.0934513212231859,1.89649055627243e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42679,-0.0413312500871912,0.00327301150829126,-0.0477463526434421,-0.0349161475309404,2.37953919923758e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLAT,Tissue-type plasminogen activator,42760,-0.0632975300701369,0.00501641988575689,-0.0731297130462204,-0.0534653470940534,2.6844524906343e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,-0.0908930318773009,0.00720962906721339,-0.105023904849039,-0.0767621589055627,3.10623202717846e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL25,C-C motif chemokine 25,42754,-0.0599217070681562,0.00476341911514965,-0.0692580085338495,-0.0505854056024629,4.35028075492953e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,-0.0478052032619547,0.00380228026323939,-0.0552576725779039,-0.0403527339460055,4.76171616106145e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,-0.0346456362257606,0.00275845579320467,-0.0400522095804418,-0.0292390628710795,5.60156829839227e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMSB10,Thymosin beta-10,42611,-0.0918069929220062,0.00733448473536522,-0.106182583003322,-0.0774314028406903,9.52370953643274e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,-0.0652209532401046,0.00521829599051211,-0.0754488133815083,-0.0549930930987008,1.19575408436268e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,-0.0463092072572299,0.00370436493658954,-0.0535697625329454,-0.0390486519815144,1.28062558366097e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIAE,Sialate O-acetylesterase,42646,-0.0565223193626054,0.00454382120598975,-0.0654282089263453,-0.0476164297988655,2.49845981228423e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD46,Membrane cofactor protein,42580,-0.0357561205573672,0.002878956488371,-0.0413988752745744,-0.0301133658401601,3.18914728577609e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,-0.0557553987469966,0.004503670203669,-0.0645825923461879,-0.0469282051478054,5.72990467758045e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD244,Natural killer cell receptor 2B4,42754,-0.0335893456602559,0.00272114593667656,-0.0389227916961419,-0.0282558996243698,8.08900376823301e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRP,Gastrin-releasing peptide,40223,-0.0691812015562751,0.00560308623353814,-0.0801632505740098,-0.0581991525385403,8.58214771479243e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPON1,Spondin-1,42638,-0.0416289244180176,0.0033768028853968,-0.0482474580733953,-0.0350103907626398,9.87053699942011e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBKS,Ribokinase,42317,-0.0606958456212293,0.00492425040840143,-0.0703473764216961,-0.0510443148207625,1.02229070618743e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL3A1,Collagen alpha-1(III) chain,40527,-0.028805745565054,0.00233598227060828,-0.0333842708154462,-0.0242272203146618,1.02527224020151e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,-0.0380825859497672,0.00309807744698766,-0.0441548177458631,-0.0320103541536714,1.65738385180726e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,-0.0370020870965144,0.00301509038802545,-0.0429116642570443,-0.0310925099359846,1.95439747723595e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPON2,Spondin-2,42562,-0.0437192096282183,0.0035732416747729,-0.0507227633107732,-0.0367156559456634,3.07436844628891e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,-0.0416242064656953,0.00340391162397602,-0.0482958732486884,-0.0349525396827023,3.32429597105915e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAG3,Lymphocyte activation gene 3 protein,42587,-0.0499574726064195,0.00408963680214486,-0.0579731607386234,-0.0419417844742156,3.89675793410995e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPIND1,Heparin cofactor 2,40516,-0.034266762206545,0.00280584685914484,-0.0397662220504689,-0.0287673023626212,4.3594544592195e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD7,T-cell antigen CD7,40166,-0.054666642946559,0.00447757996590174,-0.0634426996797264,-0.0458905862133916,4.62876480600976e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDT,D-dopachrome decarboxylase,40527,-0.0506122164038234,0.00414833019208141,-0.058742943580303,-0.0424814892273438,5.04022584193909e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDN1,Endothelin-1,40223,-0.0370969809712994,0.00304784503404723,-0.0430707572380319,-0.0311232047045668,7.26339534059017e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BSG,Basigin,42746,-0.0262848551432291,0.00216192198095456,-0.0305222222259001,-0.0220474880605582,7.79426901219524e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,-0.0702443293301848,0.00578604154666062,-0.0815849707616396,-0.05890368789873,9.69316046549907e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42587,-0.101689991478647,0.00838195383986074,-0.118118621004774,-0.0852613619525195,1.07356250718539e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTYMK,Thymidylate kinase,40511,-0.0821922201392461,0.00677906988025167,-0.0954791971045394,-0.0689052431739528,1.26700320223911e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL5A1,Collagen alpha-1(V) chain,40283,-0.0501671310446607,0.00414452568921105,-0.0582904013955144,-0.042043860693807,1.62724570876288e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTGR1,Prostaglandin reductase 1,40511,-0.101395321665973,0.00838283698759615,-0.117825682161662,-0.0849649611702849,1.79242104481123e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,-0.0360188037636525,0.00297813358326968,-0.041855945586861,-0.0301816619404439,1.82239358571035e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SORD,Sorbitol dehydrogenase,42658,-0.0801309880463092,0.00662963253779361,-0.0931250678203847,-0.0671369082722337,1.84822580941019e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,-0.0419125489500404,0.00347005831611061,-0.0487138632496172,-0.0351112346504637,2.04510135954161e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MET,Hepatocyte growth factor receptor,42654,0.0238831856353459,0.00197908857482713,0.0200041720286847,0.027762199242007,2.32367543639438e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALB2,Calretinin,42311,-0.0384442115126492,0.00318941303661709,-0.0446954610644188,-0.0321929619608797,2.78006508128115e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GDNF,Glial cell line-derived neurotrophic factor,42311,-0.0458001240308906,0.00380044071966458,-0.0532489878414332,-0.038351260220348,2.86227783352036e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GUSB,Beta-glucuronidase,42711,-0.0724758707219895,0.00602463935794482,-0.0842841638635614,-0.0606675775804177,3.65419373288489e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42594,-0.0327992225117084,0.00272887952035919,-0.0381478263716124,-0.0274506186518044,4.16341238310493e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,-0.0642052314660201,0.0053664054662882,-0.0747233861799449,-0.0536870767520952,8.02848348324449e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM3D,Protein FAM3D,40449,-0.102870386261364,0.00859707380396472,-0.119720650917135,-0.0860201216055936,8.49024251236924e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOST,Sclerostin,42613,-0.0462848589053045,0.00387590405531246,-0.0538816308537169,-0.0386880869568921,1.05069037313862e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42565,-0.0310099121444091,0.0025973402964482,-0.0361006991254475,-0.0259191251633706,1.08505601201538e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,-0.0277415359035518,0.00232799040740483,-0.0323043971020653,-0.0231786747050384,1.51854791574706e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLF4,Krueppel-like factor 4,40136,-0.0479111634534043,0.00402065431761471,-0.0557916459159292,-0.0400306809908795,1.54749505528343e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSM,Oncostatin-M,42534,-0.0827896122727432,0.006962734967113,-0.0964365728082847,-0.0691426517372017,1.93639397870277e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OGFR,Opioid growth factor receptor,42587,-0.0383381853628483,0.0032307354653952,-0.0446704268750229,-0.0320059438506737,2.55911462942067e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLO1,Lactoylglutathione lyase,42357,-0.0685276368387845,0.00578271508448786,-0.0798617584043807,-0.0571935152731883,3.12200951545418e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUS,RNA-binding protein FUS,42336,-0.0468394489906005,0.00395601437114564,-0.0545932371580459,-0.039085660823155,3.53041274397745e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTSS1,Protein MTSS 1,40449,-0.131482713733661,0.0111538454209049,-0.153344250758635,-0.109621176708687,6.92111528840324e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGR,Tyrosine-protein kinase Fgr,42311,-0.0669280615152945,0.0056915151077769,-0.0780834311265372,-0.0557726919040518,9.13484889336496e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40449,-0.0661659437214851,0.00563064703318097,-0.0772020119065198,-0.0551298755364504,1.06826771002164e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,-0.0756966068243518,0.006443300577512,-0.0883254759562753,-0.0630677376924283,1.11505890017345e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42794,-0.0379354262259907,0.00323224210376525,-0.0442706207493706,-0.0316002317026108,1.1764208149574e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,-0.0606865814550786,0.00517089012155573,-0.0708215260933279,-0.0505516368168294,1.18407142275385e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,-0.0253400631503709,0.00215851227251283,-0.0295707472044961,-0.0211093790962457,1.22108087292659e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LATS1,Serine/threonine-protein kinase LATS1,40199,-0.0989442376570017,0.00842842069840789,-0.115463942225881,-0.0824245330881223,1.23627265650971e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFPI,Tissue factor pathway inhibitor,42618,0.0360806640059628,0.00307826243970792,0.0300472696241352,0.0421140583877903,1.4158796467317e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFRP4,Secreted frizzled-related protein 4,40283,-0.0471994579515692,0.00403726988417573,-0.0551125069245536,-0.0392864089785848,2.16669430739593e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAMDC4,Apical endosomal glycoprotein,40451,-0.0642309698497288,0.00550018871183461,-0.0750113397249246,-0.0534505999745329,2.50383223385712e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADH1B,All-trans-retinol dehydrogenase,40283,-0.0869401628487553,0.0074470065836822,-0.101536295752772,-0.0723440299447382,2.6224428813702e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,-0.0573987572147503,0.00491692596031868,-0.0670359320969749,-0.0477615823325257,2.65854914993896e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,-0.0565079022516942,0.0048424991264787,-0.0659992005395925,-0.0470166039637959,2.77010217927349e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42594,-0.0565768811997811,0.00485255228639696,-0.0660878836811191,-0.047065878718443,2.91542077633192e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42611,0.0609680374064264,0.00522944718521602,0.050718320923403,0.0712177538894498,2.9345405934731e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GM2A,Ganglioside GM2 activator,40269,-0.047707215579784,0.00409381446559289,-0.0557310919323461,-0.0396833392272219,3.34891500277623e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPO,Myeloperoxidase,42611,-0.0536958324747104,0.00461802624904942,-0.0627471639228473,-0.0446445010265735,4.21359573395686e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,-0.0953959330843348,0.00820998292748641,-0.111487499622208,-0.0793043665464614,4.92515998566198e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPA1,Carboxypeptidase A1,42794,-0.072125309931348,0.00621505874010891,-0.0843068250619615,-0.0599437948007345,5.44433121312793e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,-0.0782179601535901,0.00674678957369994,-0.0914416677180419,-0.0649942525891382,6.29491522786756e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRCAM,Neuronal cell adhesion molecule,42636,-0.0334788272513549,0.00289853830715543,-0.0391599623333795,-0.0277976921693302,1.0277504026368e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BECN1,Beclin-1,40223,-0.0691112609858608,0.00598233122367779,-0.0808366301842693,-0.0573858917874523,1.0758972838977e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPP1,Tripeptidyl-peptidase 1,42545,-0.0517415334215091,0.00448914696535275,-0.0605402614736005,-0.0429428053694177,1.36290714574903e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WDR46,WD repeat-containing protein 46,40451,-0.0414558364365786,0.00359757924178252,-0.0485070917504724,-0.0344045811226849,1.49424670022308e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42737,-0.0357774908564144,0.00310706841091173,-0.0418673449418014,-0.0296876367710274,1.54015096058761e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,-0.0509124176189288,0.0044244623639813,-0.0595843638523322,-0.0422404713855255,1.81004218707063e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA14,Carbonic anhydrase 14,42721,0.0410002023173978,0.00358005104995244,0.0339833022594911,0.0480171023753046,3.15174070167644e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAST,Gastrin,40483,-0.166908691751311,0.0145695702723371,-0.195465049485092,-0.13835233401753,3.22295420031387e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS7_LGALS7B,Galectin-7,42524,-0.04914675631372,0.00430924988419942,-0.0575928860867509,-0.0407006265406892,5.4405789875069e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPT,Dermatopontin,42794,-0.0286898153138673,0.00251985047837434,-0.033628722251481,-0.0237509083762536,6.7426679569793e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPL14,60S ribosomal protein L14,40223,-0.0456442866228079,0.00400942131566318,-0.0535027524015077,-0.0377858208441081,7.35139970691096e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,-0.0403203211991806,0.00356195835363469,-0.0473017595723046,-0.0333388828260566,1.51391105899243e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCD5,Programmed cell death protein 5,42711,-0.0645627614637617,0.00570718885410875,-0.0757488516178149,-0.0533766713097086,1.54433571093698e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLI1,Friend leukemia integration 1 transcription factor,42346,-0.123463151552488,0.0109139971318881,-0.144854585930988,-0.102071717173987,1.56031055665808e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADA,Adenosine deaminase,42754,-0.038921730167017,0.00344711356492203,-0.0456780727542642,-0.0321653875797698,1.9647495732876e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42711,-0.074821045085282,0.00662900471969481,-0.0878138943358839,-0.0618281958346802,2.06167062592472e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGL1,Fibrinogen-like protein 1,40532,-0.0743933307755691,0.00659127891882247,-0.0873122374564612,-0.0614744240946771,2.19145275532188e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LY9,T-lymphocyte surface antigen Ly-9,42443,-0.0343700884980745,0.00305527702797449,-0.0403584314729045,-0.0283817455232445,3.16267423746925e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FSTL1,Follistatin-related protein 1,40223,-0.025556726439433,0.00227090228855871,-0.030007694925008,-0.0211057579538579,3.19319674991758e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42721,-0.090267642638368,0.0080464025141902,-0.106038591566181,-0.0744966937105552,4.45167587368876e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCN1,Ficolin-1,40515,-0.0626570925855171,0.00558392299531929,-0.0736015816563429,-0.0517126035146913,4.57872293115964e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMN,Protein amnionless,42370,-0.0523411703619967,0.00467027475396586,-0.0614949088797698,-0.0431874318442236,5.07938010677591e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTRB1,Chymotrypsinogen B,42611,-0.0645063943315284,0.00576120569208332,-0.0757983574880117,-0.0532144311750451,5.68907833651426e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNCA,Alpha-synuclein,40283,-0.129116580748771,0.011529098998132,-0.15171361478511,-0.106519546712432,5.88361937133776e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FETUB,Fetuin-B,42663,-0.0357910657746943,0.00319785582783602,-0.0420588631972529,-0.0295232683521357,5.97416489171449e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUMB,Protein numb homolog,40199,-0.0919459546346962,0.00821386523955225,-0.108045130504219,-0.0758467787651738,6.25180449697847e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,-0.0710120235446784,0.00634898472574199,-0.0834560336071327,-0.0585680134822241,6.86617824006989e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGMB,RGM domain family member B,42711,-0.0316682058920596,0.00283367361143577,-0.0372222061704737,-0.0261142056136455,7.17848302488182e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFAP5,Microfibrillar-associated protein 5,42794,-0.0456689143486315,0.0040947986663608,-0.0536947197346987,-0.0376431089625643,9.23626774803785e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP53I3,Quinone oxidoreductase PIG3,40058,-0.0593968268325384,0.00532671123510109,-0.0698371808533366,-0.0489564728117403,1.01646036776952e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,-0.0278187750956997,0.00249661324543063,-0.0327121370567437,-0.0229254131346557,1.04046798378969e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAT2,Linker for activation of T-cells family member 2,42587,-0.136156060037799,0.0122429986279769,-0.160152337348634,-0.112159782726964,1.32093992776014e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THOP1,Thimet oligopeptidase,42571,-0.0341473957938921,0.00307082265386469,-0.0401662081954669,-0.0281285833923173,1.33891549170728e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RASSF2,Ras association domain-containing protein 2,42346,-0.0627460915685334,0.00565249733650485,-0.073824986348083,-0.0516671967889839,1.6677821349244e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LY6D,Lymphocyte antigen 6D,42548,-0.0452579125484685,0.00408010615570785,-0.0532549206136559,-0.0372609044832811,1.81966222453156e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBS,Cystathionine beta-synthase,40223,-0.0570974227328116,0.00514515678516058,-0.0671819300317263,-0.0470129154338968,1.82851002987194e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN3,CCN family member 3,42779,-0.0391628726204757,0.00353855542919267,-0.0460984412616933,-0.032227303979258,2.38454045807889e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,-0.0380161487542868,0.00345240619323018,-0.0447828648930179,-0.0312494326155556,4.45058695334522e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,-0.0924367716921331,0.00840101097530164,-0.108902753203724,-0.0759707901805419,5.16549506477871e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,-0.0475500654416183,0.00432381138424451,-0.0560247357547375,-0.039075395128499,5.20059949204078e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,-0.0369463098127102,0.00335822837058676,-0.0435284374190603,-0.0303641822063602,5.24504769262914e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,40302,-0.0623381810759642,0.0056708889164097,-0.0734531233521272,-0.0512232387998011,5.77520431917425e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS3BP,Galectin-3-binding protein,40539,-0.0336797815710888,0.00306557358941813,-0.0396883058063484,-0.0276712573358293,6.13975629964253e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300LF,CMRF35-like molecule 1,42721,-0.066569700259054,0.00606533618959292,-0.0784577591906561,-0.0546816413274518,6.57797946795897e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRELP,Prolargin,42618,-0.0266432772821153,0.00242998916421687,-0.0314060560439804,-0.0218804985202503,7.442304091364e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,-0.125669026571335,0.0115036390854221,-0.148216159178763,-0.103121893963908,1.15319331003813e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TALDO1,Transaldolase,40499,-0.0478292362487414,0.00439760016531354,-0.0564485325727559,-0.0392099399247268,2.04546646151403e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,-0.0347232769991497,0.00319309853708326,-0.0409817501318329,-0.0284648038664665,2.10060259293484e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YTHDF3,YTH domain-containing family protein 3,42370,-0.0913124408231194,0.0084018628243102,-0.107780091958767,-0.0748447896874714,2.13712987561829e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPR,Nucleoprotein TPR,40116,-0.0528459098767108,0.00486082219440952,-0.0623731213777535,-0.0433186983756682,2.1691216562161e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,40383,-0.0647818083437482,0.00596442344349501,-0.0764720782929985,-0.053091538394498,2.41045451134332e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NADK,NAD kinase,42636,-0.0591366506706232,0.0054501108897076,-0.0698188680144501,-0.0484544333267963,2.57281170273565e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,-0.0954971486689821,0.00881262100502042,-0.112769885838822,-0.0782244114991421,3.00814968490478e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NELL1,Protein kinase C-binding protein NELL1,42679,0.0471297310338371,0.00435410248893234,0.0385956901555297,0.0556637719121445,3.41920085269565e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXLNA,Alpha-taxilin,42495,-0.0940232344742283,0.00868658720828046,-0.111048945402458,-0.0769975235459985,3.44087726924651e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAPG,Macrophage-capping protein,42461,-0.0630448518354862,0.0058270129026301,-0.0744657971246413,-0.0516239065463312,3.61662972214387e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COCH,Cochlin,40511,-0.0507015831575774,0.00469108923431539,-0.0598961180568355,-0.0415070482583192,4.27473549982108e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,-0.115085906564443,0.0106669072343665,-0.135993044743801,-0.0941787683850843,5.01627561708825e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP20,Centrosomal protein 20,42346,-0.0801317676173853,0.00743500097349564,-0.0947043695254367,-0.0655591657093338,5.68986422422296e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NGRN,Neugrin,40483,-0.0250098509830967,0.00232005862814709,-0.029557165894265,-0.0204625360719284,5.79837354109173e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42668,0.0327432005355984,0.00304089588078809,0.0267830446092537,0.038703356461943,6.29964937359175e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEFTY2,Left-right determination factor 2,42689,-0.0533535229087945,0.00496515926688864,-0.0630852350718963,-0.0436218107456928,7.98135736599074e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLAMF1,Signaling lymphocytic activation molecule,42370,-0.0647478458081649,0.00602699390712457,-0.0765607538661291,-0.0529349377502008,8.25746285179263e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,-0.0557126248954703,0.0051845955577783,-0.0658744321887157,-0.0455508176022248,8.36582384404675e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RARRES1,Retinoic acid receptor responder protein 1,42346,-0.0352980344200785,0.00328850028138849,-0.0417434949715999,-0.0288525738685571,9.1185613378616e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,40116,-0.0388098290321653,0.00361827370815668,-0.0459016455001524,-0.0317180125641782,1.04300367385976e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFAP4,Microfibril-associated glycoprotein 4,40283,-0.035075666582476,0.00327066394632125,-0.0414861679172657,-0.0286651652476864,1.0577182807805e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLIN1,Perilipin-1,42311,-0.0372159722640503,0.00347246617832793,-0.0440220059735731,-0.0304099385545276,1.08712105611944e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA2,Annexin A2,40054,-0.0779483113309872,0.00727010078293173,-0.0921977088655334,-0.063698913796441,1.09398978418925e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL2,Fc receptor-like protein 2,42681,-0.0561597853668224,0.00524505893870855,-0.0664401008866912,-0.0458794698469537,1.20513811537143e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PVR,Poliovirus receptor,42711,-0.0390470665431606,0.00365330547762792,-0.0462075452793114,-0.0318865878070099,1.47649711378817e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,-0.0547946233929439,0.00512523918149453,-0.0648400921886732,-0.0447491545972147,1.50160530722881e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,42370,0.0420984198918116,0.0039433144870638,0.0343695234971666,0.0498273162864567,1.69351353697833e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCRG1,Scrapie-responsive protein 1,40511,-0.0305505828889316,0.00286101874755154,-0.0361581796341326,-0.0249429861437305,1.7207253318557e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6AP2,Renin receptor,42346,-0.0428058233869635,0.00402087166027191,-0.0506867318410964,-0.0349249149328305,2.33261140861411e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBLIF,Cobalamin binding intrinsic factor,42613,-0.0859674595042862,0.00807726354644081,-0.10179889605531,-0.0701360229532622,2.39058338271279e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42794,0.0360673583248595,0.00339667801309574,0.0294098694191919,0.0427248472305272,3.09947267236186e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AP3S2,AP-3 complex subunit sigma-2,40483,-0.0504834411070145,0.004754737795081,-0.0598027271853733,-0.0411641550286558,3.28403962749202e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,-0.037482232068991,0.00353728430278201,-0.0444153093024437,-0.0305491548355382,3.93083351662716e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40451,-0.0733479454966359,0.00692506951797087,-0.0869210817518588,-0.059774809241413,4.32168008913328e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH17,Cadherin-17,42636,-0.0733745365323887,0.00693979480173759,-0.0869765343437944,-0.0597725387209831,5.02954072999196e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,-0.0309434689652363,0.00292797749529068,-0.036682304856006,-0.0252046330744666,5.29347062762604e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGFL7,Epidermal growth factor-like protein 7,42346,-0.0419043746339671,0.00396797972036614,-0.0496816148858848,-0.0341271343820495,5.76235527557547e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEP,Leptin,42636,-0.0695718813760555,0.00660722818813268,-0.0825220486247956,-0.0566217141273155,7.94845354360353e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C2,Complement C2,42663,-0.0239941036555047,0.00228234549780022,-0.0284675008311932,-0.0195207064798163,9.47670106533233e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD63,CD63 antigen,42475,-0.0531949982988949,0.00506260972419943,-0.0631177133583257,-0.043272283239464,1.00722702835019e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRLB,Fc receptor-like B,42346,-0.0680970021876715,0.00648663204211877,-0.0808108009902243,-0.0553832033851187,1.1140146589863e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRLF1,Cytokine receptor-like factor 1,42676,-0.0262939645709462,0.00250632377376417,-0.0312063591675239,-0.0213815699743684,1.19224066050596e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42676,-0.021675507192507,0.00206767581446583,-0.02572815178886,-0.017622862596154,1.29692072382361e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,-0.0362525102666746,0.00346237482577776,-0.043038764925199,-0.0294662556081502,1.47878738834166e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAB2,Stabilin-2,40527,-0.0293547597094041,0.00280344482919898,-0.0348495115746341,-0.0238600078441741,1.53584214855236e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,-0.101640633906706,0.00972590082268142,-0.120703399519162,-0.0825778682942507,1.82095596138286e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42618,-0.0543971394994582,0.00521738605199415,-0.0646232161613667,-0.0441710628375497,2.35453054664339e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BPIFA2,BPI fold-containing family A member 2,39838,0.118023329118819,0.0113445737294914,0.0957879646090159,0.140258693628622,3.15669652482528e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAP18,Chromatin complexes subunit BAP18,40483,-0.0704893548832272,0.00677753612940708,-0.0837733256968651,-0.0572053840695893,3.20782926136372e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL6,Fc receptor-like protein 6,42594,-0.072530617061363,0.00697816961902816,-0.0862078295146582,-0.0588534046080678,3.29444887708944e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMB1,Laminin subunit beta-1,40223,-0.0316748553639327,0.0030464720621706,-0.037645940605787,-0.0257037701220783,3.33722736138624e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEFL,Neurofilament light polypeptide,42262,-0.047956855092234,0.00461652988358905,-0.0570052536640685,-0.0389084565203994,3.52093203811682e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHB6,Ephrin type-B receptor 6,42476,-0.0346489823441927,0.00334030690208984,-0.0411959838722888,-0.0281019808160966,4.10337255171965e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT5,ADP-sugar pyrophosphatase,42611,-0.0519466799345964,0.00500909732724184,-0.0617645106959904,-0.0421288491732024,4.20313872682232e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLK1,Protein delta homolog 1,42794,-0.0568192323960128,0.00548009929189163,-0.0675602270081204,-0.0460782377839052,4.28689713650802e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EEF1D,Elongation factor 1-delta,40511,-0.0946594813588962,0.00913332670585974,-0.112560801702381,-0.0767581610154111,4.6702319579364e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,-0.0709878184934854,0.00685742922689002,-0.0844283797781899,-0.057547257208781,5.33598003930995e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGB1A1,Uteroglobin,42646,-0.0575030020134613,0.00556139912082392,-0.0684033442902762,-0.0466026597366464,5.78116476463457e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,-0.0694219815865668,0.00672017162419992,-0.0825935179699987,-0.056250445203135,6.37215428446835e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA9,Carbonic anhydrase 9,42721,-0.0498506598921951,0.004829334978404,-0.0593161564498669,-0.0403851633345232,6.89847304919961e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAT,Linker for activation of T-cells family member 1,42754,-0.0770037088851169,0.00747523703844744,-0.0916551734804739,-0.06235224428976,8.59077640517365e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAMR1,Inactive serine protease PAMR1,42611,-0.027335671787564,0.00265553236180601,-0.0325405152167038,-0.0221308283584242,9.28454328756981e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,-0.0662342425251454,0.00643301896306773,-0.0788429596927581,-0.0536255253575326,9.4518722134337e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,-0.0423183670942294,0.00411354160077051,-0.0503809086317396,-0.0342558255567192,1.02959509117362e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCN2,Transcobalamin-2,42771,-0.0316405325878184,0.00307765353206466,-0.0376727335106651,-0.0256083316649716,1.0602449516037e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,-0.0380805127571203,0.00370592260892952,-0.0453441210706222,-0.0308169044436185,1.16469932926383e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FEN1,Flap endonuclease 1,42346,-0.0651549962922559,0.00634455013015101,-0.0775903145473519,-0.0527196780371599,1.19883199498898e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,-0.0798204371222572,0.00777767574678318,-0.0950646815859522,-0.0645761926585622,1.32904796991207e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN3,Contactin-3,42611,-0.0317364810004117,0.00309701323376539,-0.0378066269385919,-0.0256663350622315,1.49646970415486e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGER,Advanced glycosylation end product-specific receptor,42587,-0.0429058044975361,0.00419117017397728,-0.0511204980385315,-0.0346911109565406,1.66313340692146e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSG2,Desmoglein-2,42611,0.0276678288554546,0.00270312055877747,0.0223697125602508,0.0329659451506585,1.69132460832676e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLIN3,Perilipin-3,42636,-0.0429323645027234,0.00419675489768896,-0.0511580041021938,-0.0347067249032531,1.79088905144859e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,-0.0520653630901296,0.00508965022741097,-0.0620410775358551,-0.0420896486444041,1.80447926100165e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42674,0.024698526004008,0.00241516408178379,0.0199648044037118,0.0294322476043043,1.8543864150708e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCF2,Neutrophil cytosol factor 2,42578,-0.0842700055918987,0.00824162195158958,-0.100423584617014,-0.0681164265667831,1.8860208489364e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSNL1,Visinin-like protein 1,40483,-0.0392857317388538,0.00384453316114574,-0.0468210167346995,-0.0317504467430082,2.090487232783e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAG1,Dystroglycan,42676,-0.0465210449357082,0.00456073437212524,-0.0554600843050737,-0.0375820055663427,2.42179192742392e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SRPK2,SRSF protein kinase 2,42594,-0.084224537741636,0.00826614545211367,-0.100426182827779,-0.0680228926554932,2.71988915505768e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD248,Endosialin,40527,0.0416092513949026,0.00408533023329196,0.0336020041376503,0.0496164986521548,2.94135954142767e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TDRKH,Tudor and KH domain-containing protein,42311,-0.0855462201408723,0.00840374174938554,-0.102017553969668,-0.0690748863120766,3.0114760082203e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,0.0217568899645631,0.00214189842631691,0.0175587690489819,0.0259550108801442,3.75668248571745e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOS1,"Nitric oxide synthase, brain",42311,-0.0549368500445684,0.00541304828221333,-0.0655464246777065,-0.0443272754114303,4.11102780611294e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,-0.027746328736124,0.00273574896350104,-0.033108396704586,-0.022384260767662,4.37499078563316e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASAH1,Acid ceramidase,40418,-0.0463928758937011,0.00457380761507294,-0.0553575388192441,-0.0374282129681582,4.51298586843792e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MIA,Melanoma-derived growth regulatory protein,42679,-0.0380148598540363,0.00375196686594646,-0.0453687149112913,-0.0306610047967812,4.85823346258848e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSCAM,Down syndrome cell adhesion molecule,40482,-0.0367862656935536,0.0036298240607247,-0.043900720852574,-0.0296718105345332,4.92341935824887e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNAP29,Synaptosomal-associated protein 29,42679,-0.0915181320249142,0.00904674888410705,-0.109249759837764,-0.0737865042120643,5.70546005089222e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARF6,ADP-ribosylation factor 6,40449,-0.108430157439034,0.010714813685292,-0.129431192262207,-0.0874291226158622,5.72380837316729e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,-0.0635858146639926,0.00628649611650147,-0.0759073470523355,-0.0512642822756497,5.79460975446934e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,-0.0366347552333013,0.00362923856062109,-0.0437480628121186,-0.0295214476544839,7.1337303690357e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINH1,Serpin H1,40302,-0.130391493402498,0.0129217168861126,-0.155718058499279,-0.105064928305717,7.67970889684645e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP1,Interstitial collagenase,42136,-0.0919282599598278,0.00911457651339048,-0.109792829926073,-0.0740636899935824,7.81517574779526e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLIT2,Slit homolog 2 protein,42311,-0.0527932544242262,0.00523743330614843,-0.0630586237042771,-0.0425278851441753,8.26990778492245e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,QDPR,Dihydropteridine reductase,42581,-0.0426367882141538,0.0042318161828159,-0.0509311479324729,-0.0343424284958346,8.6366007526365e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZBP1,Z-DNA-binding protein 1,40199,-0.0404178764957868,0.00401464415327142,-0.0482865790361988,-0.0325491739553748,9.73192105637378e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40451,-0.0795470801764793,0.00790738633652666,-0.0950455573960716,-0.0640486029568871,1.04683814118621e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,-0.0450761361130435,0.00449020664196354,-0.053876941131292,-0.0362753310947949,1.24748040535862e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNMBP,Dynamin-binding protein,42495,-0.0596758432553273,0.00594744750583535,-0.0713328403667646,-0.0480188461438901,1.31279998191974e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSB,Cathepsin B,42659,0.0537997299601569,0.00536209563972726,0.0432900225062915,0.0643094374140223,1.31656389856998e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42587,-0.0392490054670935,0.00391411844935241,-0.0469206776278243,-0.0315773333063628,1.39694485360117e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,-0.0429571864218366,0.00428534199271843,-0.0513564567275647,-0.0345579161161085,1.44904778020799e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL4,C-C motif chemokine 4,42642,-0.0683157153626273,0.00681773741574965,-0.0816784806974966,-0.054952950027758,1.50140335342108e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40483,-0.032687808574809,0.00326274121545283,-0.0390827813570965,-0.0262928357925214,1.584731107401e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1RL2,Interleukin-1 receptor-like 2,42370,-0.0383882447469063,0.00383343700079833,-0.045901781268471,-0.0308747082253416,1.60467681350769e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSN,Gelsolin,40488,0.0195091702972707,0.00195050492189635,0.0156861806503538,0.0233321599441875,1.86752568742436e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA10,Annexin A10,42311,-0.0860751024942124,0.0086096694969647,-0.102950054708263,-0.0692001502801616,1.89621302483706e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,0.0648473429998118,0.00649606789089093,0.0521150499336655,0.077579636065958,2.19131379822367e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBP7,Retinoid-binding protein 7,40449,-0.0601635541186213,0.0060271834797791,-0.0719768337389883,-0.0483502744982543,2.28462186910902e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPAN8,Tetraspanin-8,40449,-0.102651330831819,0.0102881621819812,-0.122816128708503,-0.0824865329551363,2.38772699147848e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTN1,Dynactin subunit 1,42721,-0.0639819870936348,0.00641588340362408,-0.076557118564738,-0.0514068556225316,2.42256449109372e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YES1,Tyrosine-protein kinase Yes,42587,-0.112200363603411,0.0112572274710357,-0.134264529446641,-0.0901361977601812,2.56350817006167e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNXB,Tenascin-X,42611,0.0256009977621338,0.00256952726032324,0.0205647243319002,0.0306372711923673,2.65787299652435e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLSTN3,Calsyntenin-3,40483,-0.0306478711503554,0.00307623592200195,-0.0366772935574792,-0.0246184487432316,2.76686627458876e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGLC2,Immunoglobulin lambda constant 2,40519,-0.0253022885756943,0.00253981474482136,-0.0302803254755441,-0.0203242516758444,2.7794623234318e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL8,Interleukin-8,42494,-0.069001414876845,0.00694502728694221,-0.0826136683592517,-0.0553891613944383,3.51777100079134e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,0.0251847317036108,0.00254086157800973,0.0202046430107117,0.0301648203965099,4.42797606087656e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NIT2,Omega-amidase NIT2,40462,-0.0724467705632981,0.00730985752712658,-0.0867740913164662,-0.05811944981013,4.64109186751637e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42635,-0.0370676113803582,0.00374873988670644,-0.0444151415583029,-0.0297200812024136,5.62070974290784e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACAN,Aggrecan core protein,42488,0.0273910511063595,0.00277360295245957,0.0219547893195387,0.0328273128931802,6.36802426795865e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARF1,Scavenger receptor class F member 1,42794,-0.0411311258361856,0.0041659952284519,-0.0492964764839513,-0.0329657751884198,6.50498528392205e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TREML2,Trem-like transcript 2 protein,42611,-0.0341182910878979,0.00345844936039997,-0.0408968518342818,-0.0273397303415139,7.04829781460217e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS22,Brain-specific serine protease 4,40199,-0.0362113539263894,0.00367052715958115,-0.0434055871591685,-0.0290171206936104,7.31180898372432e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,-0.0240498242540504,0.00244025368303601,-0.028832721472801,-0.0192669270352998,7.76404891334569e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,-0.0289628043887819,0.00293935609701659,-0.0347239423389344,-0.0232016664386294,7.90646682878462e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MATN2,Matrilin-2,42638,-0.0290596979077114,0.00295093230679346,-0.0348435252290266,-0.0232758705863962,8.38177176998837e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCXR,L-xylulose reductase,42679,-0.0513584817734869,0.00521951106869977,-0.0615887234681385,-0.0411282400788354,9.05870626108175e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42495,-0.0576011668512339,0.00585404190756951,-0.0690750889900701,-0.0461272447123977,9.09476572669177e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C19orf12,Protein C19orf12,42311,-0.0621871788597066,0.00633239071004372,-0.0745986646513923,-0.0497756930680209,1.10025086784568e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTK7,Inactive tyrosine-protein kinase 7,42311,-0.0374318951514276,0.00381257023835567,-0.0449045328186047,-0.0299592574842505,1.1273246057547e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CIT,Citron Rho-interacting kinase,40182,-0.0445847385123025,0.00454560316622491,-0.0534941207181033,-0.0356753563065017,1.28378449277098e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,42346,-0.0483282372529963,0.0049319295020249,-0.0579948190769651,-0.0386616554290275,1.3579192345035e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFC,Platelet-derived growth factor C,42346,-0.0278556168743269,0.00284313263932688,-0.0334281568474076,-0.0222830769012462,1.37867888796091e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42754,-0.0534951240554266,0.00546491284162723,-0.064206353225016,-0.0427838948858372,1.49334252189977e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNGR1,Interferon gamma receptor 1,42676,-0.0213893969454029,0.00218660310614012,-0.0256751390334376,-0.0171036548573683,1.59820992977959e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,-0.0251538565638652,0.00257476424646646,-0.0302003944869394,-0.0201073186407909,1.87906748558277e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGN,Secretagogin,42370,-0.0439312791165879,0.00450287354136455,-0.0527569112576624,-0.0351056469755134,2.06499189346293e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,-0.0477481641448978,0.00490916664836629,-0.0573701307756957,-0.0381261975140998,2.86100039364146e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC27,Cell division cycle protein 27 homolog,42346,-0.0582294540482229,0.00599146205578029,-0.0699727196775523,-0.0464861884188935,2.9805311897666e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NBN,Nibrin,42370,-0.0516222883771852,0.00531774713092317,-0.0620450727537946,-0.0411995040005758,3.32286885493227e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL19,C-C motif chemokine 19,42711,-0.126580835704989,0.0130458198235833,-0.152150642559212,-0.101011028850765,3.46557618671142e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42569,-0.0246177426274167,0.00253898146244576,-0.0295941462938104,-0.019641338961023,3.71195259821105e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,-0.0626297562256823,0.00646239973760648,-0.075296059711391,-0.0499634527399736,3.87139278405176e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,42346,-0.0604753016310599,0.00625139782216733,-0.0727280413625079,-0.048222561899612,4.61094316322814e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLSCR3,Phospholipid scramblase 3,40457,-0.0561027809268951,0.00579769317774991,-0.067466259555285,-0.0447393022985053,4.61334733892693e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YOD1,Ubiquitin thioesterase OTU1,40116,-0.061427604745643,0.00634900206701973,-0.0738716487970017,-0.0489835606942843,4.71352297222052e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HYOU1,Hypoxia up-regulated protein 1,42794,-0.0222483257392389,0.00230313666051262,-0.0267624735938436,-0.0177341778846341,5.24607112884358e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD6,T-cell differentiation antigen CD6,42746,-0.050697893808238,0.00524893320840995,-0.0609858028967215,-0.0404099847197545,5.31600153231575e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C7,Complement component C7,40251,-0.0319012540789807,0.00330567198351343,-0.038380371166667,-0.0254221369912944,5.97218217149315e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA12,Carbonic anhydrase 12,42587,-0.0318727353357769,0.003304414814961,-0.0383493883731005,-0.0253960822984534,6.05293592527131e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17C,Interleukin-17C,42370,-0.0716982046230951,0.00743803509406468,-0.0862767534074619,-0.0571196558387283,6.43822563744873e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,-0.0510875443826324,0.00530384778416754,-0.0614830860396008,-0.040692002725664,6.8862763571499e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTA,Lymphotoxin-alpha,42594,-0.039127901071945,0.00406454282745625,-0.0470944050137592,-0.0311613971301307,7.26326120182695e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RALY,RNA-binding protein Raly,40451,-0.0456889747099483,0.00475919820550375,-0.0550170031927357,-0.036360946227161,9.67018417958424e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SWAP70,Switch-associated protein 70,40449,-0.0342551296270227,0.00357683700604263,-0.0412657301588662,-0.0272445290951791,1.208733363954e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R9B,Neurabin-2,42754,-0.0889712123136953,0.00929569276337046,-0.107190770129901,-0.0707516544974892,1.2364670342039e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK10,Kallikrein-10,42636,-0.0386823628954103,0.004042622081416,-0.0466059021749856,-0.0307588236158349,1.26945924863221e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST7,Cystatin-F,42642,-0.0895411783972359,0.00935948957213042,-0.107885777958612,-0.0711965788358603,1.29082464017274e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNL1,Interferon lambda-1,42311,-0.0437005913381553,0.00457116389745323,-0.0526600725771637,-0.034741110099147,1.38376997970966e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSE,Cathepsin E,40283,-0.0492316199145836,0.00514891641748463,-0.0593234960928535,-0.0391397437363137,1.40489974725617e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PQBP1,Polyglutamine-binding protein 1,42346,-0.0542441579117017,0.00567599621122268,-0.0653691104856982,-0.0431192053377053,1.42758160968338e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INHBB,Inhibin beta B chain,40283,-0.0524392936926567,0.00548769217822873,-0.063195170361985,-0.0416834170233284,1.48446064375929e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,42311,-0.0576378975259624,0.00603803933951509,-0.069472454631412,-0.0458033404205128,1.58653951875452e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,-0.0545724133910573,0.00571967197271839,-0.0657829704575853,-0.0433618563245292,1.65463741648116e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC16A1,Monocarboxylate transporter 1,42311,-0.0546908609800115,0.00573289942314663,-0.0659273438493788,-0.0434543781106441,1.67993269988614e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,42370,-0.0655827581317868,0.0068762989916009,-0.0790603041553246,-0.052105212108249,1.71639791958977e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,-0.103959415971848,0.0108985592116719,-0.125320592026725,-0.0825982399169711,1.74273623658873e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,-0.0564519398685795,0.00592110705360069,-0.0680573096936369,-0.0448465700435222,1.7747147261571e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,-0.0650646800260462,0.00683363965647172,-0.0784586137527308,-0.0516707462993617,2.00041406516902e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,-0.0802239848738421,0.00845626535080113,-0.0967982649614124,-0.0636497047862719,2.77307288716294e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AP3B1,AP-3 complex subunit beta-1,40449,-0.0725458615183811,0.00765047594478365,-0.087540794370157,-0.0575509286666051,2.97915009773021e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POSTN,Periostin,40527,0.0366360787400651,0.00386429789974675,0.0290620548565614,0.0442101026235687,3.02890637240402e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CR2,Complement receptor type 2,42689,-0.0452536740716579,0.00478394925012885,-0.0546302146019104,-0.0358771335414053,3.59909294812819e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VAMP5,Vesicle-associated membrane protein 5,42357,-0.0524803202580623,0.00555613041239058,-0.0633703358663479,-0.0415903046497768,4.12619479144139e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,-0.0907921200988561,0.00963591176224719,-0.109678507152861,-0.0719057330448516,5.12779450936007e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VEGFB,Vascular endothelial growth factor B,40199,-0.0279275639032699,0.00297133230487064,-0.0337513752208163,-0.0221037525857234,6.59663532494024e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTBS,Di-N-acetylchitobiase,40383,-0.0252823920462157,0.00269103010614927,-0.0305568110542682,-0.0200079730381631,6.82626949545635e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,-0.040414485446455,0.00430576798983955,-0.0488537907065405,-0.0319751801863694,7.23155570580063e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LIFR,Leukemia inhibitory factor receptor,42594,-0.0225711571783279,0.00240613125690462,-0.027287174441861,-0.0178551399147948,7.59327420437602e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD22,B-cell receptor CD22,42754,-0.0406948336596651,0.0043412537868303,-0.0492036910818525,-0.0321859762374777,8.07420726244695e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,40223,-0.0678336825644466,0.00724000259550962,-0.0820240876516455,-0.0536432774772478,8.72223132721137e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GZMH,Granzyme H,42357,-0.0728025636528258,0.00777366790682538,-0.0880389527502035,-0.057566174555448,8.80163350856345e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPK9,Mitogen-activated protein kinase 9,42594,-0.0392206342107233,0.00418877261430082,-0.0474306285347529,-0.0310106398866937,8.94552725191744e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,-0.0527050856745055,0.00562995101717438,-0.0637397896681673,-0.0416703816808437,9.08999092210091e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,-0.0542407424273746,0.00579469995843993,-0.0655983543459168,-0.0428831305088323,9.21435995716391e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGAL,Integrin alpha-L,40199,-0.0418195775453214,0.00447672362704499,-0.0505939558543295,-0.0330451992363132,1.1319471734608e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLAMF6,SLAM family member 6,42346,-0.0361411376211956,0.00387343960323769,-0.0437330792435415,-0.0285491959988497,1.22021477481899e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42565,-0.0402580322809805,0.00431625551932963,-0.0487178930988666,-0.0317981714630944,1.25705623260963e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM24,Transcription intermediary factor 1-alpha,40287,-0.0606363340156871,0.00650593817236939,-0.0733879728335311,-0.0478846951978431,1.38121584150417e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,-0.0215565848665057,0.00231567433856506,-0.0260953065700932,-0.0170178631629182,1.48825324823587e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JUN,Transcription factor AP-1,42370,-0.0444023397697686,0.00476980756916205,-0.0537511626053262,-0.035053516934211,1.49136699387608e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,-0.0402877341436922,0.00432952540407756,-0.0487736039356843,-0.0318018643517002,1.5394037923782e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGMN,Legumain,42676,-0.0330788892097471,0.00355745271773508,-0.0400514965365078,-0.0261062818829863,1.6408155455804e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40532,-0.0609252091695883,0.0065572103691646,-0.0737773414931509,-0.0480730768460257,1.80114642140457e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,-0.0661148906905625,0.00713553931915941,-0.080100547756115,-0.0521292336250101,2.23435741835334e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP6,Gastrotropin,42334,-0.0545238599942532,0.00588482964048432,-0.0660581260896025,-0.042989593898904,2.24701945688301e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSV,Cathepsin L2,42677,0.0386497785636493,0.00417204379385148,0.0304725727277004,0.0468269843995982,2.26329271161357e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNDP1,Beta-Ala-His dipeptidase,42689,0.0425873029432973,0.00460084423218734,0.0335696482482102,0.0516049576383845,2.42844658216817e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LY96,Lymphocyte antigen 96,42495,-0.0329194865409231,0.00355638283217699,-0.03988999689199,-0.0259489761898562,2.43240294527742e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42711,-0.021478183310742,0.00232123872266536,-0.0260278112071661,-0.0169285554143178,2.5085520708884e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD276,CD276 antigen,42618,-0.0339316419255141,0.00366753707578899,-0.0411200145940605,-0.0267432692569677,2.53462078817511e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH15,Cadherin-15,42692,-0.0573939691036281,0.0062073750938523,-0.0695604242875786,-0.0452275139196776,2.67286439890791e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH9,Protocadherin-9,40449,-0.0319373761435423,0.0034589300233339,-0.0387168789892767,-0.0251578732978078,3.09275126443865e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP85,Centrosomal protein of 85 kDa,42346,-0.0587521520144364,0.00636625076027898,-0.0712300035045832,-0.0462743005242896,3.15289960596188e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42676,-0.026115448862678,0.00283019862161903,-0.0316626381610513,-0.0205682595643047,3.17915778446232e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK4,Kallikrein-4,42721,-0.0584012514111595,0.0063399383129738,-0.0708275305045882,-0.0459749723177309,3.67820958325623e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNN,Tenascin-N,40527,-0.0407236578950328,0.00442147397371918,-0.0493897468835224,-0.0320575689065432,3.81833503457489e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,-0.0560701162540148,0.00609047844496916,-0.0680074540061544,-0.0441327785018753,3.97164581167817e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA3G,Semaphorin-3G,40283,-0.0414249224837954,0.00450488133499719,-0.0502544899003899,-0.0325953550672009,4.39585087919577e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42587,-0.0198949004865913,0.0021682250863021,-0.0241446216557435,-0.0156451793174392,5.13616078322914e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42611,-0.0888965849020091,0.00969090749171182,-0.107890763585764,-0.0699024062182539,5.25309846413062e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASAH2,Neutral ceramidase,42495,-0.0486680827902424,0.00532094633823984,-0.0590971376131925,-0.0382390279672924,6.72428264771967e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1R1,Interleukin-1 receptor type 1,42590,-0.0214482232730694,0.00234631748911411,-0.026047005551733,-0.0168494409944057,7.05210611010065e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP8,Neutrophil collagenase,42681,-0.0664561613579736,0.00727322990184813,-0.0807116919655959,-0.0522006307503512,7.31884396519401e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IDS,Iduronate 2-sulfatase,42754,0.0079571906876213,0.000871286497569446,0.00624946915238519,0.00966491222285742,7.61526959191474e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAMDC2,MAM domain-containing protein 2,40511,-0.0335063054595513,0.00366785380271307,-0.0406952989128689,-0.0263173120062337,7.64169567664521e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,-0.0418039446735223,0.00458052665403833,-0.0507817769154374,-0.0328261124316072,8.29876628773725e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALB1,Calbindin,42587,-0.041551563532728,0.00455469123742366,-0.0504787583580783,-0.0326243687073776,8.35204701335691e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INSL5,Insulin-like peptide INSL5,40449,-0.090220244128175,0.0099013531698289,-0.10962689634104,-0.0708135919153104,9.46116772408714e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRK1,NKG2-D type II integral membrane protein,40483,-0.0446452282995483,0.00490308935647128,-0.054255283438232,-0.0350351731608646,1.0025180370329e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL2L15,Bcl-2-like protein 15,40199,-0.0514358350703968,0.00565228895156777,-0.0625143214154696,-0.0403573487253239,1.0587007971131e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,-0.026286533446235,0.00289025941752815,-0.0319514419045902,-0.0206216249878799,1.07971104334923e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DRAXIN,Draxin,42495,-0.0396941265603729,0.00436760686221525,-0.0482546360103147,-0.031133617110431,1.14653750170538e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIMAP8,GTPase IMAP family member 8,40080,-0.0481660128357831,0.00530410069375232,-0.0585620501955376,-0.0377699754760285,1.26254115684658e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,-0.0730620965115053,0.00805392391364377,-0.0888477873822471,-0.0572764056407636,1.36667320138191e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QA,Complement C1q subcomponent subunit A,42701,-0.0198910596561274,0.00219552970583616,-0.0241942978795663,-0.0155878214326885,1.48418460646671e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,-0.12541124940482,0.0138456302406847,-0.152548684676562,-0.0982738141330783,1.54991143468426e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,-0.0249461227169017,0.00275425598953374,-0.0303444644563878,-0.0195477809774155,1.56323302733907e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42689,-0.0250068435315389,0.0027657572202807,-0.0304277276832891,-0.0195859593797887,1.75198003094192e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGFLAM,Pikachurin,40449,-0.0281539730114659,0.00311461634442285,-0.0342586210465347,-0.0220493249763971,1.83400848755285e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,-0.0641684434515827,0.00711034813206262,-0.0781047257904255,-0.05023216111274,2.04959635989925e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLAMF7,SLAM family member 7,42594,-0.0534249811146442,0.00592958263708738,-0.0650469630833355,-0.041802999145953,2.33799582891476e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRTAC1,Cartilage acidic protein 1,42794,0.0268732222593047,0.00298370230576947,0.0210251657399965,0.0327212787786128,2.4031510020828e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BOLA1,BolA-like protein 1,40136,-0.0490118649858696,0.00544545162123751,-0.0596849501634951,-0.0383387798082441,2.61771081143706e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A12,Protein S100-A12,42434,-0.0675142559281231,0.00750876708594697,-0.0822314394165792,-0.0527970724396671,2.76886771388823e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHRDL2,Chordin-like protein 2,42636,-0.0423722736543776,0.00471529864777414,-0.0516142590040149,-0.0331302883047403,2.89836820307806e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DBI,Acyl-CoA-binding protein,42562,-0.0680673974085828,0.00757610674440076,-0.0829165666276083,-0.0532182281895573,2.94379349289494e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYN,Tyrosine-protein kinase Lyn,42587,-0.0747574346456514,0.00834238990425927,-0.0911085188579996,-0.0584063504333033,3.63303407526435e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,-0.0393194559668247,0.00439603369297931,-0.0479356820050641,-0.0307032299285852,4.34138123679708e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRSF1,G-rich sequence factor 1,40014,-0.0723679535673186,0.00812109222311708,-0.088285294324628,-0.0564506128100091,5.86192418717528e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,P4HB,Protein disulfide-isomerase,42563,-0.0338380330016686,0.0038020364673825,-0.0412900244777383,-0.0263860415255989,6.29681529071241e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,-0.0193247423133167,0.00217202016407574,-0.0235819018349051,-0.0150675827917282,6.61956458874824e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,-0.0562513961739292,0.00632511260085866,-0.0686486168716122,-0.0438541754762462,6.82771107964803e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNG,Interferon gamma,42370,-0.0997816558257901,0.0112474734398718,-0.121826703767939,-0.0777366078836414,8.13898333741211e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS8,Galectin-8,42711,-0.0527118935747743,0.00594261652105392,-0.06435942195604,-0.0410643651935087,8.21096601112383e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MILR1,Allergin-1,42370,-0.0454894007578872,0.00513029047421175,-0.0555447700873422,-0.0354340314284322,8.48355406101806e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LONP1,"Lon protease homolog, mitochondrial",40223,-0.0770479907596703,0.00868849741890122,-0.0940774457007167,-0.060018535818624,8.60661388480216e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTSS2,Protein MTSS 2,40451,-0.0875238604774022,0.0098719703941804,-0.106872922449996,-0.0681747985048086,8.72994890835361e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BACH1,Transcription regulator protein BACH1,42594,-0.0641590112249916,0.00724974727023554,-0.0783685158746533,-0.04994950657533,9.85238730133669e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17A,Interleukin-17A,42347,-0.0380395003250321,0.0043012717664898,-0.0464699929873521,-0.0296090076627121,1.0420217684269e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAG4,BAG family molecular chaperone regulator 4,40199,-0.0433929536473694,0.00490631976493547,-0.0530093403866429,-0.0337765669080958,1.06144086086704e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,-0.0632555056865141,0.00715336708958257,-0.0772761051820959,-0.0492349061909323,1.07266334295834e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,-0.0349261841417598,0.00395204310227319,-0.0426721886222152,-0.0271801796613043,1.09957090790873e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDHR2,Cadherin-related family member 2,42587,-0.0621251057312112,0.00703014480032982,-0.0759041895398577,-0.0483460219225648,1.10487738741657e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMP3,Metalloproteinase inhibitor 3,42676,-0.114337544849483,0.012963179927632,-0.139745377507642,-0.0889297121913248,1.28162177238091e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,-0.0331182824372395,0.00375468700365408,-0.0404774689644015,-0.0257590959100775,1.3123996735043e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL18,C-C motif chemokine 18,42477,-0.0612380651217211,0.00695061307702745,-0.0748612667526949,-0.0476148634907473,1.39949535710465e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17RB,Interleukin-17 receptor B,42416,0.0468318743244051,0.00531656943017467,0.0364113982412628,0.0572523504075475,1.42265950698173e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,-0.0424163738551821,0.00481420860617599,-0.051852222723287,-0.0329805249870771,1.42567752361896e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THBD,Thrombomodulin,42636,-0.0265623473314551,0.00301654072871048,-0.0324747671597276,-0.0206499275031825,1.45951653591581e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,-0.0608689755135286,0.00691677035389058,-0.0744258454071541,-0.0473121056199031,1.5640525981106e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNPEP,Aspartyl aminopeptidase,40483,-0.0504532131715613,0.00573537712358697,-0.0616945523337918,-0.0392118740093308,1.61123417417733e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,-0.0562882543749967,0.00641046572596681,-0.0688527671978916,-0.0437237415521017,1.85942445001759e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RFC4,Replication factor C subunit 4,40451,-0.0185871885566582,0.00211959741039487,-0.0227415994810321,-0.0144327776322842,2.05753538183105e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP43,Centrosomal protein 43,42255,-0.0604313483368802,0.00689842702584267,-0.0739522653075318,-0.0469104313662285,2.18771504838456e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40449,-0.0412486634068068,0.00470768698779148,-0.0504757299028781,-0.0320215969107355,2.19294046348313e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DKK1,Dickkopf-related protein 1,42711,-0.0510420211049693,0.00583047749926906,-0.0624697570035367,-0.0396142852064019,2.29396601787661e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40449,-0.0723906291246345,0.00827255774825964,-0.0886048423112234,-0.0561764159380456,2.42212893711567e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SARG,Specifically androgen-regulated gene protein,40456,-0.0950935149152413,0.0108693492271657,-0.116397439400486,-0.0737895904299966,2.46315491487754e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NSFL1C,NSFL1 cofactor p47,42711,-0.0562943308697477,0.00644081837778072,-0.068918334890198,-0.0436703268492975,2.59737725138461e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C3,Complement C3,39989,-0.041319516407572,0.00473223597249041,-0.0505946989136532,-0.0320443339014908,2.88355730213749e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPPK1,Epiplakin,40223,-0.0635147979067895,0.00728015891835788,-0.0777839093867709,-0.049245686426808,3.06091704431696e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JAM3,Junctional adhesion molecule C,40283,-0.0442980798399029,0.00509325690610572,-0.0542808633758701,-0.0343152963039356,3.87422518514417e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,40182,-0.0561459995295493,0.00646188319057134,-0.0688112905830691,-0.0434807084760295,4.18184584811323e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,-0.0256093873811131,0.00295098873226742,-0.0313933252963573,-0.019825449465869,4.56763237475681e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNM3,Dynamin-3,40482,-0.0477025558811265,0.00550033196720403,-0.0584832065368464,-0.0369219052254066,4.79769801119093e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH3BP1,SH3 domain-binding protein 1,40449,-0.0416125466498095,0.00479849803062497,-0.0510176027898344,-0.0322074905097846,4.8278207034803e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL32,Interleukin-32,42594,0.0382121744461574,0.00440863726863329,0.0295712453996362,0.0468531034926787,4.91628728348235e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DHPS,Deoxyhypusine synthase,40451,-0.0352107068499827,0.0040612832621278,-0.0431708220437532,-0.0272505916562122,4.91897955244815e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,-0.0525849806834194,0.0060678952846217,-0.0644780554412779,-0.0406919059255608,4.97918178599466e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX4,Syntaxin-4,42587,-0.0512540520438412,0.00591623103059554,-0.0628498648638084,-0.0396582392238739,5.1035411963158e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,-0.0586186283712928,0.00677223738126179,-0.0718922136385659,-0.0453450431040197,5.5633773208753e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STK11,Serine/threonine-protein kinase STK11,42357,-0.0625338797520131,0.00722848228862618,-0.0767017050377204,-0.0483660544663057,5.68982388076417e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OMD,Osteomodulin,42676,0.0364197223212374,0.00421915709951857,0.028150174406181,0.0446892702362938,6.69896412793017e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCAN,Neurocan core protein,42711,0.0326906038342621,0.00378818521096489,0.025265760820771,0.0401154468477533,6.83652630217616e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LY75,Lymphocyte antigen 75,42594,-0.0334732173443732,0.00388120863157247,-0.0410803862622552,-0.0258660484264911,7.158513895826e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42521,-0.0498523554484276,0.00578273104988574,-0.0611865083062036,-0.0385182025906515,7.38567376834394e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,-0.0617987276917051,0.00716998932955028,-0.0758519067776236,-0.0477455486057865,7.51384023731366e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMP4,Metalloproteinase inhibitor 4,42611,0.0353785072622363,0.00410694428479928,0.0273288964640297,0.0434281180604429,7.81490233257074e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NT5E,5'-nucleotidase,42679,-0.04838930628804,0.00563287109137212,-0.0594297336271294,-0.0373488789489507,9.59969614889372e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,-0.0327892475900928,0.00381819056418014,-0.0402729010958858,-0.0253055940842997,1.0040837326717e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPE,Carboxypeptidase E,42588,0.0330373007170565,0.00385092692538675,0.0254894839432985,0.0405851174908145,1.06085774326547e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TARBP2,RISC-loading complex subunit TARBP2,42311,-0.0665238554748469,0.00776338402902068,-0.0817400881717274,-0.0513076227779664,1.16037151311155e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CILP,Cartilage intermediate layer protein 1,40527,-0.0474121477439415,0.00553785931678402,-0.0582663520048382,-0.0365579434830448,1.25811424983918e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH3GLB2,Endophilin-B2,40483,-0.0571057478344361,0.00667542526592325,-0.0701895813556457,-0.0440219143132266,1.33505098119858e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNLR1,Interferon lambda receptor 1,42594,-0.0309725491627799,0.00362300968678779,-0.038073648148884,-0.0238714501766758,1.37675135595313e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,-0.0320348581503162,0.00374645394904646,-0.0393779078904472,-0.0246918084101851,1.38346436405347e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNLY,Granulysin,42611,-0.0455455856744402,0.0053329961620467,-0.0559982581520517,-0.0350929131968286,1.48122100851676e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX8,Syntaxin-8,42594,-0.0405984246839726,0.00475397302589176,-0.0499162118147205,-0.0312806375532248,1.48707621903991e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GDF2,Growth/differentiation factor 2,42636,0.0305651033268365,0.00358089193159269,0.0235465551409148,0.0375836515127582,1.54240547497775e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA9,Serpin A9,42538,-0.0611011214059457,0.00715834102733405,-0.0751314698195204,-0.047070772992371,1.5429873494416e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL1,Fc receptor-like protein 1,42636,-0.0400772020276808,0.00469552705015718,-0.0492804350459889,-0.0308739690093728,1.5480504827537e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STC2,Stanniocalcin-2,42591,-0.0211465370783578,0.00247818768509156,-0.0260037849411373,-0.0162892892155784,1.57709785372892e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,-0.0388235791863191,0.00455131869556504,-0.0477441638296266,-0.0299029945430117,1.61672868671779e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA3,Carbonic anhydrase 3,42770,-0.0507396161189159,0.00595245442807429,-0.0624064267979415,-0.0390728054398903,1.70045377373502e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMOX1,Heme oxygenase 1,42500,0.0411224134951577,0.00482920057668852,0.0316571803648482,0.0505876466254672,1.83736922342683e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFD,Complement factor D,40539,-0.0179335797397549,0.00210581638097383,-0.0220609798464636,-0.0138061796330463,1.8561204599797e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDIA3,Protein disulfide-isomerase A3,40283,-0.0211879131155611,0.00248812116728795,-0.0260646306034455,-0.0163111956276768,1.87054500726177e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,-0.0999424749990749,0.0117382688809597,-0.122949482005756,-0.0769354679923939,1.8895124165112e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,-0.0828875838082939,0.00973667258442647,-0.10197146207377,-0.063803705542818,1.91028677610023e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TEK,Angiopoietin-1 receptor,42679,-0.0185800850613426,0.00218776784610874,-0.0228681100397157,-0.0142920600829695,2.22820225749869e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,40223,-0.0444862934483815,0.00523694756739908,-0.0547507106804837,-0.0342218762162793,2.2391762779283e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,-0.0441881244721548,0.00520772450902344,-0.0543952645098407,-0.0339809844344688,2.38388327004919e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASGR2,Asialoglycoprotein receptor 2,40532,-0.0229809422899151,0.00271035515207494,-0.028293238387982,-0.0176686461918482,2.55363077192844e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA5,Annexin A5,42261,-0.0259623104026892,0.00306668506903017,-0.0319730131379884,-0.0199516076673901,2.81046096499088e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MERTK,Tyrosine-protein kinase Mer,42754,-0.0215724516382408,0.00254850445083627,-0.0265675203618799,-0.0165773829146018,2.82834903249992e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL16,C-X-C motif chemokine 16,42778,-0.0201534082246289,0.00238285446492112,-0.0248238029758743,-0.0154830134733835,3.00380066537532e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,-0.0367611860829175,0.00434642817679559,-0.0452801853094369,-0.0282421868563982,3.01028519786585e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,-0.0644557614873033,0.00762400410796135,-0.0793988095389076,-0.0495127134356991,3.09522627157013e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDHR5,Cadherin-related family member 5,42636,-0.0326624478391394,0.00386407432710683,-0.0402360335202688,-0.02508886215801,3.13305924348432e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,-0.0250145291973883,0.00295876967413583,-0.0308137177586946,-0.0192153406360821,3.14961351487929e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,-0.0795426529723284,0.00942036180785065,-0.0980065621157157,-0.0610787438289411,3.39418556670737e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TLR1,Toll-like receptor 1,40199,-0.0227020996039748,0.00269291069247952,-0.0279802045612346,-0.0174239946467149,3.87681211611274e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FYB1,FYN-binding protein 1,42590,-0.0767040165434724,0.00911183565958826,-0.0945632144362653,-0.0588448186506794,4.21325958943907e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPPB,Natriuretic peptides B,42357,-0.119405169758587,0.0141881663068356,-0.147213975719985,-0.0915963637971894,4.30125152892552e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F7,Coagulation factor VII,42671,-0.0259857038217155,0.00309104005798295,-0.0320441423353621,-0.019927265308069,4.63373593554915e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHGB,Secretogranin-1,42664,-0.0359856256140964,0.00428395674958664,-0.0443821808432863,-0.0275890703849066,4.90438768543208e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42658,-0.0584961358189596,0.00696883130063193,-0.0721550451681982,-0.044837226469721,5.16568218451978e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC3B,Tetranectin,40269,0.0177241344589164,0.00211180273284901,0.0135850011025324,0.0218632678153005,5.31962141046311e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,-0.0794275054361854,0.00947591512063348,-0.0980002990726271,-0.0608547117997438,5.72137865202038e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNRD2,Protein ZNRD2,40449,-0.0586046337863378,0.00699140317274781,-0.0723077840049235,-0.0449014835677521,5.80300899373197e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYH9,Myosin-9,40527,-0.0959489143290381,0.0114521146528184,-0.118395059048562,-0.073502769609514,6.00355052215288e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,42311,-0.0553970766454836,0.00662550722802617,-0.0683830708124149,-0.0424110824785523,6.83120482361711e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHA4,Ephrin type-A receptor 4,40283,-0.0245509614697131,0.00293644609806726,-0.0303063958219249,-0.0187955271175012,6.97499729314356e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,-0.056059309462025,0.00670581037263224,-0.0692026977923842,-0.0429159211316658,7.01786546140312e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,-0.0615813876217945,0.00737237361188971,-0.0760312399010984,-0.0471315353424907,7.4600112259422e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPP4,Dipeptidyl peptidase 4,42441,0.0235225456090683,0.0028182341581664,0.0179988066590622,0.0290462845590745,7.72006368034167e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCAM2,Neural cell adhesion molecule 2,42611,0.0225871621220654,0.00270759466489147,0.0172802765788782,0.0278940476652527,8.00213956342912e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPL,Periplakin,40199,-0.0279081167923296,0.00334832251777304,-0.0344708289271647,-0.0213454046574944,8.67423354809525e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GET3,ATPase GET3,40511,-0.0450948044664432,0.00541801197275813,-0.0557141079330491,-0.0344755009998372,9.55014324327223e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,-0.0350508450979545,0.00421335420015269,-0.0433090193302538,-0.0267926708656552,9.90944456107651e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SORT1,Sortilin,42613,-0.0306162037270183,0.00368298671400002,-0.0378348576864584,-0.0233975497675783,1.02332940815505e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRR3,Small proline-rich protein 3,40483,-0.0584561593856532,0.00704028014112791,-0.0722551084622639,-0.0446572103090425,1.12979421856514e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OLFM4,Olfactomedin-4,39870,-0.103164420804787,0.0124260276766347,-0.127519435050991,-0.0788094065585829,1.14457435601089e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH7,Protocadherin-7,40449,-0.03024017809415,0.00364534837930485,-0.0373850609175875,-0.0230952952707125,1.20383253116557e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,-0.0889046096398271,0.0107309335664132,-0.109937239429997,-0.0678719798496571,1.31558825984309e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHMP6,Charged multivesicular body protein 6,40511,-0.046424311477828,0.00560621613605757,-0.0574124951045009,-0.0354361278511552,1.36021572781759e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MB,Myoglobin,42794,-0.0439113527504756,0.00530423990419884,-0.0543076629627054,-0.0335150425382459,1.3624180224927e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFX1,Transcriptional repressor NF-X1,40116,-0.0563817517130111,0.0068108613279925,-0.0697310399158763,-0.0430324635101458,1.39599498385656e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,-0.074456418745936,0.00899653851114097,-0.0920896342277723,-0.0568232032640997,1.41553309519698e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,-0.0777781602591602,0.00940384189980126,-0.0962096903827707,-0.0593466301355498,1.45511596847774e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,-0.0977009038517781,0.0118263722330843,-0.120880593428623,-0.0745212142749328,1.57543658794171e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XG,Glycoprotein Xg,42734,-0.0284362565525685,0.0034447324344318,-0.0351879321240548,-0.0216845809810821,1.65870741839145e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLMP,CXADR-like membrane protein,42721,-0.0180853813066917,0.00219109360724484,-0.0223799247768916,-0.0137908378364918,1.67208251659747e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD164,Sialomucin core protein 24,42611,-0.022465580662833,0.00272194807730514,-0.0278005988943511,-0.0171305624313149,1.68096468749896e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESYT2,Extended synaptotagmin-2,40483,-0.0679315525334899,0.00823506680895241,-0.0840722834790366,-0.0517908215879432,1.77341808461221e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,-0.0627331216613116,0.00760701819482181,-0.0776428773231624,-0.0478233659994609,1.80848059046423e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERBIN,Erbin,42587,-0.0834566080276855,0.0101355077068682,-0.103322203133147,-0.0635910129222239,1.97588249335402e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,-0.0654538959259227,0.00795670699335689,-0.0810490416329022,-0.0498587502189432,2.14391127846743e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD14,Monocyte differentiation antigen CD14,42416,-0.0343231458062507,0.00417349934023568,-0.0425032045131127,-0.0261430870993888,2.14966371795369e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,-0.0384420423777629,0.00468057278509217,-0.0476159650365436,-0.0292681197189823,2.35625159333883e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,-0.0500913270268702,0.00610303155271908,-0.0620532688701996,-0.0381293851835408,2.4590472643717e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,40283,-0.0544461156649943,0.00663746861294639,-0.0674555541463692,-0.0414366771836194,2.60670838356078e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,-0.053853201909516,0.00657094228059273,-0.0667322487794778,-0.0409741550395543,2.72149426059064e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,-0.0432869150586346,0.00528147722147107,-0.0536386104127179,-0.0329352197045513,2.75453604200766e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP2,Microtubule-associated protein 2,40483,-0.0381566154642689,0.00465581649360934,-0.0472820157917433,-0.0290312151367946,2.76540883376166e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,-0.0776535882823501,0.00949129720909441,-0.0962565308121752,-0.0590506457525251,3.05135453856994e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,-0.0285864561662913,0.00349934125760654,-0.0354451650312001,-0.0217277473013824,3.44680132006281e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,-0.0651302664531267,0.00799074284121179,-0.0807921224219018,-0.0494684104843516,4.00931127949063e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCR,Breakpoint cluster region protein,42594,-0.0736258663669593,0.00904617489735898,-0.0913563691657829,-0.0558953635681357,4.33877039557168e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OTUD7B,OTU domain-containing protein 7B,40482,-0.0504219997329939,0.00620052561216927,-0.0625750299328456,-0.0382689695331421,4.6680062269541e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,-0.0245908432413895,0.0030265808161066,-0.0305229416409584,-0.0186587448418206,4.86779506955969e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACTA2,"Actin, aortic smooth muscle",42357,-0.0357843703231951,0.00440872076084708,-0.0444254630144554,-0.0271432776319348,5.21237575647379e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A11,Protein S100-A11,42531,-0.0369242777019056,0.00454976464549155,-0.045841816407069,-0.0280067389967421,5.2528662006038e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,-0.0572499806962222,0.0070796441504564,-0.0711260832311168,-0.0433738781613277,6.6613057085515e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PREB,Prolactin regulatory element-binding protein,42370,-0.0237256658850878,0.00293752747855605,-0.0294832197430577,-0.017968112027118,7.22688615779457e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,-0.030357360570114,0.00375943552344707,-0.0377258541960703,-0.0229888669441577,7.32100894229512e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLA2,Src-like-adapter 2,40482,-0.0837508576857531,0.0103899751200393,-0.10411520892103,-0.0633865064504762,8.34765144859874e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42611,0.0360001399888523,0.00446922891317072,0.0272404513190377,0.0447598286586669,8.60702134534544e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAX1BP1,Tax1-binding protein 1,40483,-0.0508644427577011,0.00632807161931999,-0.0632674631315683,-0.0384614223838339,1.00486584396802e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,40283,-0.0434366728923206,0.00540403697471106,-0.0540285853627542,-0.0328447604218869,1.00728618290473e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFDC1,WAP four-disulfide core domain protein 1,40229,-0.0456436718067619,0.00568012571852055,-0.0567767182150622,-0.0345106253984616,1.02539939950135e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC5A,C-type lectin domain family 5 member A,42603,-0.0242091584184233,0.00301510680418051,-0.0301187677546171,-0.0182995490822295,1.06166334338873e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,-0.0617967401787991,0.00769918997386556,-0.0768871525275756,-0.0467063278300226,1.0885433001408e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,-0.0302696775820672,0.00377837279872739,-0.0376752882675729,-0.0228640668965615,1.22835104905471e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFRC,Transferrin receptor protein 1,42673,-0.030218079332192,0.00378234756405097,-0.0376314805577319,-0.0228046781066521,1.46739979587525e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL17,C-C motif chemokine 17,42604,-0.0728397328350195,0.00913525950455371,-0.0907448414639448,-0.0549346242060942,1.66704072755036e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1R2,Interleukin-1 receptor type 2,42600,-0.0158281022266895,0.00198805743109656,-0.0197246947916387,-0.0119315096617402,1.83440209579932e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATG16L1,Autophagy-related protein 16-1,40449,-0.0673410302834306,0.00845650942291544,-0.0839157887523449,-0.0507662718145163,1.83732948065501e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,-0.0177303192377654,0.00222715074318226,-0.0220955346944027,-0.0133651037811282,1.84327180236589e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,-0.0225815061987174,0.00283834039115406,-0.0281446533653793,-0.0170183590320554,1.91925666269408e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,-0.0274850715422491,0.00345658869249631,-0.0342599853795419,-0.0207101577049563,1.98770585095861e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,-0.028088568354461,0.00353245840436457,-0.0350121868270156,-0.0211649498819064,2.02184805673622e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDLIM7,PDZ and LIM domain protein 7,42676,-0.0977366348485616,0.012298284060214,-0.121841271606581,-0.0736319980905423,2.058889851523e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42602,-0.0276294887622049,0.00348135503695025,-0.0344529446346274,-0.0208060328897824,2.24551783095787e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LUZP2,Leucine zipper protein 2,40451,-0.0366522286095496,0.00462483352224153,-0.045716902313143,-0.0275875549059562,2.49459143361174e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCK2,Cytoplasmic protein NCK2,42676,-0.0823857162907594,0.0104068624515639,-0.102783166695825,-0.0619882658856942,2.63334625414049e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYDGF,Myeloid-derived growth factor,40511,-0.077731234317367,0.00982946306937423,-0.0969969819333405,-0.0584654867013935,2.85885790074079e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL5,Fc receptor-like protein 5,42611,-0.046350395956818,0.00587701386609183,-0.057869343134358,-0.034831448779278,3.34099891982294e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42711,-0.0248410138179488,0.00315297035840373,-0.0310208357204201,-0.0186611919154775,3.56235669881184e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM2,Intercellular adhesion molecule 2,42794,-0.0255341634793426,0.0032410118389315,-0.0318865466836483,-0.0191817802750368,3.56509833126411e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL5,C-C motif chemokine 5,42689,-0.0780878839206641,0.00991534483828827,-0.0975219598037091,-0.0586538080376191,3.65324469793862e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,-0.0416614491161223,0.00529017848518312,-0.0520301989470812,-0.0312926992851634,3.71972256669657e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN5,Contactin-5,42640,0.0299057986496121,0.0037997427164556,0.0224583029253592,0.0373532943738651,3.80192271559823e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL1,Angiopoietin-related protein 1,42439,-0.0227816687208647,0.00290599021908282,-0.028477409550267,-0.0170859278914624,4.86570174884738e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40449,-0.0602959803185383,0.00769467857280608,-0.0753775503212382,-0.0452144103158384,5.067208157308e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTGES2,Prostaglandin E synthase 2,40102,-0.0428125664006636,0.00546460488359834,-0.0535231919725163,-0.0321019408288108,5.1433869638544e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,42370,-0.0466886054448487,0.0059655414750073,-0.058381066735863,-0.0349961441538344,5.40281416677746e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,-0.0477084475236799,0.00609659216410353,-0.0596577681653228,-0.035759126882037,5.43707547823045e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STIP1,Stress-induced-phosphoprotein 1,42586,-0.0502046265759225,0.00641723345047978,-0.0627824041388629,-0.0376268490129821,5.52500217772691e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,-0.0214496667009739,0.00274281838094704,-0.0268255907276301,-0.0160737426743177,5.73632065563235e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDA,Cytidine deaminase,40494,-0.0367883722848759,0.00470772014649929,-0.0460155037720145,-0.0275612407977373,6.00808322319417e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCAN,Brevican core protein,42495,0.0269636049491342,0.0034525314182508,0.0201966433693626,0.0337305665289058,6.15502212329271e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,-0.0375253617852078,0.0048087192146883,-0.0469504514459968,-0.0281002721244187,6.54819328618589e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,-0.0299439263481582,0.00384303303618175,-0.0374762710990744,-0.0224115815972419,7.19802437279369e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,-0.0320027310635802,0.00411078341599252,-0.0400598665589255,-0.0239455955682348,7.57783127725684e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOD1,Superoxide dismutase [Cu-Zn],42365,-0.0371770752199476,0.00478187564114481,-0.0465495514765914,-0.0278045989633038,8.13012280092962e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AP2B1,AP-2 complex subunit beta,40182,-0.0376484797338549,0.00484139628541819,-0.0471376164532746,-0.0281593430144353,8.1308313362114e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAA80,N-alpha-acetyltransferase 80,40182,-0.0937929645211717,0.0120710681700589,-0.117452258134487,-0.0701336709078562,8.54362337649756e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPK1,Thiamin pyrophosphokinase 1,40511,-0.0213443549073685,0.00274790037316794,-0.0267302396387777,-0.0159584701759593,8.69483029767405e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40481,-0.0309486287792955,0.00399115074632398,-0.0387712842420905,-0.0231259733165005,9.64560986003012e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMOX2,Heme oxygenase 2,42311,-0.0352869862160979,0.00455416868878259,-0.0442131568461118,-0.026360815586084,9.99725501528747e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40482,-0.0583628616685032,0.00753484613543427,-0.0731311600939544,-0.043594563243052,1.0316513358399e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,-0.0670292935502224,0.00865579592402895,-0.0839946535613191,-0.0500639335391256,1.03341842059691e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGH,Gamma-glutamyl hydrolase,42437,-0.0264541280073257,0.00341786191818717,-0.0331531373669726,-0.0197551186476789,1.06632818467052e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TLR3,Toll-like receptor 3,42754,-0.0470431194699556,0.00608697053841286,-0.0589735817252448,-0.0351126572146664,1.16455756170142e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,-0.0250895151540867,0.00325081374893724,-0.0314611101020037,-0.0187179202061698,1.26578649100543e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,-0.0447007017348465,0.00579724566450851,-0.0560633032372832,-0.0333381002324099,1.35853157822193e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,42357,-0.0293445207674132,0.00380989932656124,-0.0368119234474733,-0.0218771180873532,1.43304368643727e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,42346,-0.0435008650357416,0.00564922949212303,-0.0545733548403028,-0.0324283752311805,1.45403844813297e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CES2,Cocaine esterase,42587,-0.0420739935416223,0.00546962856285069,-0.0527944655248096,-0.0313535215584349,1.54588467158124e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,-0.0407829424508739,0.00530463189910075,-0.0511800209731114,-0.0303858639286365,1.59697439608232e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEPR,Leptin receptor,42636,0.0238962199345611,0.00311295674668048,0.0177948247110674,0.0299976151580549,1.74919085160128e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ING1,Inhibitor of growth protein 1,42292,-0.0360280783337809,0.00469570718284242,-0.045231664412152,-0.0268244922554097,1.80496613035709e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,METAP2,Methionine aminopeptidase 2,42689,-0.0434413427452276,0.00566440367152365,-0.0545435739414139,-0.0323391115490412,1.84917312394658e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT5,"Keratin, type II cytoskeletal 5",42311,-0.0393103527161733,0.00512566215404388,-0.0493566505380993,-0.0292640548942473,1.85067680521465e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX15,Sorting nexin-15,40283,-0.0417547043518464,0.00544749782327719,-0.0524318000854696,-0.0310776086182231,1.93859396642474e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PKD1,Polycystin-1,40511,-0.0206727893562357,0.00269783547809322,-0.0259605468932984,-0.015385031819173,1.96877498307282e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1RL,Complement C1r subcomponent-like protein,40519,-0.0152097493713557,0.00198962209941304,-0.0191094086862053,-0.0113100900565061,2.26629809951836e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A4,Protein S100-A4,42679,-0.0432611026471069,0.00566068895521795,-0.0543560529993341,-0.0321661522948797,2.27620778450423e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOXO1,Forkhead box protein O1,42594,-0.0643990104012409,0.00842710125440652,-0.0809161288598777,-0.0478818919426042,2.28562752287226e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IMPACT,Protein IMPACT,40483,-0.0428919498356188,0.00561336344588077,-0.0538941421895451,-0.0318897574816925,2.32900468576649e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,-0.0290807678202109,0.00381017514378318,-0.0365487111020259,-0.0216128245383958,2.49028765060684e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPAN1,Tetraspanin-1,42357,-0.0518700655132687,0.00680710410313345,-0.0652119895554103,-0.0385281414711271,2.71011987849665e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,-0.0266940154194767,0.00350760743799458,-0.0335689259979461,-0.0198191048410074,2.91697300964843e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLRX,Glutaredoxin-1,42546,-0.0425485619492298,0.00559670731463833,-0.0535181082859209,-0.0315790156125387,3.09992871124611e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP9,Matrix metalloproteinase-9,42594,-0.0454788894852669,0.00598702339810888,-0.0572134553455603,-0.0337443236249735,3.25022297265555e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GOLGA3,Golgin subfamily A member 3,40482,-0.0596121981464307,0.00784899693662536,-0.0749962321422164,-0.0442281641506449,3.32391300449641e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,-0.037525967178445,0.00494119028282415,-0.0472107001327803,-0.0278412342241096,3.33389252698727e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM4,Intercellular adhesion molecule 4,42594,0.0398780941527294,0.00526190465545829,0.0295647610280311,0.0501914272774277,3.72079357505122e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,-0.0398971132648432,0.00528466732581449,-0.0502550612234396,-0.0295391653062468,4.65275546144198e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GHR,Growth hormone receptor,40283,-0.021513788548104,0.00285033222448074,-0.0271004397080862,-0.0159271373881218,4.77304472181503e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPI,Glucose-6-phosphate isomerase,40532,-0.0355641728455262,0.00471199678015228,-0.0447996865346247,-0.0263286591564277,4.77383120826826e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42594,-0.0831687933374103,0.0110357181503822,-0.104798800912159,-0.0615387857626613,5.14365590404129e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,-0.0431451748465945,0.005727738659373,-0.0543715426189656,-0.0319188070742234,5.29665651966183e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F2R,Proteinase-activated receptor 1,42654,-0.0419894606559533,0.00557586853574189,-0.0529181629860074,-0.0310607583258992,5.373241537799e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,-0.0265536218744423,0.00352940269828331,-0.0334712511630776,-0.0196359925858071,5.74710484206184e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LARP1,La-related protein 1,40451,-0.04620878404319,0.00614497042485269,-0.0582529260759012,-0.0341646420104787,5.90422225021048e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL22,Interleukin-22,40451,-0.0529971730903861,0.00704937020676618,-0.0668139386956478,-0.0391804074851244,5.9843768962751e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPO,Lactoperoxidase,42134,-0.045551588846219,0.00606529326352472,-0.0574395636427274,-0.0336636140497105,6.29020762280217e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TJAP1,Tight junction-associated protein 1,42679,-0.0614199570264796,0.00817904095571898,-0.0774508772996888,-0.0453890367532704,6.31105999798996e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAB2,Disabled homolog 2,42721,-0.0814011067159143,0.0108415261279515,-0.102650497926699,-0.0601517155051293,6.36590984892665e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGBP1,Immunoglobulin-binding protein 1,40482,-0.0457917598945552,0.00611190856180077,-0.0577711006756847,-0.0338124191134257,7.27753048084491e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FDX1,"Adrenodoxin, mitochondrial",40116,-0.0466802357811437,0.00623237678652244,-0.0588956942827277,-0.0344647772795598,7.42124221574669e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,-0.0294088954272858,0.00393094475151435,-0.037113547140254,-0.0217042437143177,7.9005187742962e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,-0.057921756191166,0.00775596113595371,-0.0731234400176353,-0.0427200723646967,8.74030164758221e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,-0.0509424079673432,0.00682335932681329,-0.0643161922478973,-0.0375686236867892,8.7851514887709e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,40199,-0.0665308457403812,0.00891804933094905,-0.0840102224290413,-0.0490514690517211,9.28667725734551e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLNK,B-cell linker protein,40199,-0.0305744535931395,0.00409944716820075,-0.038609370042813,-0.0225395371434661,9.43204044159849e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CR1,Complement receptor type 1,40509,-0.0271266419808457,0.00363853983825457,-0.0342581800638247,-0.0199951038978667,9.61625562476508e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42611,-0.022292447027041,0.00299137219753923,-0.0281555365342179,-0.0164293575198641,9.73750989853154e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,-0.0636785345487217,0.00854920404941247,-0.0804349744855702,-0.0469220946118733,1.0037909593142e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AXIN1,Axin-1,42594,-0.0700265146744704,0.00940237783878899,-0.0884551752384968,-0.051597854110444,1.00749135966534e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DFFA,DNA fragmentation factor subunit alpha,42754,-0.0494498800409808,0.0066434525310586,-0.0624710470018557,-0.036428713080106,1.04033451069939e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40449,-0.0298053245742987,0.00400595724932877,-0.0376570007829831,-0.0219536483656143,1.0781155292823e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC39A14,Zinc transporter ZIP14,42311,-0.0256566058588797,0.00345061110455762,-0.0324198036238126,-0.0188934080939468,1.10734588067095e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PEPD,Xaa-Pro dipeptidase,40532,0.0197809273321139,0.00266201173171635,0.0145633843379498,0.0249984703262779,1.1568586623559e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EHBP1,EH domain-binding protein 1,40511,-0.0552191604985459,0.00743321328500919,-0.0697882585371639,-0.0406500624599279,1.17554118637518e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,L1CAM,Neural cell adhesion molecule L1,42679,0.0216975480411815,0.00292153904357859,0.0159713315157674,0.0274237645665955,1.1797430060491e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AZU1,Azurocidin,42216,-0.0564002861703019,0.00762367638859214,-0.0713426918919425,-0.0414578804486613,1.46668295518926e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAT2,Signal transducer and activator of transcription 2,40199,-0.056322290816295,0.00761892827880534,-0.0712553902427535,-0.0413891913898366,1.54650165987343e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,-0.0404466348916832,0.00547622869840285,-0.0511800431405528,-0.0297132266428136,1.60427268364819e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATXN2L,Ataxin-2-like protein,40482,-0.0357328215257934,0.00483807458456302,-0.0452154477115369,-0.0262501953400499,1.62273785181127e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC1A,C-type lectin domain family 1 member A,42357,-0.0260024722328474,0.00352225339729512,-0.0329060888915459,-0.019098855574149,1.6486915649041e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40451,-0.0254856237577668,0.00345505795633084,-0.0322575373521753,-0.0187137101633584,1.74158165329865e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VNN2,Vascular non-inflammatory molecule 2,42587,-0.0335504666635294,0.0045500458928837,-0.0424685566135815,-0.0246323767134774,1.75758025672376e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42587,-0.10039352362907,0.0136206627996373,-0.127090022716359,-0.0736970245417806,1.79710912914031e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PKD2,Polycystin-2,40116,-0.0431225324717904,0.00584947636070225,-0.0545875061387668,-0.031657558804814,1.80202144559036e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,-0.0758412437113905,0.0102910846552523,-0.096011769635685,-0.055670717787096,1.81150398351936e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,-0.025417987195463,0.00345241587743326,-0.0321847223152322,-0.0186512520756939,1.9326522789839e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSMB,Beta-microseminoprotein,42559,-0.0532021587584114,0.00723355287908521,-0.0673799224014184,-0.0390243951154044,2.02174133496141e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGA4,Pepsin A-4,40532,-0.0597644060116052,0.00812790814911042,-0.0756951059838616,-0.0438337060393488,2.07175771256142e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,40135,-0.0314639351881191,0.00428151733085848,-0.0398557091566017,-0.0230721612196365,2.14281776775571e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATOX1,Copper transport protein ATOX1,42679,-0.0507442573101848,0.00691974189928308,-0.0643069514327797,-0.03718156318759,2.37428862805642e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELP,P-selectin,42689,-0.0408680963227493,0.00557443812395934,-0.0517939950457096,-0.029942197599789,2.40831555383547e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB44,Ras-related protein Rab-44,40451,-0.0309292460512187,0.00422205976683278,-0.039204483194211,-0.0226540089082265,2.54031681508138e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CETN2,Centrin-2,42311,-0.0490307448474109,0.0066970344081059,-0.0621569322872984,-0.0359045574075233,2.59962393150894e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42594,-0.0768202509624363,0.0105064384671476,-0.0974128703580457,-0.0562276315668269,2.78677466380448e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACYP1,Acylphosphatase-1,40250,-0.0480980759751555,0.00657926510506201,-0.0609934355810771,-0.035202716369234,2.84412598438772e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APLP1,Amyloid-like protein 1,42636,0.0376628858002599,0.00515770161226214,0.0275537906402261,0.0477719809602937,2.98882008100762e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,42346,-0.0381963238973239,0.00523120694384821,-0.0484494895072664,-0.0279431582873814,3.00650000385811e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,-0.0610509474128002,0.00836037957421095,-0.0774372913782537,-0.0446646034473468,3.02021001175083e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE3,Eosinophil cationic protein,42578,-0.0800724005056409,0.0109865182936382,-0.101605976361172,-0.05853882465011,3.31625440796982e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40527,0.0375425400596605,0.00515941335605437,0.0274300898817939,0.047654990237527,3.65184957506767e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DGKA,Diacylglycerol kinase alpha,40199,-0.039861517324049,0.00548272023396476,-0.0506076489826199,-0.0291153856654781,3.8276975626956e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40429,-0.063070539339237,0.0086822868751883,-0.080087821614606,-0.0460532570638679,3.99862681815373e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,40283,-0.02797057970596,0.00385323432325942,-0.0355229189795484,-0.0204182404323715,4.16086409347037e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,-0.0221104536451891,0.00304752695592628,-0.0280836064788046,-0.0161373008115736,4.27248366381948e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42794,-0.0477087171231716,0.0065781059353608,-0.0606018047564787,-0.0348156294898644,4.30779061312112e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,-0.0316375233608288,0.00436225367229518,-0.0401875405585274,-0.0230875061631303,4.36213290536978e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,-0.030716551424491,0.00423930195753647,-0.0390255832612625,-0.0224075195877195,4.53856003819152e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,42311,-0.0480981210339441,0.00664691408635944,-0.0611260726432086,-0.0350701694246796,4.87228831066268e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,-0.0635740096788412,0.0087857030910816,-0.0807939877373611,-0.0463540316203213,4.91888004683987e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BOLA2_BOLA2B,BolA-like protein 2,40223,-0.0393305501060539,0.00543554252494615,-0.0499842134549483,-0.0286768867571594,4.93488484579906e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IKBKG,NF-kappa-B essential modulator,42594,-0.0652219039832731,0.00903698190849116,-0.0829343885239158,-0.0475094194426305,5.59155195286241e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,-0.0501939760821176,0.00696049573001526,-0.0638365477129475,-0.0365514044512877,5.90792281396197e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42636,-0.04895652437668,0.00679257222646192,-0.0622699659405454,-0.0356430828128146,6.00894120299396e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATXN3,Ataxin-3,40483,-0.0448925379471997,0.00623764218880166,-0.057118316637251,-0.0326667592571485,6.54388175120041e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FBLN2,Fibulin-2,40527,-0.0236152323618547,0.00328155820933834,-0.0300470864521579,-0.0171833782715516,6.57530909614896e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAT,Catalase,40361,-0.0392429521084016,0.00545552627423798,-0.049935783605908,-0.0285501206108951,6.73178318089348e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLVRB,Flavin reductase,42611,-0.0470495665513985,0.00655092473018635,-0.0598893790225637,-0.0342097540802332,7.22524768096596e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,-0.0559742091972565,0.00779655932029867,-0.0712554654650418,-0.0406929529294711,7.38176971767296e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40511,-0.0349387583841027,0.00487223743717522,-0.0444883437609661,-0.0253891730072392,7.91008886344594e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASC3,Protein CASC3,40182,-0.0301198427878032,0.00420291617311303,-0.0383575584871047,-0.0218821270885016,8.19224244297912e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE10,Inactive ribonuclease-like protein 10,40223,-0.0356245983611337,0.00497788067663897,-0.045381244487346,-0.0258679522349213,8.79681021805386e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42495,-0.0408469246960063,0.00571144810556265,-0.0520413629829091,-0.0296524864091035,9.01480557749752e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PALM,Paralemmin-1,40384,-0.0226768985374809,0.00317231746664811,-0.0288946407721112,-0.0164591563028506,9.32835727771881e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNAP23,Synaptosomal-associated protein 23,42636,-0.0616748877031511,0.00862981944110768,-0.0785893338077221,-0.04476044159858,9.34596433458144e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42794,-0.0113948597671893,0.00159450372596962,-0.0145200870700897,-0.00826963246428884,9.36643736332574e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40482,-0.0480581127916074,0.00672441634801605,-0.0612379688337188,-0.0348782567494959,9.42964626533923e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CES3,Carboxylesterase 3,42587,-0.0501452537201943,0.00702288854590064,-0.0639101152701595,-0.036380392170229,9.7957801720261e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USO1,General vesicular transport factor p115,42587,-0.0638693445660307,0.00895038476298616,-0.0814120987014836,-0.0463265904305778,1.01078075003638e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRTN3,Myeloblastin,42276,-0.0347694504863083,0.00487359418790107,-0.0443216950945944,-0.0252172058780222,1.02437540330851e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,-0.0508148730091019,0.00712463303782652,-0.0647791537632419,-0.036850592254962,1.04869915989667e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTNAP2,Contactin-associated protein-like 2,42594,-0.0297615054148624,0.00417635626097015,-0.0379471636863639,-0.0215758471433609,1.08461805692031e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,-0.0361147411868075,0.00507041371689524,-0.0460527520719222,-0.0261767303016929,1.11384735782841e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSNK2A1,Casein kinase II subunit alpha,40482,0.0320534038197762,0.00450236334162502,0.0232287716701912,0.0408780359693612,1.15113161751223e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLGN,Calmegin,40182,-0.0332217864322,0.00467229656739606,-0.0423794877042963,-0.0240640851601037,1.2291436526565e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL15A1,Collagen alpha-1(XV) chain,40527,-0.0199873635836165,0.00281305757704159,-0.025500956434618,-0.014473770732615,1.27347180277681e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40451,-0.0808639203344586,0.0113864666207563,-0.103181394911141,-0.0585464457577763,1.30606687268175e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFRP1,Secreted frizzled-related protein 1,42457,-0.0312524437874635,0.00440386613255482,-0.039884021407271,-0.0226208661676561,1.34367971503038e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,-0.0293425826594591,0.00413642852850457,-0.0374499825753281,-0.0212351827435902,1.38386835152845e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB1,Integrin beta-1,42638,0.0151441370148965,0.00213762840127856,0.0109543853483905,0.0193338886814025,1.46439410018003e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,-0.067641099721894,0.00958647052623596,-0.0864305819533164,-0.0488516174904715,1.79923733640931e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TREH,Trehalase,40527,-0.0525301529842241,0.00744771799999044,-0.0671276802642053,-0.0379326257042428,1.85048391738193e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,-0.0476414788985567,0.00676082439713356,-0.0608926947169384,-0.0343902630801749,1.92326061969751e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17D,Interleukin-17D,42370,-0.024179702115412,0.00343406569636916,-0.0309104708802955,-0.0174489333505284,2.00139866694382e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,-0.0789680115478054,0.0112298371333951,-0.10097849232926,-0.056957530766351,2.15578965136028e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FDX2,"Ferredoxin-2, mitochondrial",40116,-0.0399242406871321,0.00568148174806762,-0.0510599449133447,-0.0287885364609196,2.23463967421807e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APRT,Adenine phosphoribosyltransferase,42480,-0.0330516194902475,0.00471074032520272,-0.0422846705276448,-0.0238185684528501,2.38986480419729e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,40116,-0.0275726777479551,0.00393135221107595,-0.035278128081664,-0.0198672274142462,2.46109703973026e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIF1C,Kinesin-like protein KIF1C,40116,-0.0253202423574581,0.0036142308463372,-0.032404134816279,-0.0182363498986372,2.60206573348897e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM5,Tripartite motif-containing protein 5,42594,-0.0593533034112808,0.0084765339432668,-0.0759673099400837,-0.0427392968824779,2.64221206774301e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YJU2,Splicing factor YJU2,40451,-0.0227950821129036,0.00325672152683153,-0.0291782563054933,-0.0164119079203138,2.71686073855353e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEXIM1,Protein HEXIM1,42594,-0.0560257368049173,0.00801313223665036,-0.071731475988752,-0.0403199976210826,2.84358067646817e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,-0.0433159809514137,0.00620654071390552,-0.0554808007506685,-0.0311511611521589,3.14328853037878e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,-0.0640883640024626,0.00918405560969051,-0.082089112997456,-0.0460876150074692,3.16090105106716e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PARK7,Parkinson disease protein 7,42611,-0.0358965406399626,0.00514819835707754,-0.0459870094198346,-0.0258060718600907,3.25598966920567e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RILP,Rab-interacting lysosomal protein,42674,-0.0412305490323824,0.00592532457470691,-0.0528441851988079,-0.0296169128659568,3.60153436311685e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40449,-0.0441905545217599,0.0063524827679532,-0.0566414207469482,-0.0317396882965716,3.68384948294284e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,-0.0399685546056938,0.0057473122523719,-0.0512332866203427,-0.0287038225910449,3.70631354290284e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,-0.0531496518223578,0.00764458281489149,-0.0681330341395451,-0.0381662695051705,3.7890868582184e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF19,Fibroblast growth factor 19,42676,-0.0538045434195525,0.00774066592012044,-0.0689762486229886,-0.0386328382161165,3.79670528212414e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MANSC1,MANSC domain-containing protein 1,42679,-0.0194568897214928,0.00280302417048937,-0.0249508170956519,-0.0139629623473336,4.06005792412928e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOL1,Apolipoprotein L1,40532,0.0406066286634199,0.00585385861070115,0.0291330657864456,0.0520801915403941,4.23128573755124e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAP3,Cytosol aminopeptidase,42370,-0.0333925932469337,0.00482021943396148,-0.0428402233374982,-0.0239449631563692,4.47892367566234e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBXN1,UBX domain-containing protein 1,40283,-0.0475476571606714,0.00686646138763412,-0.0610059214804342,-0.0340893928409085,4.61311555736875e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WASHC3,WASH complex subunit 3,40483,-0.0518670707515256,0.00749729186637335,-0.0665617628096174,-0.0371723786934339,4.82475920786389e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSLN,Mesothelin,42553,-0.0411495446239241,0.0059600399646456,-0.0528312229546295,-0.0294678662932187,5.27532991162363e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPHOSPH8,M-phase phosphoprotein 8,42357,-0.052006703831895,0.00753275256046419,-0.0667708988504048,-0.0372425088133852,5.28482459028243e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GMPR2,GMP reductase 2,40283,-0.0466551813309996,0.00676102602330008,-0.0599067923366678,-0.0334035703253315,5.460468837784e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LBP,Lipopolysaccharide-binding protein,42689,-0.0404878268950546,0.00586946909100477,-0.051991986313424,-0.0289836674766853,5.50743654471996e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TADA3,Transcriptional adapter 3,40451,-0.027382038643144,0.00396888942313053,-0.0351610619124799,-0.0196030153738082,5.5114205567026e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,0.0305763667536823,0.00443438819720929,0.0218849658871521,0.0392677676202125,5.61484888195807e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL4A1,Collagen alpha-1(IV) chain,42636,-0.0274898134536963,0.00398871234601969,-0.0353076896518949,-0.0196719372554977,5.75052530672508e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,-0.0459950788246815,0.00667896861808793,-0.0590858573161338,-0.0329043003332292,6.03001050640867e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HPSE,Heparanase,40408,-0.0646287670921883,0.00938562867943703,-0.0830245993038849,-0.0462329348804918,6.04806124304209e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNAPIN,SNARE-associated protein Snapin,40482,-0.0397125533402787,0.00577120517086697,-0.051024115475178,-0.0284009912053795,6.25128282128258e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,42370,-0.0224115200801238,0.00326562387494222,-0.0288121428750105,-0.016010897285237,7.05142873199495e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA2,Carbonic anhydrase 2,42573,-0.0474259020186524,0.00691432029685635,-0.0609779698004909,-0.0338738342368139,7.23488370487779e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,-0.0510078689740498,0.00746054965709003,-0.0656305463019462,-0.0363851916461533,8.51341494189102e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEMIP2,Cell surface hyaluronidase,40199,-0.023636393447938,0.00346012496457918,-0.0304182383785132,-0.0168545485173628,8.87243516482e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42721,-0.023149228061988,0.00339055391388764,-0.0297947137332078,-0.0165037423907682,9.00521179205891e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMA4,Laminin subunit alpha-4,42676,-0.0225803111765782,0.0033081044876901,-0.0290641959724508,-0.0160964263807056,9.12037573324861e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,-0.0134845373562196,0.00197748417054955,-0.0173604063304967,-0.00960866838194245,9.56899814687683e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEP1B,Meprin A subunit beta,42636,0.0804237692078948,0.0118047824808517,0.0572863955454254,0.103561142870364,9.97825419494861e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42636,-0.0533095750776674,0.00784093058476531,-0.0686777990238074,-0.0379413511315274,1.09883891141377e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD5L,CD5 antigen-like,40479,-0.0326222494898067,0.00479827173959564,-0.0420268620994141,-0.0232176368801992,1.10855911146268e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLYR1,Putative oxidoreductase GLYR1,40451,-0.0402402372058788,0.00592423161166798,-0.051851731164748,-0.0286287432470095,1.15775761121867e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AAMDC,Mth938 domain-containing protein,40223,-0.0361484510774435,0.00533017480786026,-0.0465955937008496,-0.0257013084540374,1.2471392378366e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP10,Caspase-10,42311,-0.0483010542848674,0.00712503848564437,-0.0622661297167304,-0.0343359788530044,1.26136096728877e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSC22D1,TSC22 domain family protein 1,40482,-0.0442644825888619,0.00653732794782552,-0.0570776453665999,-0.0314513198111239,1.34208950163299e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,-0.0529978338652336,0.00783185961817527,-0.0683482787168572,-0.0376473890136101,1.36988209428116e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCBP2,Poly(rC)-binding protein 2,40482,-0.0487800685002489,0.00721670957367399,-0.0629248192646499,-0.0346353177358478,1.45470953638905e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,-0.0523990233042586,0.00775433089429166,-0.0675975118570702,-0.0372005347514469,1.46352156402485e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMIGO2,Amphoterin-induced protein 2,42587,-0.0158460242936899,0.00234549934567539,-0.0204432030112137,-0.0112488455761662,1.47787584159776e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42721,-0.0360242659053751,0.00533269737376773,-0.0464763527579599,-0.0255721790527904,1.48310961365539e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,42311,-0.0351380273712938,0.00520306501955176,-0.0453360348096153,-0.0249400199329724,1.50575436113684e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RCOR1,REST corepressor 1,42357,-0.0299217647527706,0.00444297533634617,-0.0386299964120091,-0.0212135330935321,1.71179772183994e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBPL,FK506-binding protein-like,40449,-0.0395537824076954,0.00587334034624357,-0.0510655294863328,-0.028042035329058,1.72552720561199e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC1B,C-type lectin domain family 1 member B,42711,-0.0636967851998889,0.00946781378944878,-0.0822537002272085,-0.0451398701725693,1.7928102626242e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAMBP,STAM-binding protein,42476,-0.0421170832903199,0.00627279265122813,-0.054411756886727,-0.0298224096939128,1.96723344105079e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40470,-0.0276604393246174,0.00412102522927522,-0.0357376487739968,-0.0195832298752379,2.01144066328772e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARF2,Scavenger receptor class F member 2,42711,-0.0202831879687655,0.00302313791225925,-0.0262085382767936,-0.0143578376607374,2.03323703270085e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,0.0182993104719193,0.00272829476188151,0.0129518527386315,0.0236467682052071,2.07787231670787e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DMD,Dystrophin,40223,-0.0346991893311711,0.0051783609311347,-0.0448487767561951,-0.0245496019061471,2.17376035155678e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTPP1,dCTP pyrophosphatase 1,42636,-0.0212101924135831,0.00316850458525023,-0.0274204614006735,-0.0149999234264926,2.25659033435206e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEO1,RNA polymerase-associated protein LEO1,40482,-0.021916466783163,0.00327432859286935,-0.0283341508251869,-0.015498782741139,2.28340502942612e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,40199,-0.0202879402904883,0.00303276224444865,-0.0262321542896076,-0.0143437262913689,2.34653197391106e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40980,0.0211694189398717,0.0031664293924948,0.0149632173305819,0.0273756205491615,2.40392104324844e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SYTL4,Synaptotagmin-like protein 4,40511,-0.0494180647161298,0.00739151593879717,-0.0639054359561722,-0.0349306934760873,2.40501339362213e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VAMP8,Vesicle-associated membrane protein 8,40199,-0.0589941267433212,0.00882553173848095,-0.0762921689507439,-0.0416960845358986,2.42949350754893e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARSA,Arylsulfatase A,42611,-0.0296180342337392,0.00443190843502535,-0.0383045747663889,-0.0209314937010895,2.43497680984186e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCRIB,Protein scribble homolog,40223,-0.0609241736072496,0.00911911847031664,-0.0787976458090702,-0.043050701405429,2.48869291024544e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,-0.0975502587908012,0.0146035977233721,-0.126173310328611,-0.0689272072529918,2.50414833877879e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COMMD1,COMM domain-containing protein 1,40223,-0.0404397225444341,0.0060551237161853,-0.0523077650281573,-0.028571680060711,2.52845439161699e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL3,Fc receptor-like protein 3,42370,-0.0375614355176351,0.00562922356911639,-0.0485947137131032,-0.026528157322167,2.61395830434428e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42636,-0.0193055494986719,0.0028937946670686,-0.0249773870461264,-0.0136337119512175,2.6336223909889e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,-0.0346077852031433,0.0051884832138011,-0.0447772123021935,-0.0244383581040932,2.65706794022937e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADD1,Alpha-adducin,40283,-0.0476353748830977,0.00714621789856577,-0.0616419619642866,-0.0336287878019088,2.75691026365552e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTSL4,ADAMTS-like protein 4,40223,-0.0159090626903776,0.00238926621534693,-0.0205920244724576,-0.0112261009082976,2.89671869834875e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHAD,Chondroadherin,40283,0.0348373269342872,0.00523712844768856,0.0245725551768177,0.0451020986917568,3.02767045273103e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAGK,N-acetyl-D-glucosamine kinase,40209,-0.0371382612570953,0.00558580433968681,-0.0480864377628815,-0.0261900847513092,3.09707966238746e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AIF1,Allograft inflammatory factor 1,42346,-0.034527805474412,0.00519955018770446,-0.0447189238423127,-0.0243366871065113,3.24822065217055e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,-0.0339702844651381,0.00511698809635105,-0.0439995811339861,-0.02394098779629,3.2853027403437e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOXO3,Forkhead box protein O3,42346,-0.0628507582875433,0.00946944673623746,-0.0814108738905687,-0.0442906426845178,3.32198747656436e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,-0.0243217165872005,0.0036661676584123,-0.0315074051976886,-0.0171360279767124,3.41814470361927e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40511,-0.0189259434464059,0.002854489437751,-0.0245207427443979,-0.013331144148414,3.50397409604662e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLPS,Colipase,42590,-0.0481443798820038,0.00726570187824159,-0.0623851555633573,-0.0339036042006503,3.57478592860602e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GMPR,GMP reductase 1,42754,-0.0325403714310656,0.0049167528395993,-0.0421772069966802,-0.022903535865451,3.77098675939248e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,-0.0583371066294357,0.00881379689933008,-0.0756121485521226,-0.0410620647067487,3.78482735975231e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALCB,Calcitonin gene-related peptide 2,40483,-0.027312091376878,0.00412673999606495,-0.0354005017691653,-0.0192236809845907,3.79755495159222e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,-0.0382725046121969,0.00579675484924245,-0.0496341441167121,-0.0269108651076817,4.20083306809689e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40483,-0.0133067756859688,0.00201818522577128,-0.0172624187284805,-0.00935113264345712,4.48935529640812e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BID,BH3-interacting domain death agonist,42594,-0.0439963584092587,0.00668126636727337,-0.0570916404891145,-0.0309010763294029,4.71740601655867e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MBL2,Mannose-binding protein C,40379,0.0720494107735759,0.0109455899201214,0.0505960545301381,0.0935027670170138,4.83281024892315e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL10,Interleukin-10,42370,-0.055715647927935,0.00847480657077889,-0.0723262688066617,-0.0391050270492084,5.07355080922613e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,-0.0288143333161206,0.00438229988676164,-0.0374036410941734,-0.0202250255380678,5.0796094999943e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK6,Kallikrein-6,42656,-0.0207887194978944,0.00316666499740178,-0.0269953828928019,-0.0145820561029869,5.3990177328511e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PROK1,Prokineticin-1,42594,-0.0361785330191514,0.00551589554355287,-0.046989688284515,-0.0253673777537877,5.61731921407976e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A13,Protein S100-A13,40199,-0.0234819082907668,0.0035818285302954,-0.0305022922101457,-0.0164615243713878,5.78044096717082e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHGA,Chromogranin-A,40527,-0.0644517559095324,0.00983928882682708,-0.0837367620101134,-0.0451667498089513,5.98480306686179e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,-0.0548068656782407,0.0083831253038623,-0.0712377912738108,-0.0383759400826706,6.51404382906522e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ST13,Hsc70-interacting protein,40283,-0.0370437129551269,0.00566669633571193,-0.0481504377731222,-0.0259369881371315,6.5480697688825e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YWHAQ,14-3-3 protein theta,40283,-0.0482182752030988,0.00737895334753687,-0.062681023764271,-0.0337555266419265,6.65898208291764e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,-0.0302432639946923,0.00463198375699092,-0.0393219521583945,-0.0211645758309901,6.89562171227347e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,42311,-0.0329607171321812,0.00504901866537199,-0.0428567937163103,-0.0230646405480521,6.90409872381098e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,QSOX1,Sulfhydryl oxidase 1,40342,-0.0284678069853395,0.00436168684540814,-0.0370167132023395,-0.0199189007683396,7.01107978569515e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP1,Caspase-1,42311,-0.0449366424820292,0.00690968694767023,-0.0584796288994629,-0.0313936560645956,8.13571774200623e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DOK2,Docking protein 2,42636,-0.0778992864535044,0.0119824185286681,-0.101384826769694,-0.0544137461373149,8.25330977472455e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL15,Interleukin-15,42594,-0.0215302567764679,0.0033124203747818,-0.0280226007110403,-0.0150379128418956,8.32428501904471e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOBR,Apolipoprotein B receptor,40223,0.0278572921622101,0.00428937439177458,0.0194501183543319,0.0362644659700882,8.68996600992768e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,0.0187619419294334,0.00289588132351819,0.0130860145353378,0.0244378693235291,9.56146721253381e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4G,C-type lectin domain family 4 member G,42594,-0.0213722423684994,0.00330089944668598,-0.0278420052840039,-0.0149024794529949,9.83301377385944e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNIP1,TNFAIP3-interacting protein 1,40483,-0.0575043935410164,0.00888619739419596,-0.0749213404336405,-0.0400874466483923,1.0125099951172e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,-0.0419380372905378,0.00648523746035739,-0.0546491027128383,-0.0292269718682373,1.03712443790672e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP25,Rho GTPase-activating protein 25,42346,-0.0383005397332956,0.00592640506841115,-0.0499162936673815,-0.0266847857992098,1.06482771131576e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECI2,Enoyl-CoA delta isomerase 2,40116,-0.0400014479111156,0.00618884456250106,-0.0521315832536177,-0.0278713125686135,1.06685894278309e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OPLAH,5-oxoprolinase,40223,-0.0438743279923133,0.00678999289066331,-0.0571827140580134,-0.0305659419266132,1.07956970143485e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RABEP1,Rab GTPase-binding effector protein 1,40283,-0.0505847877071309,0.00784533022662614,-0.0659616349513181,-0.0352079404629436,1.18235022041342e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN2,CCN family member 2,42624,-0.0354261215821341,0.00549687238816667,-0.0461999914629408,-0.0246522517013274,1.19722970107005e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,A1BG,Alpha-1B-glycoprotein,40539,-0.0109998859545397,0.00170661151409312,-0.0143448445221622,-0.00765492738691719,1.19928390434722e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP53,Cellular tumor antigen p53,42346,-0.0276697667664242,0.00429537754135561,-0.0360887067474812,-0.0192508267853672,1.22211927699664e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBCA,Tubulin-specific chaperone A,40283,-0.0548274168978936,0.00851098892776412,-0.0715089551963113,-0.038145878599476,1.22827729810871e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFB,Complement factor B,40344,-0.0208971467036837,0.0032542747186314,-0.0272755251522012,-0.0145187682551661,1.40475446928514e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPOCK1,Testican-1,42495,0.0164622388764955,0.00256855513197038,0.0114278708178335,0.0214966069351574,1.51275508205125e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,-0.0342159870146306,0.00533839872854832,-0.0446792485225854,-0.0237527255066759,1.5192253740104e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX9,Sorting nexin-9,42636,-0.0428045177926422,0.00668271813981906,-0.0559026453466876,-0.0297063902385969,1.55115460463828e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOXJ3,Forkhead box protein J3,40199,-0.0280958766039958,0.0043878060134521,-0.0366959763903619,-0.0194957768176296,1.58381797625789e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,-0.0215197535751328,0.00336146109016566,-0.0281082173118574,-0.0149312898384081,1.59796587272535e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40451,-0.0264137819099947,0.00412977737723475,-0.0345081455693748,-0.0183194182506145,1.65893961253071e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42590,-0.0529388663070506,0.00829002711380607,-0.0691873194501105,-0.0366904131639907,1.76074720577689e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CMIP,C-Maf-inducing protein,40451,-0.0529397707227951,0.00830625244441823,-0.0692200255138549,-0.0366595159317354,1.92003181786093e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGA,Fibrinogen alpha chain,40284,-0.0198733525166766,0.00311918624581754,-0.025986957558479,-0.0137597474748743,1.94827500619146e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPR15L,Protein GPR15L,40449,-0.0389673224970915,0.00612154193468663,-0.0509655446890773,-0.0269691003051057,2.02087371316689e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,-0.0337522635797876,0.00530314095669514,-0.0441464198549101,-0.0233581073046652,2.03540338222021e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NID1,Nidogen-1,42652,-0.0243589178137553,0.00382922519800915,-0.0318641992018532,-0.0168536364256574,2.0650257095941e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSPN,Persephin,42594,-0.0590185562976712,0.00928766442508338,-0.0772223785708346,-0.0408147340245078,2.15858455647266e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,-0.0234696588584996,0.0036944062611842,-0.0307106951304206,-0.0162286225865785,2.1990634381859e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,-0.0587351311151635,0.00925173710564225,-0.0768685358422223,-0.0406017263881047,2.24486936864005e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42674,-0.0459096243809411,0.0072357911437962,-0.0600917750227817,-0.0317274737391006,2.29839919588965e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,-0.0370041503343261,0.00583558656030748,-0.0484418999925288,-0.0255664006761235,2.36814125047014e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD101,Immunoglobulin superfamily member 2,40449,-0.0278040086474172,0.00438602505961879,-0.03640061776427,-0.0192073995305644,2.39756452875489e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA4,Kallistatin,40342,-0.0153291462712199,0.00242126454751256,-0.0200748247843445,-0.0105834677580953,2.52858575497768e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAX,Protein max,42311,-0.0660012067427835,0.0104365532984955,-0.0864568512078346,-0.0455455622777323,2.63074698727017e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN4B,Sodium channel subunit beta-4,40223,-0.0279887220823631,0.0044291158205194,-0.0366697890905811,-0.0193076550741451,2.72961463842399e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40451,-0.0327653976173389,0.00518704243867246,-0.0429320007971369,-0.0225987944375408,2.77146176803424e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,-0.0551087080043355,0.0087444909926577,-0.0722479103499446,-0.0379695056587264,3.02828546766803e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,-0.0570189419643881,0.00905764303615358,-0.0747719223152491,-0.0392659616135271,3.18595206012938e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,40183,-0.0528719959964343,0.00839890997252702,-0.0693338595425873,-0.0364101324502814,3.18911297967882e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,-0.021599106310296,0.00343251573802684,-0.0283268371568286,-0.0148713754637634,3.22121739874598e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KAZN,Kazrin,40449,-0.0656864965150949,0.0104494380152067,-0.0861673950249,-0.0452055980052897,3.37527824457202e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,-0.0288376110451829,0.00459135506325874,-0.03783666696917,-0.0198385551211958,3.47040988921251e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST5,Cystatin-D,42357,-0.0356250001282804,0.00568721531759664,-0.0467719421507699,-0.024478058105791,3.86783010635178e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AFM,Afamin,40539,-0.0125326045154692,0.00200059529754156,-0.0164537712986506,-0.0086114377322877,3.87720730340028e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAX,Apoptosis regulator BAX,42292,-0.0554060723676024,0.00886766082746817,-0.0727866875894401,-0.0380254571457648,4.28331792903352e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASS1,Argininosuccinate synthase,40116,-0.0488074057253095,0.00781090695682497,-0.0641167833606864,-0.0334980280899325,4.29516598517147e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DYNLT1,Dynein light chain Tctex-type 1,40182,-0.0504344094198085,0.00807895924465111,-0.0662691695393247,-0.0345996493002923,4.45985097245923e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,-0.024903689769342,0.00400511051234643,-0.032753706373541,-0.0170536731651429,5.2139362640137e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITM2A,Integral membrane protein 2A,42594,-0.0382741856743577,0.00616316868590347,-0.0503539962987285,-0.0261943750499869,5.44989135989966e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,-0.0387611307588268,0.00624636954305446,-0.0510040150632135,-0.02651824645444,5.62008829975947e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMPD3,AMP deaminase 3,40483,-0.0441269958291769,0.0071201819619179,-0.058082552474536,-0.0301714391838178,5.93849673177999e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,-0.0326927478735147,0.00527798032640461,-0.0430375893132677,-0.0223479064337616,6.06237088159737e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINI2,Serpin I2,40449,-0.0349061346555083,0.00563626198061692,-0.0459532081375174,-0.0238590611734991,6.10361203164999e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD2,T-cell surface antigen CD2,40116,-0.0240266055168232,0.00387958313257979,-0.0316305884566796,-0.0164226225769669,6.11176263281975e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EREG,Proepiregulin,42476,-0.0494939215821966,0.00799504866866989,-0.0651642169727896,-0.0338236261916036,6.17112929125921e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELENOP,Selenoprotein P,40539,0.0143095656829139,0.00231521670084291,0.0097717409492618,0.018847390416566,6.6025452687931e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,42346,0.0236925701742351,0.00383576615132607,0.016174468517636,0.0312106718308342,6.73629977264523e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,-0.0550160260983934,0.00891205234838333,-0.0724836487012247,-0.037548403495562,6.92189426340395e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUB1,NEDD8 ultimate buster 1,42594,-0.0509632216340518,0.00825932490876593,-0.067151498455233,-0.0347749448128706,7.00857689748216e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARSB,Arylsulfatase B,42587,-0.0337994610376396,0.00547891183578549,-0.0445381282357791,-0.0230607938395,7.06976344453504e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATG4A,Cysteine protease ATG4A,42346,-0.0361834507715001,0.00587305753791418,-0.0476946435458119,-0.0246722579971883,7.44326109073959e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM5,Intercellular adhesion molecule 5,42636,-0.0282598948293923,0.00459005151693732,-0.0372563958025894,-0.0192633938561951,7.63564101560057e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OGA,Protein O-GlcNAcase,40449,-0.0432569343065231,0.00702492666740864,-0.0570257905746441,-0.0294880780384022,7.63567583395722e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC12A,C-type lectin domain family 12 member A,40199,-0.0128340451709662,0.00208574948977138,-0.0169221141709181,-0.00874597617101434,7.85732931900905e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,-0.0400489645786239,0.0065180010969422,-0.0528242467286306,-0.0272736824286171,8.3055420244541e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KEL,Kell blood group glycoprotein,42311,-0.0222501352528444,0.00362616546815152,-0.0293574195704214,-0.0151428509352674,8.70639417240044e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42636,-0.0448234534574186,0.00730596583609999,-0.0591431464961745,-0.0305037604186626,8.74477549697911e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSNAX,Translin-associated protein X,40116,-0.0243217621625111,0.00396581691090488,-0.0320947633078847,-0.0165487610171375,8.93041448082392e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,0.0367762218982906,0.00600757349490677,0.0250013778482733,0.0485510659483079,9.5200551091875e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,40223,-0.0628307072233872,0.0102652291648659,-0.0829505563865243,-0.04271085806025,9.63124613728251e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,42190,-0.0737895038731368,0.0120866782551282,-0.0974793932531881,-0.0500996144930856,1.05710820573885e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP3R1,Calcineurin subunit B type 1,42495,-0.0243062322229986,0.00398650838901054,-0.0321197886654593,-0.016492675780538,1.10983992936434e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACE,Angiotensin-converting enzyme,40532,-0.0165010659145684,0.00270610648650504,-0.0218050346281183,-0.0111970972010185,1.11098184870099e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INSR,Insulin receptor,40199,-0.010664308282813,0.0017488666383903,-0.014092086894058,-0.00723652967156804,1.11119297852346e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPAG1,Sperm-associated antigen 1,40482,-0.0351330585316039,0.00576229482271708,-0.0464271563841294,-0.0238389606790784,1.1156827742697e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40482,-0.0292713686158359,0.00481530289784229,-0.0387093622956068,-0.019833374936065,1.24979534037692e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40511,-0.0199416244600788,0.00328635148773845,-0.0263828733760461,-0.0135003755441114,1.33645259287728e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LIF,Leukemia inhibitory factor,42311,-0.0311912797554922,0.0051430790799172,-0.0412717147521299,-0.0211108447588544,1.35826615631344e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42760,-0.0277643514216724,0.00458127376932622,-0.0367436480095518,-0.018785054833793,1.39381256963406e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,-0.0668415639613575,0.0110310535645537,-0.0884624289478828,-0.0452206989748322,1.4032651357925e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,-0.0548079497664393,0.00904728823454857,-0.0725406347061545,-0.0370752648267241,1.42255856826804e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM13A,Protein FAM13A,40449,-0.0408582756749225,0.00675208331270843,-0.054092358967831,-0.0276241923820139,1.48336156603573e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MINK1,Misshapen-like kinase 1,40483,-0.0561403812451619,0.00928762587508286,-0.0743441279603243,-0.0379366345299995,1.54471185132734e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,-0.0171732501460929,0.00284257243760282,-0.0227446921237945,-0.0116018081683914,1.56750347197451e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHSG,Alpha-2-HS-glycoprotein,40532,-0.0164975213152098,0.00273115345428404,-0.0218505820856065,-0.0111444605448131,1.58459943985997e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRND,Prion-like protein doppel,40483,-0.0316619787198194,0.00526971597311048,-0.041990622027116,-0.0213333354125229,1.9327359486977e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEC31A,Protein transport protein Sec31A,40223,-0.046185843142943,0.00768864901369078,-0.0612555952097769,-0.0311160910761091,1.94930509232357e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX7,Syntaxin-7,40199,-0.0300963022560011,0.00502831217493513,-0.0399517941188739,-0.0202408103931282,2.22630810641202e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SBSN,Suprabasin,40511,0.0210508355866066,0.00351890669097046,0.0141537784723045,0.0279478927009087,2.26788382522965e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD55,Complement decay-accelerating factor,42201,-0.016303078112813,0.00272703438694615,-0.0216480655112274,-0.0109580907143985,2.31360596457954e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,0.0204337959300982,0.00341836328410537,0.0137338038932517,0.0271337879669447,2.32106350832915e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,-0.0249850729604824,0.0041871721321914,-0.0331919303395776,-0.0167782155813873,2.49002771658937e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,-0.0114749184729849,0.0019274007438103,-0.0152526239308531,-0.0076972130151167,2.68833553892248e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDC,Nuclear migration protein nudC,42754,-0.0366814854359824,0.0061706504280721,-0.0487759602750037,-0.0245870105969611,2.84098810736521e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCAM,Basal cell adhesion molecule,42611,-0.0146036299316659,0.00245919493292672,-0.0194236520002023,-0.00978360786312953,2.94973557136218e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NIT1,Deaminated glutathione amidase,40223,-0.0282923391150007,0.00476366852790004,-0.0376291294296848,-0.0189555488003166,2.95072500987033e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HPCAL1,Hippocalcin-like protein 1,42754,-0.0428472621677097,0.00721579475868946,-0.056990219894741,-0.0287043044406784,2.9560877948824e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPK13,Mitogen-activated protein kinase 13,40080,-0.0250737598898636,0.00422303840799852,-0.0333509151695407,-0.0167966046101865,2.98465907301123e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C8B,Complement component C8 beta chain,40539,0.018129030445905,0.0030546893223536,0.012141839374092,0.0241162215177181,3.02767852479113e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40483,-0.0422211044583683,0.00711519018234,-0.0561668772157547,-0.0282753317009819,3.04435688326073e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFBR1,TGF-beta receptor type-1,40199,-0.0129167392703085,0.00217753024614971,-0.0171846985527619,-0.00864877998785504,3.08590168184322e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AZI2,5-azacytidine-induced protein 2,40482,-0.032733806932137,0.0055217607178197,-0.0435564579390636,-0.0219111559252104,3.15334935521046e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA5,Plasma serine protease inhibitor,40387,-0.0187374002958409,0.00316548125397701,-0.0249417435536359,-0.012533057038046,3.32818473185159e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,-0.0238668635254415,0.0040337937637905,-0.0317730993024709,-0.0159606277484121,3.37916620906423e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRAP,BRCA1-associated protein,40342,-0.0646599119199268,0.0109375890811972,-0.0860975865190734,-0.0432222373207803,3.48483780760283e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGAM,Integrin alpha-M,42611,0.0186430233184059,0.00315567617333404,0.0124578980186711,0.0248281486181406,3.55162538751797e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,-0.0608224459565278,0.0103004987950361,-0.0810114235947986,-0.040633468318257,3.63260586366697e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42698,-0.0385347062531238,0.00653504256337061,-0.0513433896773302,-0.0257260228289173,3.79873229837903e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK8,Kallikrein-8,42154,-0.0219836026038711,0.00373113980179663,-0.0292966366153925,-0.0146705685923497,3.91196548098812e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTN6,Dynactin subunit 6,42311,-0.0421510853744567,0.00715742839673004,-0.0561796450320476,-0.0281225257168658,3.97719857448283e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSR,"Glutathione reductase, mitochondrial",40490,-0.0133258788447758,0.00226406798433171,-0.0177634520940659,-0.00888830559548561,4.07359698953421e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,40329,-0.0329917342985117,0.00562184927797345,-0.0440105588833396,-0.0219729097136837,4.52330569741387e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEDD9,Enhancer of filamentation 1,40199,-0.0196558233745078,0.00335366750881407,-0.0262290116917834,-0.0130826350572322,4.73308531005162e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRKL,Crk-like protein,42636,-0.0610751046796863,0.0104246701618462,-0.0815074581969049,-0.0406427511624677,4.77398211697474e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH6,Cadherin-6,42636,-0.022691457171638,0.00387458614349418,-0.0302856460128866,-0.0150972683303894,4.8381351596813e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PZP,Pregnancy zone protein,40539,-0.0300147355403847,0.00512528902824109,-0.0400603020357372,-0.0199691690450322,4.86702201945562e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HLA_DRA,,42549,-0.0215869290867059,0.00368952519672131,-0.0288183984722797,-0.0143554597011322,5.00470776854086e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,-0.0466075683676712,0.00797547820442491,-0.062239505648344,-0.0309756310869984,5.24153426381057e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRAF2,TNF receptor-associated factor 2,42594,-0.0403521328786347,0.00690770243743129,-0.053891229656,-0.0268130361012693,5.28973271811995e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBC1D17,TBC1 domain family member 17,42311,-0.0264690824836164,0.0045326809794639,-0.0353531372033656,-0.0175850277638671,5.35628656689164e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNST,Consortin,42636,-0.0631452055834193,0.0108141664924463,-0.0843409719086141,-0.0419494392582245,5.36897055086367e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,-0.0554091282099657,0.00949661180617592,-0.0740224873500705,-0.0367957690698609,5.51585177687527e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40511,-0.0420769778575209,0.00721662190366796,-0.0562215567887101,-0.0279323989263317,5.67498391262425e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,-0.0329169955132408,0.00565048178738798,-0.0439919398165213,-0.0218420512099604,5.82396567468133e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUSD4,Sushi domain-containing protein 4,40451,-0.0246426942199764,0.00423117689934113,-0.032935800942685,-0.0163495874972678,5.90005377388739e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIMAP7,GTPase IMAP family member 7,40283,0.0186848239129222,0.00321019117274711,0.0123928492143378,0.0249767986115065,6.03079658544382e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GYS1,"Glycogen [starch] synthase, muscle",42357,-0.053668564241686,0.00923724021809989,-0.0717735550691618,-0.0355635734142102,6.39098705674384e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,-0.0239162223074826,0.0041165682885531,-0.0319846961530467,-0.0158477484619185,6.39673441254933e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA1,Carbonic anhydrase 1,42362,-0.0349469053746594,0.00601538096508361,-0.0467370520662232,-0.0231567586830955,6.40732961098207e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BMP6,Bone morphogenetic protein 6,42342,-0.0236119195815809,0.00406545934929205,-0.0315802199061933,-0.0156436192569685,6.4711232694959e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,40302,-0.0394903772381217,0.00681475210831918,-0.0528472913704273,-0.0261334631058161,7.02464795966214e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFB,Platelet-derived growth factor subunit B,42676,-0.0493266585351208,0.00851859859139435,-0.0660231117742537,-0.0326302052959879,7.17553992102412e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42582,-0.0197280350766513,0.00340705108664318,-0.0264058552064719,-0.0130502149468307,7.18139917642923e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS27,Serine protease 27,42603,-0.0233162250715071,0.00403458566661243,-0.0312240129780675,-0.0154084371649467,7.67766143925875e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LMNB1,Lamin-B1,40434,-0.0347533387452023,0.00601707031589487,-0.0465467965643563,-0.0229598809260483,7.8623228648918e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAFB2,Scaffold attachment factor B2,40482,-0.0159753486434178,0.00276692242213965,-0.0213985165908115,-0.0105521806960241,7.95991028545905e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF5,Fibroblast growth factor 5,42370,-0.0190365622426084,0.0032979794615503,-0.025500601987247,-0.0125725224979698,8.00105999000167e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40483,-0.0304906998790315,0.00528224243564531,-0.0408438950528963,-0.0201375047051667,8.02548832612015e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST6,Cystatin-M,42332,-0.029263978386742,0.00507375182359713,-0.0392085319609924,-0.0193194248124916,8.2160970768931e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,-0.0193930329463584,0.00336371477381681,-0.0259859139030394,-0.0128001519896775,8.33115078031765e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,-0.0495362192521684,0.00859361858460301,-0.0663797116779903,-0.0326927268263465,8.41436311574575e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA7,Thyroxine-binding globulin,40539,-0.0107067350078405,0.001857555785074,-0.0143475443465855,-0.00706592566909542,8.43417097602743e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DXO,Decapping and exoribonuclease protein,40483,-0.0263719864634225,0.0045816736995488,-0.0353520669145381,-0.0173919060123068,8.83879269093989e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPSAB1,Tryptase alpha/beta-1,42741,-0.0300929809935783,0.00523465278669477,-0.0403529004555,-0.0198330615316565,9.18155401228948e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HS1BP3,HCLS1-binding protein 3,40223,-0.0509955728725175,0.00887630168063288,-0.068393124166558,-0.0335980215784771,9.42771476014692e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL2,Apoptosis regulator Bcl-2,40449,-0.0329651877521943,0.00576200343078269,-0.0442587144765284,-0.0216716610278602,1.08514880027121e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MIF,Macrophage migration inhibitory factor,42586,-0.0384857192110611,0.00672781921173121,-0.0516722448660542,-0.0252991935560679,1.0855577435336e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLB1,Beta-galactosidase,42495,-0.0235274155019038,0.00411807418736741,-0.0315988409091439,-0.0154559900946636,1.13241629860498e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXN,Thioredoxin,40384,-0.0255623165872574,0.00448294790373866,-0.0343488944785852,-0.0167757386959296,1.21321101311286e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,-0.024571695337265,0.00431965560457195,-0.033038220322226,-0.0161051703523039,1.31464903494231e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CIAPIN1,Anamorsin,42679,-0.0350437994379195,0.00616898866426015,-0.0471350172198694,-0.0229525816559696,1.36965358441127e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TTR,Transthyretin,40424,-0.014388962927233,0.00253532857776299,-0.0193582069396484,-0.00941971891481749,1.41805361027669e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYO9B,Unconventional myosin-IXb,42370,-0.0372353584694331,0.00656551329163863,-0.0501037645210448,-0.0243669524178214,1.44650079224643e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM3,Intercellular adhesion molecule 3,42794,-0.0152557620009878,0.0026916734108179,-0.0205314418861909,-0.0099800821157847,1.47613468284942e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCHE,Cholinesterase,40346,-0.0158656496458175,0.00280040587508654,-0.0213544451609871,-0.0103768541306478,1.5024360367818e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,-0.0617725252374042,0.0109091881281686,-0.0831545339686147,-0.0403905165061937,1.52898609703038e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIL1,Nucleotide exchange factor SIL1,40223,-0.0176406792124547,0.00311761518211809,-0.0237512049694062,-0.0115301534555033,1.56609696973084e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAG6,Large proline-rich protein BAG6,42357,-0.0201528173484656,0.00356342674404357,-0.027137133766791,-0.0131685009301402,1.58663887733842e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHNAK2,Protein AHNAK2,40223,-0.0172133066277484,0.00304347063587469,-0.0231785090740628,-0.0112481041814341,1.58968310050941e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLTA,Clathrin light chain A,42357,-0.0269950294728661,0.00477755711437501,-0.0363590414170411,-0.0176310175286911,1.63410080957967e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMOTL2,Angiomotin-like protein 2,40404,-0.0274357975208217,0.00485515910280162,-0.0369519093623128,-0.0179196856793305,1.63546798711189e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C7orf50,Uncharacterized protein C7orf50,40483,-0.0129254004010191,0.0022874109782822,-0.0174087259184522,-0.00844207488358598,1.63696105424692e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,-0.0214934659071557,0.00380591939991949,-0.0289530679309979,-0.0140338638833135,1.66921507558112e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,-0.0176675584057876,0.00312913346848417,-0.0238006600040166,-0.0115344568075586,1.68144867663146e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERI1,3'-5' exoribonuclease 1,40302,-0.0195752385049466,0.00346811248037221,-0.0263727389664762,-0.0127777380434171,1.69870891123004e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NACC1,Nucleus accumbens-associated protein 1,40451,-0.0313010622919509,0.00554586557443105,-0.0421709588178358,-0.020431165766066,1.70125710388273e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCAM1,Neural cell adhesion molecule 1,42689,0.0170588172277015,0.00302460307485079,0.011130595200994,0.022987039254409,1.73445659685491e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCT5,T-complex protein 1 subunit epsilon,42346,-0.0258486001621785,0.00458547635834023,-0.0348361338245254,-0.0168610664998317,1.76535932778847e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLB1,"Phospholipase B1, membrane-associated",40483,0.0340669220278925,0.00605086450068329,0.0222072276065532,0.0459266164492317,1.84413891420012e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALPP,"Alkaline phosphatase, placental type",42587,-0.0567367466223201,0.0100798567585259,-0.0764932658690309,-0.0369802273756093,1.85190226125742e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACHE,Acetylcholinesterase,40283,-0.0188856081379596,0.00335503639501436,-0.0254614794721878,-0.0123097368037315,1.8562561755182e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,-0.0410828600491603,0.00729869838374908,-0.0553883088813085,-0.0267774112170121,1.85804390121252e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CETN3,Centrin-3,40449,-0.0427633060921902,0.00759965913778361,-0.0576586380022461,-0.0278679741821344,1.87748996968058e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPTLC1,Serine palmitoyltransferase 1,40483,-0.0218982326633745,0.00389594077364783,-0.0295342765797242,-0.0142621887470247,1.94604304696135e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL2,C-C motif chemokine 2,42475,-0.0297562235416184,0.00529875453729586,-0.0401417824347183,-0.0193706646485185,1.99693635229338e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AOC3,Membrane primary amine oxidase,42689,-0.0169671062559225,0.00302309889439265,-0.0228923800889321,-0.0110418324229129,2.03366126934804e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,42292,-0.0241180056518074,0.00429778631569119,-0.0325416668305621,-0.0156943444730526,2.04380536185638e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMG4,Proteasome assembly chaperone 4,40199,-0.032158073841631,0.00573610677944483,-0.0434008431293429,-0.0209153045539191,2.11733046048136e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRY2,Protein sprouty homolog 2,42370,-0.0512244872025426,0.00914155459397816,-0.0691419342067398,-0.0333070401983454,2.14306882722641e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDHB,Succinate dehydrogenase,40449,-0.0374171826756477,0.00667985674082321,-0.0505097018876612,-0.0243246634636342,2.17499474927167e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SRPX,Sushi repeat-containing protein SRPX,40511,-0.0208540672403733,0.00372348956784962,-0.0281521067933586,-0.0135560276873881,2.18495923777544e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,-0.0433207719889276,0.00773621844167416,-0.0584837601346089,-0.0281577838432462,2.18980887907147e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP10,Stromelysin-2,42608,-0.032862785308998,0.00587255009405103,-0.044372983493338,-0.0213525871246579,2.23651622042776e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,-0.0369954894312725,0.00661070029361783,-0.0499524620067634,-0.0240385168557816,2.24075534036927e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,-0.0199499728289985,0.00356695633676204,-0.0269412072490521,-0.0129587384089449,2.27499645940733e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RWDD1,RWD domain-containing protein 1,42711,-0.0349515542987962,0.00625451745564041,-0.0472104085118514,-0.0226927000857409,2.33857945764496e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42689,0.0176929894969681,0.00316746877673288,0.0114847506945716,0.0239012282993645,2.37062632215614e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CMC1,COX assembly mitochondrial protein homolog,40511,-0.050649208340159,0.00907034716957393,-0.0684270887925239,-0.0328713278877941,2.40409293614635e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IST1,IST1 homolog,40375,-0.0551382869466951,0.00990749592209958,-0.0745569789540103,-0.0357195949393799,2.67715050930677e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALPI,Intestinal-type alkaline phosphatase,40199,-0.0702225990601874,0.0126330626033595,-0.094983401762772,-0.0454617963576028,2.78225480326636e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL33,Interleukin-33,42370,-0.021472694083092,0.00386883425388061,-0.029055609220698,-0.013889778945486,2.90901085018184e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPD52L2,Tumor protein D54,40283,-0.0597580201043267,0.0107658904945474,-0.0808591654736396,-0.0386568747350138,2.91101820122318e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,40223,-0.0325941374601375,0.00587296901839846,-0.0441051567361984,-0.0210831181840765,2.92509069603689e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,0.0147455706742584,0.00265820654462604,0.00953548584679138,0.0199556555017255,2.95804524433327e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,-0.0268510586882906,0.00484050314441057,-0.0363384448513353,-0.0173636725252459,2.9596340802685e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLITRK6,SLIT and NTRK-like protein 6,42357,-0.0197781457038704,0.00356747777336726,-0.0267704021396702,-0.0127858892680706,3.01305860394568e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACRBP,Acrosin-binding protein,40451,-0.021846812901622,0.00394157257787954,-0.0295722951542659,-0.0141213306489781,3.04611812517047e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,-0.0420055941520761,0.00759297909247213,-0.0568878331733215,-0.0271233551308307,3.22229160125375e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,-0.0158303593664781,0.00286251601627403,-0.0214408907583752,-0.010219827974581,3.27178411439846e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INSL4,Early placenta insulin-like peptide,40451,-0.0271005583521146,0.00490955024831445,-0.0367232768388109,-0.0174778398654183,3.46574954930329e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGCC,Regulator of cell cycle RGCC,40482,-0.041710203151719,0.00756071512005449,-0.0565292047870258,-0.0268912015164122,3.53037610607446e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITPA,Inosine triphosphate pyrophosphatase,40116,-0.0371664118624101,0.00674520282678421,-0.0503870094029071,-0.023945814321913,3.66866808444821e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYBB1,Beta-crystallin B1,40511,-0.0352537283592663,0.00640222844411245,-0.0478020961097267,-0.0227053606088059,3.74075416872337e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42654,0.0477335705916048,0.00869345595098129,0.0306943969276815,0.0647727442555281,4.07489931246442e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,-0.0509038747788821,0.00927893683896884,-0.069090590983261,-0.0327171585745031,4.18747155171378e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBP4,Guanylate-binding protein 4,42311,-0.0270828240529705,0.0049384955255749,-0.0367622752830973,-0.0174033728228437,4.23456606607144e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PADI2,Protein-arginine deiminase type-2,42370,-0.030478810125968,0.00555986739342918,-0.0413761502170892,-0.0195814700348468,4.28449321419782e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHACTR2,Phosphatase and actin regulator 2,40482,-0.0622685961387565,0.0113657543298205,-0.0845454746252047,-0.0399917176523083,4.37864077436465e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A14,Protein S100-A14,40482,-0.0302552102107492,0.00552276120855994,-0.0410798221795267,-0.0194305982419717,4.38702233261757e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH2B3,SH2B adapter protein 3,42346,-0.0530358617157977,0.00970468351697427,-0.0720570414090672,-0.0340146820225281,4.71401506599574e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,-0.0336809238821993,0.00616388551726908,-0.0457621394960467,-0.0215997082683519,4.73272350368526e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,-0.0619645024957331,0.0113466332948363,-0.0842039037536122,-0.039725101237854,4.8175768447469e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UROD,Uroporphyrinogen decarboxylase,40283,-0.0378192542777377,0.00692589835214731,-0.0513940150479464,-0.0242444935075289,4.84881010183861e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFHR4,Complement factor H-related protein 4,40509,0.0409696938313803,0.00750425564576678,0.0262613527656774,0.0556780348970832,4.87481307158272e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF3,Granulocyte colony-stimulating factor,42370,-0.02657737570178,0.00487441510042485,-0.0361312292986127,-0.0170235221049473,5.05831350300327e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,-0.0415745849158723,0.00762780909259279,-0.0565250907373542,-0.0266240790943905,5.11482075917594e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,42357,-0.0295161898875575,0.00541952480559418,-0.0401384585065221,-0.018893921268593,5.23608859788627e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL4,Angiopoietin-related protein 4,42654,-0.0243974882567131,0.00448108958195118,-0.0331804238373374,-0.0156145526760888,5.28490344354078e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFRA2,GDNF family receptor alpha-2,42587,-0.0115966159960838,0.00213098059475674,-0.015773337961807,-0.00741989403036062,5.36378701948093e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA4D,Semaphorin-4D,42711,-0.0161957017922822,0.00297700025264138,-0.0220306222874593,-0.0103607812971051,5.41241964854065e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,-0.0463873938784956,0.00852601378616402,-0.0630983808993771,-0.0296764068576141,5.4204613159498e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGCT,Gamma-glutamylcyclotransferase,40500,-0.0260059110677975,0.00478137544201214,-0.0353774069341413,-0.0166344152014537,5.46953828062314e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,-0.0385836671208081,0.00709914472578732,-0.0524979907833513,-0.024669343458265,5.59646303648732e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,-0.0273778272208909,0.00503878136233894,-0.0372538386910753,-0.0175018157507066,5.64347970993763e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,-0.0161232403204359,0.00297308600300772,-0.021950488886331,-0.0102959917545407,5.961197582134e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB6,Serpin B6,42679,-0.0311993006282445,0.00575862715410109,-0.0424862098502826,-0.0199123914062064,6.13602056040314e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40449,-0.0615815417941008,0.0113724284492008,-0.0838715015545343,-0.0392915820336672,6.2553463173232e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDGF,Hepatoma-derived growth factor,42700,-0.0501526002624305,0.00927269215517925,-0.0683270768865819,-0.0319781236382792,6.45885870462231e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COMP,Cartilage oligomeric matrix protein,42511,0.0181905771865103,0.00336949746776157,0.0115863621496976,0.024794792223323,6.8313634822893e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GHRL,Appetite-regulating hormone,42636,-0.0457922925272179,0.00849054807701585,-0.0624337667581689,-0.0291508182962668,7.03357341562282e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA1,Annexin A1,40235,-0.0225845309804439,0.00418793903280122,-0.0307928914847343,-0.0143761704761535,7.08163678846409e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,-0.0265829127577549,0.00494159409762463,-0.0362684371890992,-0.0168973883264106,7.62429913450768e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNAS,Neuroendocrine secretory protein 55,40482,-0.0464665154529618,0.00863898870721929,-0.0633989333191116,-0.029534097586812,7.65240812200736e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTF3,Neurotrophin-3,42594,-0.0192199414271305,0.003583650679168,-0.0262438967582997,-0.0121959860959612,8.31046516413004e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPME1,Protein phosphatase methylesterase 1,42587,-0.0319424905893359,0.00595596591298252,-0.0436161837787816,-0.0202687973998901,8.31610718354915e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAS2,Growth arrest-specific protein 2,40302,-0.0284819265767399,0.0053123909209954,-0.0388942127818909,-0.0180696403715889,8.42275739819674e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDK2,Protein sidekick-2,40283,-0.0218234776159382,0.0040770590425902,-0.029814513339415,-0.0138324418924614,8.83552999819397e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,-0.0356394906972404,0.00665850138499187,-0.0486901534118245,-0.0225888279826564,8.84565241913416e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOE,Apolipoprotein E,40539,-0.0390910955494055,0.00731015474983046,-0.0534189988590732,-0.0247631922397379,9.09059980289602e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMCN2,Hemicentin-2,40269,-0.0315471132430982,0.00590150058674509,-0.0431140543931186,-0.0199801720930778,9.19039099330331e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,-0.0312873142308902,0.00585421855370436,-0.0427615825961507,-0.0198130458656296,9.21978842776965e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,-0.0804859921528293,0.0150668339904867,-0.110016986774183,-0.0509549975314753,9.34652907600609e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DGCR6,Protein DGCR6,40136,-0.0238910289849007,0.00447289538423503,-0.0326579039380013,-0.0151241540318,9.41378069532894e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NXPH1,Neurexophilin-1,42311,-0.0207682332755891,0.00389247839554238,-0.0283974909308522,-0.0131389756203261,9.68777493078351e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFT20,Intraflagellar transport protein 20 homolog,40182,-0.0229947342370011,0.0043134936595304,-0.0314491818096807,-0.0145402866643215,9.96720392030591e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,-0.0305454249110199,0.00573569892929806,-0.0417873948124441,-0.0193034550095957,1.02292054502053e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ISM1,Isthmin-1,42594,-0.0204094450952051,0.00383424026849272,-0.0279245560214508,-0.0128943341689594,1.03747918773354e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CENPF,Centromere protein F,40302,-0.0292701594525373,0.00549920368230609,-0.0400485986698572,-0.0184917202352173,1.04276624722243e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRISP2,Cysteine-rich secretory protein 2,42721,0.0314469814226135,0.00593408704993601,0.0198161708047389,0.043077792040488,1.18021005023243e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEPTIN9,Septin-9,42587,-0.0150378704109953,0.00284308876347761,-0.0206103243874114,-0.00946541643457919,1.24737069701534e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDHB15,Protocadherin beta-15,40451,-0.0214313441911429,0.00406206369913111,-0.0293929890414398,-0.0134696993408459,1.34504392767912e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAP,Prolyl endopeptidase FAP,42794,0.0143982916829884,0.00273154372501747,0.00904446598195411,0.0197521173840226,1.37668349644679e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX6,Syntaxin-6,42346,-0.0348151835819957,0.00661167609007283,-0.0477740687185385,-0.021856298445453,1.41847014565897e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIT1,ARF GTPase-activating protein GIT1,40199,-0.0509852412176446,0.00971547414465062,-0.0700275705411599,-0.0319429118941294,1.56756962465796e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH12,Protocadherin-12,40482,-0.0136338752205852,0.00259911557859749,-0.0187281417546363,-0.00853960868653413,1.58609665786097e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42583,-0.0172539555304197,0.00329284873743128,-0.023707939055785,-0.0107999720050544,1.63167639263051e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VEGFC,Vascular endothelial growth factor C,42679,-0.0289501372459658,0.00552755213738728,-0.0397841394352449,-0.0181161350566867,1.65282565351023e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELOB,Elongin-B,40116,-0.0211193731837365,0.00403503986516048,-0.029028051319451,-0.013210695048022,1.68963996881302e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,-0.0482485889080471,0.00922265364437691,-0.0663249900510259,-0.0301721877650684,1.71124557094691e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDIA4,Protein disulfide-isomerase A4,40527,-0.0313653000894352,0.00599996697011187,-0.0431252353508544,-0.0196053648280159,1.7479973779854e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,40182,-0.0360847616033203,0.00690338568790682,-0.0496153975516177,-0.0225541256550229,1.75338426860931e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,-0.0539641563050755,0.0103254027437724,-0.0742019456828695,-0.0337263669272816,1.75486218372694e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,-0.0141318577312125,0.00270517946307389,-0.0194340094788373,-0.00882970598358768,1.77725788378084e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,-0.0154931115029819,0.00296911025805293,-0.0213125676087656,-0.00967365539719815,1.83974994494663e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX2,Sorting nexin-2,40451,-0.0430806077843467,0.00826564196491109,-0.0592812660355724,-0.0268799495331209,1.90112982574013e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MITD1,MIT domain-containing protein 1,42495,-0.0495753366391701,0.00951483220738156,-0.068224407765638,-0.0309262655127023,1.91331539994467e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RANBP1,Ran-specific GTPase-activating protein,40223,-0.0274481778042037,0.00527023877927914,-0.0377778458115908,-0.0171185097968166,1.94173263596944e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICA1,Islet cell autoantigen 1,42370,-0.0406819672286829,0.00781674012075719,-0.056002777865367,-0.0253611565919989,1.97477328351018e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB27B,Ras-related protein Rab-27B,40511,-0.042967138423579,0.00825909140582921,-0.0591549575790042,-0.0267793192681537,2.0016556926807e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBCC,Tubulin-specific chaperone C,42495,-0.0414425759108095,0.00796919460127238,-0.0570621973293034,-0.0258229544923156,2.01868471173291e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,0.0232941265581093,0.00447944514042798,0.0145144140828705,0.0320738390333482,2.01959081883483e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42698,-0.0214339213984004,0.00412672557076337,-0.0295223035170966,-0.0133455392797042,2.08895711195134e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,-0.0440196985367176,0.00847657518009837,-0.0606337858897104,-0.0274056111837248,2.1048693977506e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPE,Ribulose-phosphate 3-epimerase,40302,-0.0365342511197082,0.00703666835415941,-0.0503261210938607,-0.0227423811455558,2.11745846704214e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DBNL,Drebrin-like protein,42676,-0.0472615182252833,0.00913109741778567,-0.0651584691641433,-0.0293645672864234,2.30091964126049e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RSPO1,R-spondin-1,42495,-0.0174854429544398,0.00338569620605935,-0.0241214075183161,-0.0108494783905634,2.44558893255215e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL1,Growth-regulated alpha protein,42607,-0.0492627198842822,0.00954663972981459,-0.0679741337547188,-0.0305513060138456,2.50187017754099e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,40199,-0.0466943777884729,0.00904994311946067,-0.0644322663026158,-0.02895648927433,2.51744465406756e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TYMP,Thymidine phosphorylase,42563,-0.0335114903182199,0.00649610444594367,-0.0462438550322694,-0.0207791256041703,2.52220669956336e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42636,-0.0343961492312055,0.00666784007938837,-0.0474651157868067,-0.0213271826756043,2.52458314111549e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIRREL2,Kin of IRRE-like protein 2,42311,-0.0208405457195233,0.00404383058369189,-0.0287664536635594,-0.0129146377754872,2.59156157145841e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,0.030698743882766,0.00597488092482736,0.0189879772701044,0.0424095104954277,2.81674543220782e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,-0.0512031293329724,0.00998738354445267,-0.0707784010800996,-0.0316278575858451,2.98844643475153e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAGED1,Melanoma-associated antigen D1,42346,-0.0247118028855101,0.00483009883364495,-0.0341787965994542,-0.015244809171566,3.16125623585409e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX16,Syntaxin-16,42346,-0.0295747794919338,0.00578264275640508,-0.0409087592944877,-0.0182407996893798,3.19157494643562e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TST,Thiosulfate sulfurtransferase,42277,-0.0379426912549079,0.00743663149777777,-0.0525184889905524,-0.0233668935192635,3.40549288505637e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINE2,Glia-derived nexin,40511,-0.0328740188692283,0.00644544529465666,-0.0455070916467554,-0.0202409460917013,3.44515975546841e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,40199,-0.0291231705770634,0.00571269297912171,-0.040320048816142,-0.0179262923379849,3.49009948639212e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL13,C-C motif chemokine 13,42734,-0.0350766874050033,0.00688341163949626,-0.0485681742184159,-0.0215852005915906,3.51895203917155e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF2,Fibroblast growth factor 2,42594,-0.0346924756848793,0.00681983974514941,-0.0480593615853721,-0.0213255897843864,3.68703407952252e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BMP10,Bone morphogenetic protein 10,40283,0.0147404889390714,0.00290113779482052,0.00905425886122316,0.0204267190169196,3.81698071173921e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,0.0210651443736044,0.00414675974515624,0.0129374952730982,0.0291927934741106,3.82704175698935e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL5,C-X-C motif chemokine 5,42605,-0.0573442738206595,0.0112979484191716,-0.0794882527222358,-0.0352002949190833,3.91373405451198e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,-0.0553965996626893,0.0109263790650076,-0.0768123026301041,-0.0339808966952745,4.03119135981317e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RRAS,Ras-related protein R-Ras,40182,-0.0658715602351183,0.0129953258922893,-0.0913423989840053,-0.0404007214862312,4.06708059464079e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBP2,Guanylate-binding protein 2,42370,-0.0307082542000862,0.00605987357079304,-0.0425856063988406,-0.0188309020013319,4.08589348560896e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSDE1,Cold shock domain-containing protein E1,40116,-0.0593727623155577,0.011722594735274,-0.0823490479966948,-0.0363964766344206,4.15473363489084e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRG2,Bone marrow proteoglycan,40527,-0.0269017176356515,0.00531269261658085,-0.0373145951641499,-0.016488840107153,4.17726809002963e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APP,Amyloid-beta precursor protein,42592,-0.0334192938963002,0.0066137848387846,-0.046382312180318,-0.0204562756122824,4.40709176596346e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,-0.0334110803350319,0.00661692900675697,-0.0463802611882755,-0.0204418994817882,4.50386650656107e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRAP2,GRB2-related adapter protein 2,42636,-0.063914617176717,0.0126642700029737,-0.0887365863825454,-0.0390926479708886,4.5503322027285e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,-0.0409430583576305,0.00812461451990047,-0.0568673028166354,-0.0250188138986256,4.73117994014597e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASPN,Asporin,40511,0.0142414779179011,0.00283032191596064,0.00869404696261825,0.019788908873184,4.93481533466588e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPP,Lipoma-preferred partner,40116,-0.0332158182151721,0.00660424287998112,-0.0461601342599351,-0.0202715021704091,4.99660861994143e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LACTB2,Endoribonuclease LACTB2,42636,-0.0326379679143466,0.00649294643943126,-0.0453641429356318,-0.0199117928930613,5.05463297532498e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFHR2,Complement factor H-related protein 2,40451,-0.029257594321978,0.00582010667442597,-0.0406650034038529,-0.0178501852401031,5.05913300167195e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,40332,-0.0288044259954096,0.00573047459167365,-0.0400361561950899,-0.0175726957957292,5.0718602855621e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,-0.0331066935486115,0.0065947501356847,-0.0460324038145536,-0.0201809832826695,5.24458563997859e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,42311,-0.0314877820127667,0.0062762640105037,-0.0437892594733539,-0.0191863045521794,5.31818293158825e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRG3,Proteoglycan 3,40527,0.0251409700740764,0.00501141313271582,0.0153186003339534,0.0349633398141994,5.33515287666975e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,40116,-0.0347348897164107,0.00692961404209475,-0.0483169332389164,-0.021152846193905,5.45617190964033e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SYAP1,Synapse-associated protein 1,40283,-0.0288539801502255,0.00575876965423506,-0.0401411686725262,-0.0175667916279248,5.51425279211909e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPARCL1,SPARC-like protein 1,42644,0.0138647573683501,0.00276909282607725,0.00843733542923868,0.0192921793074615,5.59945528440896e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST1,Cystatin-SN,39042,-0.0555837218684712,0.0111123661813541,-0.0773639595839254,-0.0338034841530171,5.77269579410643e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCN,Decorin,42357,-0.0120755095706634,0.00241471256890994,-0.0168083462057269,-0.00734267293559996,5.78264118283726e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MASP1,Mannan-binding lectin serine protease 1,42476,-0.011657789490489,0.00233286088984747,-0.01623019683459,-0.00708538214638798,5.89068946463754e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB5,Integrin beta-5,42679,0.0185517864983792,0.00371558093758004,0.0112692478607223,0.0258343251360361,6.02005054847209e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXNA4,Plexin-A4,42594,-0.0406867580429033,0.00815260038048022,-0.0566658547886445,-0.024707661297162,6.09324237295794e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STK24,Serine/threonine-protein kinase 24,42311,-0.030546648228254,0.00612872649495808,-0.0425589521583719,-0.0185343442981362,6.30205730231177e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTF1,Cardiotrophin-1,42357,-0.0419055410647591,0.00840807627960335,-0.0583853705727817,-0.0254257115567366,6.30869281282802e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RCC1,Regulator of chromosome condensation,40451,-0.0263534691157678,0.00529156394939337,-0.0367249344565788,-0.0159820037749568,6.44343298139235e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42676,-0.0517066527459764,0.0103834601386599,-0.0720582346177499,-0.0313550708742029,6.44662549554184e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42611,-0.0171042598165015,0.00343901505945417,-0.0238447293330317,-0.0103637902999714,6.65363882605839e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40451,-0.0243154606057736,0.00490430530989648,-0.0339278990131708,-0.0147030221983765,7.22673886472809e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REEP4,Receptor expression-enhancing protein 4,40482,-0.0308013449616679,0.0062189468501126,-0.0429904807878886,-0.0186122091354471,7.42035424519017e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,40199,-0.0452728824123031,0.00914429501624644,-0.0631957006441461,-0.02735006418046,7.49502710453352e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,0.0118551932335468,0.00239733955465589,0.00715640770642129,0.0165539787606724,7.70028393912913e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUSD2,Sushi domain-containing protein 2,42611,0.0142268098500942,0.00288050172666557,0.00858102646582969,0.0198725932343587,7.94680086614697e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42679,-0.029791201591241,0.00603240781740518,-0.0416147209133552,-0.0179676822691269,7.96579833166407e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYAR,Cell growth-regulating nucleolar protein,42346,-0.0268397496916462,0.00543942946356696,-0.0375010314402374,-0.016178467943055,8.142528745961e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPART,Spartin,40283,-0.037986859681474,0.00769813093552463,-0.0530751963151023,-0.0228985230478457,8.15006222969525e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OPHN1,Oligophrenin-1,40483,-0.0527232810638466,0.0107131626976603,-0.0737210799512607,-0.0317254821764324,8.71609540091334e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TWF2,Twinfilin-2,40527,-0.0408894052279409,0.00830989217754696,-0.0571767938959329,-0.0246020165599488,8.75060126414947e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPI,Mannose-6-phosphate isomerase,42587,-0.0414018697522106,0.00841640043486695,-0.0578980146045498,-0.0249057248998714,8.79352956464852e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,-0.0159614391744934,0.00324703860054671,-0.022325634831565,-0.00959724351742188,8.95107895166397e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AK1,Adenylate kinase isoenzyme 1,42636,-0.0309270253492195,0.00629833565455741,-0.0432717632321521,-0.018582287466287,9.1982769357272e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TK1,"Thymidine kinase, cytosolic",40302,-0.022485298753318,0.00458380670174877,-0.0314695598887456,-0.0135010376178904,9.45702016910565e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,-0.0267498180365796,0.00545370047362307,-0.0374390709648808,-0.0160605651082784,9.45759112177332e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYL4,Myosin light chain 4,40223,-0.0257292535892281,0.00525676729150693,-0.0360325174805817,-0.0154259896978745,9.99506695355637e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRUNE2,Protein prune homolog 2,40302,-0.0148519597144749,0.00303596622749019,-0.0208024535203557,-0.00890146590859412,1.01214502621577e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCN2,Ficolin-2,42597,-0.020047401991606,0.00410117301874355,-0.0280857011083434,-0.0120091028748686,1.02934433923911e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFNB2,Ephrin-B2,40182,-0.0268722320369823,0.00549819051145475,-0.0376486854394336,-0.016095778634531,1.03584312636218e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,-0.0271379275975818,0.0055532914149531,-0.0380223787708899,-0.0162534764242738,1.03891094141317e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XRCC4,DNA repair protein XRCC4,42311,-0.017912108876902,0.00368279398796565,-0.0251303850933147,-0.0106938326604894,1.16532078394805e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPEP1,Dipeptidase 1,42476,0.0242239047895318,0.00498245633937002,0.0144582903643665,0.033989519214697,1.1763066334582e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40483,0.0180669843164466,0.00371670345753539,0.0107822455396772,0.025351723093216,1.1835279815144e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LCN15,Lipocalin-15,40482,-0.0306434131077549,0.00630950078245386,-0.0430100346413645,-0.0182767915741454,1.20954337291625e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42587,-0.0103032934640397,0.00212355026813656,-0.0144654519895873,-0.00614113493849201,1.23649441132293e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBCB,Tubulin-folding cofactor B,42495,-0.0479881352658185,0.00989430371437723,-0.0673809705459979,-0.0285952999856392,1.24810731835702e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,-0.0138504393864429,0.00285957222482823,-0.0194552009471062,-0.00824567782577954,1.29238620791118e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPNMB,Transmembrane glycoprotein NMB,42315,-0.0140885176692447,0.00291242784988795,-0.0197968762550251,-0.00838015908346431,1.33057097982816e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HRG,Histidine-rich glycoprotein,40479,-0.0149857664989368,0.00310488457741787,-0.0210713402706758,-0.00890019272719774,1.40765050117246e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TTF2,Transcription termination factor 2,40182,-0.0237236531912763,0.00491621034616596,-0.0333594254697615,-0.014087880912791,1.41461635772716e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,-0.0399239232862739,0.00827769032224504,-0.0561481963178742,-0.0236996502546736,1.42911338177241e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,-0.0469135208260118,0.0097570715293509,-0.0660373810235396,-0.027789660628484,1.54290467863754e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEZ6L,Seizure 6-like protein,42679,-0.0134757662214538,0.00280478532776502,-0.0189731454638733,-0.00797838697903441,1.56760092195636e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,-0.044777407379606,0.00934646552175629,-0.0630964798022484,-0.0264583349569637,1.68200183243808e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSC,Dipeptidyl peptidase 1,42616,-0.0210895692333979,0.00440421734232467,-0.0297218352243543,-0.0124573032424416,1.69831758449329e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,-0.020914171917409,0.00437833414851053,-0.0294957068484896,-0.0123326369863283,1.80081559639075e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENAH,Protein enabled homolog,42370,-0.0224602851142679,0.00470672433992723,-0.0316854648205253,-0.0132351054080106,1.844030419957e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN1,Contactin-1,42794,0.013281468815368,0.00278572865322744,0.00782144065504224,0.0187414969756938,1.88288539252467e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,-0.0347972231394166,0.00730857628505997,-0.0491220326581342,-0.0204724136206991,1.94879864317333e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,-0.0357322533339635,0.00751293584120351,-0.0504576075827224,-0.0210068990852046,1.99892152678417e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,-0.0259263248103967,0.00545182676650145,-0.0366119052727396,-0.0152407443480539,2.00438736196353e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,-0.0327060816665239,0.0068918823393638,-0.0462141710516769,-0.0191979922813709,2.10531791335655e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX5,Sorting nexin-5,40223,-0.0138656842192502,0.00292424842217706,-0.0195972111267172,-0.00813415731178315,2.14667444562637e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FXN,"Frataxin, mitochondrial",42721,-0.0345497319403914,0.00729362885496737,-0.0488452444961274,-0.0202542193846553,2.19137150737217e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP5,Rho GTPase-activating protein 5,40080,-0.038196574789409,0.00806470972507661,-0.0540034058505591,-0.0223897437282588,2.20446492044837e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABHD14B,Protein ABHD14B,42460,-0.0267976461169082,0.00567300354237604,-0.0379167330599652,-0.0156785591738511,2.33949947838823e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,0.045914921514278,0.00972932130599512,0.0268454517545276,0.0649843912740285,2.39115560825322e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACYBP,Calcyclin-binding protein,40267,-0.0483068162419825,0.0102451636700236,-0.0683873370352287,-0.0282262954487363,2.44558749571605e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,-0.0234320527604693,0.00498000002456191,-0.0331928528086107,-0.013671252712328,2.5616080706863e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,-0.0146403977937758,0.0031188384740194,-0.0207533212028538,-0.00852747438469777,2.70374067596018e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD36,Platelet glycoprotein 4,40199,-0.0211137673014045,0.00450054342899631,-0.0299348324222373,-0.0122927021805717,2.74634364334943e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL34,Interleukin-34,42292,-0.0171593277152211,0.00365947445398113,-0.0243318976450241,-0.00998675778541811,2.77294822869456e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,-0.0280588174567357,0.00602768897591214,-0.0398730878495235,-0.0162445470639479,3.27166410516143e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WIF1,Wnt inhibitory factor 1,42721,0.0160057801657339,0.0034458712355395,0.00925187254407644,0.0227596877873913,3.43421253422545e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBA,Lysosomal acid glucosylceramidase,40182,-0.0259087023311631,0.00558386707725992,-0.0368530818025925,-0.0149643228597336,3.52571537264435e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAPK2,Death-associated protein kinase 2,40199,-0.0252399951545536,0.00544739837993394,-0.0359168959792242,-0.0145630943298831,3.63831671032704e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42594,-0.0266345842345644,0.00576747127509221,-0.0379388279337451,-0.0153303405353836,3.90928774926661e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSNK1D,Casein kinase I isoform delta,40199,-0.0292025446554801,0.00632716336537965,-0.0416037848516242,-0.016801304459336,3.96729201526666e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,42357,-0.0505248401718633,0.0109587439137539,-0.0720039782428209,-0.0290457021009057,4.0556123496764e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL2RG,Cytokine receptor common subunit gamma,40451,-0.0170066509512,0.0036928273783948,-0.0242445926128538,-0.00976870928954616,4.16347044764844e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPXM1,Probable carboxypeptidase X1,42679,-0.0318935679430372,0.00693182255304681,-0.045479940147009,-0.0183071957390655,4.24224480309193e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRRT3,Proline-rich transmembrane protein 3,40223,-0.0185434634713185,0.00403090058993157,-0.0264440286275844,-0.0106428983150526,4.26527305577675e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOA2,Apolipoprotein A-II,40532,0.0227703774242338,0.00495489065250901,0.0130587917453161,0.0324819631031515,4.36298034625847e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBP1,Retinol-binding protein 1,40182,-0.0316400776983027,0.00688734154851008,-0.0451392671333824,-0.0181408882632229,4.39779978426814e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42559,-0.00994333463692081,0.00216579496205713,-0.0141882927625528,-0.00569837651128884,4.44981988268229e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSF,Cathepsin F,42679,-0.0181446826881186,0.00395400219967123,-0.0258945269994742,-0.010394838376763,4.49518792130152e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,-0.0108165985051016,0.00235948225822337,-0.0154411837312195,-0.00619201327898383,4.59545537853291e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB1,Leukocyte elastase inhibitor,42569,-0.0403894477191376,0.00881481477841046,-0.0576664846848221,-0.0231124107534531,4.64722485809429e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FBN2,Fibrillin-2,40182,-0.0281051815569228,0.00613682811475044,-0.0401333646618336,-0.0160769984520119,4.70634061610742e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHMP1A,Charged multivesicular body protein 1a,42495,-0.0358878169259229,0.00784679591414806,-0.0512675369176531,-0.0205080969341927,4.83827860135406e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MKI67,Proliferation marker protein Ki-67,40199,-0.017840618503969,0.00390367898522224,-0.0254918293150046,-0.0101894076929334,4.92549574395479e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH1,Protocadherin-1,42721,-0.00990052469547844,0.00216957073702737,-0.0141528833400521,-0.00564816605090481,5.07852706673969e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,-0.0173417459968536,0.00380213249771964,-0.0247939256923841,-0.0098895663013231,5.14326140846766e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NID2,Nidogen-2,42611,-0.0335919291833293,0.00736898588064138,-0.0480351415093864,-0.0191487168572722,5.19618940952381e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,-0.0132473519930282,0.0029073242509976,-0.0189457075249835,-0.00754899646107287,5.25492137061649e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARG1,Arginase-1,42488,-0.0235551027168523,0.00517078276952973,-0.0336898369451306,-0.0134203684885741,5.27453368467205e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17RA,Interleukin-17 receptor A,42611,-0.0199867126156461,0.00439159834228502,-0.0285942453665247,-0.0113791798647674,5.38284606636887e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THBS4,Thrombospondin-4,42652,-0.0208111312452816,0.00457910911661975,-0.0297861851138563,-0.0118360773767069,5.54665175826568e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXNB3,Plexin-B3,42597,-0.0212464059202204,0.0046750065097211,-0.0304094186792737,-0.012083393161167,5.54999763959141e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42594,-0.0163060088787369,0.00359021202883007,-0.0233428244552438,-0.00926919330222993,5.62637347404102e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,-0.0273131559637295,0.00603336311137445,-0.0391385476620234,-0.0154877642654355,6.04444871964097e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,-0.0191362680801892,0.00423099271768745,-0.0274290138068566,-0.0108435223535218,6.16279525015994e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFA,Platelet-derived growth factor subunit A,42794,-0.032337122152263,0.00715386769792439,-0.0463587028401948,-0.0183155414643312,6.22940341226505e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40511,-0.0318228174184286,0.00704958967680072,-0.045640013184958,-0.0180056216518992,6.42168203894829e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GH1,Somatotropin,42613,0.0773669304060008,0.0171531009708945,0.0437468525030476,0.110987008308954,6.52618238367909e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",40223,-0.0385371306508199,0.00854608904930962,-0.0552874651874668,-0.0217867961141731,6.57039148719973e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCN1,Transcobalamin-1,40337,-0.0155563713714582,0.00345064533063685,-0.0223196362195064,-0.00879310652340993,6.60315000956828e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPC1,Glypican-1,42721,-0.0134588866820682,0.0029872573351962,-0.0193139110590528,-0.00760386230508368,6.67928670918819e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CIRBP,Cold-inducible RNA-binding protein,40449,-0.0429344321838558,0.00953238958288821,-0.0616179157663167,-0.0242509486013949,6.73391430165982e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PODXL2,Podocalyxin-like protein 2,42679,-0.0127173143635598,0.00282702587354712,-0.0182582850757121,-0.00717634365140739,6.90134732143209e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRL,Prolactin,42711,-0.0336286074995934,0.00747651852166337,-0.0482825838020536,-0.0189746311971332,6.9200839192382e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRH,Corticoliberin,42322,0.0385986110133506,0.00859858007467434,0.0217453940669889,0.0554518279597123,7.21838930551242e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,-0.0312346917379546,0.00696577873801728,-0.0448876180644685,-0.0175817654114408,7.39894319827571e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGA2,Integrin alpha-2,40283,0.0157674033359457,0.00351711570719017,0.00887385654985297,0.0226609501220384,7.43222899263834e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NELL2,Protein kinase C-binding protein NELL2,42676,-0.0129843076833906,0.00289975640383169,-0.0186678302349007,-0.00730078513188049,7.60626138448179e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G1B,Phospholipase A2,42782,-0.020416670021858,0.00456494100091402,-0.0293639543836495,-0.0114693856600665,7.79396528835174e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PMS1,PMS1 protein homolog 1,40182,-0.0233600901488834,0.00523800362514765,-0.0336265772541728,-0.013093603043594,8.28769562378577e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAEP,Glycodelin,42495,-0.0400609731707916,0.00899485153745347,-0.0576908821842004,-0.0224310641573828,8.50645768381394e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40428,-0.0185403660767989,0.00417018228593752,-0.0267139233572364,-0.0103668087963613,8.83492853355553e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,-0.0455680476429254,0.0102550994320276,-0.0656680425296995,-0.0254680527561512,8.9372571347278e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYTL1,Cytokine-like protein 1,40527,-0.0114218764793769,0.00257268625471799,-0.0164643415386242,-0.00637941142012967,9.09493182966152e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBM17,Splicing factor 45,40482,-0.0339965598074172,0.00766395324950964,-0.0490179081764561,-0.0189752114383783,9.2554588801447e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,40199,-0.0165360215054205,0.00372912915544235,-0.0238451146500875,-0.00922692836075352,9.32740367281942e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,-0.0149608950424606,0.00337609717663523,-0.0215780455086656,-0.00834374457625552,9.45192218274804e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,-0.025938239407748,0.00586696677201711,-0.0374374942809015,-0.0144389845345944,9.89942211621925e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,40302,-0.0305506717775084,0.00691045951015338,-0.044095172417409,-0.0170061711376078,9.92092282346949e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,-0.0452907298926664,0.0102460639336837,-0.0653730152026864,-0.0252084445826464,9.93328370894435e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HLA_A,,40482,-0.0147793005186781,0.00334453478182323,-0.0213345886910516,-0.00822401234630453,1.00111013404126e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDK1,Cyclin-dependent kinase 1,40080,-0.0164351904902808,0.00372674157992835,-0.0237396039869404,-0.00913077699362127,1.04329184286714e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1B,Interleukin-1 beta,42293,-0.0250228483213239,0.00567560287662966,-0.036147029959518,-0.0138986666831298,1.04751390269048e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLG4,Disks large homolog 4,40483,-0.0308855923336628,0.00702580123354643,-0.0446561627514138,-0.0171150219159118,1.11259575862155e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,-0.0292472879083263,0.00668086697314709,-0.0423417871756946,-0.0161527886409581,1.2083868827388e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERP29,Endoplasmic reticulum resident protein 29,40283,-0.0520160018229441,0.0118948006507903,-0.0753298110984931,-0.028702192547395,1.23666816029929e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,-0.0219553218409258,0.00502741581129329,-0.0318090568310607,-0.012101586850791,1.27047578757173e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL8,C-C motif chemokine 8,42706,-0.0262489747968566,0.00603070986379998,-0.0380691661299046,-0.0144287834638087,1.35551158948019e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDHD2,Phospholipase DDHD2,40482,-0.0286186269810885,0.00657910265397597,-0.0415136681828815,-0.0157235857792956,1.37377672534631e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,-0.0325869469410672,0.00750359053774546,-0.0472939843950483,-0.0178799094870861,1.41872184224468e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SF3B4,Splicing factor 3B subunit 4,42587,-0.0315334015428068,0.00726451521455092,-0.0457718513633267,-0.017294951722287,1.4304296191833e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSBP1,Heat shock factor-binding protein 1,40223,-0.0412989482362991,0.00951981267397035,-0.059957781077281,-0.0226401153953173,1.44925588599871e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,-0.021317156181236,0.00491676869678786,-0.0309540228269402,-0.0116802895355318,1.46419102321871e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LCP1,Plastin-2,40527,-0.02087253784243,0.00482456994819121,-0.0303286949408848,-0.0114163807439753,1.52933595582341e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,40223,-0.0396871095488542,0.00919132905282274,-0.0577021144923868,-0.0216721046053216,1.5890724555524e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNPY4,Protein canopy homolog 4,42587,-0.0318337717173668,0.00737315488496581,-0.0462851552918998,-0.0173823881428338,1.58923674038434e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDF1,Endothelial differentiation-related factor 1,40482,-0.0290763172802143,0.00673836296386589,-0.0422835086893914,-0.0158691258710371,1.60931463371098e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,40116,-0.0238374847614538,0.00552511052440278,-0.0346667013892832,-0.0130082681336243,1.61451489781578e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,-0.0367597009195978,0.00852895689229557,-0.0534764564284971,-0.0200429454106985,1.64647388857003e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OTUD6B,Deubiquitinase OTUD6B,40449,-0.0253005438697575,0.00587683590452699,-0.0368191422426304,-0.0137819454968846,1.68300211342168e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA12,Serpin A12,42249,-0.0444926302272876,0.0103412007438074,-0.0647613836851501,-0.0242238767694251,1.70139339761164e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,-0.0260018154745875,0.00606356640640178,-0.037886405631135,-0.01411722531804,1.81384486584714e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THTPA,Thiamine-triphosphatase,40436,-0.0377404218458172,0.00882942494386575,-0.0550460947357941,-0.0204347489558404,1.93240079068902e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,-0.0444732956106073,0.0104151848039204,-0.0648870578262913,-0.0240595333949233,1.97061997808558e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRR4,Proline-rich protein 4,40198,-0.0298679758357776,0.00702069158726439,-0.0436285313468159,-0.0161074203247394,2.11459603356194e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEXN,Nexilin,40532,-0.0294451666316349,0.00693260809225964,-0.0430330784924638,-0.015857254770806,2.18046518441651e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATXN10,Ataxin-10,42311,-0.0306520103590556,0.00722436892315084,-0.0448117734484312,-0.0164922472696799,2.22201236596539e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HGFAC,Hepatocyte growth factor activator,40428,0.0118589668830705,0.00279716676005855,0.00637652003335579,0.0173414137327853,2.25673881216615e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42587,0.0280637862998769,0.0066250074932267,0.0150787716131526,0.0410488009866012,2.29018440071189e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40483,-0.0447163010278184,0.0105850261585628,-0.0654629522986015,-0.0239696497570354,2.41366317550302e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,40182,-0.0205713924262703,0.00487211724426951,-0.0301207422250386,-0.0110220426275021,2.43801658550196e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,40166,-0.0238457683554783,0.00565042202526634,-0.0349205955250003,-0.0127709411859563,2.46077410698964e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,42475,-0.0144345031256881,0.00342606801684473,-0.0211495964387038,-0.00771940981267244,2.53507999033943e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,-0.0133655934788666,0.00317896326252929,-0.019596361473424,-0.00713482548430924,2.63520291726853e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42618,-0.124907945110261,0.0297136712413199,-0.183146740743248,-0.0666691494772741,2.64264534070754e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATRN,"Attractin, Isoform 2",40539,-0.00707394107921251,0.00168336568096122,-0.0103733378138965,-0.00377454434452853,2.66286107288463e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDC4,Syndecan-4,42636,0.019801310493759,0.00471280461056897,0.0105642134570438,0.0290384075304742,2.66748346749629e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,-0.0141399163758135,0.00337830771525422,-0.0207613994977118,-0.00751843325391528,2.86742795430409e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,-0.0117436155696938,0.00280879811301406,-0.0172488598712014,-0.00623837126818626,2.9210027177969e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS53,Serine protease 53,40483,0.0156862247364976,0.00375874210421065,0.00831909021224473,0.0230533592607505,3.02516291005548e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNGR2,Interferon gamma receptor 2,42495,-0.0216777757929232,0.00519498647360773,-0.0318599492811943,-0.011495602304652,3.02756332925171e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLITRK1,SLIT and NTRK-like protein 1,40199,0.0138027480693067,0.0033081070774217,0.00731885819756019,0.0202866379410532,3.03722424336362e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC51B,Organic solute transporter subunit beta,40116,-0.0323921443895157,0.0077670086812747,-0.0476154814048141,-0.0171688073742173,3.0630909251815e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COPB2,Coatomer subunit beta',40116,-0.0181943103838749,0.00436417571116725,-0.0267480947777627,-0.00964052598998706,3.08280595621895e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,-0.0460788060375707,0.011059411051098,-0.0677552516977228,-0.0244023603774186,3.11269660788918e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNMA1,Paraneoplastic antigen Ma1,40223,-0.0233611071468913,0.00560653882855312,-0.0343499232508554,-0.0123722910429272,3.11314177152232e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX1,Peroxiredoxin-1,42261,0.0371386514845403,0.00892490278404196,0.019645842027818,0.0546314609412625,3.18552050490257e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,-0.0405421343102492,0.00974443072789434,-0.0596412185369221,-0.0214430500835763,3.19841968615886e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PF4,Platelet factor 4,40463,-0.0409513925501563,0.00984697928633232,-0.0602514719513676,-0.0216513131489449,3.22326229065543e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THPO,Thrombopoietin,42357,0.0162205403502925,0.00390734750166356,0.0085621392470319,0.023878941453553,3.32685373047567e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42679,-0.0344455764691408,0.00830697870813209,-0.0507272547370797,-0.018163898201202,3.39539080965865e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAVS,Mitochondrial antiviral-signaling protein,42346,-0.0375217821241385,0.00904912094086856,-0.0552580591682409,-0.0197855050800361,3.39779478864658e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CGN,Cingulin,40182,-0.0172148924077455,0.00415410884486484,-0.0253569457436806,-0.00907283907181047,3.43762483646953e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RHOC,Rho-related GTP-binding protein RhoC,42443,-0.0474203308197558,0.0114523005297418,-0.0698668398580497,-0.0249738217814618,3.48420430737977e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BGN,Biglycan,42328,0.049789157665696,0.0120287381105216,0.0262128309690737,0.0733654843623183,3.50718854304237e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,-0.0340539591587376,0.00824213719649842,-0.0502085480638745,-0.0178993702536007,3.62710243733071e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA6,Corticosteroid-binding globulin,40539,0.00652587560388415,0.00158053017088773,0.00342803646894419,0.0096237147388241,3.67087691129327e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOLH1,Glutamate carboxypeptidase 2,40199,-0.0422876868540506,0.0102442105695324,-0.0623663395703341,-0.0222090341377672,3.68695598364644e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPARC,SPARC,42679,-0.0287648630572353,0.00697172222356851,-0.0424294386154296,-0.0151002874990411,3.71450757803223e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42636,-0.00722983370093074,0.00175257726130841,-0.0106648851330952,-0.00379478226876626,3.72548318290634e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40511,-0.0441313614848491,0.0107018719091585,-0.0651070304267997,-0.0231556925428985,3.75489536841633e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMBS,Porphobilinogen deaminase,42721,-0.0177845906629671,0.00431316411690851,-0.0262383923321078,-0.00933078899382643,3.75667101835769e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PKLR,Pyruvate kinase PKLR,42636,-0.0269197632311287,0.00652923481901808,-0.0397170634764041,-0.0141224629858533,3.76284190812167e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40483,-0.0158545871478347,0.00384938887201169,-0.0233993893369776,-0.00830978495869183,3.83684331695512e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,42346,-0.0215057757039156,0.00522704738100135,-0.0317507885706782,-0.0112607628371529,3.90677937595039e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40539,-0.0110353193547655,0.0026877840603207,-0.016303376112994,-0.00576726259653687,4.05861958441884e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SATB1,DNA-binding protein SATB1,40482,-0.012112726437892,0.00295227972842922,-0.0178991947056133,-0.00632625817017075,4.1097909971308e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYZL2,Lysozyme-like protein 2,40080,-0.0149225843885272,0.00363739186026643,-0.0220518724346494,-0.00779329634240499,4.11596056756708e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42602,-0.0233934070326638,0.00571140919916621,-0.0345877690630295,-0.012199045002298,4.22986623476681e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,42370,-0.0268415500358046,0.00655919162450539,-0.0396975656198351,-0.013985534451774,4.29837680334574e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,-0.0293095681947715,0.00716697211511501,-0.0433568335403969,-0.0152623028491461,4.34752979282331e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,-0.00774097586012562,0.00189587836613588,-0.0114568974577519,-0.0040250542624993,4.47057386436987e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JCHAIN,Immunoglobulin J chain,42370,-0.0255006294828813,0.00625501631153829,-0.0377604614534964,-0.0132407975122663,4.59221894832474e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPP1,Osteopontin,42771,-0.0192557794264686,0.00472906239372924,-0.0285247417181779,-0.00998681713475931,4.69165197623251e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX3,Syntaxin-3,40483,-0.0159013864427481,0.00390911340516339,-0.0235632487168683,-0.00823952416862784,4.77872237938919e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UNC79,Protein unc-79 homolog,40080,-0.0227862331423942,0.00561002294249009,-0.0337818781096748,-0.0117905881751136,4.90580665360802e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIF22,Kinesin-like protein KIF22,40116,-0.0509641103229163,0.0125650798939479,-0.0755916669150541,-0.0263365537307785,5.02647040177281e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LMOD1,Leiomodin-1,40482,-0.014597176562518,0.00360326722730545,-0.0216595803280366,-0.00753477279699929,5.13197928054652e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42794,-0.00922618306856474,0.00227788788369127,-0.0136908433205996,-0.00476152281652985,5.14306721327554e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCD6,Programmed cell death protein 6,42636,0.0285651797630388,0.00705578804830014,0.0147358351883705,0.0423945243377071,5.18414329862488e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,-0.0289351421023962,0.00714824797543985,-0.0429457081342583,-0.014924576070534,5.19755648641961e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLKB1,Plasma kallikrein,40293,0.00999861303165728,0.00247402797749183,0.0051495181957733,0.0148477078675413,5.34844318824029e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX5,Syntaxin-5,40199,-0.0167022584465177,0.00413838942244131,-0.0248135017145026,-0.00859101517853271,5.47540790426413e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,-0.0198859899952701,0.00492764841724294,-0.0295441808930662,-0.0102277990974739,5.47654571852251e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DENR,Density-regulated protein,40199,-0.0231184789457848,0.00573362584832854,-0.0343563856085088,-0.0118805722830609,5.56565274423601e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,-0.0294042139087349,0.00729318268151605,-0.0436988519645063,-0.0151095758529634,5.56785475669617e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,-0.0360992537599945,0.00896809688437743,-0.0536767236533743,-0.0185217838666148,5.72742249725551e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,-0.0131773514282858,0.00327616048300219,-0.0195986259749701,-0.00675607688160154,5.80461291385618e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHCY,Adenosylhomocysteinase,42636,-0.0269372807592206,0.00670865682804332,-0.0400862481421855,-0.0137883133762557,5.96923333755924e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA3,Annexin A3,42681,-0.027760007458348,0.00691627161774294,-0.0413158998291242,-0.0142041150875719,6.00912685931118e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFIC,Nuclear factor 1 C-type,40482,-0.019197987659346,0.00478545489218887,-0.0285774792480362,-0.00981849607065584,6.06623019522729e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,-0.0254144768800496,0.00635638457025325,-0.037872990637746,-0.0129559631223532,6.41594500482888e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,-0.015715797472529,0.00393573469930857,-0.0234298374831738,-0.00800175746188423,6.56411002097648e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD226,CD226 antigen,40199,-0.0170146095002058,0.00426188881768935,-0.0253679115828769,-0.00866130741753465,6.58689317471902e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42587,-0.0223593701639694,0.0056027808005932,-0.0333408205331321,-0.0113779197948068,6.6211916374735e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,0.0168861357659494,0.00423369031039093,0.00858810275758322,0.0251841687743157,6.68393883975672e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PARD3,Partitioning defective 3 homolog,40302,-0.029845569249741,0.00748935549023434,-0.0445247060106003,-0.0151664324888817,6.78927397767265e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFRA3,GDNF family receptor alpha-3,42474,-0.0114526455602421,0.00287487016270316,-0.0170873910791403,-0.00581790004134386,6.82100720268032e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42781,-0.0236516243471738,0.00594707601513894,-0.0353078933368461,-0.0119953553575015,7.01467445103589e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,-0.033526073688413,0.00843114779148793,-0.0500511233597293,-0.0170010240170966,7.03247721485479e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,-0.0243165487512398,0.00611786634780403,-0.0363075667929357,-0.0123255307095439,7.09253526599298e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPA4,Carboxypeptidase A4,40060,-0.0177510293200906,0.00446828520017644,-0.0265088683124365,-0.00899319032774481,7.15298933188473e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PON2,Serum paraoxonase/arylesterase 2,42357,-0.0139325492912198,0.00350891005484055,-0.0208100129987073,-0.00705508558373234,7.20669345042775e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIFBP,KIF-binding protein,42587,-0.0322740745805858,0.0081365901626768,-0.0482217912994323,-0.0163263578617393,7.33044886027536e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPBP,Platelet basic protein,40471,-0.0334390830834255,0.00844465306694245,-0.0499906030946327,-0.0168875630722183,7.54754986670704e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,-0.036241778621032,0.0091608098645281,-0.0541969659555071,-0.0182865912865569,7.66324247573272e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RALB,Ras-related protein Ral-B,40199,-0.0119554660822248,0.00302267103995908,-0.0178799013205446,-0.00603103084390498,7.69290436413332e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP2,Caspase-2,42594,-0.0264705520343197,0.00670120092550386,-0.0396049058483073,-0.0133361982203321,7.85118688959625e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMEM106A,Transmembrane protein 106A,40451,-0.0277865508383546,0.00704299140718398,-0.0415908139964352,-0.013982287680274,8.01916918066708e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA4C,Semaphorin-4C,42587,-0.0109762821202714,0.0027845815799923,-0.0164340620170563,-0.00551850222348646,8.12812699440907e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP8,Caspase-8,42674,-0.0240785433286906,0.00611408596635645,-0.0360621518227492,-0.0120949348346319,8.25055454832346e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRP2,Neuropilin-2,42611,-0.0112655523402096,0.00286619074582045,-0.0168832862020177,-0.00564781847840153,8.51961764141684e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,-0.0158991698679496,0.0040557109099021,-0.0238483632513577,-0.00794997648454149,8.90143537607318e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,-0.0191762119404366,0.00489316378704529,-0.0287668129630453,-0.00958561091782782,8.9461626120833e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCRN1,Secernin-1,42594,-0.0215638883906009,0.00550975554263642,-0.0323630092541683,-0.0107647675270335,9.13174503932324e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C2orf69,UPF0565 protein C2orf69,40182,-0.0240082986629466,0.00613626090922769,-0.0360353700450329,-0.0119812272808603,9.18849545000584e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,42370,-0.0226625403949173,0.00579298554318173,-0.0340167920595535,-0.0113082887302811,9.19694856379715e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,0.0148312777414719,0.00380191905921302,0.00737951638541442,0.0222830390975295,9.62641290945523e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PADI4,Protein-arginine deiminase type-4,42292,-0.0279450982762812,0.00719086989113855,-0.0420392032629127,-0.0138509932896496,0.000102330757335594
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,-0.031306299324721,0.00806635211315516,-0.0471163494665051,-0.0154962491829369,0.000104493734438458
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB33A,Ras-related protein Rab-33A,40116,-0.0255539269538724,0.00659194223541603,-0.0384741337352878,-0.0126337201724569,0.000106572715323027
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC11A,C-type lectin domain family 11 member A,42592,-0.0189331665385489,0.00489478905991891,-0.0285269530959899,-0.00933937998110781,0.000110239500930218
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP7,Caspase-7,40483,-0.0324091426022706,0.00838486600651947,-0.0488434799750488,-0.0159748052294924,0.000111622178613758
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,-0.0177980832956019,0.00460476200150981,-0.0268234168185611,-0.00877274977264267,0.000111664938864551
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL1A1,Collagen alpha-1(I) chain,42794,0.00970025161177413,0.00251050894626351,0.00477965407709764,0.0146208491464506,0.000112127899310996
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX2,Peroxiredoxin-2,40333,-0.0243426652163603,0.00630037565985043,-0.0366914015096671,-0.0119939289230534,0.000112322442611872
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNU13,NHP2-like protein 1,40116,-0.0246329378726287,0.00638451190813864,-0.0371465812125804,-0.0121192945326769,0.000114866242333607
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42705,-0.00776925368100197,0.0020228808324452,-0.0117341001125946,-0.00380440724940938,0.000123250453456971
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VGF,Neurosecretory protein VGF,40482,-0.0122064267662772,0.00317812676591298,-0.0184355552274666,-0.00597729830508774,0.000123324043966742
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MESD,LRP chaperone MESD,42611,-0.0459147540015361,0.0119620782073004,-0.0693604272878449,-0.0224690807152273,0.00012442753642797
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,-0.0283047519207172,0.00737936775747552,-0.0427683127253693,-0.0138411911160652,0.000125919614768588
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPB1,Heat shock protein beta-1,42448,-0.0259203602438068,0.00675838274062272,-0.0391667904154273,-0.0126739300721862,0.000125996890502145
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CERT,Ceramide transfer protein,42311,-0.0233700019466433,0.00609681507719723,-0.0353197594979499,-0.0114202443953368,0.000127103975775332
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWF,von Willebrand factor,42794,-0.0275510866037244,0.00719282988075232,-0.041649033169999,-0.0134531400374499,0.000128533630376585
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PALM3,Paralemmin-3,40116,-0.0274030156959184,0.00721319710111924,-0.0415408820141121,-0.0132651493777247,0.000146062576114634
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JPT2,Jupiter microtubule associated homolog 2,40449,-0.0331235621660322,0.00872972923070475,-0.0502338314582135,-0.0160132928738509,0.000148812163333526
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM26,Tripartite motif-containing protein 26,40080,-0.0215658263904188,0.00568546972979472,-0.0327093470608164,-0.0104223057200212,0.000149554416667975
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,-0.0283634677025089,0.0074782345788976,-0.0430208074771482,-0.0137061279278696,0.000149609646954052
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD69,Early activation antigen CD69,42585,-0.0330608613989657,0.00873705480807146,-0.0501854888227858,-0.0159362339751456,0.00015501119096559
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,-0.022191036773127,0.00587277962246026,-0.0337016848331491,-0.0106803887131049,0.00015853710947739
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKG1,cGMP-dependent protein kinase 1,40283,-0.0472408389037885,0.0125068652113145,-0.071754294717965,-0.022727383089612,0.000159435170305542
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRK1,Protein BRICK1,42311,-0.0169756630041659,0.00449637688480707,-0.0257885616983878,-0.00816276430994408,0.000160449657352195
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,-0.0539186372367385,0.0142945623228651,-0.0819359793895541,-0.0259012950839228,0.00016278886401864
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRTN,Neurturin,42370,-0.0185351125296168,0.00491441684860127,-0.0281673695528753,-0.00890285550635834,0.000162927107005265
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,-0.0177863884596895,0.00472499482433544,-0.0270473783153869,-0.00852539860399201,0.000167850025923632
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,-0.0349365928705605,0.00929184167574131,-0.0531486025550135,-0.0167245831861075,0.000170685974973654
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRING1,SREBP regulating gene protein,40080,-0.0224777219760709,0.00598507986603469,-0.0342084785134989,-0.0107469654386429,0.000173809786555891
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF2RB,Cytokine receptor common subunit beta,40199,-0.0164755982646806,0.00438855819846331,-0.0250771723336687,-0.0078740241956925,0.000174779513414865
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COMT,Catechol O-methyltransferase,42214,-0.0312206017074581,0.00831817731954723,-0.0475242292537707,-0.0149169741611455,0.000175281332987813
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,0.0183304174947404,0.00488677212363442,0.00875234413241693,0.0279084908570639,0.000177010331777604
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40428,-0.0260765121315017,0.00695230696937244,-0.0397030337914716,-0.0124499904715317,0.000177177461259279
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX1B,Syntaxin-1B,40182,-0.0152844579981627,0.0040901314624685,-0.0233011156646009,-0.00726780033172441,0.000187238586027108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42689,-0.0134520376984452,0.00360334646673581,-0.0205145967732474,-0.00638947862364301,0.000189833998473036
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,0.0104901157280028,0.002813696289037,0.00497527100149027,0.0160049604545153,0.000193611486936707
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,42346,-0.0274291364698871,0.00738101217167656,-0.0418959203263732,-0.0129623526134011,0.000203099329822133
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSH,Pro-cathepsin H,42332,-0.0276658105471486,0.00747783793383159,-0.0423223728974585,-0.0130092481968387,0.000216729014492896
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB7,Integrin beta-7,42721,-0.0170263816611217,0.00460700278622822,-0.026056107122129,-0.00799665620011441,0.000220094238538497
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCT,Secretin,40182,-0.0185788078487128,0.00503230475297027,-0.0284421251645345,-0.00871549053289105,0.000223655162741388
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GZMB,Granzyme B,42594,-0.0244816549497421,0.00663164141372746,-0.0374796721206479,-0.0114836377788362,0.000223693707092317
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX18,Sorting nexin-18,40449,-0.0162863772576495,0.00441850205166657,-0.024946641278916,-0.00762611323638308,0.000228921434752111
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLC,Galectin-10,42611,-0.02427059639901,0.00659776010426835,-0.037202206203376,-0.0113389865946441,0.000235424049687844
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHIT1,Chitotriosidase-1,42699,-0.0568414500250652,0.0154533570829496,-0.0871300299076463,-0.026552870142484,0.000235743280436861
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPESP1,Sperm equatorial segment protein 1,40511,-0.011771127958737,0.0032007673325838,-0.0180446319306012,-0.00549762398687271,0.000236533339290661
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMED8,Protein TMED8,40449,-0.0376771413735982,0.0102477618072583,-0.0577627545158245,-0.0175915282313719,0.000237442952659323
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEPACAM2,HEPACAM family member 2,40483,0.015587053308811,0.00424510196989422,0.0072666534478183,0.0239074531698036,0.000241984838005883
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEK7,Serine/threonine-protein kinase Nek7,40302,-0.0279198899886844,0.00768041443089692,-0.0429735022732424,-0.0128662777041264,0.000279013324796376
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STXBP1,Syntaxin-binding protein 1,40482,-0.0280283099284807,0.007711063921476,-0.0431419952145736,-0.0129146246423877,0.000279413752567798
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42613,-0.0172856812389995,0.00475787713619953,-0.0266111204259505,-0.00796024205204838,0.00028111831611513
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NME3,Nucleoside diphosphate kinase 3,42638,0.00871076327568956,0.00239880914690674,0.00400909734775234,0.0134124292036268,0.000283060124607717
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,-0.0103419269440287,0.00284800782927853,-0.0159240222894146,-0.00475983159864274,0.000283292089763683
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDLIM5,PDZ and LIM domain protein 5,40482,-0.0424585640934829,0.0117152466643631,-0.0654204475556346,-0.0194966806313312,0.000291115290940833
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GMFG,Glia maturation factor gamma,40511,-0.0259517061219305,0.00717301738499851,-0.0400108201965276,-0.0118925920473334,0.000298225145448212
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBC1D23,TBC1 domain family member 23,42587,-0.0321667102976295,0.00891734530578626,-0.0496447070969706,-0.0146887134982884,0.000310637118839818
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB10,Ras-related protein Rab-10,40511,-0.0193382884448599,0.00537152060874179,-0.0298664688379938,-0.00881010805172596,0.000319391687395531
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPQ,Carboxypeptidase Q,40516,-0.0129244010251993,0.00359140920151897,-0.0199635630601765,-0.00588523899022207,0.000321177888082862
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPT1,Angiopoietin-1,42554,-0.0300803493615908,0.00836644534186867,-0.0464785822316533,-0.0136821164915282,0.00032511563409345
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTF4,Neurotrophin-4,42346,-0.0140618960447873,0.00391162443583788,-0.0217286799390295,-0.00639511215054505,0.000325704383179127
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,-0.0171539954581965,0.00477843459362108,-0.0265197272616938,-0.00778826365469915,0.000332037361565601
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,-0.0300709447622195,0.00839657265250697,-0.0465282271611331,-0.0136136623633058,0.000343316242232711
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,-0.0409929084802123,0.0115041521394236,-0.0635410466734824,-0.0184447702869421,0.000367474897938562
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MUC16,Mucin-16,42587,-0.0684397543029472,0.0192171655202349,-0.106105398722608,-0.0307741098832868,0.000370181284201132
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,-0.0384350470314366,0.010797522115931,-0.0595981903786614,-0.0172719036842118,0.000372921687335351
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",40182,-0.0138585529892461,0.00389809220911827,-0.0214988137191179,-0.0062182922593743,0.000379258184186788
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP53BP1,TP53-binding protein 1,40199,-0.0311148727630911,0.00875540315656164,-0.0482754629499519,-0.0139542825762303,0.000381311618139646
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMEM25,Transmembrane protein 25,40482,-0.0163064761091987,0.00459916406858979,-0.0253208376836347,-0.00729211453476269,0.000393410125177465
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1S,Complement C1s subcomponent,40539,-0.00740699615936956,0.00209146919099954,-0.0115062757737287,-0.00330771654501047,0.000399412794672563
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC10A,C-type lectin domain family 10 member A,42495,0.0128586938374446,0.00363707278252179,0.00573003118370187,0.0199873564911873,0.000408462828152403
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,-0.0159279707092467,0.00450826402362506,-0.0247641681955518,-0.0070917732229416,0.000412474463544555
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNNI3,"Troponin I, cardiac muscle",42357,-0.0299258618953174,0.00847630933874175,-0.0465394281992512,-0.0133122955913836,0.000416145455620412
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP45,Rho GTPase-activating protein 45,40283,-0.0291084712543732,0.00827992047959452,-0.0453371153943785,-0.012879827114368,0.00044059689303734
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELAVL4,ELAV-like protein 4,40136,-0.0301459133804556,0.00858364458768526,-0.0469698567723187,-0.0133219699885924,0.000446510785221875
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42636,0.00899137727433135,0.0025625051149946,0.00396886724894193,0.0140138872997208,0.000451565665540943
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL2A1,Collagen alpha-1(II) chain,40223,-0.0285387516366297,0.00813591223560899,-0.0444851396184233,-0.012592363654836,0.000453711519572283
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTA4H,Leukotriene A-4 hydrolase,42721,-0.020502173630435,0.00584736588910248,-0.0319630107730759,-0.00904133648779417,0.000455985433142841
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42679,-0.0096135291784448,0.0027524529730249,-0.0150083370055736,-0.00421872135131599,0.000479671259080341
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMPRSS5,Transmembrane protease serine 5,42438,0.0132722882256506,0.0038037641503052,0.00581691049105239,0.0207276659602488,0.000485950073668796
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDHR1,Cadherin-related family member 1,42311,-0.0149301275821234,0.00428492193918905,-0.0233285745829339,-0.00653168058131286,0.000494961559253308
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,-0.0347028850688895,0.00996765446038792,-0.0542394878112499,-0.0151662823265292,0.000500406713986285
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRADD,Death domain-containing protein CRADD,42476,-0.0258760281391519,0.0074378825331963,-0.0404542779042166,-0.0112977783740871,0.000504994139102028
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CABP2,Calcium-binding protein 2,40182,-0.0226166302477319,0.00650453545616477,-0.0353655197418149,-0.00986774075364899,0.000508913439589502
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCTN3,Tectonic-3,40511,-0.0104675251469989,0.0030139275979155,-0.0163748232389132,-0.00456022705508449,0.000516500691530165
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL14,C-X-C motif chemokine 14,42370,-0.0195762445342374,0.00563810737896843,-0.0306269349970155,-0.00852555407145928,0.000518001333246195
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,-0.0151388271529619,0.0043735645960809,-0.0237110137612805,-0.00656664054464336,0.0005392904553293
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NINJ1,Ninjurin-1,42346,-0.018653028597647,0.00540929794016991,-0.0292552525603801,-0.00805080463491402,0.000565837030099176
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,-0.0112943099964228,0.00327612183559867,-0.0177155087941961,-0.00487311119864937,0.000567940380433299
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK13,Kallikrein-13,42381,-0.0158873555663121,0.00460916744822927,-0.0249213237648415,-0.00685338736778277,0.000568819430598132
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFAP,Glial fibrillary acidic protein,42326,0.0168961921286103,0.00490227448932293,0.00728773412953734,0.0265046501276832,0.000569460134856461
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,-0.0225317835092929,0.00658557121058792,-0.0354395030820453,-0.00962406393654061,0.000625271629385981
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDRG1,Protein NDRG1,42311,-0.0222563450603389,0.00651994663128609,-0.0350354404576597,-0.00947724966301819,0.000643097279266109
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMS,Spermine synthase,40136,-0.0219090782760995,0.00643113229926016,-0.0345140975826494,-0.00930405896954959,0.000659847176376103
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,-0.0301635477977762,0.00886913561560859,-0.0475470536043691,-0.0127800419911834,0.000673921173734022
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESM1,Endothelial cell-specific molecule 1,42618,0.011645852240124,0.00343941373320507,0.00490460132304202,0.0183871031572059,0.000711228981648659
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,-0.013637163770766,0.00403179604706715,-0.0215394840230176,-0.00573484351851436,0.000721041286306668
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DGKZ,Diacylglycerol kinase zeta,42370,-0.0117618721467234,0.00347862165916645,-0.0185799705986897,-0.00494377369475721,0.000723829651785522
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNL1,Thioredoxin-like protein 1,40124,-0.0336435003270557,0.00996408517017782,-0.0531731072606043,-0.0141138933935072,0.000736764912453432
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOLR3,Folate receptor gamma,42629,-0.062588976344446,0.0185483566996813,-0.0989437554758214,-0.0262341972130706,0.000741946980361694
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,-0.0113848808463752,0.00337672513924574,-0.0180032621192969,-0.00476649957345359,0.000749913164086355
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,-0.0273394671688739,0.00811016950652132,-0.0432353994016557,-0.0114435349360921,0.00075104556305282
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,-0.0299341496968075,0.0088798335759674,-0.0473386235057036,-0.0125296758879114,0.000751444969100207
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDNRB,Endothelin receptor type B,40199,-0.0151557521989414,0.00449710628728343,-0.0239700805220169,-0.00634142387586587,0.000753958690913981
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRK5,G protein-coupled receptor kinase 5,42357,-0.0171659441619791,0.00509588726745781,-0.0271538832061965,-0.00717800511776182,0.000757710111622159
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FZD8,Frizzled-8,40136,-0.0155752336430976,0.0046245958387256,-0.0246394414869998,-0.0065110257991954,0.000760008459027477
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,-0.0249571918884039,0.00743576336481968,-0.0395312880834504,-0.0103830956933573,0.000792369776565986
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,-0.00802753736780039,0.0023938434347986,-0.0127194705000056,-0.00333560423559513,0.00080085084324714
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB2,Integrin beta-2,42569,-0.00957286781386495,0.00286560449687299,-0.015189452627736,-0.00395628299999389,0.000838232481694288
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TEX101,Testis-expressed protein 101,40182,-0.0177976007165605,0.00533532994908477,-0.0282548474167667,-0.00734035401635437,0.000853357941796644
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,-0.0256318050005206,0.00768932361364093,-0.0407028792832569,-0.0105607307177844,0.000860654178569798
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,-0.0267231766123442,0.00802042919050346,-0.042443217825731,-0.0110031353989575,0.000865429578291112
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,40182,-0.0239777593166367,0.00720766501145079,-0.0381047827390802,-0.00985073589419313,0.000881683495650173
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42689,-0.0227558165645895,0.00684300770720119,-0.0361681116707038,-0.00934352145847517,0.000885235714823466
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATXN2,Ataxin-2,40136,-0.0370712778150885,0.0111529043379622,-0.0589309703174943,-0.0152115853126826,0.000890555676875189
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STXBP3,Syntaxin-binding protein 3,42346,-0.0143927394079119,0.00433192414482056,-0.0228833107317602,-0.00590216808406357,0.000894638205643859
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOP56,Nucleolar protein 56,40116,-0.0374100206269506,0.0112835530373828,-0.0595257845802209,-0.0152942566736804,0.000917949399444432
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,42311,-0.0495424104547933,0.0149457880120721,-0.0788361549584547,-0.020248665951132,0.000919549045976022
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,40302,-0.0147119860425592,0.00444803634131461,-0.0234301372715358,-0.00599383481358251,0.000944236838124214
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40532,-0.0239428814532026,0.00725076768634324,-0.0381543861184354,-0.00973137678796988,0.000962549180152108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40483,-0.0156558683895256,0.00474375719724917,-0.024953632496134,-0.0063581042829172,0.000968775574020577
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UROS,Uroporphyrinogen-III synthase,40182,-0.0225528456909841,0.00683790850919696,-0.0359551463690101,-0.00915054501295801,0.000976131652175034
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRP1,Neuropilin-1,42705,-0.00914127611487466,0.002774346988113,-0.0145789962115762,-0.00370355601817317,0.000987000102067389
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMP2,Metalloproteinase inhibitor 2,40511,-0.00923838768214702,0.00280650335595864,-0.0147391342598259,-0.00373764110446809,0.000998608902098475
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,40182,-0.0206779326113625,0.00629715401499218,-0.0330203544807471,-0.0083355107419778,0.00102776062144294
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,-0.031015928879639,0.00945565477603156,-0.0495490122406609,-0.0124828455186172,0.00104068679870113
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL36G,Interleukin-36 gamma,40154,-0.0227225387739358,0.00694071161070006,-0.0363263335309079,-0.00911874401696363,0.00106438550591045
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40511,-0.0198143962763778,0.00605254471293638,-0.0316773839137331,-0.00795140863902251,0.00106456577453962
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFHD1,EF-hand domain-containing protein D1,40482,-0.0119090304119421,0.00363938791996645,-0.0190422307350764,-0.00477583008880789,0.00107011192148476
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBPMS,RNA-binding protein with multiple splicing,40199,-0.0210434641056276,0.00643763085571864,-0.0336612205828361,-0.00842570762841907,0.00108328005262534
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,-0.0264281695285265,0.00808923192046202,-0.042283064092632,-0.0105732749644209,0.0010898739966008
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,-0.0097375473093621,0.00298125806092511,-0.0155808131087753,-0.00389428150994889,0.001093046106143
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA11,Annexin A11,42570,-0.0215806848256204,0.00664016673914873,-0.0345954116343519,-0.00856595801688886,0.00115681484003434
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PROCR,Endothelial protein C receptor,40116,0.0113937150610767,0.00352281888771669,0.00448899004115202,0.0182984400810014,0.00122320669296661
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PKN3,Serine/threonine-protein kinase N3,40302,-0.024377056433868,0.00753821986058448,-0.0391519673606135,-0.00960214550712237,0.00122514130863175
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPB41L5,Band 4.1-like protein 5,40182,-0.0199796541497331,0.00617888293506978,-0.0320902647024699,-0.00786904359699632,0.00122628048050187
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKAP12,A-kinase anchor protein 12,40283,0.00719179308227621,0.00222571769778051,0.00282938639462642,0.011554199769926,0.00123620916732386
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD58,Lymphocyte function-associated antigen 3,42600,0.00574670410969344,0.00177862641894254,0.00226059632856606,0.00923281189082083,0.00123664817670339
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD93,Complement component C1q receptor,42141,-0.010435293470826,0.00323074918066132,-0.0167675618649222,-0.00410302507672979,0.00124102725949103
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DBN1,Drebrin,40199,-0.016223224787703,0.0050262381156683,-0.0260746514944128,-0.00637179808099311,0.00125152146876311
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MICALL2,MICAL-like protein 2,40182,-0.0222974937764196,0.00691170567002546,-0.0358444368896695,-0.00875055066316971,0.00125879833134474
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,-0.0109257024560121,0.00339380721000832,-0.0175775645876284,-0.0042738403243958,0.00128877082624897
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42771,0.0199147068621457,0.00619225757289447,0.00777788201927256,0.0320515317050189,0.00130265507857797
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTN2,Dynactin subunit 2,42587,-0.0300319147237988,0.00935427815997902,-0.0483662999173576,-0.0116975295302399,0.00132816664522006
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DKK3,Dickkopf-related protein 3,42794,-0.00969983398762107,0.00302151271449119,-0.0156219989080238,-0.00377766906721834,0.00132924133016134
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYM,Ketimine reductase mu-crystallin,40136,-0.0245431104642995,0.0076483335796197,-0.0395338442803541,-0.00955237664824491,0.0013360533688645
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,-0.0175559455376089,0.00547913408014278,-0.0282950483346887,-0.00681684274052904,0.00135840228206487
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,-0.0174586343724744,0.00544911181096604,-0.0281388935219679,-0.00677837522298099,0.0013593675598315
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,0.0178648788038552,0.00558395635543171,0.00692032434720904,0.0288094332605014,0.00138071697086224
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,-0.012749832315377,0.00398602570055306,-0.020562442688461,-0.00493722194229297,0.00138460774296946
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40483,-0.0108812507831231,0.00341311138763204,-0.0175709491028819,-0.00419155246336428,0.00143614723662358
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCNE1,G1/S-specific cyclin-E1,40199,-0.0284278084284169,0.00893933044582925,-0.0459488961022422,-0.0109067207545915,0.00147641355332025
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD109,CD109 antigen,42611,-0.0106690301498216,0.00335967865867065,-0.017254000320816,-0.00408405997882709,0.00149859909004254
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRTG,Protogenin,42721,-0.00789842057888922,0.00248824183757458,-0.0127753745805354,-0.00302146657724303,0.00150536000376155
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6V1F,V-type proton ATPase subunit F,42292,-0.0210008218522009,0.00663016425088299,-0.0339959437839315,-0.00800569992047023,0.00154126513409036
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPP7,Dipeptidyl peptidase 2,42551,-0.0190796976315913,0.00603045502200432,-0.0308993894747198,-0.00726000578846282,0.00156024468519832
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,-0.0103887342896883,0.00329563090521611,-0.0168481708639118,-0.00392929771546469,0.00162355583832317
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA1,Alpha-1-antitrypsin,40327,-0.00259590755257255,0.000823882641519709,-0.00421071752995117,-0.000981097575193917,0.00163242978697357
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,-0.0185809005681975,0.00589734409572568,-0.0301396949958198,-0.00702210614057515,0.0016330301498441
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,-0.0182727323385687,0.00580362297057063,-0.0296478333608872,-0.00689763131625032,0.00164475222917856
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C9orf40,Uncharacterized protein C9orf40,40449,-0.0257809368089267,0.00819436840639525,-0.0418418988854614,-0.009719974732392,0.00165850735413851
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,-0.00673603259170206,0.00214318221789064,-0.0109366697387677,-0.00253539544463641,0.00167586094005255
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EP300,Histone acetyltransferase p300,40199,-0.00979029605473863,0.00312256171303897,-0.015910517012295,-0.00367007509718224,0.00172106152867858
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP3,Caspase-3,42794,-0.0271266321533762,0.00865256278766883,-0.0440856552172071,-0.0101676090895453,0.00172162422412562
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,-0.00804379537384954,0.00257492794896518,-0.0130906541538213,-0.00299693659387779,0.00178925828760966
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,42346,-0.012329335550512,0.00396404866502924,-0.0200988709339693,-0.0045598001670547,0.00187304188404157
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMARCA2,Probable global transcription activator SNF2L2,42311,-0.022505620650203,0.00726695338533262,-0.0367488492854549,-0.00826239201495102,0.00195914571326094
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDSN,Corneodesmosin,42710,-0.0137684157669195,0.00445779289264464,-0.022505689836503,-0.00503114169733604,0.00201498095928261
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTB,Lymphotoxin-beta,40451,-0.0111445273398366,0.00361205161882188,-0.0182241485127275,-0.00406490616694574,0.00203789947476119
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC13A1,Solute carrier family 13 member 1,40451,-0.0194660205173775,0.00631418987498716,-0.0318418326723524,-0.00709020836240269,0.00205489260963491
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM171B,Protein FAM171B,40451,-0.00821459785360876,0.00266550242746139,-0.0134389826114331,-0.00299021309578443,0.00206236317460269
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C5,Complement C5,40539,-0.00463991186656719,0.00151524918626714,-0.00760980027165078,-0.00167002346148359,0.00220271793911632
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,-0.0150788200546808,0.00493450989891182,-0.0247504594565479,-0.00540718065281359,0.00224908526963502
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,-0.014067225613041,0.00460878302599241,-0.0231004403439861,-0.00503401088209585,0.00227651241831592
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40483,-0.0736573097027497,0.0241511661142144,-0.12099359528661,-0.0263210241188895,0.00229490335692833
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,-0.0145032211772949,0.00476061535968135,-0.0238340272822704,-0.00517241507231946,0.00232069748328902
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CKB,Creatine kinase B-type,40527,0.018453100068575,0.00605939287566125,0.00657669003227895,0.030329510104871,0.00232927072848132
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40449,-0.0170849427475539,0.00561608081648992,-0.0280924611478742,-0.00607742434723371,0.00235438349417705
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PMVK,Phosphomevalonate kinase,42303,-0.0326883215302807,0.0107743518441497,-0.0538060511448141,-0.0115705919157474,0.0024188599498919
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACRV1,Acrosomal protein SP-10,40199,-0.0245235504728373,0.0080859698869592,-0.0403720514512774,-0.00867504949439732,0.00242818712308929
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,-0.0100307557695778,0.00331354684034737,-0.0165253075766587,-0.00353620396249701,0.00247301387417035
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,-0.0192207623421373,0.00635125391631552,-0.0316692200181157,-0.00677230466615887,0.00248127011121872
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRGN,Neurogranin,40532,-0.0276376395341779,0.00913281785284148,-0.0455379625257472,-0.00973731654260856,0.00248212381461097
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,-0.0355295999798315,0.0117634071347752,-0.0585858779639909,-0.0124733219956722,0.0025295610571853
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,-0.018358794553146,0.00608319091654067,-0.0302818487495657,-0.00643574035672627,0.00255073681797847
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA4,Carbonic anhydrase 4,42794,-0.00728079730094008,0.00241354213967597,-0.012011339894705,-0.00255025470717518,0.00256062257122044
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,-0.0114416181097592,0.00379764309609678,-0.0188849985781089,-0.00399823764140953,0.0025940709389162
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NMI,N-myc-interactor,40421,-0.021829445274357,0.007254518522538,-0.0360483015785315,-0.0076105889701825,0.00262619312170829
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,-0.0226827494073687,0.00754243984309536,-0.0374659314998356,-0.00789956731490181,0.00264035030816351
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,42311,-0.0125781159297473,0.00419251383936626,-0.0207954430549052,-0.00436078880458943,0.00270365106194858
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBQLN3,Ubiquilin-3,40116,-0.0163962283496873,0.00547084392298385,-0.0271190824387356,-0.00567337426063893,0.00273245657075453
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,40199,-0.0186560501984831,0.00626520511883696,-0.0309358522314036,-0.00637624816556266,0.00291030267893949
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEPTIN3,Neuronal-specific septin-3,40482,-0.0224757746670833,0.00755528597824396,-0.0372841351844415,-0.00766741414972518,0.00293760873916748
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,42346,-0.0138723233661059,0.00466796893227218,-0.0230215424733594,-0.00472310425885243,0.00296584227089111
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB37,Ras-related protein Rab-37,42370,-0.0239762270881165,0.00807025923504697,-0.0397939351888085,-0.00815851898742442,0.00297428973152125
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTX3,Pentraxin-related protein PTX3,42594,-0.014477548553388,0.00488596374428146,-0.0240540374921796,-0.0049010596145963,0.00305103067790277
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STK4,Serine/threonine-protein kinase 4,42636,-0.025325460380219,0.00855941121117489,-0.0421019063541218,-0.00854901440631619,0.00309392348955946
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD33,Myeloid cell surface antigen CD33,42679,-0.0237039655520501,0.00801328593426303,-0.0394100059832056,-0.00799792512089456,0.00310095905168368
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCG3,Secretogranin-3,42638,-0.010097310118115,0.00342219183415618,-0.0168048061130611,-0.00338981412316887,0.00317767189773013
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUCA1,Tissue alpha-L-fucosidase,42721,-0.0248094395043583,0.00841255155245916,-0.0412980405471782,-0.00832083846153834,0.00319248132692291
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MGLL,Monoglyceride lipase,42654,-0.0251948596881941,0.00855823066184903,-0.0419689917854182,-0.00842072759096998,0.00324623601554508
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,-0.00823217692396952,0.0027989183411761,-0.0137180568726747,-0.00274629697526436,0.00327625861394215
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,-0.0272710007027025,0.00928697648105363,-0.0454734746055676,-0.00906852679983736,0.0033252731831719
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,-0.0146019165606205,0.00498535953776287,-0.0243732212546357,-0.00483061186660528,0.00340778865399902
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,40116,-0.0203153178964452,0.00694211598746664,-0.0339218652318798,-0.00670877056101057,0.00343630672750181
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TF,Serotransferrin,40539,-0.0062661431487962,0.00214488745450104,-0.0104701225596182,-0.00206216373797416,0.00349113078290703
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ROBO2,Roundabout homolog 2,42711,-0.00683108786220993,0.00233931125835321,-0.0114161379285822,-0.00224603779583764,0.00350465821517582
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40451,-0.0153012881752911,0.00526055775262732,-0.0256119813704407,-0.00499059498014159,0.00363665944003057
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPM1F,Protein phosphatase 1F,40511,-0.0151621013245727,0.00523087567018266,-0.0254146176381307,-0.00490958501101467,0.0037557901780809
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,0.0261367667444693,0.00901884482494893,0.00845983088756943,0.0438137026013692,0.00376138781856854
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,-0.0336818581908381,0.0116251811932459,-0.0564672133296001,-0.0108965030520761,0.00377090477448501
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,40283,-0.0250628037764186,0.00866425559495211,-0.0420447447425248,-0.00808086281031249,0.00382729654441302
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDZD2,PDZ domain-containing protein 2,40116,-0.017533679273048,0.00607781832910101,-0.0294462031980859,-0.00562115534800998,0.00392348827411429
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMTN,Smoothelin,40460,-0.0266884854251825,0.00926428047904838,-0.0448464751641173,-0.00853049568624769,0.00397423012472495
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,-0.0139272128065418,0.0048389419887249,-0.0234115391044426,-0.00444288650864102,0.00400658744193975
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTD,Deoxycytidylate deaminase,40283,-0.0272143141753413,0.00945701487280161,-0.0457500633260325,-0.00867856502465016,0.00401369291411097
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOX9,Transcription factor SOX-9,40182,-0.0080345811751838,0.00279245664309242,-0.0135077961956449,-0.00256136615472265,0.00401936950492728
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NXPH3,Neurexophilin-3,40199,-0.0089169468828211,0.003099911671959,-0.0149927737598607,-0.00284112000578145,0.00402863748604156
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MUC2,Mucin-2,40527,-0.026882930384132,0.0093592143384717,-0.0452269904875365,-0.00853887028072743,0.00408188785627191
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,-0.0249906867737339,0.00872757200029814,-0.0420967278943182,-0.00788464565314953,0.00419881883320285
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G4A,Cytosolic phospholipase A2,42676,-0.0247056910789307,0.0086447910676283,-0.0416494815714821,-0.00776190058637921,0.00427147967417271
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM172A,Cotranscriptional regulator FAM172A,40223,-0.0174808520720193,0.00612051941830504,-0.0294770701318972,-0.00548463401214141,0.00429673167239001
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GTPBP2,GTP-binding protein 2,40182,-0.0230642531255245,0.00810136539781257,-0.0389429293052371,-0.00718557694581184,0.00442208922182567
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,40145,-0.0110030641986284,0.0038652326858726,-0.0185789202629387,-0.0034272081343181,0.00442604650790678
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,-0.0412756294545056,0.0144997150227036,-0.0696950708990047,-0.0128561880100065,0.00442643842458217
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,0.00756114534149194,0.00266211477638252,0.00234340037978219,0.0127788903032017,0.0045141553628728
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39633,-0.0156985701239703,0.00554064464683534,-0.0265582336317676,-0.00483890661617306,0.00461516454815306
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD1C,T-cell surface glycoprotein CD1c,42679,0.00710180569137136,0.00251682330084742,0.00216883202171042,0.0120347793610323,0.004783463505625
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,40136,-0.0280540582034562,0.00996141918915321,-0.0475784398141965,-0.00852967659271589,0.00486715849929826
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,-0.0132395407573932,0.004713195896709,-0.0224774047149428,-0.00400167679984354,0.0049775607519538
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,-0.0133054847277736,0.0047704312152646,-0.0226555299096922,-0.00395543954585503,0.00529338654724835
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,-0.0098743173224952,0.00355919722459907,-0.0168503438827094,-0.00289829076228102,0.0055411940125387
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGB3A1,Secretoglobin family 3A member 1,40283,0.00748301202108003,0.00269839572399063,0.0021941564020584,0.0127718676401017,0.00556120458387121
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKD2,Serine/threonine-protein kinase D2,40116,-0.0126922931224713,0.00460223465284425,-0.0217126730420461,-0.00367191320289662,0.00582788297136405
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSHB,Thyrotropin subunit beta,42636,-0.0219004573868626,0.00794198849477551,-0.0374667548366227,-0.00633415993710265,0.00583143275583218
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VIM,Vimentin,42357,-0.0320944663033806,0.0116443124213143,-0.0549173186491567,-0.00927161395760455,0.00585513764083001
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPTP,Ceramide-1-phosphate transfer protein,40116,-0.0110979383365262,0.00403200217739562,-0.0190006626042216,-0.00319521406883076,0.00592464028674478
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL2L1,Bcl-2-like protein 1,40483,-0.0273461154253328,0.00994518143534349,-0.0468386710386061,-0.0078535598120596,0.00597475184295746
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F12,Coagulation factor XII,40539,-0.0114717145730313,0.00417232703868582,-0.0196494755688555,-0.00329395357720714,0.00597850583685043
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBC1D5,TBC1 domain family member 5,42594,-0.0214636901303647,0.00780959067500999,-0.0367704878533843,-0.00615689240734514,0.00599714666529234
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,42357,-0.0171799797897852,0.00625454153626389,-0.0294388812008624,-0.00492107837870795,0.00602614866215451
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RABEPK,Rab9 effector protein with kelch motifs,42346,-0.0157701224419677,0.00575498155647095,-0.0270498862926508,-0.00449035859128465,0.00614741757709954
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL3,C-X-C motif chemokine 3,42620,-0.0253741875997866,0.00930283278623667,-0.0436077398608105,-0.00714063533876277,0.00638843921086081
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,-0.00925531755477844,0.00339535690489855,-0.0159102170883796,-0.00260041802117728,0.00642147019635963
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RP2,Protein XRP2,42587,-0.0114249668295529,0.00419211990599844,-0.0196415218453098,-0.00320841181379592,0.00643180591838365
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,40116,-0.0275668965041766,0.0101236797266103,-0.0474093087683327,-0.00772448424002047,0.0064792539253102
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN2,Contactin-2,42721,-0.0121279501580078,0.00445928293328126,-0.0208681447072391,-0.00338775560877655,0.00654228824553888
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HRAS,GTPase Hras,40286,-0.0273938868978808,0.0100780886311662,-0.0471469406149665,-0.00764083318079501,0.00657475055502199
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BMP4,Bone morphogenetic protein 4,42475,-0.012610653397765,0.0046528084734033,-0.0217301580056355,-0.00349114878989453,0.00673023137129285
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,-0.0105871459027667,0.00391206832741922,-0.0182547998245084,-0.00291949198102504,0.00681468812473735
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AFP,Alpha-fetoprotein,42459,0.018085336645299,0.00668552397207003,0.00498170966004174,0.0311889636305563,0.00683610017948871
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,-0.00745409113931208,0.00275669930531899,-0.0128572217777373,-0.00205096050088686,0.00685972726542516
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSCA,Prostate stem cell antigen,40449,-0.0725706545132221,0.0268529157914554,-0.125202369464475,-0.0199389395619696,0.00689183944826251
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,40116,-0.00886650522704273,0.00328487726252366,-0.0153048646615891,-0.00242814579249637,0.00696156101734884
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PMM2,Phosphomannomutase 2,40116,-0.0162591253331415,0.00604429967817992,-0.0281059527023741,-0.00441229796390885,0.00715620830710163
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,-0.0203275933363344,0.0075605286272923,-0.0351462294458273,-0.00550895722684144,0.00718305493137054
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDI2,Protein DDI1 homolog 2,40283,-0.0212160061639629,0.00790923969517297,-0.036718115966502,-0.00571389636142392,0.00731971068524367
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,42370,-0.0119184792400774,0.0044922015951428,-0.0207231943665573,-0.00311376411359751,0.00798403498651927
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAD51,DNA repair protein RAD51 homolog 1,40302,-0.0145615012791519,0.00548904838429891,-0.0253200361123778,-0.00380296644592605,0.00799340424504411
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFCAB2,Dynein regulatory complex protein 8,40302,-0.00932487819163296,0.00351944020008059,-0.0162229809837909,-0.00242677539947501,0.00807168597576982
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DIPK2B,Divergent protein kinase domain 2B,40283,-0.00746094895583459,0.00281720643949529,-0.0129826735772454,-0.00193922433442381,0.00810002400512456
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,-0.0189153688085977,0.00714713090730555,-0.0329237453869166,-0.00490699223027883,0.00814277870158787
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,-0.00967862658966751,0.00365919050412322,-0.016850639977749,-0.002506613201586,0.00817833508423755
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,42346,-0.010880315138693,0.00412246505902984,-0.0189603466543915,-0.00280028362299451,0.00831817563923365
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,-0.0052399346955588,0.0019914798503743,-0.00914323520229244,-0.00133663418882517,0.0085204926349193
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB39B,Ras-related protein Rab-39B,40116,-0.0244221766288947,0.00930944240717747,-0.0426686837469625,-0.00617566951082685,0.00871838859075199
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLAU,Urokinase-type plasminogen activator,42611,-0.00771820358283572,0.00294356628971062,-0.0134875935106685,-0.00194881365500291,0.00874990741542603
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP30,Rho GTPase-activating protein 30,40302,-0.0100901166720946,0.00385387503344045,-0.0176437117376379,-0.00253652160655131,0.00885215791233238
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYPLA2,Acyl-protein thioesterase 2,40136,-0.0295845273482789,0.0113231063626263,-0.0517778158190264,-0.0073912388775314,0.00899378972978182
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSRP3,Cysteine and glycine-rich protein 3,40116,-0.0262804133903316,0.0100800354184944,-0.0460372828105806,-0.00652354397008264,0.00914168727464178
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEB,Nebulin,40116,-0.010086538249143,0.00387282107086447,-0.0176772675480374,-0.00249580895024863,0.00921486008076576
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL28,C-C motif chemokine 28,42538,-0.0151700255252152,0.00587000644558596,-0.0266752381585637,-0.00366481289186671,0.00976739970128652
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GASK1A,Golgi-associated kinase 1A,40116,-0.011243988760075,0.00435315395701384,-0.0197761705158221,-0.00271180700432782,0.0098087699319747
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNR,Tenascin-R,42495,0.0109082019636907,0.00423392990603507,0.00260969934786194,0.0192067045795194,0.00999483934109263
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDIA5,Protein disulfide-isomerase A5,40080,-0.0158831017333563,0.00619917090759085,-0.0280334767122344,-0.00373272675447825,0.010416476876654
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA6C,Semaphorin-6C,40199,-0.00678030779173893,0.00264778054633247,-0.0119699576625506,-0.00159065792092728,0.0104578253104786
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,-0.025812399048434,0.0100881810004125,-0.0455852338092425,-0.00603956428762558,0.0105180995713406
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD86,T-lymphocyte activation antigen CD86,40449,-0.00781035607649085,0.00306222990384285,-0.0138123266880228,-0.00180838546495887,0.0107685777861224
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GJA8,Gap junction alpha-8 protein,40080,-0.0168237658252558,0.00660330102720931,-0.0297662358385861,-0.00388129581192558,0.0108546695519827
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FADD,FAS-associated death domain protein,42636,-0.0191401196251085,0.00754204808063129,-0.0339225338631458,-0.00435770538707115,0.011166747193397
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX6,Peroxiredoxin-6,42721,0.0153758569124738,0.00605977699672901,0.00349869399888496,0.0272530198260627,0.0111802238504232
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DOC2B,Double C2-like domain-containing protein beta,40182,-0.00925770481016122,0.00365099815519038,-0.0164136611943344,-0.00210174842598807,0.011237173253029
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLASP1,CLIP-associating protein 1,40080,-0.0186202726719775,0.00734862239623812,-0.0330235725686042,-0.00421697277535081,0.0112957556000456
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRD2,Bromodomain-containing protein 2,40136,-0.00915450886544977,0.00361517330379301,-0.0162402485408841,-0.00206876919001547,0.0113473038671503
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPSD1,Tryptase delta,40482,-0.00979534442979292,0.00387391920017373,-0.0173882260621334,-0.00220246279745242,0.0114674446717827
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL2RB,Interleukin-2 receptor subunit beta,42370,-0.00989617481628404,0.00392265246910792,-0.0175845736557356,-0.00220777597683251,0.0116532273663299
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42587,-0.0133199154317715,0.00528339504286132,-0.0236753697157797,-0.00296446114776336,0.0117106978657672
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DOK1,Docking protein 1,40483,-0.0343542391220819,0.0136280444416653,-0.0610652062277459,-0.00764327201641788,0.0117208779624244
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WAS,Wiskott-Aldrich syndrome protein,42370,-0.0166336432257652,0.00661469585176692,-0.0295984470952283,-0.00366883935630201,0.0119268791720282
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ROBO4,Roundabout homolog 4,40223,-0.00460815666137623,0.00183553492404136,-0.0082058051124973,-0.00101050821025516,0.0120693650267159
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,40182,-0.0129200281061555,0.00516540296589243,-0.0230442179193046,-0.00279583829300631,0.0123895799221262
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNW1,Interferon omega-1,40116,0.00928484289724611,0.00371781297794193,0.00199792946047993,0.0165717563340123,0.0125255958847169
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,40223,-0.0183657990384094,0.00735955447543526,-0.0327905258102625,-0.00394107226655628,0.0125923244852847
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP170,Centrosomal protein of 170 kDa,40223,-0.0193271359996193,0.00775736679457946,-0.034531574916995,-0.00412269708224353,0.0127366618041146
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAGLN3,Transgelin-3,40080,-0.0154519087108662,0.00620284025483542,-0.0276094756103436,-0.00329434181138876,0.0127495288609682
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MORF4L2,Mortality factor 4-like protein 2,40080,-0.00926473478849499,0.00371959142120474,-0.0165551339740563,-0.00197433560293371,0.0127605964441491
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,-0.0227138552740412,0.00914342496530211,-0.0406349682060333,-0.00479274234204904,0.0129996776481681
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,40199,-0.0137338168509797,0.00553078831104817,-0.0245741619406341,-0.00289347176132529,0.0130371419714179
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCC,Netrin receptor DCC,40182,-0.00579959839728837,0.00233664275748444,-0.0103794182019579,-0.00121977859261887,0.0130787540030866
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBX2,Chromobox protein homolog 2,40116,0.0100071319254134,0.00404836635029063,0.00207233387884378,0.017941929971983,0.0134550684644766
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPHS1,Nephrin,40199,0.00837461881537141,0.0033893064250912,0.00173157822219265,0.0150176594085502,0.0134925885921596
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGF,Pro-epidermal growth factor,42597,-0.0251726618769552,0.0102510149624572,-0.0452646512033714,-0.00508067255053902,0.0140765349239917
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PYDC1,Pyrin domain-containing protein 1,40223,-0.0105819528800613,0.00431605653262261,-0.0190414236840016,-0.00212248207612094,0.0142311740202766
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,-0.0291399807232683,0.0119102072390656,-0.0524839869118369,-0.00579597453469983,0.0144322660248221
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPA2,Replication protein A 32 kDa subunit,40199,-0.00781381624913511,0.00319558229699469,-0.0140771575512447,-0.00155047494702551,0.0144930201177544
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRTAP,Cartilage-associated protein,40182,-0.011784268415992,0.00482974036403022,-0.0212505595294912,-0.00231797730249277,0.01470547027361
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL9A2,Collagen alpha-2(IX) chain,40302,-0.0110255513003722,0.00452078597403956,-0.0198862918094898,-0.00216481079125469,0.0147493420020298
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AIF1L,Allograft inflammatory factor 1-like,40223,-0.0136865328318622,0.00561322169607254,-0.0246884473561644,-0.00268461830755999,0.0147735473458402
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHP1,Calcineurin B homologous protein 1,40136,-0.0181613768018623,0.00749319643955259,-0.0328480418233854,-0.00347471178033919,0.0153787382831185
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TTN,Titin,40116,-0.0160328529301296,0.00661957597819911,-0.0290072218473998,-0.00305848401285929,0.0154499814496896
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RILPL2,RILP-like protein 2,40511,-0.0235325741932491,0.00972168121573224,-0.0425870693760843,-0.00447807901041391,0.0155093560181027
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYGD,Gamma-crystallin D,40483,-0.0236951753926149,0.00979702645905733,-0.0428973472523673,-0.00449300353286258,0.0155956956286775
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTNAP4,Contactin-associated protein-like 4,40182,-0.025036376104573,0.0103758617190322,-0.0453730650738761,-0.00469968713526987,0.0158405026117921
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,-0.0130481126914011,0.00541284742053627,-0.0236572936356522,-0.00243893174714997,0.015943377669204
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXK,Tyrosine-protein kinase TXK,40302,-0.0182049336217282,0.00758571565680917,-0.0330729363090742,-0.00333693093438222,0.0164160605363977
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,-0.025308790097681,0.010588366228444,-0.0460619879054312,-0.00455559228993077,0.01685369437688
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOS2,"Nitric oxide synthase, inducible",40116,-0.00959934019735528,0.00401772161014966,-0.0174740745532486,-0.00172460584146195,0.0168996865873508
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VNN1,Pantetheinase,40532,-0.0174636978404619,0.00733205707541788,-0.0318345297082809,-0.00309286597264283,0.017243344539462
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,0.00492747894124739,0.00209547774155592,0.000820342567797783,0.009034615314697,0.0187164429859266
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPING1,Plasma protease C1 inhibitor,40516,0.00431383301237939,0.00184280327729984,0.000701938588871691,0.00792572743588708,0.0192541643230436
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFRAL,GDNF family receptor alpha-like,40109,0.0148167263752124,0.00633976484921811,0.00239078727074491,0.0272426654796799,0.0194514614844194
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MELTF,Melanotransferrin,40511,-0.00709719376295498,0.00304244665676668,-0.0130603892102177,-0.00113399831569228,0.0196799776465255
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,-0.0227760893771985,0.00979772730002312,-0.0419796348852438,-0.00357254386915319,0.020106906975056
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F3,Tissue factor,42636,0.00632319330810058,0.00272857225463155,0.000975191689022742,0.0116711949271784,0.0204968972932322
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,-0.022593898955997,0.00975265003098681,-0.0417090930167312,-0.0034787048952629,0.0205383049121767
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40451,-0.0101180494123815,0.0043731495245079,-0.018689422480417,-0.00154667634434603,0.0207034448043266
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40483,-0.00729788184815133,0.00316135978650897,-0.0134941470297089,-0.00110161666659374,0.020991381687507
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,-0.0180414457176711,0.00781622872619385,-0.033361254021011,-0.00272163741433111,0.0210032497028547
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,-0.00513157668325151,0.00223204849788826,-0.00950639173911251,-0.000756761627390511,0.0215205611509931
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,0.00620006629220594,0.00270226432813398,0.000903628209063348,0.0114965043753485,0.0217859938649216
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAA10,N-alpha-acetyltransferase 10,40116,-0.0118400428606135,0.0051740777681953,-0.0219812352862763,-0.00169885043495076,0.0221368101722653
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,-0.0114962406127587,0.00503179956065803,-0.0213585677516485,-0.00163391347386899,0.0223483698358698
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOSB,Protein fosB,42311,-0.00875379456634692,0.00384002502180057,-0.016280243609076,-0.0012273455236178,0.0226462697590639
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,0.014570459165319,0.00639467658203863,0.00203689306452326,0.0271040252661147,0.022714153270085
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA7,Carbonic anhydrase 7,40302,0.00809875447359636,0.00356000730952291,0.00112114014693146,0.0150763688002613,0.0229293200615243
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP112,Centrosomal protein of 112 kDa,40116,-0.0102649136613396,0.00452485564593898,-0.01913363072738,-0.0013961965952992,0.0233144306883354
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZP3,Zona pellucida sperm-binding protein 3,40223,-0.0619738262991392,0.0273263097088294,-0.115533393328445,-0.0084142592698335,0.0233534677889297
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSTN,Growth/differentiation factor 8,42357,-0.0120939711389041,0.00535206758720467,-0.0225840236098252,-0.00160391866798293,0.0238572679256215
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARG2,"Arginase-2, mitochondrial",40451,-0.00972900154971565,0.0043124982978758,-0.0181814982135522,-0.00127650488587909,0.0240896624105479
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,-0.00844083058930539,0.00374840839818279,-0.0157877110497437,-0.00109395012886712,0.0243481494137181
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLNS1A,Methylosome subunit pICln,40182,-0.00754764898016872,0.00336353189675153,-0.0141401714978017,-0.000955126462535729,0.0248544612891285
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,-0.0149001835837681,0.00664428365508963,-0.0279229795477437,-0.00187738761979237,0.0249419988565563
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PER3,Period circadian protein homolog 3,40199,-0.0277042401041664,0.012402127873524,-0.0520124107362736,-0.00339606947205933,0.0255142985444717
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,-0.0117799912862734,0.00528671735044759,-0.0221419572931507,-0.00141802527939614,0.025885850890036
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,42357,0.00744280660290107,0.00334371041178132,0.000889134195809694,0.0139964790099925,0.0260369137589455
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDA1,DET1- and DDB1-associated protein 1,40116,-0.0090329527266247,0.00406090378388933,-0.0169923241430478,-0.00107358131020162,0.026143917867258
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,42346,-0.0117960476112876,0.00530513397312005,-0.0221941101986029,-0.00139798502397232,0.026197982049233
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UNG,Uracil-DNA glycosylase,40451,-0.00765185094192444,0.00344364265040773,-0.0144013905367236,-0.000902311347125289,0.0263015969182026
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,-0.00618554819180378,0.00278670015856418,-0.0116474805025896,-0.000723615881017975,0.0264583114556848
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTLA,B- and T-lymphocyte attenuator,40080,-0.0197370695952122,0.00891225143942075,-0.0372050824164769,-0.00226905677394755,0.0268081829272922
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD40LG,CD40 ligand,42754,-0.0169824874032732,0.00773566838702025,-0.0321443974418329,-0.00182057736471352,0.0281554985022176
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CORO1A,Coronin-1A,42353,-0.0195567943972591,0.00891018090327021,-0.0370207489676687,-0.00209283982684947,0.0281894809783124
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,-0.0185934134271795,0.00847652854683027,-0.0352074093789669,-0.00197941747539218,0.0282909924584954
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LXN,Latexin,42461,0.0148421182737595,0.006766996257205,0.00157880560963768,0.0281054309378813,0.0283023682822595
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40502,-0.00335057328521722,0.00152960208614887,-0.00634859337406901,-0.000352553196365442,0.0285092905503374
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,0.00861341025626216,0.00393454770031791,0.000901696763639065,0.0163251237488853,0.028605272787288
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFP,Properdin,40539,-0.00488864791639952,0.00224229255398436,-0.00928354132220886,-0.000493754510590173,0.0292630654044857
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EVPL,Envoplakin,40302,0.00774937155331225,0.00355863678813387,0.000774443448569863,0.0147242996580546,0.0294550395392278
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD84,SLAM family member 5,42594,-0.00680164727016658,0.0031295246708362,-0.0129355156250055,-0.000667778915327635,0.0297691603332881
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PFDN2,Prefoldin subunit 2,42311,-0.0120462333035991,0.00554349889096843,-0.0229114911298972,-0.00118097547730096,0.0297952998704032
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOS,Proto-oncogene c-Fos,40065,-0.00780783762493846,0.00361570199258441,-0.0148946135304039,-0.000721061719473007,0.0308390026963146
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,42346,-0.0124674849750129,0.00578028273371576,-0.0237968391330958,-0.00113813081693001,0.0310316107591735
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GC,Vitamin D-binding protein,40539,-0.0056140033280221,0.00260510415725395,-0.0107200074762398,-0.000507999179804364,0.0311826933251873
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,-0.00883727539699929,0.00411446405509669,-0.0169016249449888,-0.000772925849009773,0.0317471460418567
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYOM3,Myomesin-3,40283,0.0200731465545356,0.00934935217425504,0.00174841629299571,0.0383978768160755,0.0318141552756988
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF5,Eukaryotic translation initiation factor 5,40116,-0.00952043488236112,0.00444250083571871,-0.0182277365203698,-0.000813133244352447,0.0321323146999989
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,-0.00684248730496346,0.00319413145223064,-0.0131029849513355,-0.000581989658591404,0.0321952223756486
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBM25,RNA-binding protein 25,40080,0.0102907209247011,0.00480381407280979,0.0008752453419939,0.0197061965074083,0.0321996701589397
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARTN,Artemin,42370,-0.00954136980679853,0.00446740885155439,-0.0182974911558451,-0.000785248457751915,0.0327163266435646
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,-0.0254674684205783,0.011932739982724,-0.0488556387867172,-0.00207929805443933,0.0328402952575823
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYL3,Myosin light chain 3,40223,-0.0157838816611305,0.00739829232096435,-0.0302845346102206,-0.00128322871204034,0.0329098899285091
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPMT,Thiopurine S-methyltransferase,42346,-0.0154965309234267,0.00728122157701615,-0.0297677252143783,-0.001225336632475,0.0333318133604864
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCUN1D1,DCN1-like protein 1,40136,-0.0161163303452675,0.00757656891096627,-0.0309664054107614,-0.00126625527977362,0.0334317708269939
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYB5A,Cytochrome b5,40080,-0.0156526359122012,0.00739699052359832,-0.0301507373384539,-0.00115453448594854,0.0343605019448052
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40449,-0.00582961981707947,0.00275664591943787,-0.0112326458191777,-0.000426593814981253,0.0344730931490337
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,-0.0228655811210203,0.0108190003441205,-0.0440708217954964,-0.00166034044654412,0.0345829091762872
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,-0.0117117266400246,0.00554973512800759,-0.0225892074909195,-0.000834245789129743,0.0348531931931347
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARFIP1,Arfaptin-1,40482,-0.0144909288131614,0.0068727609129762,-0.0279615402025947,-0.00102031742372803,0.0350133546877478
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC1A4,Neutral amino acid transporter A,40182,-0.0110614546600998,0.00525594517977604,-0.0213631072124609,-0.000759802107738777,0.0353522341360214
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP9,Fatty acid-binding protein 9,42594,-0.0119373809009088,0.00567648317689584,-0.0230632879276246,-0.000811473874192923,0.0354884228576558
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SYT1,Synaptotagmin-1,40483,-0.00897078642210936,0.00427144075080224,-0.0173428102936818,-0.000598762550536969,0.0357353051716822
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,40116,-0.0125349329163465,0.00597131805100732,-0.0242387162963209,-0.000831149536372183,0.035823021934631
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,0.0106393075198943,0.00507341777845168,0.000695408674129034,0.0205832063656596,0.0360100416814857
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECE1,Endothelin-converting enzyme 1,42311,0.00744684055331557,0.00356066953362933,0.000467928267402089,0.014425752839229,0.0365099930467267
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRR1B,Cornifin-B,40302,-0.0175469975005883,0.00839774412546634,-0.0340065759865023,-0.00108741901467423,0.0366863829222182
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VIT,Vitrin,40511,-0.00810025859588827,0.00388288178102849,-0.0157107068867041,-0.00048981030507243,0.0369877292542634
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PI16,Peptidase inhibitor 16,40532,0.00527183341346832,0.00253469826641587,0.000303824811293221,0.0102398420156434,0.0375602114853216
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENSA,Alpha-endosulfine,40451,-0.0111282936678638,0.00535403672629013,-0.0216222056513925,-0.000634381684335134,0.03768715957978
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,40080,-0.0123983690469079,0.00597811220449119,-0.0241154689677106,-0.000681269126105144,0.0381064254676399
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL24,C-C motif chemokine 24,42654,-0.0171682564294907,0.00827942685993129,-0.033395933074956,-0.000940579784025387,0.0381350345305704
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TET2,Methylcytosine dioxygenase TET2,40286,-0.0214427420963196,0.010351039680518,-0.0417307798701349,-0.00115470432250436,0.0383300759788274
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESR1,Estrogen receptor,40199,-0.0115437650393078,0.0055805992674718,-0.0224817396035525,-0.000605790475063043,0.0386113585063939
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",40182,-0.0175298368551617,0.00847879890480801,-0.0341482827085853,-0.000911391001737965,0.0387113078520913
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,-0.0109249032982527,0.00529990439557805,-0.0213127159135857,-0.000537090682919702,0.0392903054809423
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,-0.0161956062354679,0.00786471453158899,-0.0316104467173823,-0.000780765753553458,0.0394916779088669
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOD3,Extracellular superoxide dismutase,40532,0.0121112748117307,0.00589727187585963,0.000552621935045803,0.0236699276884156,0.0400268389296108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F2,Prothrombin,40539,0.00305811289711196,0.00149632572541206,0.000125314475304309,0.0059909113189196,0.0410014819882148
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F11,Coagulation factor XI,40383,0.00619436500728131,0.00303096361482309,0.000253676322228065,0.0121350536923346,0.0410070613525722
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,-0.0241555572533069,0.0118295740780792,-0.0473415224463421,-0.000969592060271716,0.0411745988677931
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,-0.00527932266552849,0.00259105145451832,-0.0103577835163844,-0.000200861814672586,0.0416173641410447
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK3,Prostate-specific antigen,40527,0.0201288847063086,0.00988852531544106,0.000747375088044146,0.0395103943245731,0.04181575789457
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPN1,Epsin-1,40302,-0.00915429789092844,0.0045003708877467,-0.017975024830912,-0.000333570950944913,0.0419631302466053
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCLN,Nicalin,42370,-0.0105169654843924,0.00518082664568122,-0.0206713857099276,-0.000362545258857193,0.0423787990158962
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40449,-0.0102419998061838,0.0050473550272801,-0.0201348156596527,-0.000349183952714766,0.0424632864920693
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,-0.0170922779131272,0.00842882122161159,-0.0336127675074859,-0.000571788318768491,0.0425969768717324
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRP2BP,LRP2-binding protein,40182,-0.0175485324419916,0.00870385141292979,-0.034608081211334,-0.000488983672649237,0.0438054292432011
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNF174,Zinc finger protein 174,40199,-0.00758953122559151,0.00377739511546627,-0.0149932256519054,-0.000185836799277618,0.0445406099116495
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP9,Caspase-9,40199,-0.012645298190418,0.00629834783304179,-0.0249900599431799,-0.000300536437656079,0.0446978019752273
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB9,Serpin B9,42495,-0.00657014749799925,0.00327351797482806,-0.0129862427286623,-0.000154052267336241,0.0447634538172716
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,40302,-0.0109625922713276,0.00546492407484995,-0.0216738434580335,-0.000251341084621742,0.0448813362386559
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,40199,-0.00716293075004527,0.0035761336846532,-0.0141721527719655,-0.000153708728124992,0.0452037200192597
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACTN4,Alpha-actinin-4,42370,-0.00653536555717733,0.00327164643404091,-0.0129477925678975,-0.000122938546457151,0.0457830663402754
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FIS1,Mitochondrial fission 1 protein,42624,-0.0149992623576338,0.00752256631956748,-0.029743492343986,-0.000255032371281501,0.0461829185227182
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,0.00744766723000086,0.00373882853022029,0.000119563310769096,0.0147757711492326,0.0463979966840637
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAP1A,Ras-related protein Rap-1A,40199,-0.0142546072735699,0.00716392935956364,-0.0282959088183147,-0.000213305728825219,0.0466404361663253
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALMS1,Alstrom syndrome protein 1,40302,0.00896052016305385,0.00450910800469661,0.000122668473848501,0.0177983718522592,0.0469242478351594
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,-0.00852938477009059,0.00431022229148159,-0.0169774204613945,-8.1349078786673e-05,0.0478510353447871
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSG4,Desmoglein-4,42543,0.00992613956244704,0.00501802214997686,9.08161484924064e-05,0.0197614629764017,0.0479381811182122
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NENF,Neudesin,40451,-0.0219226465024841,0.0111092859870241,-0.0436968470370513,-0.000148445967916841,0.0484787163536884
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RELB,Transcription factor RelB,40199,-0.00988769611824479,0.00501338055469239,-0.0197139220054419,-6.1470231047708e-05,0.0486047903462479
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40451,-0.0106814502752638,0.00541894538110713,-0.0213025832222338,-6.0317328293806e-05,0.048733370097177
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCIN,Adseverin,40136,-0.0145194234405434,0.00737272459188169,-0.0289699636406315,-6.88832404552569e-05,0.0489389082863094
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGR,Progesterone receptor,40199,-0.01932832846274,0.00986916449681889,-0.038671890876505,1.52339510250746e-05,0.0502017035718632
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLMH,Bleomycin hydrolase,42794,-0.00612138980290847,0.00312921870720659,-0.0122546584690334,1.18788632164505e-05,0.0504615794728956
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,40182,-0.0149413094702638,0.00766832439584946,-0.0299712252861288,8.86063456011169e-05,0.0513871431968705
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,-0.0125257723773388,0.00643489865544705,-0.025138173742015,8.66289873374532e-05,0.0516153687396272
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCNA,Proliferating cell nuclear antigen,40080,-0.0122931549550869,0.00632972932909207,-0.0246994244401073,0.00011311452993356,0.0521471676334515
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLG,Plasminogen,40285,-0.0041741118698285,0.00215828560458771,-0.00840435165482041,5.61279151634056e-05,0.0531392480805568
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,40199,-0.00473201774526916,0.0024546883529988,-0.0095432069171468,7.91714266084771e-05,0.0539123242036203
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,-0.00960438622202563,0.00499754865896353,-0.0193995815935941,0.000190809149542882,0.0546544683145483
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40482,-0.0241245986223138,0.0126253134903682,-0.0488702130634355,0.000621015818807889,0.0560540695024459
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KDR,Vascular endothelial growth factor receptor 2,42679,-0.00468798864104743,0.00246288598344388,-0.00951524516859744,0.000139267886502584,0.0570026816222678
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,-0.0210211619733268,0.0110494770570777,-0.0426781370051991,0.000635813058545421,0.0571332311100855
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCP2,Non-specific lipid-transfer protein,42346,-0.0140825896775189,0.00741363439959538,-0.0286133131007258,0.000448133745688053,0.0575136920328493
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,0.00607876561554116,0.00320024609428824,-0.000193716729263785,0.0123512479603461,0.0575292176742377
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENO1,Alpha-enolase,42588,-0.0149101992547367,0.00786129243728888,-0.0303183324318229,0.000497933922349546,0.0578943147947661
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTR,Methionine synthase,40116,-0.0126866546145248,0.00669375049839718,-0.0258064055913833,0.000433096362333666,0.0580792587575301
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17F,Interleukin-17F,42370,-0.0143131968774046,0.00755251264333053,-0.0291161216583325,0.000489727903523198,0.0580934785367051
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,40080,0.0091248256123428,0.00482430827874146,-0.000330818613990464,0.0185804698386761,0.0585939251029003
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40483,-0.00538852291013773,0.00285207244659653,-0.0109785849054669,0.00020153908519146,0.0588724349589521
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RRP15,RRP15-like protein,40136,0.0175336102079273,0.00928548075430757,-0.000665932070515522,0.0357331524863702,0.0590144740571958
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYOM1,Myomesin-1,40136,-0.00918519652741573,0.00486633342839367,-0.0187232100470673,0.000352816992235865,0.0591197631836613
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD70,CD70 antigen,42594,-0.00816491995289105,0.0043284494150627,-0.0166486808064139,0.000318840900631841,0.0592709839192078
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40527,0.0062745859968255,0.00333572105702321,-0.000263427274939991,0.012812599268591,0.0599936731154987
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPEP2,Dipeptidase 2,42587,-0.00554750888533039,0.00295595938566116,-0.0113411892812263,0.000246171510565488,0.060578167363775
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,-0.00898291162464497,0.00478696489578976,-0.0183653628203929,0.000399539571102947,0.0606079209178792
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HBQ1,Hemoglobin subunit theta-1,42721,0.0113061818779727,0.00602677507503482,-0.000506297269095559,0.023118661025041,0.0606778939585837
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUOX2,Dual oxidase 2,42357,0.0134476685021231,0.00718974777080345,-0.000644237128651675,0.0275395741328978,0.0614511562677668
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAD2,Glutamate decarboxylase 2,40199,0.00865824985974999,0.00465274385904049,-0.000461128103969366,0.0177776278234693,0.0627861987448522
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXDC2,Plexin domain-containing protein 2,40483,-0.00511804689524193,0.00275176295231759,-0.0105115022817844,0.00027540849130055,0.0629234557460772
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MATN3,Matrilin-3,42475,0.00608029712785166,0.00327104574026946,-0.000330952523076474,0.0124915467787798,0.0630742453996066
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,42357,-0.0108327380327846,0.00584401170083302,-0.0222870009664173,0.000621524900848113,0.0638119564569683
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB6,Integrin beta-6,42370,-0.00577714270822414,0.00311818347926591,-0.0118887823275853,0.00033449691113703,0.0639438443515847
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPTX2,Neuronal pentraxin-2,40527,-0.00612242062499992,0.00330747175924678,-0.0126050652731236,0.000360224023123776,0.0641829226904872
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40449,-0.00812137119626103,0.00443252557249532,-0.0168091213183518,0.000566378925829798,0.0669447496290783
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFAT5,Nuclear factor of activated T-cells 5,40199,-0.0158939545361267,0.00870240085598785,-0.0329506602138629,0.00116275114160945,0.0678190188117382
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,-0.00928369557210575,0.00508750777745022,-0.0192552108159082,0.000687819671696687,0.0680536116148632
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,-0.00901981825906011,0.00495130050702899,-0.0187243672528369,0.000684730734716702,0.0685268103176165
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40482,-0.00695695037729111,0.00383127376925926,-0.0144662469650393,0.000552346210457044,0.0694226305215315
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,-0.0104018174245132,0.00575880319930705,-0.0216890716951551,0.000885436846128591,0.070907328645571
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BOC,Brother of CDO,42357,0.00425270672013426,0.00235498366127635,-0.000363061255967392,0.0088684746962359,0.0709672964035699
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRNN,Cornulin,42209,0.0124036993110208,0.00691200414525105,-0.0011438288136713,0.0259512274357128,0.0727541079478752
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,40302,-0.010382917108174,0.00579288778872382,-0.0217369771740727,0.000971142957724712,0.0731031636208789
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,40182,0.00669939158767046,0.0037427772164048,-0.000636451756482941,0.0140352349318239,0.0734891528167659
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EHD3,EH domain-containing protein 3,40223,-0.0209963700551414,0.0117837168173354,-0.0440924550171188,0.002099714906836,0.0748073734005697
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFAP3,Microfibril-associated glycoprotein 3,42357,-0.00868040484306599,0.00488164208667583,-0.0182484233329506,0.000887613646818641,0.0753985005962767
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,-0.0111718230726243,0.00628771559319204,-0.0234957456352807,0.00115209949003212,0.0756335333634831
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HIP1,Huntingtin-interacting protein 1,40116,-0.00597220071072282,0.00337037102518125,-0.0125781279200781,0.000633726498632419,0.0764271968191722
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP15,Matrix metalloproteinase-15,40511,-0.00871956988148996,0.00492467320487996,-0.0183719293630547,0.000932789600074748,0.0766560656767711
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP6,Platelet glycoprotein VI,42590,-0.0153227920434482,0.00865906450486508,-0.0322945584729837,0.00164897438608736,0.0768220990328931
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,-0.0061947028736504,0.00350072425034364,-0.0130561224043239,0.000666716657023139,0.0768303022057902
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSTN,Osteocrin,40182,-0.00745626578974932,0.00421964489652191,-0.0157267697869323,0.000814238207433612,0.0772499005764529
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPR1,Atrial natriuretic peptide receptor 1,40116,0.00728814464979414,0.00414006489385933,-0.000826382542170136,0.0154026718417584,0.0783690418700069
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BGLAP,Osteocalcin,40527,-0.0160036737772871,0.00910202345287014,-0.0338436397449126,0.00183629219033836,0.0787312037160386
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,-0.00787130856150203,0.00447984819289659,-0.0166518110195793,0.000909193896575285,0.0789368007970892
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPS10,40S ribosomal protein S10,40116,0.00720712461372797,0.00410703414067824,-0.000842662302001382,0.0152569115294573,0.0793173480337499
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,40199,-0.00708979649782879,0.0040489583499972,-0.0150257548638233,0.000846161868165728,0.0799707731137391
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VASN,Vasorin,42449,0.00482133271055385,0.00275924140097957,-0.000586780435366113,0.0102294458564738,0.0806015455101433
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERC2,ERC protein 2,40182,-0.0133258858213153,0.00765153751009279,-0.0283228993410972,0.00167112769846658,0.0816071757331222
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LACRT,Extracellular glycoprotein lacritin,40419,-0.0090546138699369,0.00520368998593905,-0.0192538462423774,0.00114461850250364,0.0818799019495575
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,-0.00592886576165085,0.00341872843709104,-0.0126295734983493,0.000771841975047586,0.0829000918801515
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,-0.0152330358644414,0.00879392846204627,-0.0324691356500521,0.00200306392116932,0.0832574783896862
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX25,ATP-dependent RNA helicase DDX25,40182,0.00661950191043388,0.00382222400623129,-0.000872057141779457,0.0141110609626472,0.0833291178868387
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSLNL,Mesothelin-like protein,40182,0.00686910354385582,0.00397033215949557,-0.000912747488755508,0.0146509545764671,0.0836390551965021
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,0.00594497631342859,0.00343986577399165,-0.000797160603595048,0.0126871132304522,0.0839701511507929
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,0.0317251664089612,0.0183593923904065,-0.00425924267623563,0.067709575494158,0.0840099727078995
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,-0.00641503345188922,0.00372507179814033,-0.0137161741762443,0.000886107272465827,0.0850749978484682
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GKN1,Gastrokine-1,42017,-0.00484643970400678,0.00281781684568756,-0.0103693607215544,0.000676481313540849,0.0854698131056989
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,0.00408350428907872,0.00237932606052108,-0.000579974789542598,0.00874698336770004,0.0861454579880126
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGB2A2,Mammaglobin-A,40116,0.00549168456627312,0.00320665999121006,-0.000793369016498608,0.0117767381490448,0.0868169098665677
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,-0.013089934860848,0.00764522960092858,-0.028074584878668,0.00189471515697203,0.0868936284542585
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUSD1,Sushi domain-containing protein 1,42357,-0.00845094781053511,0.00493921179974408,-0.0181318029380335,0.00122990731696329,0.0871063024301855
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRDT,Bromodomain testis-specific protein,40116,-0.00640499608707572,0.00374709727446215,-0.0137493067450215,0.0009393145708701,0.0874197136355666
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,-0.00688134507711285,0.0040278161612408,-0.0147758647531448,0.00101317459891911,0.0875800807720649
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GHRHR,Growth hormone-releasing hormone receptor,42311,0.00961371567744384,0.00563292133492695,-0.00142681013901297,0.0206542414939007,0.0879012045546922
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CORO6,Coronin-6,40136,-0.00639481175089987,0.00376227516184189,-0.01376887106811,0.000979247566310243,0.0892121568924782
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB2B,Ras-related protein Rab-2B,40451,-0.0103494645034603,0.00609151594911528,-0.0222888357637263,0.00158990675680561,0.0893474674361832
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MST1,Hepatocyte growth factor-like protein,40370,-0.0111495726980572,0.00660417760880302,-0.0240937608113111,0.00179461541519674,0.0913891190658224
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLSPN,Claspin,42292,-0.00592139419848437,0.00350959467793485,-0.0128001997672367,0.000957411370267936,0.0915883808051568
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,-0.0129658253299277,0.00773880629283482,-0.0281338856638839,0.00220223500402857,0.0938738029300615
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RASA1,Ras GTPase-activating protein 1,42311,-0.00540368747737494,0.00324468059451831,-0.0117632614426308,0.000955886487880957,0.0958570801400929
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DKKL1,Dickkopf-like protein 1,42587,0.014657194374609,0.00880617958994195,-0.00260291762167718,0.0319173063708952,0.0960516250040799
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYL6B,Myosin light chain 6B,40182,-0.0152249132673262,0.00917474894925241,-0.0332074212078609,0.00275759467320851,0.0970564043601236
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DOCK9,Dedicator of cytokinesis protein 9,40136,-0.0202334083742207,0.012203797039608,-0.0441528505718523,0.00368603382341092,0.0973541879835831
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,-0.0120467328896593,0.00727438936403422,-0.0263045360431664,0.00221107026384773,0.0977400348743927
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NECTIN1,Nectin-1,40199,-0.00546024015672063,0.00329964994005785,-0.011927554039234,0.00100707372579276,0.0979948544452747
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGMA,Repulsive guidance molecule A,42711,-0.00529035113264007,0.00320233802548417,-0.011566933662589,0.000986231397308906,0.0985521305027885
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEO1,Neogenin,40482,-0.00367896969291124,0.00224155039296166,-0.00807240846311609,0.000714469077293604,0.100771065073728
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPM1B,Protein phosphatase 1B,40199,-0.0100987322744226,0.006155609926462,-0.0221637277302882,0.00196626318144289,0.100914498682299
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,0.00407103036691597,0.00248593288008373,-0.000801398078048132,0.00894345881188007,0.101522698711496
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH3GL3,Endophilin-A3,40250,-0.0141278386227756,0.00863116729369125,-0.0310449265184104,0.00278924927285926,0.101692396840926
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,-0.0143031249673116,0.00876154541754378,-0.0314757539856974,0.00286950405107418,0.102605473386514
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DHODH,Dihydroorotate dehydrogenase,40116,-0.00800729668644048,0.00490600043886297,-0.0176230575466119,0.00160846417373094,0.102678089799838
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRR5,Proline-rich protein 5,40199,-0.00783236071910161,0.00482283202554037,-0.0172851114891607,0.00162039005095752,0.104400840728194
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCARE,Photoreceptor cilium actin regulator,40136,-0.0137800322885393,0.00849919987017988,-0.0304384640340919,0.00287839945701321,0.104975077696056
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARB1,Scavenger receptor class B member 1,42311,-0.00942645889359977,0.00582485949645949,-0.0208431835066604,0.00199026571946084,0.105618721080226
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,-0.0105080341836287,0.00649789497280129,-0.0232439083303192,0.00222783996306184,0.105875784840348
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUSP29,Dual specificity phosphatase 29,40182,-0.0109659394654928,0.00679284860859398,-0.024279922738337,0.00234804380735138,0.106483297472781
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTC,Probetacellulin,42346,-0.0120728188792437,0.00747991222244228,-0.0267334468352305,0.0025878090767432,0.106544440436526
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,-0.00971747049097569,0.00604874790664444,-0.0215730163879988,0.00213807540604741,0.108187305244139
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN4,Contactin-4,42611,0.00384533891305681,0.00240251028078597,-0.000863581237283686,0.0085542590633973,0.109500067951353
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,40417,-0.00699696042490219,0.00437220732933681,-0.0155664867904023,0.00157256594059795,0.109554258307499
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MANSC4,MANSC domain-containing protein 4,40116,-0.0115261128536158,0.00722190238449288,-0.0256810415272219,0.00262881581999021,0.110519065156652
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP350,Centrosome-associated protein 350,40080,-0.00613789853782777,0.00384757441920034,-0.0136791443994604,0.0014033473238049,0.110682149299229
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,40302,0.00466271342104083,0.0029288164194648,-0.00107776676111018,0.0104031936031918,0.111410268404326
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIF20B,Kinesin-like protein KIF20B,40136,-0.0125770421718066,0.00791109758728882,-0.0280827934428927,0.00292870909927953,0.111909376178432
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGT,Angiotensinogen,40532,-0.00382561027843422,0.00241120382426848,-0.00855156977400044,0.000900349217132005,0.112631690315638
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PROS1,Vitamin K-dependent protein S,40539,0.00416458372443375,0.00262783938897259,-0.000985981477952538,0.00931514892682003,0.113041049972231
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,-0.00649202152915942,0.00409721944263505,-0.0145225716367241,0.00153852857840527,0.113109707002503
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP152,Centrosomal protein of 152 kDa,40080,-0.00666191488486876,0.00421800006319883,-0.0149291950087385,0.00160536523900094,0.114273088049363
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCL2,Phosducin-like protein 2,40080,-0.00846089897136437,0.00536944981638104,-0.0189850206114712,0.00206322266874246,0.115112984918057
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,-0.00708291980070791,0.0045010513671281,-0.015904980480279,0.00173914087886317,0.115605339887301
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,-0.0054390698818248,0.0034702790997893,-0.0122408169174118,0.00136267715376222,0.117066741276043
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,42425,0.0268397761110885,0.0172012733387488,-0.00687471963285917,0.0605542718550361,0.118704278880507
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YY1,Transcriptional repressor protein YY1,40199,-0.00443169621349382,0.00284460647457174,-0.0100071249036544,0.00114373247666679,0.11927872718697
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP290,Centrosomal protein of 290 kDa,40302,-0.00858625444153601,0.00551379929771731,-0.0193933010650619,0.00222079218198992,0.119444344021732
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TLR2,Toll-like receptor 2,40302,-0.00368381827724602,0.0023677744212167,-0.00832465614283075,0.000957019588338716,0.11978064775607
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4C,C-type lectin domain family 4 member C,42594,-0.00744106894357424,0.00479515666180872,-0.0168395760007193,0.00195743811357085,0.120736455533043
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,-0.0101759949953107,0.00658990632969192,-0.0230922114015069,0.00274022141088549,0.122568309359575
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK1,Kallikrein-1,42505,0.0199734668851921,0.0129639659939426,-0.0054359064629354,0.0453828402333195,0.123415757224797
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCND2,G1/S-specific cyclin-D2,40302,0.00574380628038513,0.00373170480616332,-0.00157033513969497,0.0130579477004652,0.12378616928947
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SKIV2L,Helicase SKI2W,40116,-0.00617759305159347,0.00401627593253418,-0.0140494938793605,0.00169430777617353,0.124043453828763
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,-0.0102132558353605,0.00665261061017771,-0.0232523726313089,0.00282586096058776,0.12475661009053
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,-0.0155417088819719,0.0102332619149059,-0.0355989022351875,0.0045154844712437,0.128855518113274
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UGDH,UDP-glucose 6-dehydrogenase,40116,-0.0146431984251874,0.00964882115244017,-0.0335548878839701,0.00426849103359535,0.129140354888288
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN2B,Sodium channel subunit beta-2,40182,0.00445833863095896,0.00293869289385331,-0.00130149944099353,0.0102181767029115,0.129266113678276
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAA4,Serum amyloid A-4 protein,40539,-0.00492406752210495,0.00326252116382927,-0.0113186090032103,0.00147047395900041,0.131254341304226
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,-0.00730906205718691,0.0048448813823512,-0.0168050295665953,0.00218690545222144,0.131426053341964
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPR101,Probable G-protein coupled receptor 101,40136,0.00919718019212059,0.00610706513439263,-0.00277266747128897,0.0211670278555301,0.132098557765516
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,0.00622716795316452,0.00415225729785228,-0.00191125635062594,0.014365592256955,0.133714201217522
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BIN2,Bridging integrator 2,42611,-0.01343970134203,0.00898769209791222,-0.0310555778539379,0.00417617516987796,0.134847919573219
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,-0.00424537435866933,0.00284522022697512,-0.00982200600354056,0.0013312572862019,0.135694441334969
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,40136,-0.00752530895881102,0.00504947640526482,-0.0174222827131301,0.00237166479550803,0.136170330944716
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,0.00436508655184001,0.00293441321306878,-0.00138636334577479,0.0101165364494548,0.136898407481129
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENO2,Gamma-enolase,42711,-0.00953900315581601,0.00642581099772122,-0.0221335927113496,0.00305558639971758,0.137704314301881
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEG1,Protein LEG1 homolog,39926,-0.0104592396658151,0.00705538801146399,-0.0242878001682845,0.00336932083665437,0.138250725185634
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,0.00797410351625456,0.00538462403883172,-0.00257975959985561,0.0185279666323647,0.138661387111572
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6V1D,V-type proton ATPase subunit D,42587,0.00387711642182559,0.00261869037126548,-0.00125551670585475,0.00900974954950592,0.138748585004108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLSTN2,Calsyntenin-2,42754,-0.0058733565142873,0.00396751189423173,-0.0136496798269815,0.0019029667984069,0.138799718532781
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAG3,BAG family molecular chaperone regulator 3,42475,-0.00598610223775416,0.00404944252463672,-0.0139230095860421,0.00195080511053381,0.139363676360788
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40527,0.00315950351374423,0.00213771752481442,-0.00103042283489203,0.00734942986238049,0.139440950556595
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNMA2,Paraneoplastic antigen Ma2,40136,-0.00662088450373295,0.00449040732022211,-0.0154220828513683,0.00218031384390239,0.140389034622933
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,-0.0106749910167695,0.00725264417367064,-0.0248901735971639,0.003540191563625,0.141078128478029
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPHA2,Glycoprotein hormone alpha-2,40449,-0.00689024396820972,0.00469951028827256,-0.0161012841332239,0.00232079619680451,0.142632062619808
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FH,"Fumarate hydratase, mitochondrial",40136,-0.0126886100954427,0.0086551901389435,-0.029652782767772,0.00427556257688655,0.14267383234258
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADRA2A,Alpha-2A adrenergic receptor,40116,-0.0102389867152357,0.00701653058467647,-0.0239913866612016,0.00351341323073018,0.144520581997763
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,0.00308966044210352,0.002117945814001,-0.00106151335333843,0.00724083423754548,0.1446484985429
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMA1,Laminin subunit alpha-1,40116,0.00792557063073685,0.00543898730201024,-0.00273484448120322,0.0185859857426769,0.145096102580017
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,-0.00396568956818762,0.00272233310714276,-0.00930146245818742,0.00137008332181218,0.145221262157167
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RANGAP1,Ran GTPase-activating protein 1,42346,-0.00705280738944719,0.00484296365550557,-0.0165450161542381,0.00243940137534372,0.145333609785075
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,-0.00941593160818755,0.00647873218381461,-0.0221142466884642,0.0032823834720891,0.146152592074509
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FSHB,Follitropin subunit beta,40223,0.00793464974667065,0.00546076388772295,-0.00276844747326633,0.0186377469666076,0.14624407876909
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC2L,C-type lectin domain family 2 member L,40182,-0.00721150254475971,0.00496938476640683,-0.0169514966869171,0.00252849159739768,0.146756568978514
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PROC,Vitamin K-dependent protein C,42663,-0.00363955658066705,0.00250929546429959,-0.00855777569069424,0.00127866252936014,0.146962025712084
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,-0.00590242573744029,0.00407322742631977,-0.013885951493027,0.00208110001814645,0.147344408856218
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAM,Signal transducing adapter molecule 1,40451,-0.005453513888978,0.00377057482203643,-0.0128438405401694,0.00193681276221341,0.148111138204389
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPLX2,Complexin-2,40080,0.00464250019422822,0.00321386673276676,-0.00165667860199463,0.0109416789904511,0.148621064778354
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,0.00572339766010321,0.00396285842222574,-0.00204380484745924,0.0134906001676657,0.148689754974332
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,-0.00762955894684726,0.00529203451543021,-0.0180019465970905,0.00274282870339595,0.149413466083115
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MUCL3,Mucin-like protein 3,40080,-0.00618572306549071,0.00430863691514353,-0.014630651419172,0.00225920528819061,0.151128809909097
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD177,CD177 antigen,42595,-0.0188849003014958,0.0131667364567863,-0.0446917037567969,0.00692190315380526,0.151513249213976
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IKZF2,Zinc finger protein Helios,42346,-0.0126408993997532,0.00882079202354082,-0.0299296517658932,0.00464785296638683,0.15185878579533
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40482,-0.00494986317329615,0.0034559460540734,-0.01172351743928,0.00182379109268771,0.15209298723369
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SULT1A1,Sulfotransferase 1A1,42711,0.0182062766656606,0.0127374629072745,-0.00675915063259734,0.0431717039639186,0.15292713111868
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TJP3,Tight junction protein ZO-3,40136,0.00607624684802999,0.00425437997211307,-0.00226233789731162,0.0144148315933716,0.153253280618725
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NXPE4,NXPE family member 4,40116,-0.00485689639390831,0.00340065073309941,-0.0115221718307832,0.00180837904296654,0.153255531547459
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHD,SH2 domain-containing adapter protein D,40083,-0.0125883644041053,0.00886609974674384,-0.0299659199077232,0.00478919109951261,0.155685478153434
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDAC8,Histone deacetylase 8,40199,-0.00844681471596652,0.00596425270991586,-0.0201367500274016,0.00324312059546856,0.156733479370195
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,-0.0119316022651146,0.00843029565721883,-0.0284549817532635,0.00459177722303432,0.157001946360714
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTP1,Glutathione S-transferase P,42237,0.00992564594367018,0.00703173969114562,-0.00385656385097522,0.0237078557383156,0.158106617993046
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DIPK1C,Divergent protein kinase domain 1C,40182,0.00597820196690177,0.00423913932114184,-0.00233051110253624,0.0142869150363398,0.158497264749242
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEBP1,Heme-binding protein 1,42357,0.00747708819082615,0.0053029196153391,-0.00291663425523849,0.0178708106368908,0.158564895654008
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPBGL,Trophoblast glycoprotein-like,40182,0.00597448845922017,0.00423726794290056,-0.00233055670886492,0.0142795336273053,0.158572122542928
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUMF1,Formylglycine-generating enzyme,40199,-0.00912896710812984,0.00647494566479676,-0.0218198606111315,0.00356192639487182,0.158600153893414
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,-0.00472826741747422,0.00335434959950749,-0.0113027926325089,0.00184625779756046,0.158687400311402
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1A,Interleukin-1 alpha,42370,-0.00818613041904679,0.00582612956486406,-0.0196053443661803,0.00323308352808676,0.160023501080041
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC12A2,Solute carrier family 12 member 2,40116,0.00385101388369091,0.00274772258619213,-0.00153452238524566,0.00923655015262748,0.16108424878333
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POMC,Pro-opiomelanocortin,40223,-0.0098696382474376,0.00704399028615299,-0.0236758592082975,0.00393658271342225,0.161199428020161
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYOC,Myocilin,42611,-0.00623943115011095,0.00446504456646731,-0.0149909185003869,0.00251205620016497,0.162317914881035
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,-0.00785559420360557,0.0056437667297168,-0.0189173769938505,0.00320618858663937,0.163978960360632
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN3B,Sodium channel subunit beta-3,40136,0.0067679693760197,0.00486855223405977,-0.00277439300273744,0.0163103317547768,0.164514635096987
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,-0.00420979251496873,0.00303984247597714,-0.0101678837678839,0.00174829873794646,0.166119150019619
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSAPL1,Proactivator polypeptide-like 1,40449,0.00713050857331514,0.00515333504828796,-0.00297002812132926,0.0172310452679595,0.166487352293597
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CREG1,Protein CREG1,42445,-0.0053070388655357,0.00384304367050749,-0.0128394044597304,0.00222532672865897,0.167318606905375
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PODXL,Podocalyxin,42587,0.00211061974065766,0.00152933163567164,-0.000886870265258743,0.00510810974657407,0.167581077321404
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,-0.0075838057866909,0.0054983319347874,-0.0183605363788742,0.00319292480549241,0.167832783295008
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,-0.0147420782602346,0.0107357132206502,-0.035784076172709,0.00629991965223974,0.169724710919688
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,-0.00985213554380167,0.00718953054527542,-0.0239436154125415,0.00423934432493815,0.170607300468437
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COPE,Coatomer subunit epsilon,42311,-0.00649362676191627,0.0047524854085322,-0.0158084981626394,0.00282124463880685,0.171848046029614
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,0.00654336159112792,0.00479988246162176,-0.00286440803365073,0.0159511312159066,0.17283696588623
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,40136,0.00737886136480941,0.00541865945036172,-0.00324171115789956,0.0179994338875184,0.173304723251335
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,-0.00764601466923294,0.00562003782712488,-0.0186612888103977,0.00336925947193183,0.173702554211525
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGM2,Phosphoglucomutase-2,40182,0.00810507647169058,0.00603120599480215,-0.00371608727812165,0.0199262402215028,0.179022484022437
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FMR1,Synaptic functional regulator FMR1,42346,-0.00475898237762223,0.00355226109567167,-0.0117214141251387,0.00220344936989425,0.180364379781392
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERCC1,DNA excision repair protein ERCC-1,40080,-0.00463133900727339,0.00345831507607333,-0.0114096365563771,0.00214695854183033,0.180536971839096
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOH,Beta-2-glycoprotein 1,42611,-0.00486992604038089,0.00363851915341507,-0.0120014235810744,0.00226157150031264,0.180776938632762
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPTXR,Neuronal pentraxin receptor,42636,-0.00454330005068944,0.00340565163608714,-0.0112183772574202,0.00213177715604136,0.182210986829187
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMPRSS11B,Transmembrane protease serine 11B,40136,-0.0104739777817816,0.00787904566638593,-0.0259169072878981,0.00496895172433479,0.183761561809947
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH4,Cadherin-4,40136,-0.00666609591253811,0.00503005436712525,-0.0165250024721036,0.00319281064702738,0.185114838963329
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UNC5D,Netrin receptor UNC5D,40199,-0.00349064724632784,0.00264001038705914,-0.00866506760496376,0.00168377311230807,0.186125823513736
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGSF21,Immunoglobulin superfamily member 21,40223,0.00526300305268272,0.00399274661121245,-0.00256278030529367,0.0130887864106591,0.187483823350487
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPR158,Probable G-protein coupled receptor 158,40482,-0.00476222319591751,0.00363367833254192,-0.0118842327276997,0.00235978633586465,0.19002663881632
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPA33,Cell surface A33 antigen,42587,-0.0182231225894113,0.013911189702068,-0.0454890544054645,0.00904280922664189,0.190231336113098
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FRZB,Secreted frizzled-related protein 3,42454,-0.00325576005295433,0.00248671218619888,-0.00812971593790414,0.00161819583199548,0.190467992430399
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUGT1,Protein SGT1 homolog,42346,-0.0104019454967612,0.00799905408375824,-0.0260800915009274,0.00527620050740492,0.193487742492231
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,0.00586760077647133,0.004517826614799,-0.00298733938853472,0.0147225409414774,0.194050686768886
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBLN4,Cerebellin-4,42721,-0.00421981314026093,0.00325172953347347,-0.0105932030258689,0.00215357674534707,0.194407949790871
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTNNA1,Catenin alpha-1,40136,0.00460347795692324,0.00355644970174047,-0.00236716345848809,0.0115741193723346,0.195553688125248
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FES,Tyrosine-protein kinase Fes/Fps,42346,-0.00611393764450412,0.00475951271752265,-0.0154425825708485,0.00321470728184027,0.198964448981454
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK12,Kallikrein-12,42346,-0.0179729814640663,0.0139995349704103,-0.0454120700060705,0.0094661070779378,0.199225099063422
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNPO1,Transportin-1,40302,0.00459446892246457,0.00358313354272601,-0.0024284728212784,0.0116174106662075,0.199782118099062
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,-0.00680495364535374,0.00531534533521085,-0.017223030502367,0.00361312321165953,0.200485099092994
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40449,0.0191376818275409,0.0149959461680895,-0.0102543726619146,0.0485297363169964,0.201914572031656
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUSP3,Dual specificity protein phosphatase 3,42311,-0.010882381214598,0.0085679445746175,-0.0276755525808483,0.00591079015165225,0.204061780541799
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL26,C-C motif chemokine 26,42594,-0.0117562798374479,0.00931568926004548,-0.030015030787137,0.00650247111224127,0.206975386775297
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERVV_1,,40116,0.0055305747142467,0.00440253282475256,-0.00309838962226833,0.0141595390507617,0.209061034198635
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMC3,26S proteasome regulatory subunit 6A,40080,0.00388780157132961,0.00309976199158502,-0.00218773193217704,0.00996333507483626,0.20978686238475
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNF75D,Zinc finger protein 75D,40302,-0.00778055209532586,0.00620385410512516,-0.0199401061413712,0.00437900195071945,0.209814555955178
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,-0.00567249046721672,0.00453240320637404,-0.0145560007517098,0.0032110198172764,0.210763008272053
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C4BPB,C4b-binding protein beta chain,42679,-0.00503459964041221,0.00402460700349012,-0.0129228293672528,0.00285363008642842,0.210972835700691
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PMCH,Pro-MCH,40116,-0.0106187255039686,0.00854845433978632,-0.0273736960099498,0.00613624500201257,0.214196547965348
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TG,Thyroglobulin,40451,-0.014434502903549,0.0116263074529278,-0.0372220655112874,0.00835305970418951,0.214432925007913
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDAC9,Histone deacetylase 9,40136,-0.00822356142200043,0.00663583327345925,-0.0212297946379806,0.0047826717939797,0.215273649195171
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNPY2,Protein canopy homolog 2,42357,-0.00765532394934782,0.00620163779177264,-0.0198105340212222,0.00449988612252655,0.217074588687123
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40451,-0.00499210312281236,0.00405135939447633,-0.012932767535986,0.00294856129036125,0.217898452995916
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42618,-0.00317491161998668,0.00257886904616329,-0.00822949495046674,0.00187967171049337,0.218297472673532
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,-0.00753737966317872,0.00612285912249786,-0.0195381835432745,0.0044634242169171,0.218340766924464
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",40080,-0.0114943610658308,0.0093518276601513,-0.0298239432797274,0.00683522114806572,0.219059691895376
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP164,Centrosomal protein of 164 kDa,42370,-0.00808846285214494,0.0065956834654008,-0.0210160024443305,0.00483907674004062,0.220097666260025
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,-0.00469528374472466,0.00383605709202931,-0.0122139556451021,0.00282338815565279,0.220983413713667
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,0.00746085251855004,0.00614437317299266,-0.00458211890051558,0.0195038239376157,0.224671188214443
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,0.0048517935176454,0.00399566914439319,-0.00297971800536525,0.012683305040656,0.224673278448921
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,0.00227910265071705,0.00188729658128719,-0.00141999864860583,0.00597820395003994,0.227225660838213
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTD,Biotinidase,40539,-0.00249527212640146,0.00207001939665885,-0.0065525101438528,0.00156196589104989,0.228060875904451
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA4,Annexin A4,42584,-0.00858417800862775,0.0071392238273919,-0.0225770567103159,0.00540870069306037,0.229231192439989
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40449,-0.0116919466305249,0.00977314206812573,-0.0308473050840513,0.00746341182300156,0.231591267490904
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,0.00661453391739731,0.00555044100599787,-0.00426433045435853,0.0174933982891531,0.233399559690428
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KDM3A,Lysine-specific demethylase 3A,40199,-0.0105302646871817,0.00884309773608903,-0.0278627362499162,0.00680220687555279,0.233762059638769
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC123,Cell division cycle protein 123 homolog,40080,-0.00760249778824869,0.00639040109152401,-0.0201276839276358,0.00492268835113838,0.234200262937125
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,40116,0.00577000797892164,0.00486455832210979,-0.00376452633241354,0.0153045422902568,0.235596002460753
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMEM132A,Transmembrane protein 132A,40223,0.00749167335072442,0.00632107104029966,-0.00489762588826292,0.0198809725897118,0.235967671179633
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRISP3,Cysteine-rich secretory protein 3,40439,0.00325736683019315,0.00275844010351177,-0.00214917577268992,0.00866390943307623,0.237678242317776
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,0.00338243804557663,0.00286699534062316,-0.00223687282204476,0.00900174891319801,0.238111246403915
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGS10,Regulator of G-protein signaling 10,40482,-0.00703180736599274,0.00596882144297707,-0.0187306973942278,0.00466708266224233,0.238785662886047
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL36A,Interleukin-36 alpha,40199,-0.00682690280964192,0.00580938324186361,-0.0182132939636946,0.00455948834441075,0.239959714868502
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,42297,-0.00665253827161886,0.00566170328046536,-0.017749476701331,0.00444440015809325,0.240013458814763
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,-0.0127256917768374,0.0108349391314733,-0.0339621724745251,0.00851078892085023,0.240218204521608
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPTX1,Neuronal pentraxin-1,42611,0.00469718238777711,0.00400354453521376,-0.00314976490124187,0.0125441296767961,0.240714014933335
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,-0.00822695533935714,0.00705237168856631,-0.0220496038489471,0.00559569317023282,0.24341697714565
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,-0.0143469490336451,0.0123112935714065,-0.0384770844336019,0.00978318636631163,0.243899038531894
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,0.00381556810008048,0.00327612858107536,-0.00260564391882723,0.0102367801189882,0.244183049638014
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBM19,Probable RNA-binding protein 19,40116,-0.00565664450088699,0.00487084102210425,-0.0152034929042113,0.00389020390243735,0.245533879854139
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEPTIN7,Septin-7,40302,-0.00636844592611952,0.00550177402437127,-0.0171519230138872,0.00441503116164816,0.247082453082617
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPT1,Palmitoyl-protein thioesterase 1,40182,-0.00897189178692698,0.00777222927207586,-0.0242054611601957,0.00626167758634171,0.248380812353323
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,-0.00721526273269583,0.0062513297588054,-0.0194678690599544,0.00503734359456275,0.248444837831923
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBP2,Retinol-binding protein 2,42587,-0.00889422174094441,0.00773160885684527,-0.0240481751003611,0.00625973161847232,0.250011471797914
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BDNF,Brain-derived neurotrophic factor,40527,-0.00967122392699711,0.00842215825175122,-0.0261786541004295,0.00683620624643528,0.250866055435542
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,40302,-0.00760097603457038,0.00665414545950853,-0.0206431011352071,0.00544114906606635,0.253357354784323
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,-0.00417468880718911,0.00365676435330673,-0.0113419469396703,0.00299256932529209,0.253626084172909
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYOM2,Myomesin-2,40116,-0.00579673212221821,0.00508406282865356,-0.0157614952663792,0.00416803102194276,0.254237519007141
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMOD4,Tropomodulin-4,40080,-0.00474505209179315,0.0041756247052599,-0.0129292765141026,0.00343917233051625,0.255827016663404
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,-0.0024787950609966,0.00218631964685953,-0.00676398156884127,0.00180639144684807,0.256909350107039
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA8,Carbonic anhydrase-related protein,40199,-0.00325533327724187,0.00288999704413521,-0.00891972748374688,0.00240906092926315,0.260014863786874
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PITHD1,PITH domain-containing protein 1,40065,-0.00917083558183732,0.00817056214060017,-0.0251851373774137,0.00684346621373902,0.26170696588767
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TEX33,Testis-expressed protein 33,40302,0.00430168266076912,0.00385799513592913,-0.00325998780565198,0.0118633531271902,0.264872535416474
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTO1,Protein LTO1 homolog,42370,-0.00468244236245102,0.00420711451345617,-0.0129283868088251,0.00356350208392307,0.265736501723325
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSG3,Desmoglein-3,42651,-0.00391187699233619,0.00351744329153258,-0.01080606584374,0.00298231185906766,0.266099342244974
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPM3,Tropomyosin alpha-3 chain,40116,0.00490368387896699,0.00442117490599258,-0.00376181893677847,0.0135691866947124,0.267395973889111
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPM1A,Protein phosphatase 1A,42346,0.00351757462232192,0.00319038850100286,-0.00273558683964369,0.00977073608428752,0.27024120409739
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,-0.0033195507926946,0.0030131205560674,-0.00922526708258671,0.0025861654971975,0.270612926819586
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRD3,Bromodomain-containing protein 3,40116,-0.00552385347722123,0.00501672308996673,-0.015356630733556,0.00430892377911355,0.270882634508005
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC4A1,Band 3 anion transport protein,40527,0.0051900473712977,0.00472294580137037,-0.00406692639938823,0.0144470211419836,0.271834824778028
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42794,0.00378114425363284,0.00346309861658966,-0.0030065290348829,0.0105688175421486,0.274923453312556
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA13,Carbonic anhydrase 13,42483,-0.0112281506710599,0.0102869244889952,-0.0313905226694904,0.00893422132737064,0.275073892239658
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPB2,Carboxypeptidase B2,40516,0.00242559078036774,0.0022325811176629,-0.00195026821025154,0.00680144977098701,0.2773024813343
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40482,-0.00821796140426626,0.00761389363188317,-0.0231411929227573,0.00670527011422476,0.28046033488841
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP5,Platelet glycoprotein V,40283,-0.00392684562669016,0.00364301334397831,-0.0110671517808877,0.00321346052750733,0.281096743181196
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSC1,Hamartin,40199,-0.00797718355336721,0.00740655944274917,-0.0224940400611556,0.00653967295442116,0.281484631500371
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP4,Caspase-4,40302,-0.0188116202505825,0.0174670241887959,-0.0530469876606224,0.0154237471594575,0.281512984923889
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL9A1,Collagen alpha-1(IX) chain,42594,0.00522191106201243,0.00485935770791059,-0.00430243004549232,0.0147462521695172,0.282569028458409
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,0.00765536728171431,0.00712953151134408,-0.00631851448052009,0.0216292490439487,0.282956005757792
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSLP,Thymic stromal lymphopoietin,42357,-0.00658785767564552,0.0061373337506718,-0.0186170318269622,0.0054413164756712,0.283108173820832
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,-0.00522883980534487,0.0048827029223313,-0.0147989375331142,0.00434125792242447,0.284242365395954
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,0.00548220443234584,0.00513874276163512,-0.004589731380459,0.0155541402451507,0.286068577144013
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMY2A,Pancreatic alpha-amylase,42114,-0.00521930446555167,0.00489316876732716,-0.0148099152495129,0.00437130631840957,0.286149290309235
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40449,-0.00275945342967421,0.00258904669423248,-0.00783398495036986,0.00231507809102144,0.286528635055005
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,40302,-0.00721401447260289,0.00677837560026705,-0.0204996306491263,0.00607160170392053,0.287230027888347
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,40136,0.00835709574422931,0.00793292367895687,-0.00719143466652615,0.0239056261549848,0.292148977475573
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,40116,-0.011707774386462,0.0111204558892115,-0.0335038679293164,0.0100883191563925,0.292449425199136
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FRMD7,FERM domain-containing protein 7,40182,0.00353509191653674,0.00337633423390012,-0.00308252318190749,0.010152707014981,0.295113050204578
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZPR1,Zinc finger protein ZPR1,40136,-0.0102857681232345,0.00985884646967682,-0.0296091072038011,0.00903757095733203,0.296830842169564
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEZ6L2,Seizure 6-like protein 2,42587,0.00247323732388652,0.0023781200654611,-0.00218787800441724,0.00713435265219028,0.298360148510962
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLHL41,Kelch-like protein 41,40482,-0.0049819564859843,0.00483492540034295,-0.0144584102706565,0.00449449729868788,0.302839560638135
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,40136,-0.00729727892718177,0.0070953845583093,-0.021204232661468,0.00660967480710446,0.303758899544781
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,40429,-0.00408515858431442,0.00398417813676352,-0.0118941477323709,0.00372383056374207,0.305222333244865
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,40302,0.0045315910112709,0.00443838221085933,-0.00416763812201338,0.0132308201445552,0.307276378086902
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH5,Cadherin-5,42794,0.00307221098546919,0.00301672566760535,-0.0028405713230373,0.00898499329397568,0.30850955070649
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAMT,Guanidinoacetate N-methyltransferase,40116,-0.00386705648173929,0.00382254650383111,-0.0113592476292483,0.00362513466576969,0.311730679469138
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTF,Ciliary neurotrophic factor,40136,0.00351151224410116,0.00347538359269762,-0.00330023959758618,0.0103232640857885,0.312328143556117
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,40080,0.00295409262331168,0.00292759776516198,-0.00278399899640581,0.00869218424302916,0.312973066792238
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,-0.00547263256204605,0.00544535351174518,-0.0161455254450666,0.0052002603209745,0.314914450556816
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLIC5,Chloride intracellular channel protein 5,40182,-0.00318509352793715,0.00319058816581418,-0.00943864633293295,0.00306845927705864,0.318166623076875
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSB,Lupus La protein,42311,-0.00582022608924229,0.00583483006554512,-0.0172564930177107,0.00561604083922614,0.31854167961953
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,-0.00285697058503676,0.00286940731123112,-0.00848100891504974,0.00276706774497623,0.319434467599655
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINI1,Neuroserpin,40267,-0.00303521912150134,0.00305182245688752,-0.00901679113700088,0.00294635289399819,0.319972269312604
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAPPA,Pappalysin-1,42370,0.00463591382718417,0.00466941559958229,-0.00451614074799712,0.0137879684023655,0.320813342305047
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INSL3,Insulin-like 3,40483,0.00782418772093821,0.007882494518997,-0.00762550153629591,0.0232738769781723,0.320924735961937
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GH2,Growth hormone variant,42346,-0.0165025285786459,0.0167285016315572,-0.049290391776498,0.0162853346192062,0.323910017115725
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MDM1,Nuclear protein MDM1,40182,-0.00311132952026905,0.00315485411358302,-0.00929484358289178,0.00307218454235367,0.324054766971052
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,0.0030000753099721,0.00307917959223145,-0.00303511669080154,0.00903526731074573,0.329920585659313
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC44A4,Choline transporter-like protein 4,40182,0.00699129891918719,0.00719379525380313,-0.00710853977826694,0.0210911376166413,0.331145947240623
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,-0.00696956815084173,0.00723352321757832,-0.0211472736572952,0.00720813735561178,0.335313115401373
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALY,Neuron-specific vesicular protein calcyon,40116,0.00380448818985618,0.00395101755925789,-0.00393950622628928,0.0115484826060016,0.335612246500621
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICOSLG,ICOS ligand,42587,0.00185588226424442,0.00193833312088475,-0.00194325065268969,0.00565501518117853,0.338350890784737
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,-0.00611391408598473,0.00640876758223269,-0.0186750985471608,0.00644727037519135,0.340108365545849
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRXN3,Neurexin-3,40182,-0.00341180425910597,0.00358591561044289,-0.010440198855574,0.0036165903373621,0.341399059789316
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,0.00460759444616481,0.00490637865682678,-0.00500890772121567,0.0142240966135453,0.347698680400429
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,40136,-0.00410535067217001,0.00437259390578242,-0.0126756347275035,0.00446493338316353,0.347811943009688
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,0.00479771548528923,0.00513511862477816,-0.00526711701927597,0.0148625479898544,0.350172414605628
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACTN2,Alpha-actinin-2,40116,-0.00560220046026822,0.00599974766164313,-0.0173617058770888,0.00615730495655231,0.350459005169379
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,40136,0.00607611023625701,0.00650752881084596,-0.00667864623300106,0.0188308667055151,0.350476843073961
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OMP,Olfactory marker protein,40136,-0.00473330574792339,0.0050887607419759,-0.0147072768021962,0.00524066530634938,0.352314460045657
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAGEA3,Melanoma-associated antigen 3,40302,-0.00815608942802474,0.00877941833348977,-0.0253637493616647,0.00905157050561521,0.352908694829172
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,40182,0.00347730861869307,0.0037509728625784,-0.00387459819196059,0.0108292154293467,0.353925195493294
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELL,L-selectin,40539,0.00221502080144546,0.00240395467122504,-0.00249673035415563,0.00692677195704654,0.356857537975621
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB5,Serpin B5,42357,-0.00449156253510749,0.00489447700753719,-0.0140847374698804,0.0051016123996654,0.358803355406228
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,-0.00351845219285037,0.00383986261089648,-0.0110445829102075,0.00400767852450673,0.359531097194986
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,-0.00630061868791199,0.00688861054385822,-0.0198022953538741,0.00720105797805013,0.360395712431352
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAG,S-arrestin,40136,0.0048427175982208,0.00529857035342904,-0.00554248029450011,0.0152279154909417,0.36075440908984
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,0.00281317997076268,0.0030878151116427,-0.003238937648057,0.00886529758958236,0.362281274192196
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCP11,T-complex protein 11 homolog,40302,0.00543838206414099,0.00598623164657009,-0.00629463196313639,0.0171713960914184,0.363643473227335
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDAN1,Codanin-1,40483,0.00204368997195849,0.00228079697972927,-0.00242667210831089,0.00651405205222787,0.370249418164156
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CGA,Glycoprotein hormones alpha chain,42611,-0.00561422340284361,0.00629497417439382,-0.0179523727846555,0.00672392597896829,0.372485015258499
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40527,-0.0056914532518641,0.00638617159310432,-0.0182083495743486,0.00682544307062036,0.372832646673363
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB6B,Ras-related protein Rab-6B,42311,-0.0043869004842275,0.00493656420252028,-0.0140625663211673,0.00528876535271226,0.374205033406656
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK7,Kallikrein-7,40009,-0.00351139104052251,0.00396365693226922,-0.0112801586277702,0.00425737654672516,0.37569283115407
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,-0.00391774080622877,0.00445128747647291,-0.0126422642601157,0.00480678264765813,0.378804517769605
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,40199,-0.00258257634121882,0.00293541249238186,-0.00833598482628727,0.00317083214384963,0.378986796144588
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZP4,Zona pellucida sperm-binding protein 4,40080,0.00280159659548274,0.0031927274227141,-0.00345614915303689,0.00905934234400238,0.380238176906977
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EVI2B,Protein EVI2B,40080,-0.00363075424232173,0.00414415759885733,-0.0117533031360821,0.00449179465143864,0.380987426623662
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL5,Interleukin-5,42370,0.0121816214938382,0.0139321163084269,-0.0151253264706785,0.0394885694583549,0.381940659982954
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RYR1,Ryanodine receptor 1,40116,0.00303254959373422,0.00347958969304397,-0.00378744620463195,0.0098525453921004,0.383486688883469
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LIPF,Gastric triacylglycerol lipase,40223,0.00546974893090962,0.00627767451385151,-0.00683449311623934,0.0177739909780586,0.383608368247342
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,-0.00514114485530758,0.00591281217887392,-0.0167302567259005,0.0064479670152853,0.384596972145014
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT17,"Keratin, type I cytoskeletal 17",40116,-0.00345348169393371,0.00397694042902609,-0.0112482849348248,0.00434132154695742,0.385207323941769
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLSTN1,Calsyntenin-1,42311,0.00460140847020762,0.00532384552277567,-0.00583332875443269,0.0150361456948479,0.387438008713831
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPC5,Glypican-5,42495,0.00483948118171152,0.00561448682237668,-0.00616491299014678,0.0158438753535698,0.388723293043103
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF16,Fibroblast growth factor 16,40199,-0.00410805306901198,0.00477708884842515,-0.0134711472119253,0.00525504107390132,0.389835855227286
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBLN1,Cerebellin-1,40136,0.00818992055595324,0.00959621278571521,-0.0106186565040486,0.0269984976159551,0.39342659411124
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NLGN1,Neuroligin-1,40182,0.00601565378019343,0.00704912180021865,-0.00780062494823512,0.019831932508622,0.393461374498903
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLP1R,Glucagon-like peptide 1 receptor,40136,-0.00326208705208711,0.00383615891106191,-0.0107809585177684,0.00425678441359424,0.395147781645361
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VEGFD,Vascular endothelial growth factor D,42734,-0.00306168171697428,0.00360739041272233,-0.0101321669259101,0.0040088034919615,0.396049445763367
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,40136,-0.00440009610552752,0.00519413038781785,-0.0145805916656505,0.00578039945459547,0.396942005122063
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,40136,0.00626772872873956,0.00741670754948825,-0.00826901806825742,0.0208044755257365,0.398083333494911
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,-0.00348096760334273,0.00412048699253058,-0.0115571221087027,0.00459518690201721,0.398243103571457
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REXO2,"Oligoribonuclease, mitochondrial",40116,0.00405899987338594,0.00483487105177232,-0.00541734738808781,0.0135353471348597,0.40119258996015
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,0.00724883749657238,0.00865070664448349,-0.00970654752661526,0.02420422251976,0.402075195162916
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,0.00218606163046558,0.00260939154905548,-0.00292834580568316,0.00730046906661433,0.402180015362314
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,-0.00538185107793307,0.00643292057076987,-0.017990375396642,0.00722667324077587,0.402829109674765
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,-0.00556570906684213,0.00667996286558924,-0.018658436283397,0.00752701814971278,0.404753260711382
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFHR5,Complement factor H-related protein 5,40382,0.00354640612320964,0.00426502975114053,-0.00481305218902581,0.0119058644354451,0.405704487742458
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFL4,Insulin growth factor-like family member 4,40199,-0.00617158944731939,0.0074286294123239,-0.0207317030954742,0.00838852420083546,0.406113458796582
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PFDN4,Prefoldin subunit 4,40080,0.00441445335443429,0.00531509025997188,-0.00600312355511059,0.0148320302639792,0.406245558792943
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KCNIP4,Kv channel-interacting protein 4,42311,0.00408565457199692,0.00494116427662212,-0.00559902741018244,0.0137703365541763,0.40833105931365
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABO,Histo-blood group ABO system transferase,40532,0.0120345997659308,0.0146695834016662,-0.016717783701335,0.0407869832331965,0.412018044529226
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNC,Tenascin,42689,0.00396260877593733,0.00483743128424624,-0.0055187565411853,0.01344397409306,0.412712126567529
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDKL5,Cyclin-dependent kinase-like 5,40136,-0.00447417161365812,0.00546248095110041,-0.0151806342778149,0.00623229105049868,0.41276250450788
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,0.00354984340180152,0.0043690681603517,-0.00501353019248782,0.0121132169960909,0.416525708853866
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSAP,Gamma-secretase-activating protein,42346,0.00692606798059904,0.00858341712305631,-0.00989742958059133,0.0237495655417894,0.419731393279254
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEZ6,Seizure protein 6 homolog,40182,-0.00255297903647123,0.00316487061530151,-0.00875612544246218,0.00365016736951972,0.419879033753128
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA11,Serpin A11,42794,-0.0032983016535285,0.00409453915123926,-0.0113235983899575,0.00472699508290046,0.42052410661318
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,0.00486730713553258,0.00604318113555215,-0.00697732789014964,0.0167119421612148,0.420594106550653
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,0.00250248591796324,0.00311222339962139,-0.00359747194529468,0.00860244378122116,0.421366601968384
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTM4,Glutathione S-transferase Mu 4,40116,0.00600032133603477,0.00751469044546745,-0.00872847193708142,0.020729114609151,0.424610027146302
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,0.00632482039745579,0.00795101744971506,-0.00925917380398573,0.0219088145988973,0.42635554302877
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAP1,Antigen peptide transporter 1,40302,-0.0049313177038765,0.00623040391996331,-0.0171429093870046,0.00728027397925158,0.428673576587019
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CADPS,Calcium-dependent secretion activator 1,40182,0.0034188045758101,0.00432075077166014,-0.00504986693664377,0.011887476088264,0.428813776684045
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,-0.00449078739109949,0.00567860092476277,-0.0156208452036345,0.00663927042143554,0.429059549961278
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMY2B,Alpha-amylase 2B,41779,-0.00393573117140879,0.00501112620841112,-0.0137575385398946,0.00588607619707701,0.432234726150062
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,0.0051123647314417,0.00657581372912063,-0.00777623017763474,0.0180009596405181,0.436907492154205
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLL4,Delta-like protein 4,40223,-0.00668315762170509,0.00864830636762551,-0.0236338381022511,0.0102675228588409,0.439674666557121
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTPN,Myotrophin,42357,0.00257187139238799,0.00333676836778255,-0.00396819460846582,0.00911193739324179,0.44085880517138
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,0.00351978972302825,0.00457287986097184,-0.00544305480447655,0.0124826342505331,0.441488255383647
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,40080,0.00196105460298192,0.00255235218647598,-0.00304155568251101,0.00696366488847484,0.442306461913469
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTRC,Chymotrypsin-C,42626,-0.0050962390869632,0.00663810108940268,-0.0181069172221925,0.00791443904826606,0.442663813618724
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KHDC3L,KH domain-containing protein 3,40080,0.00534964512187598,0.0069862653255157,-0.00834343491613479,0.0190427251598868,0.443849130124866
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF9,Fibroblast growth factor 9,40065,0.00318728011195855,0.00417027932193888,-0.00498646735904165,0.0113610275829587,0.444714270705206
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TERF1,Telomeric repeat-binding factor 1,40199,0.00227643085950098,0.00298404928155557,-0.00357230573234793,0.0081251674513499,0.445559442471272
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CX3CL1,Fractalkine,42495,0.00261004573947489,0.00343932459085393,-0.00413103045859882,0.00935112193754859,0.447935861582475
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,-0.00444654123135638,0.00586855317514403,-0.0159489054546387,0.00705582299192591,0.448653191840028
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,-0.00195785408863166,0.00258588935243101,-0.00702619721939645,0.00311048904213313,0.44898823007737
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APPL2,DCC-interacting protein 13-beta,40283,-0.0084500218396586,0.0111622703895348,-0.0303280718031467,0.0134280281238296,0.449056116103547
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRC1,Protein regulator of cytokinesis 1,40451,-0.0033912680660574,0.00449510513770552,-0.0122016741359602,0.00541913800384543,0.450603386503498
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINF2,Alpha-2-antiplasmin,40317,-0.00102390699291959,0.00135931155835992,-0.00368815764730503,0.00164034366146584,0.451313183043
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.00178140449037279,0.00237127110722911,-0.00286628687979627,0.00642909586054184,0.452518670996531
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,0.00686130099098152,0.00913996093365592,-0.0110530224389841,0.0247756244209471,0.452853730840542
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGLON5,IgLON family member 5,40080,0.0071971233677572,0.00959247939755188,-0.0116041362514445,0.0259983829869589,0.453097409500353
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RUVBL1,RuvB-like 1,42346,-0.00794841983380976,0.0105978789573338,-0.028720262590184,0.0128234229225645,0.453267517313674
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,0.00307911658895422,0.00413470992534923,-0.00502491486473027,0.0111831480426387,0.456469302490454
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100G,Protein S100-G,40482,0.00360571813062861,0.00486718499169408,-0.00593396445309178,0.013145400714349,0.458816732641246
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLI2,Zinc finger protein GLI2,40199,-0.00239546558693802,0.00323868147543434,-0.00874328127878933,0.00395235010491329,0.459532887381654
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,42357,0.00443254806138026,0.00602161979408583,-0.00736982673502796,0.0162349228577885,0.46167955119919
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",40116,-0.00288787516345986,0.00395226692745066,-0.0106343183412632,0.00485856801434344,0.464985243092947
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRN1,Neuritin,40482,0.00262592878184512,0.00367066194839335,-0.00456856863700584,0.00982042620069608,0.474387273408756
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LMOD2,Leiomodin-2,40136,-0.00449063711780439,0.00630788821743773,-0.0168540980239823,0.00787282378837357,0.47653682422691
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,0.00328743401143415,0.00464912375562791,-0.00582484854959654,0.0123997165724648,0.479514171639378
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBR1,T-box brain protein 1,40182,0.00343167740994466,0.00489463195290218,-0.00616180121774361,0.0130251560376329,0.483248961968786
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAT1,Diamine acetyltransferase 1,40116,0.00360907970276901,0.0051839538511975,-0.00655146984557809,0.0137696292511161,0.486317069889006
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNM1,Dynamin-1,40449,-0.00794987122387767,0.0114660207096525,-0.0304232718147967,0.0145235293670413,0.488109395975215
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,-0.00549534758884155,0.00792640582418509,-0.0210311030042443,0.0100404078265612,0.488138297581343
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42587,0.00138665457971359,0.00200390433597858,-0.00254099791880442,0.0053143070782316,0.488964123224537
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNF830,Zinc finger protein 830,40451,-0.00541268161533089,0.00782831583168609,-0.0207561806454356,0.00993081741477385,0.489313692099132
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,-0.00295282883158685,0.00428471827957809,-0.0113508766595599,0.0054452189963862,0.490741170560994
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNL2,Interferon lambda-2,40136,-0.00425698474927619,0.0062603003491648,-0.0165271734336392,0.00801320393508681,0.496520817994609
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAND5,DAN domain family member 5,40199,-0.00379034177870682,0.00559365507149415,-0.0147539057188353,0.00717322216142171,0.498030395662803
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIAA1549,UPF0606 protein KIAA1549,40302,-0.0048398735572668,0.00715791179794729,-0.0188693806812435,0.00918963356670988,0.498954924377539
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTTG1,Securin,40302,-0.00279905972158385,0.00414208572821303,-0.0109175477488814,0.0053194283057137,0.499206509190422
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,40080,-0.00325336403457871,0.00482781322576892,-0.0127158779570858,0.00620914988792836,0.500402277331974
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,-0.00412488365582344,0.00618324438717789,-0.0162440426546921,0.00799427534304522,0.5047180844699
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MORF4L1,Mortality factor 4-like protein 1,40302,0.0026913417274602,0.00403819412759947,-0.00522351876263476,0.0106062022175552,0.505123548029987
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,-0.00201515106854413,0.00302689352668881,-0.00794786238085419,0.00391756024376593,0.505585154603032
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH23,Cadherin-23,40483,0.00173924283146089,0.00263325292240373,-0.00342193289645042,0.00690041855937221,0.508951543990783
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TLR4,Toll-like receptor 4,40199,0.00195077827971267,0.00295706121043219,-0.00384506169273442,0.00774661825215976,0.509459086711445
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK15,Kallikrein-15,40429,-0.00354818631200119,0.00539080521935787,-0.0141141645419426,0.00701779191794024,0.510428079059806
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,0.0019449426206369,0.00295784287969743,-0.00385242942357006,0.00774231466484385,0.510838252137467
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DIABLO,"Diablo homolog, mitochondrial",42603,-0.00714723582394615,0.010870409241374,-0.0284532379370391,0.0141587662891468,0.510874201308508
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXDC1,Plexin domain-containing protein 1,42346,-0.00207541176221257,0.00316175703140731,-0.00827245554377089,0.00412163201934576,0.511571266460956
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,-0.00577494600060922,0.0088397754681967,-0.0231009059182748,0.0115510139170563,0.513579834431972
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASQ2,Calsequestrin-2,40116,0.00318301553183515,0.00495414183766207,-0.0065271024699825,0.0128931335336528,0.520564774154499
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CENPJ,Centromere protein J,40302,-0.00458434387314317,0.00716355716612941,-0.0186249159187568,0.00945622817247047,0.522215993774712
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF3,Fibroblast growth factor 3,40199,-0.00187723157090019,0.00293629095825626,-0.00763236184908246,0.00387789870728209,0.522627636216141
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKCQ,Protein kinase C theta type,42370,0.00278531630950487,0.00437792475681976,-0.00579541621386186,0.0113660488328716,0.524645129282571
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A3,Protein S100-A3,40451,-0.00279474968345939,0.00439348094334372,-0.0114059723324131,0.00581647296549431,0.524715803293092
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,-0.00212889970171297,0.00336366316674952,-0.00872167950854202,0.00446388010511608,0.526804935504518
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,-0.00223968858253869,0.00356147323291083,-0.00922017611904392,0.00474079895396653,0.529449994115223
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,40080,-0.00401334488065786,0.00640994078429368,-0.0165768288178735,0.00855013905655775,0.53125419614241
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,0.00189665034451557,0.00305189104462175,-0.00408505610294306,0.00787835679197419,0.534305180841562
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC25A,M-phase inducer phosphatase 1,40080,0.00243969322826547,0.00394591817180166,-0.00529430638846579,0.0101736928449967,0.536401891078476
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,-0.00210856352000661,0.00342398439623563,-0.00881957293662844,0.00460244589661522,0.53802510803845
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECM1,Extracellular matrix protein 1,40269,0.00230289611485887,0.00376464757650256,-0.00507581313508616,0.00968160536480389,0.540738062308558
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL9,Interleukin-9,40302,-0.00346832921086046,0.00568793489072939,-0.0146166815966901,0.00768002317496915,0.542026981374291
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,0.00302114916413545,0.00495552771435012,-0.00669168515599079,0.0127339834842617,0.542104843378839
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APCS,Serum amyloid P-component,40419,-0.00208518060274409,0.00343626218816423,-0.00882025449154598,0.0046498932860578,0.543984967926897
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F10,Coagulation factor X,40532,-0.0017220814987591,0.00285803337596331,-0.0073238269156472,0.00387966391812899,0.546826314368543
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FRMD4B,FERM domain-containing protein 4B,40116,-0.00419349512210463,0.00705617199064896,-0.0180235922237766,0.00963660197956733,0.552322640725553
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BPIFB2,BPI fold-containing family B member 2,40473,0.00408822420340388,0.00693085470037378,-0.00949625100932874,0.0176726994161365,0.555297272188992
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TREML1,Trem-like transcript 1 protein,40532,0.0030870082723374,0.00528581332898404,-0.00727318585247131,0.0134472023971461,0.55922005671451
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,0.00361823966764226,0.00623033358124335,-0.00859321415159471,0.0158296934868792,0.561423791796425
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,0.00410555671584985,0.00711224307342494,-0.00983443970806303,0.0180455531397627,0.56378076335327
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF6,Fibroblast growth factor 6,40199,-0.00237912915065702,0.00418538719519112,-0.0105824880532316,0.00582422975191758,0.569749837104956
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANPEP,Aminopeptidase N,42666,-0.00157831470225984,0.00277888934542959,-0.00702493781930183,0.00386830841478215,0.570067511430262
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,40182,-0.00380557576933426,0.00680834883523404,-0.017149939486393,0.00953878794772446,0.576202304700306
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL13,Interleukin-13,42370,-0.00265068213237605,0.00474550282296799,-0.0119518676653933,0.00665050340064121,0.576466635430931
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AFAP1,Actin filament-associated protein 1,40283,0.00468298867623201,0.00838517372782484,-0.0117519518303047,0.0211179291827687,0.576524933814027
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,40199,0.00344832172967462,0.00620742464107877,-0.00871823056683978,0.015614874026189,0.578553279199118
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,-0.00327493985571795,0.00594263838063543,-0.0149225110817634,0.00837263137032749,0.581581990054172
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HCG22,Protein PBMUCL2,40116,0.00313821704580632,0.00575068125334773,-0.00813311821075522,0.0144095523023679,0.585274914070837
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F13B,Coagulation factor XIII B chain,40479,0.00142097157235444,0.00260484472673539,-0.00368452409204693,0.0065264672367558,0.585412867130437
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42644,-0.00267846411705692,0.00492849901342257,-0.0123383221833652,0.00698139394925132,0.586819052603507
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,-0.00263568929476123,0.00490560037984029,-0.0122506660392482,0.00697928744972574,0.591083991983341
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDIA2,Protein disulfide-isomerase A2,40080,0.00227652307595498,0.00426565524667517,-0.00608416120752835,0.0106372073594383,0.593569273152785
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,-0.00171670525080864,0.00324144237087006,-0.00806993229771397,0.00463652179609668,0.596391687968235
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHC1,SHC-transforming protein 1,40080,-0.00632536575372213,0.0119578164329184,-0.0297626859622422,0.0171119544547979,0.596834749198778
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ID4,DNA-binding protein inhibitor ID-4,40302,0.00231424595958987,0.00439162083918077,-0.00629333088520443,0.0109218228043842,0.59822596868206
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYBB2,Beta-crystallin B2,40483,-0.0043007168229049,0.00823375663746126,-0.020438879832329,0.0118374461865192,0.601452633279405
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL3,Interleukin-3,40080,-0.00323627700293329,0.00625474736096714,-0.0154955818304289,0.00902302782456231,0.604879581786147
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD99L2,CD99 antigen-like protein 2,42611,-0.0012499575438474,0.00241846063595228,-0.00599014039031387,0.00349022530261908,0.605276272992118
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,-0.00505456351971069,0.00986155022032201,-0.0243832019515418,0.0142740749121205,0.608272743096568
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NMRK2,Nicotinamide riboside kinase 2,40080,0.0022023774244696,0.00429734202673405,-0.00622041294792913,0.0106251677968683,0.608313205734682
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HBZ,Hemoglobin subunit zeta,40511,-0.0054746702763248,0.0107239216317932,-0.0264935566746394,0.0155442161219898,0.609704099593896
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ISM2,Isthmin-2,40527,-0.0022003735865167,0.00436488581333246,-0.0107555497806483,0.00635480260761493,0.614195328784244
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,-0.00128047606346967,0.00254588757594247,-0.00627041571231692,0.00370946358537757,0.615003150138469
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUSD5,Sushi domain-containing protein 5,40235,0.0017660709733583,0.00351286930565913,-0.00511915286573359,0.00865129481245019,0.615154896760473
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMA1,Proteasome subunit alpha type-1,42346,-0.00231342720962297,0.00463583488932097,-0.0113996635926921,0.00677280917344613,0.617765604781014
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAD1,Glutamate decarboxylase 1,40080,0.00131657543999552,0.00264913973197423,-0.00387573843467397,0.006508889314665,0.619211600662119
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYH4,Myosin-4,40116,0.00226989396022328,0.00457478396986938,-0.0066966826207207,0.0112364705411673,0.619780851552887
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPA,Apolipoprotein(a),40324,-0.00903969700686771,0.0183493425742985,-0.0450044084524928,0.0269250144387574,0.62227373646948
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL24,Interleukin-24,42370,-0.00248689641470218,0.00505128882692386,-0.0123874225154729,0.00741362968606859,0.622494924023196
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,-0.00415238352673163,0.00844057831891069,-0.0206959170317966,0.0123911499783333,0.622759487258222
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINC1,Antithrombin-III,40516,-0.000727897858106426,0.00148091454442817,-0.00363049036518563,0.00217469464897278,0.623068839286048
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMMR,Hyaluronan mediated motility receptor,40059,-0.00245572435451212,0.0050292738038058,-0.0123131010099715,0.00740165230094726,0.625357079025676
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,0.00223020894004054,0.00457757101729786,-0.00674183025386328,0.0112022481339444,0.626123885950303
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1R,Complement C1r subcomponent,40539,-0.000945873473509627,0.00195627917021705,-0.00478018064713504,0.00288843370011579,0.628745557227368
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYTH3,Cytohesin-3,40080,-0.00363337775999837,0.00756044550014055,-0.0184518509402739,0.0111850954202771,0.630826677648306
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,-0.00176550406339192,0.00368743695288865,-0.00899288049105367,0.00546187236426984,0.632098219419716
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,-0.00272026492302703,0.00568229484547956,-0.013857562820167,0.00841703297411291,0.632142801692488
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,40116,0.00179109773962731,0.00381384782476539,-0.00568404399691286,0.00926623947616748,0.638628690468978
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPAN7,Tetraspanin-7,40136,0.00443732120734835,0.00953132771301532,-0.0142440811101617,0.0231187235248584,0.641546034603577
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,-0.00819446491215422,0.017677600532399,-0.0428425619556563,0.0264536321313478,0.642978613624115
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PXDNL,Peroxidasin-like protein,40451,0.00259689347031398,0.0056271603362354,-0.0084323407887074,0.0136261277293354,0.644454067831274
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,0.00314131365514924,0.00681913481298589,-0.0102241905783031,0.0165068178886016,0.645050570190048
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,0.00166585805452053,0.00361940168190198,-0.00542816924200735,0.00875988535104841,0.645338757186426
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLB,Beta-klotho,42311,-0.0034231350415778,0.00746520611659081,-0.0180549390300958,0.0112086689469402,0.646568335176161
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,0.00543645259226859,0.0119507197259594,-0.0179869580706119,0.028859863255149,0.649184381807423
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL11,Interleukin-11,42370,-0.0028361072164983,0.00626299061281321,-0.0151115688176122,0.00943935438461559,0.650674340873508
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,0.00317604760425166,0.0070632786073124,-0.0106679784660806,0.017020073674584,0.652967072032836
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,0.00368712136111453,0.00820382570320316,-0.0123923770171637,0.0197666197393927,0.653123583643381
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BSND,Barttin,40080,0.00154872121838877,0.00345566557837541,-0.00522438331522704,0.00832182575200458,0.654040354961897
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,-0.00380184387874067,0.00863784813818085,-0.0207320262295751,0.0131283384720938,0.659844601479301
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NGF,Beta-nerve growth factor,42495,0.000523877562355666,0.001199386599077,-0.00182692017183525,0.00287467529654658,0.662272260214311
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSP90B1,Endoplasmin,42247,-0.00282815344688642,0.00668200217384573,-0.015924877707624,0.0102685708138512,0.672120277059094
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,-0.00199404590518933,0.00476074397377559,-0.0113251040937895,0.00733701228341083,0.675331142778145
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IMPA1,Inositol monophosphatase 1,42495,-0.00251366703094912,0.00602798767964118,-0.0143285228830458,0.00930118882114759,0.67668560230074
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,0.00279110188375051,0.00674516557796158,-0.0104294226490542,0.0160116264165552,0.679033880929511
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNAP25,Synaptosomal-associated protein 25,40136,-0.00196301588653255,0.00478073195861817,-0.0113332505254242,0.00740721875235907,0.681366641031564
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FZD10,Frizzled-10,40182,-0.0024879600383952,0.00612124752862122,-0.0144856051944928,0.00950968511770239,0.684422426237047
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL25,Interleukin-25,40036,-0.00143222664148041,0.00353964758170947,-0.00836993590163096,0.00550548261867015,0.685761838571658
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,-0.00235845349025431,0.00583742129815301,-0.0137997992346342,0.00908289225412559,0.686203613497374
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41948,-0.00118790611031653,0.0029404638166894,-0.00695121519102774,0.00457540297039469,0.6862298139721
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,0.00171077827836317,0.00423906307375622,-0.00659778534619903,0.0100193419029254,0.686533436728912
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,-0.00358020013104536,0.00887627355852147,-0.0209776963057474,0.0138172960436567,0.686702372639123
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STEAP4,Metalloreductase STEAP4,40136,0.00296990676368634,0.00736411658860491,-0.0114637617499793,0.017403575277352,0.686739562681539
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGAX,Integrin alpha-X,40302,-0.00216811346233684,0.00550394627939267,-0.0129558481699465,0.00861962124527279,0.693647806900087
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP73,Tumor protein p73,40182,0.00136900520120078,0.00348761986951826,-0.005466729743055,0.00820474014545656,0.694672193234089
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,0.00144581380123691,0.00370510275504481,-0.00581618759865091,0.00870781520112474,0.696378464706996
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FN1,Fibronectin,40539,-0.00104300398937079,0.00267908082568081,-0.00629400240770517,0.00420799442896359,0.697051100801322
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PALLD,Palladin,40199,0.00152495166168568,0.00393314910706402,-0.00618402058815981,0.00923392391153116,0.698232428706975
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,-0.00101734049975274,0.00263457393793146,-0.00618110541809839,0.00414642441859292,0.699392922168324
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL2,Interleukin-2,42370,-0.00123787926346649,0.00320650424312315,-0.00752262757998788,0.00504686905305489,0.699463955040881
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL4A4,Collagen alpha-4(IV) chain,40284,0.00208799417504019,0.0054132482198582,-0.00852197233588188,0.0126979606859623,0.699711985108455
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,-0.00166561623632775,0.0043189185584926,-0.0101306966109732,0.00679946413831774,0.699759025479897
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIRREL1,Kin of IRRE-like protein 1,40136,-0.00223611097232062,0.00581900772699519,-0.0136413661172312,0.00916914417258995,0.700780602744621
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGBL2,Cytosolic carboxypeptidase 2,40136,-0.00352686821929775,0.00918635379769325,-0.0215321216627765,0.014478385224181,0.701041711061536
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,0.00246522342101176,0.00644995798519004,-0.0101766942299607,0.0151071410719842,0.702314755073586
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF12,Fibroblast growth factor 12,40199,0.00178298826531434,0.00472541167595169,-0.00747881861955098,0.0110447951501797,0.705943726493685
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTSL5,ADAMTS-like protein 5,40511,-0.00150036345442903,0.00397999097575578,-0.00930114576691037,0.0063004188580523,0.706198065072525
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP1B4,Protein ATP1B4,40080,0.00160771459132634,0.00427959005449162,-0.00678028191547723,0.00999571109812992,0.707169390336039
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OBP2B,Odorant-binding protein 2b,42462,0.00230420407206637,0.00613619069639708,-0.00972272969287191,0.0143311378370046,0.70728683755197
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PFDN6,Prefoldin subunit 6,40182,-0.00243035118774124,0.00653533009115352,-0.0152395981664022,0.0103788957909197,0.709990206933939
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,-0.0028529413528015,0.00773600385308839,-0.0180155089048548,0.0123096261992517,0.712293074196045
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHPK,Sedoheptulokinase,40302,-0.00151304272074456,0.00415336399355025,-0.00965363614810305,0.00662755070661394,0.715645928429527
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,-0.00135582959294059,0.00374522101333697,-0.00869646277908105,0.00598480359319986,0.717346917883785
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CREBZF,CREB/ATF bZIP transcription factor,40080,0.000953014745900361,0.00264645514194074,-0.00423403733230348,0.0061400668241042,0.71877192181984
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFR4,Fibroblast growth factor receptor 4,40283,-0.00192165314070426,0.00536679759243161,-0.0124405764218702,0.0085972701404617,0.720302774532979
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM171A2,Protein FAM171A2,40482,0.00576380823313902,0.0161372635835616,-0.0258652283906418,0.0373928448569198,0.720968353418554
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPCAM,Epithelial cell adhesion molecule,42616,-0.0035347074330823,0.0098974884860068,-0.0229337848656556,0.015864369999491,0.720998787518874
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,-0.00150082190795983,0.00420775754586353,-0.00974802669785235,0.00674638288193269,0.721338405437371
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRX,Cone-rod homeobox protein,42357,0.00380268356784267,0.0106886019347397,-0.0171469762242472,0.0247523433599325,0.72201854275833
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLGAP5,Disks large-associated protein 5,40482,0.00181698913920587,0.00512693584620817,-0.00823180511936213,0.0118657833977739,0.723045305165263
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP3,Stromelysin-1,42611,-0.00175528249763683,0.00504109116881957,-0.0116358211885232,0.00812525619324952,0.727699241365778
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP13,Collagenase 3,42311,-0.00114619446505557,0.00334092840104167,-0.00769441413109725,0.00540202520098611,0.731546308015836
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,40281,-0.00188136440480784,0.00550828426855477,-0.0126776015711752,0.00891487276155952,0.732694689170184
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYH7B,Myosin-7B,40080,0.00154837006766751,0.00454028186665506,-0.00735058239097641,0.0104473225263114,0.733087953097561
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GUCY2C,Heat-stable enterotoxin receptor,40302,0.00277136075688595,0.0081481447367136,-0.0131990029270727,0.0187417244408446,0.733771319557381
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,-0.00212694829415326,0.0063304126095881,-0.0145345570089459,0.0102806604206394,0.736885688169296
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL20RB,Interleukin-20 receptor subunit beta,40199,0.0013771412806597,0.00414616507610619,-0.00674934226850843,0.00950362482982783,0.739783678958388
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOB,Apolipoprotein B-100,40532,0.000746107839901068,0.00225262226204458,-0.00366903179370631,0.00516124747350845,0.740486348557302
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANK2,Ankyrin-2,40116,0.00244485290893567,0.00742803406608176,-0.0121140938605846,0.0170037996784559,0.742057222673454
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,-0.00165126283709072,0.00511703911626621,-0.0116806595049725,0.00837813383079104,0.746929491177476
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAPN3,Calpain-3,40451,0.00124288715763119,0.00385985910616122,-0.0063224366904448,0.00880821100570719,0.747456215343127
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QL2,Complement C1q-like protein 2,40199,-0.00142261973690665,0.00444712818309354,-0.01013899097577,0.0072937515019567,0.749053035056198
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB116,Beta-defensin 116,40136,-0.00237972972437967,0.00778678683955759,-0.0176418319299125,0.0128823724811532,0.759906461052007
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCS,Copper chaperone for superoxide dismutase,42495,0.00143687149951325,0.00473908289681993,-0.00785173097825382,0.0107254739772803,0.761745155156233
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,-0.00131119378328982,0.00437026763709021,-0.00987691835198664,0.00725453078540699,0.764163013752381
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOP1,DNA topoisomerase 1,40449,-0.00338503566899149,0.0113233165961974,-0.0255787361975384,0.0188086648595554,0.764988420677517
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPAN15,Tetraspanin-15,40116,0.0015713065501158,0.00525748521828457,-0.00873336447772195,0.0118759775779536,0.765044642152919
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EXOSC10,Exosome component 10,40116,-0.00181216318204958,0.00609327359246256,-0.0137549794232762,0.010130653059177,0.766163841252944
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NME1,Nucleoside diphosphate kinase A,40199,0.000659380912180794,0.00222127485492652,-0.00369431780347518,0.00501307962783676,0.766588189290201
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD200,OX-2 membrane glycoprotein,42594,0.000811707067237111,0.00274453803564655,-0.00456758748263013,0.00619100161710436,0.767422825579736
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAP18,Histone deacetylase complex subunit SAP18,40302,0.00220520661787704,0.00748871771177432,-0.0124726800972006,0.0168830933329547,0.768403887552807
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAS6,Growth arrest-specific protein 6,42718,0.000745772592774161,0.002536197231981,-0.0042251739819086,0.00571671916745692,0.768723065623528
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP1,Rho GTPase-activating protein 1,42346,-0.00130468838959536,0.00452092970018591,-0.0101657106019597,0.00755633382276903,0.772900833262916
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,40136,-0.00205163870225276,0.00720019466564569,-0.0161640202469183,0.0120607428424128,0.775693881796159
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NLGN2,Neuroligin-2,40136,-0.00133268765486478,0.00486027228634372,-0.0108588213360985,0.0081934460263689,0.78393594707259
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,-0.00173580724588037,0.0063638774095707,-0.0142090069686389,0.0107373924768782,0.785043257530426
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYO6,Unconventional myosin-VI,40482,-0.000997232009294264,0.0036676044377861,-0.00818573670735502,0.00619127268876649,0.785701711382525
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,-0.00138194618920432,0.00508651817278308,-0.0113515218078592,0.00858762942945052,0.78586701835022
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAG,Myelin-associated glycoprotein,40182,0.00134286787314161,0.00494905221061595,-0.00835727445966564,0.0110430102059489,0.786135877601168
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EXTL1,Exostosin-like 1,40116,-0.00129015621276317,0.00477501827102197,-0.0106491920239662,0.0080688795984399,0.787020152885549
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DBH,Dopamine beta-hydroxylase,40515,0.00297549740308018,0.0110674274162315,-0.0187166603327336,0.024667655138894,0.788048655144748
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,-0.00138612240825822,0.00522574983340621,-0.0116285920817344,0.00885634726521795,0.790822995405549
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL4,Interleukin-4,42370,0.00247075050882949,0.00936135823076891,-0.0158775116234776,0.0208190126411366,0.79183739078625
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MN1,Transcriptional activator MN1,40182,-0.00157191118471323,0.00598133051093034,-0.0132953189861367,0.0101514966167102,0.792707404060732
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,-0.000996423518584441,0.00380899314141546,-0.00846205007575875,0.00646920303858986,0.793636435335027
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OTOA,Otoancorin,40136,-0.00142839958526817,0.0055256915976286,-0.0122587551166202,0.00940195594608387,0.796024750898525
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,0.000915387720577283,0.00365766555543669,-0.00625363676807863,0.00808441220923319,0.802386694982275
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPT1,Translationally-controlled tumor protein,42370,0.001634245429672,0.00653211946010813,-0.0111687087121399,0.0144371995714839,0.802447342133527
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BEX3,Protein BEX3,40080,-0.00119627103050187,0.004839179371945,-0.0106810625995141,0.00828852053851032,0.804753966867982
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,40116,-0.00141949712747603,0.00578135580049812,-0.0127509544964523,0.00991196024150028,0.80605058337805
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REST,RE1-silencing transcription factor,40080,0.00084060194127367,0.00347227051486994,-0.00596504826787142,0.00764625215041876,0.808714993078792
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COMMD9,COMM domain-containing protein 9,40451,-0.000964314831412359,0.00400671348558999,-0.00881747326316874,0.00688884360034402,0.809811580688633
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPTN,Neuroplastin,42346,0.00188043081922932,0.00788694789001016,-0.0135779870451906,0.0173388486836492,0.811556642277656
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMC3,Structural maintenance of chromosomes protein 3,40080,-0.0013385624259125,0.00562356223149261,-0.012360744399638,0.00968361954781301,0.811864249600441
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLINT1,Clathrin interactor 1,40080,-0.00110136191331814,0.00467567756509179,-0.010265689940898,0.00806296611426177,0.81378530056998
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF7,Fibroblast growth factor 7,40080,-0.0018777899877512,0.00802539578853265,-0.0176075657332752,0.0138519857577728,0.815004142986299
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK14,Kallikrein-14,42721,-0.00108596175744133,0.00471637395476413,-0.010330054708779,0.00815813119389637,0.817898249039669
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANKRA2,Ankyrin repeat family A protein 2,40080,-0.00132804841982701,0.00581082529850608,-0.0127172660048989,0.0100611691652449,0.819225083519707
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,0.000889312219637257,0.00392009588873775,-0.00679407572228873,0.00857270016156324,0.820536997743375
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,40182,0.000685270830513225,0.00303414735157329,-0.00526165797857043,0.00663219963959688,0.821320070143966
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DENND2B,DENN domain-containing protein 2B,40116,0.00113285427106179,0.00503932309095789,-0.00874421898721567,0.0110099275293392,0.8221368422249
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,40136,0.000917732232605892,0.00410834442229759,-0.00713462283509738,0.00897008730030916,0.823241996149457
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MORN4,MORN repeat-containing protein 4,40080,-0.00173443015863192,0.007782766032664,-0.0169886515826534,0.0135197912653895,0.823652358097692
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOA4,Apolipoprotein A-IV,40539,-0.000797975302709684,0.00363487586109522,-0.00792233199045631,0.00632638138503694,0.826238804538935
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH22,Cadherin-22,40302,0.000618410624792781,0.00284203307787304,-0.00495197420783837,0.00618879545742394,0.827749105706185
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RTKN2,Rhotekin-2,40116,0.00109832872932125,0.0052060930125924,-0.00910561357535986,0.0113022710340024,0.832914723829866
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESPL1,Separin,40080,-0.00121417728134924,0.00582239176512316,-0.0126260651409906,0.0101977105782922,0.834814513137413
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,-0.00120222826220277,0.00598793360340097,-0.0129385781248687,0.0105341216004631,0.840878126988447
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,-0.00133533795730452,0.00669811699101499,-0.0144636472596939,0.0117929713450849,0.841984079782916
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,-0.000899662752495425,0.0045685829068351,-0.00985408524989222,0.00805475974490137,0.843890211777236
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,-0.000730564844235685,0.00377413615510707,-0.00812787170824554,0.00666674201977417,0.846514532095042
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HK2,Hexokinase-2,42357,0.000532842946896187,0.00277503330063535,-0.0049062223223491,0.00597190821614147,0.847734849417257
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,-0.000516374700763649,0.00274221297492951,-0.00589111213162548,0.00485836273009818,0.850640297405046
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNLZ,DNL-type zinc finger protein,40136,0.00171904700845392,0.00920596322980787,-0.0163246409219695,0.0197627349388773,0.851874305004238
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGA6,Integrin alpha-6,42594,0.000938392350520964,0.00507632577101878,-0.00901120616067584,0.0108879908617178,0.853344305641639
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMBN,Ameloblastin,42370,0.000525212360736966,0.00286324657451354,-0.00508675092530956,0.0061371756467835,0.854461531590937
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TEF,Thyrotroph embryonic factor,40116,-0.000799647223026962,0.00438241445243153,-0.00938917954979276,0.00778988510373884,0.855219420494429
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOX2,Transcription factor SOX-2,40461,0.000434334782994132,0.00241463969645845,-0.00429835902206444,0.0051670285880527,0.857253459771416
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40483,0.000720014936371516,0.00402582684033224,-0.00717060567067968,0.00861063554342271,0.858059511368009
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL12,Stromal cell-derived factor 1,42370,0.000709018035624433,0.00401659707450031,-0.00716351223039617,0.00858154830164504,0.859886523459838
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ODAM,Odontogenic ameloblast-associated protein,42292,-0.00099436259926722,0.00563592627540937,-0.0120407780990696,0.0100520529005351,0.859956617679777
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,-0.000821584200226175,0.00470857047408819,-0.010050382329439,0.00840721392898668,0.861485382462536
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENOPH1,Enolase-phosphatase E1,40451,0.000959443981376426,0.0055511511396649,-0.00992081225236677,0.0118397002151196,0.862782706676285
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A16,Protein S100-A16,42292,-0.00102990961252487,0.00608394169994922,-0.0129544353444253,0.0108946161193756,0.86557644016386
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,-0.000876948767903293,0.00521273800485387,-0.0110939152574169,0.0093400177216103,0.866404047918609
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA11,Carbonic anhydrase-related protein 11,42346,-0.000543870253368833,0.00325670490734819,-0.00692701187177128,0.00583927136503362,0.867372487332028
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TUBB3,Tubulin beta-3 chain,40136,-0.000474089594573052,0.00284451380904335,-0.00604933666029801,0.00510115747115191,0.867634319022389
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUP50,Nuclear pore complex protein Nup50,40116,0.000569840603683436,0.00350218724606591,-0.00629444639860575,0.00743412760597262,0.870749846850808
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRD1,Bromodomain-containing protein 1,40302,0.000497181039828563,0.00309287614629553,-0.00556485620691067,0.0065592182865678,0.872292924965769
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCUN1D2,DCN1-like protein 2,40080,-0.00128040306881161,0.00811191342866509,-0.0171797533889952,0.014618947251372,0.874583993831175
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL7,Interleukin-7,42594,-0.000994653847307891,0.00632622554336294,-0.0133940559122992,0.0114047482176835,0.875068271036562
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,0.000597440811544817,0.0038069174026573,-0.00686411729766349,0.00805899892075313,0.875298514923447
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PVALB,Parvalbumin alpha,42654,-0.00169782596025916,0.0109708063950592,-0.0232006064945753,0.019804954574057,0.877013999467947
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,-0.000671090413988658,0.00451021672268713,-0.00951111519045543,0.00816893436247811,0.881719412391976
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42636,0.00117612920878889,0.0079239860490263,-0.0143548834473027,0.0167071418648804,0.882008444643671
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL21R,Interleukin-21 receptor,40199,-0.000805631490377886,0.00564707900020297,-0.0118739063307757,0.0102626433500199,0.886558635257715
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,0.000906936195041474,0.00642293384709927,-0.0116820141452731,0.013495886535356,0.887712308484045
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,H2AP,Huntingtin-interacting protein M,40080,0.000745251494144717,0.00533137911368194,-0.00970425156867189,0.0111947545569613,0.888831759879041
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMIGO1,Amphoterin-induced protein 1,40182,-0.000706049900674983,0.005100894856685,-0.0107038038197776,0.00929170401842762,0.889913501407957
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,-0.000694049895198846,0.00521644808330638,-0.0109182881384793,0.00953018834808166,0.89415606030383
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHH,Sonic hedgehog protein,40199,-0.00054874012849157,0.00426304937363373,-0.00890431690081367,0.00780683664383053,0.897581484849213
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40451,0.00065746739618706,0.00531968721655982,-0.00976911954827019,0.0110840543406443,0.90164103754731
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VCAN,Versican core protein,42711,-0.000367852439518082,0.00305580191334556,-0.00635722418967538,0.00562151931063922,0.904185217767446
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,40199,-0.000592317541343493,0.00494038865457231,-0.0102754793043052,0.00909084422161824,0.904570174476387
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,-0.00084402778919681,0.00723044772218236,-0.0150157053246742,0.0133276497462806,0.907074230589589
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTNL10,Butyrophilin-like protein 10,40080,-0.000494921044265186,0.00431687364021656,-0.00895599337908964,0.00796615129055927,0.908726225291379
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHA10,Ephrin type-A receptor 10,42311,0.000735343742048864,0.00670997747027563,-0.0124162120996914,0.0138868995837891,0.912736535994606
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40483,-0.000777577892208377,0.00712723738251798,-0.0147469631619436,0.0131918073775269,0.91312552641891
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL20,Interleukin-20,42370,-0.000533343701242815,0.0049143561290249,-0.0101654817141316,0.00909879431164599,0.913578772149065
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LHB,Lutropin subunit beta,42346,0.000913748734550696,0.00844692691380478,-0.0156422280165067,0.0174697254856081,0.913858298979348
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OPTC,Opticin,42587,0.000499985350545719,0.00464082236460522,-0.00859602648408051,0.00959599718517195,0.914206432956512
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD82,CD82 antigen,40302,-0.000441181809799292,0.00414245563483136,-0.00856039485406876,0.00767803123447018,0.915185608906683
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPEP,Glutamyl aminopeptidase,40116,-0.000506797758752333,0.0048123933228094,-0.00993908867145875,0.00892549315395409,0.916131000713248
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,0.000738098974397119,0.00703911681812108,-0.0130585699891202,0.0145347679379144,0.916491017527583
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,-0.000548305541736449,0.00524336109461682,-0.0108252932871854,0.00972868220371251,0.91671784027826
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFAP2A,Transcription factor AP-2-alpha,40136,-0.000630520592664876,0.00616859352514341,-0.012720963901946,0.0114599227166162,0.918588177205401
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,-0.000866185446402525,0.00856114114633296,-0.0176460220932151,0.0159136512004101,0.919412293461382
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,0.000296003088177479,0.00297390286730092,-0.00553284653173232,0.00612485270808728,0.92071617108696
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RLN1,Prorelaxin H1,40482,-0.00048467766851341,0.0048856714754891,-0.0100605937604721,0.00909123842344523,0.920978139312552
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,0.000506442630600707,0.00521326572633776,-0.00971155819302131,0.0107244434542227,0.922613043785945
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPSG1,Tryptase gamma,40199,-0.000249161533222991,0.00268319264305755,-0.00550821911361578,0.0050098960471698,0.926016395810707
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB118,Beta-defensin 118,40136,-0.000530845303136928,0.00576573153877534,-0.0118316791191366,0.0107699885128627,0.926644880795965
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,-0.000365475067132838,0.00409924765562552,-0.00840000047215885,0.00766905033789318,0.928958801094581
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLK,STE20-like serine/threonine-protein kinase,40302,-0.000651517477456548,0.00807990726299499,-0.0164881357129267,0.0151851007580136,0.935734258785939
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD164L2,CD164 sialomucin-like 2 protein,40182,0.000287223542097624,0.00367688947043873,-0.00691947981996228,0.00749392690415753,0.93773727926493
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGS8,Regulator of G-protein signaling 8,42370,-0.000498914902867895,0.00644437935294271,-0.0131298984346356,0.0121320686288998,0.938291710733688
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPGN,Epigen,40451,0.000346892387579886,0.00459433428001494,-0.0086580028012494,0.00935178757640917,0.939814749904815
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLU,Clusterin,40539,0.000236369444015892,0.00317704161335612,-0.0059906321181621,0.00646337100619388,0.940694034604466
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42794,0.000216747947247666,0.0031748827650031,-0.00600602227215841,0.00643951816665374,0.945572034275774
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40532,0.000179739990935162,0.00287860838602826,-0.00546233244568022,0.00582181242755055,0.950213629939099
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPHS2,Podocin,40199,-0.000599060712835993,0.0106006205553048,-0.0213762770012335,0.0201781555755615,0.954935079039605
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPT,Microtubule-associated protein tau,42311,-0.000299248105041229,0.00533324243388216,-0.0107524032754503,0.0101539070653678,0.955255051350749
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,0.000310686482150945,0.00586132944450034,-0.0111775192290697,0.0117988921933716,0.957727983706486
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBP6,Guanylate-binding protein 6,40116,0.000245237539016233,0.00465455853003057,-0.00887769717984369,0.00936817225787616,0.957981779041574
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL31,Interleukin-31,40199,0.000294922533677332,0.0056872965242066,-0.0108521786537676,0.0114420237211223,0.958644083027737
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF20,Fibroblast growth factor 20,40199,-0.000232428327183866,0.00455433920989585,-0.00915893317857973,0.008694076524212,0.959298972560073
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,-0.000579508460784245,0.011388606245219,-0.0229011767014134,0.0217421597798449,0.959417983361139
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,-0.000477090749260705,0.00974518899763121,-0.0195776611846179,0.0186234796860965,0.960954827393529
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,0.000110181458962856,0.00235220676378938,-0.00450014379806433,0.00472050671599004,0.962640055013667
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAGE2A,G antigen 2A,40080,0.000305952670960167,0.00674771281881534,-0.0129195644539179,0.0135314697958382,0.963835793210218
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIPR,Gastric inhibitory polypeptide receptor,40199,-0.000223999883754804,0.00494168697977199,-0.0099097063641079,0.00946170659659829,0.963846192613851
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,40182,0.000145466331424246,0.00371858458248804,-0.00714295945025231,0.0074338921131008,0.968796433301456
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAPS,Calcyphosin,40483,-0.000389783315083391,0.0104392052971324,-0.0208506256974629,0.0200710590672962,0.970215841230816
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,0.000185339960468385,0.00567798379090581,-0.010943508269707,0.0113141881906438,0.973960682283291
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,7.33496240467716e-05,0.00268021780553664,-0.00517987727480505,0.00532657652289859,0.978167490426543
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,40136,8.54399838643618e-05,0.00328286224409685,-0.00634897001456546,0.00651984998229418,0.97923702378837
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,-0.000108395692794987,0.00526712627822761,-0.0104319631981211,0.0102151718125311,0.983581339931524
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,METAP1,Methionine aminopeptidase 1,42311,4.89850428967903e-05,0.00292500762739623,-0.00568402990679982,0.0057819999925934,0.986638722857371
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MZT1,Mitotic-spindle organizing protein 1,42346,8.32031813210453e-05,0.00516180606888796,-0.0100339367136994,0.0102003430763415,0.98713969564793
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,-5.48817033978694e-05,0.00365965340651621,-0.00722780238016964,0.0071180389733739,0.988035307912725
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,9.62786604861119e-05,0.00713284847431469,-0.0138841043491707,0.0140766616701429,0.989230739514088
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UPK3A,Uroplakin-3a,40136,-6.8551115142249e-05,0.00516890438869788,-0.0101996037169901,0.0100625014867056,0.989418836337779
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENG,Endoglin,42794,-2.29823382494703e-05,0.00174191700327974,-0.00343713966467776,0.00339117498817882,0.989473445792378
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GUK1,Guanylate kinase,40116,-4.41378079394142e-05,0.00387610887209755,-0.00764131119725061,0.00755303558137179,0.990914778335996
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,3.58288670645192e-05,0.00319831472628631,-0.00623286799645664,0.00630452573058568,0.991062151807542
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCLRE1C,Protein artemis,40080,-3.31165525166652e-05,0.0031631764617828,-0.00623294241761096,0.00616670931257763,0.991646973621251
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,0.000121992642126664,0.0127227118216447,-0.024814522528297,0.0250585078125503,0.992349688866344
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FST,Follistatin,42654,2.03992332067219e-05,0.0049166549344845,-0.0096162444383829,0.00965704290479634,0.996689642767205
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD99,CD99 antigen,42611,1.19229797481673e-06,0.00201860591113231,-0.00395527528784451,0.00395765988379414,0.999528734975145
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MLLT1,Protein ENL,40080,-8.03127938202222e-07,0.0067196156643438,-0.0131712498300521,0.0131696435741757,0.999904639089992
